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Indonesia is facing a dual burden of communicable and non-communicable 
diseases. Childhood-immunisation coverage is lower than most countries in 
Southeast Asia, with vaccine-preventable disease outbreaks frequently reported. 
Prevalences of non-communicable diseases are also rising, including type 2 
diabetes. Diabetes is further linked to tuberculosis and stunting - health problems 
which remain common in Indonesia. Understanding people’s health behaviour is 
an important step to establishing effective interventions. In Indonesia, a 
multicultural country with multiple health providers, health-related behaviour is 
more complex as. I aimed to improve outcomes related to child immunisation or 
diabetes through implementing an intervention based on understanding people’s 
health behaviour. Two stages of studies were conducted.  
A qualitative study explored the perceptions, beliefs and behaviour of diverse 
communities in relation to child immunisation and diabetes. Six focus groups 
involving 53 mothers and six focus groups involving 45 people with diabetes were 
performed in West Sumatera and East Nusa Tenggara. Recorded discussions were 
transcribed, translated, and analysed for common themes. 
For child immunisation, themes underlined the role of fathers and community-
based health workers in influencing mothers’ behaviour. Issues related to 
Posyandu (an outreach programme for mother and child health) including lack of 
financial support, and potential missed opportunities were highlighted.  
Diabetes patients’ behaviour in managing the disease was prompted by the 
individual lay evaluation of the disease and its treatment, a process influenced by 
family and peers with diabetes. This process changed the appeal and acceptability 
of specific health services. Further, cultural beliefs, family and community support 
challenged people with diabetes in practising self-management behaviours. 
This qualitative work on diabetes revealed a complex situation contributing to late 
diagnosis, uncontrolled blood glucose, and prevalent diabetes-related 
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complications. Therefore, while acknowledging the importance of child 
immunisation, I subsequently focused on diabetes.  
Informed by the literature review and qualitative work, a quasi-experimental pilot 
study was developed and conducted in Kupang, East Nusa Tenggara. Usual care 
was compared to an intervention consisting of ten sessions of weekly group 
activities including education, exercise, and healthy snacking, conducted in 
collaboration with primary health centres (PHCs). Sixty-seven participants were 
recruited from four PHCs, and were allocated into groups (intervention: 36; 
control: 31) based on the PHCs they were registered in. 
Participants were 60% female, mean age 57, and had diabetes for an average of 
4.5 years. Groups did not differ at baseline. Counter to prediction, no effects of the 
group-based intervention over usual care were observed. However, both groups 
made statistically significant improvement in HbA1c (intervention improved from 
8.26%±1.89 to 7.84%±1.82; control from 8.35%±2.60 to 7.95%±2.53). 
Exploratory analyses found more intervention than control participants achieved 
an HbA1c reduction of 0.5% (43% compared to 31%). The intervention appears to 
have provided a positive impact through stimulating local healthcare providers to 
more intensively manage their diabetes patients, including the control group.  
These findings are important for government and related stakeholders in 
managing health problems related to child immunisation and diabetes. Tailored 
interventions – based in socio-cultural context – to influence behaviour should be 








In the name of Alloh, the Most Gracious and the Most Merciful, all praise to Alloh 
for the strength and His blessing in completing this thesis.  
 
Immeasurable thanks and appreciation are due to all those who assisted and 
supported me through this endeavour.  
First and foremost, Professor Pauline Norris, my primary supervisor, for accepting 
me to be her student, for continuous support, invaluable motivation, enthusiasm, 
and immense knowledge.  
Dr. Susan Heydon, my co-supervisor, for fruitful suggestions which have widened 
my perspectives, and for continuous encouragement, motivation, and personal 
support. 
Dr. James Green, for worthwhile recommendations and for assisting me in 
statistical matters. I am very grateful to have him as my co-supervisor, and I am 
always impressed by his ideas.  
Dr. Shakila Rizwan, my facilitator, for her encouragement and personal support 
during my programme.  
I would like to express my gratitude to my thesis examination committee. 
Associate Professor Bruce Russell, my convener, for organising the thesis 
examination process.  
Associate Professor Kay Stewart, Professor Sri Suryawati, and Dr. Alesha Smith, 
my examiners, for giving me detailed insightful comments which have helped me 
greatly in making this thesis better. 
vi 
 
This thesis would not have been possible without the scholarship provided by the New 
Zealand Government through the New Zealand ASEAN Scholars Awards.  
I am thankful to the scholarship team and student advisers, Claire Slocombe, 
Gepke Schouten, Rebecca Guest, and Donna Scott for personal support and advice 
during my stay in Dunedin.  
I share the credit of my work with all participants involved in the study.  
I am grateful for those who have technically supported and enhanced my work 
during the data collection processes.  
Bapak Marselinus Laga Nur, SKM., M.Kes., a lecturer at the Faculty of Public Health 
Universitas Nusa Cendana Kupang, and Ibu Maria Hilaria, S.Farm., Apt., M.Si., a 
lecturer at Politeknik Kemenkes Kupang, for connecting me with research 
assistants and local communities in East Nusa Tenggara.  
Bapak Syofyan, S.Si., M.Farm., Apt., a lecturer at the Faculty of Pharmacy 
Universitas Andalas Padang for assisting me in collecting data in West Sumatera.  
Health professionals in Puskesmas Oepoi, Puskesmas Kota Ruteng, Puskesmas 
Naras, and Puskesmas Ulak Karang, for immeasurable help during qualitative data 
collection process.  
Prolanis teams in Puskesmas Oepoi led by Mas Muhamad Zainudin, S.Kep., Ns., 
Puskesmas Oebobo led by Mba Sri Herlin Ernawati, S.Kep., Ns., Puskesmas 
Sikumana led by Ibu Maria Angela Gonsalves, Amd. Kep., and LKC health centre led 
by Mba Ria Ruslan, Amd. Kep., for fully supporting and welcoming the intervention 
project.  
Ibu Maria Sambriong, SST., MPH., and Ibu Margareta Teli, S.Kep., Ns., M.Sc.PH., 
academic staff at Politeknik Kemenkes Kupang, for delivering some educational 
and exercise sessions.  
vii 
 
Research assistants, Garline Mooy, Lilyen Sede, Patricia Djerabat, Susana Yongsi, 
Ronny Sasko, Fadli, M. Fariz Permana, Jeni L. Londa, Elisabeth V. Fanggidae, Regina 
Duba Nyanyi, Irma Fallo, Ansgarius Gantur, Arifin Umbu Damu, Jessy Z.H. Moata, 
Robertus Lali, Yunita Mboeik, and Yeni Hege Udju for helping me in collecting data 
and guiding me in enjoying the beauty of the provinces.  
Staff at the clinical laboratory Prodia Kupang, for assistance in blood sampling and 
HbA1c testing. 
My newly-met friends in Kupang, Mba Umi Kalsum, and Radiah Kurniati, for letting 
me live in their house at no cost.  
I would like to thank to all people around me for helping and supporting me in doing 
the programme.  
Lea Doughty for proof-reading the thesis.  
Aly Diana, Fachry Ramadyan, Reza Pahlevi, and Saras Siti Nur Miawati for assisting 
me in the translation process.  
My roommates at ‘The Barn’: Eeva-Katri Kumpula, Lea Doughty, Rakhee 
Raghunandan, Noni Richards, Amber Young, Patti Napier, for personal support 
and encouragement.  
To Indonesian postgraduate students at the University of Otago, and Indonesian 
community in Dunedin for food sharing and relieving my homesickness.  
I am also thankful to the School of Pharmacy, University of Otago including all the 
academic and administrative staff for providing positive learning environment. 
Immeasurable thanks also go to Faculty of Pharmacy, Universitas Gadjah Mada for 





Last but not least, my deepest gratitude goes to my family in Indonesia.  
My mum Ibuk Ropingah, and my Dad Bapak Tuniman for continuous prayers and 
thought.  
My brothers and sisters-in-law Cahya Budi Hermanto, Anis Sawayaningsih, Arif 
Widhi Sasongko, Adelia Ajeng Pramesti for availability in helping me any time 
when I needed.  









I dedicate this thesis to my husband, Nugroho Waskito, for his remarkable 
patience and unwavering love and support throughout this life journey, and 







Table of contents 
 
Abstract ………………………………………………………………………………………………………... iii 
Acknowledgements ……………………………………………………………..…………………………. v 
Table of contents …………………………………………………………………………………………… xi 
List of tables ………………………………………………………………………………………………….. xv 
List of figures …………………………………….………………………………………………………… xvii 
List of abbreviations……………………………………………………………………………………… xxi 
Glossary …………………………………………………..………………………………………………… xxiii 
 
Section A – Introduction and literature review 
1 Chapter 1: Introduction .......................................................................................................... 1 
1.1 Background .......................................................................................................................... 1 
1.2 Aims of the thesis .............................................................................................................. 4 
1.3 The researcher’s personal motivation for the topic ............................................ 5 
1.4 Indonesia .............................................................................................................................. 7 
1.5 Overview of study locations ........................................................................................ 16 
1.6 Scope of the thesis ........................................................................................................... 24 
1.7 Structure of the thesis ................................................................................................... 25 
2 Chapter 2: Literature review .............................................................................................. 27 
2.1 Introduction ...................................................................................................................... 27 
2.2 Literature review strategy ........................................................................................... 27 
2.3 Child immunisation ........................................................................................................ 28 
2.4 Diabetes mellitus ............................................................................................................. 43 
2.5 Health behaviour ............................................................................................................. 54 




Section B - Understanding health-seeking behaviours of people in Indonesia in child 
immunisation and diabetes 
3 Chapter 3: Indonesian people’s perceptions and experiences related to child 
immunisation and diabetes: A qualitative study ...................................................... 79 
3.1 Introduction ...................................................................................................................... 79 
3.2 Methodology and methods ......................................................................................... 79 
3.3 Results ................................................................................................................................. 92 
3.4 Conclusion and further study direction ............................................................... 147 
 
Section C - Developing, piloting, and evaluating a culturally appropriate intervention 
for people with diabetes 
4 Chapter 4: Literature review of diabetes interventions ........................................ 149 
4.1 Introduction .................................................................................................................... 149 
4.2 Approach .......................................................................................................................... 149 
4.3 Diabetes intervention ................................................................................................. 150 
4.4 Key findings and recommendations for diabetes intervention in the 
Indonesian context ....................................................................................................... 156 
5 Chapter 5: Methodology and methods ......................................................................... 161 
5.1 Introduction .................................................................................................................... 161 
5.2 Study design ................................................................................................................... 161 
5.3 The research process .................................................................................................. 164 
5.4 Participants ..................................................................................................................... 169 
5.5 The intensive group-based intervention ............................................................. 174 
5.6 Outcomes measured .................................................................................................... 191 
5.7 Data collection ............................................................................................................... 202 




6 Chapter 6: Results of the intervention study ............................................................. 213 
6.1 Introduction ................................................................................................................... 213 
6.2 Participants’ response rate and completion rate ............................................. 213 
6.3 Demographic characteristics and diabetes experiences ............................... 214 
6.4 Outcome measures: HbA1c ...................................................................................... 220 
6.5 Outcome measures: knowledge .............................................................................. 228 
6.6 Outcome measures: medication adherence ....................................................... 238 
6.7 Outcome measures: self-management behaviours ......................................... 243 
6.8 Acceptability of the intervention programme to participants and health 
professionals ................................................................................................................... 257 
6.9 Discussion of overall results of type 2 diabetes intervention study ........ 259 
 
Section D - Discussion and conclusion 
7 Chapter 7: Discussion and conclusion .......................................................................... 267 
7.1 Introduction ................................................................................................................... 267 
7.2 Summary of the thesis findings .............................................................................. 268 
7.3 Lessons learned ............................................................................................................ 273 
7.4 Strengths and limitations .......................................................................................... 279 
7.5 Implications of and recommendations from the study ................................. 283 
7.6 Future research direction ......................................................................................... 286 




Appendix 1  Articles included in the literature review about health-seeking 
behaviours of people in Indonesia …………………………………..………..345 
xiv 
 
Appendix 2 – Ethics and local government letters of approval to conduct the 
qualitative study…………………………..…………………………………………..359 
Appendix 3 – Participant information sheet and consent forms for the qualitative 
study…………….………………………………………………………………………….367 
Appendix 4 – Ethics and local government letters of approval to conduct the 
intervention study ………………..………………………………………………….379 
Appendix 5 – Participant information sheet and consent forms for the intervention 
study…………………………………………...…………………………………………. 385 
Appendix 6 – Education materials used in the intervention study ……………….…  391 
Appendix 7 – The questionnaire used in the intervention study …………….………. 399 
Appendix 8 – Rasch analysis output …………………………………………………………...….409 
Appendix 9 – Results of HbA1c measurement of participants in the intervention 





List of tables 
 
Table 1.1:  Characteristics and health-related indicators in West Sumatera and 
East Nusa Tenggara ................................................................................................ 17 
Table 2.1:  Key words used in the literature search in each topic reviewed .......... 28 
Table 2.2:  Indonesia's current basic immunisation programme ............................... 31 
Table 2.3:  Level of FPG and 2-h PG for diabetes, IGT, and IFG diagnosis ............... 44 
Table 3.1:  Population and healthcare facilities available in study locations in 
East Nusa Tenggara Province ............................................................................. 82 
Table 3.2:  Population and healthcare facilities available in study locations in 
West Sumatera Province ...................................................................................... 82 
Table 3.3:  The focus group discussions conducted in the study ................................ 86 
Table 3.4:  Focus group discussions guide for child immunisation topic in English
 ........................................................................................................................................ 89 
Table 3.5:  Focus group discussion guide for diabetes topic in English ................... 90 
Table 3.6:  Socio-demographic characteristics of participants in mother group . 92 
Table 3.7:  Characteristics of participants involved in focus group discussions 
about diabetes ....................................................................................................... 109 
Table 3.8:  Participants narrative concept of diet causality ....................................... 113 
Table 4.1:  Keywords applied for locating relevant literature .................................. 150 
Table 5.1:  Population and healthcare facilities in sub-districts in Kupang city 
[535] .......................................................................................................................... 166 
Table 5.2:  Prolanis programme implementation in the healthcare facilities that 
collaborated in the study and the number of diabetes patients in the 
Prolanis club ........................................................................................................... 169 
Table 5.3:  New initiatives in the Prolanis implementation ....................................... 175 
Table 5.4:  Intervention sessions in each group and percentage of participants 
attending each session ....................................................................................... 176 
Table 5.5:  Percentage of sessions attended by each participant in the 
intervention groups ............................................................................................. 177 
Table 5.6:  Questions on knowledge outcome ................................................................. 198 
Table 5.7:  Questions on medication adherence ............................................................. 199 
xvi 
 
Table 5.8:  The timing and the number of participants who attended baseline 
data collection ........................................................................................................ 203 
Table 5.9:  Follow-up data collection .................................................................................. 206 
Table 6.1:  Demographic characteristics of participants ............................................. 215 
Table 6.2:  Participants' diabetes experiences ................................................................ 215 
Table 6.3:  Statistic tests of HbA1c outcome .................................................................... 221 
Table 6.4:  Paired t-test comparing HbA1c at baseline and at follow up .............. 222 
Table 6.5:  Statistical tests associating HbA1c at baseline with demographic 
characteristics ........................................................................................................ 224 
Table 6.6:  Statistical tests of knowledge outcome ........................................................ 229 
Table 6.7:  Statistical analysis of association of total knowledge score and 
participants’ demographic characteristics and HbA1c outcome ....... 230 
Table 6.8:  Statistical analysis of medication adherence outcome .......................... 239 
Table 6.9:  Association of medication adherence with sociodemographic 
characteristics and other outcomes .............................................................. 240 
Table 6.10:  Statistical test of dietary behaviour scores................................................. 245 
Table 6.11:  The mean number of days within the last week the participants 
applied dietary behaviours at baseline ........................................................ 246 
Table 6.12:  Statistical test of exercise behaviour scores .............................................. 248 
Table 6.13:  Statistical test of other self-management behaviour scores ................ 250 
Table 6.14:  Statistical test of total self-management scores ....................................... 252 
Table 6.15:  Association analysis of self-management behaviour score at baseline 





List of Figures 
 
Figure 1.1:  Map of Indonesia ....................................................................................................... 9 
Figure 1.2:  A community health centre (Puskesmas) in Kupang, East Nusa 
Tenggara ..................................................................................................................... 15 
Figure 1.3:  Typical health professional – patient consultation at the Puskesmas 15 
Figure 1.4:  People of West Sumatera ...................................................................................... 19 
Figure 1.5:  People of East Nusa Tenggara ............................................................................ 19 
Figure 1.6:  Map of West Sumatera Province (Provinsi Sumatera Barat) [91] ....... 20 
Figure 1.7:  Map of East Nusa Tenggara Province (Provinsi Nusa Tenggara Timur) 
[92] ................................................................................................................................ 21 
Figure 2.1:  Activity in a Posyandu: a nurse is preparing vaccine for a child ........... 33 
Figure 2.2:  Activity in a Posyandu: a child is weighed with a traditional scale. .... 33 
Figure 2.3:  The Health Belief Model components and linkages [276] ....................... 58 
Figure 2.4:  Stages in health seeking [277] ............................................................................ 59 
Figure 2.5:  Determinants of choices healthcare services: the Kroeger’s model 
[279] ............................................................................................................................. 61 
Figure 2.6:  The Social Cognitive Theory [280] ................................................................... 62 
Figure 2.7:  Coverage of geographical areas in the studies reviewed ......................... 67 
Figure 2.8:  The pathway of seeking care ............................................................................... 72 
Figure 3.1:  Map of study locations in East Nusa Tenggara Province ......................... 83 
Figure 3.2:  Map of study locations in West Sumatera Province ................................... 83 
Figure 3.3:  Focus group discussion with diabetes participants in Manggarai 
Timur district ............................................................................................................ 87 
Figure 3.4:  Focus group discussion with mother participants in Kupang city ....... 87 
Figure 3.5:  Participants’ knowledge and perception related to child health and 
immunisation ............................................................................................................ 93 
Figure 3.6:  Posyandu: activities, problems and implementation ................................ 96 
Figure 3.7:  Factors influencing mothers’ behaviour in relation to child 
immunisation ......................................................................................................... 101 
Figure 3.8:  Participants' illness experiences .................................................................... 115 
Figure 3.9:  Participants' patterns of and reasons for medication taking behaviour
 ..................................................................................................................................... 120 
xviii 
 
Figure 3.10: Participants' experiences of diabetes self-management ....................... 127 
Figure 3.11: Participants’ behaviour in medicines taking in Model of medicines 
taking described by Pound, et al. [406] ........................................................ 138 
Figure 3.12: Factors influencing diabetes patients' behaviour in managing the 
disease ....................................................................................................................... 145 
Figure 4.1:  Design of the intervention study based on qualitative study findings 
and literature review .......................................................................................... 159 
Figure 5.1:  Main transportation methods in Kupang, motorbikes, and ‘bemo’ a 
public transport ..................................................................................................... 162 
Figure 5.2:  Experimental design of the study ................................................................... 163 
Figure 5.3:  Sub-districts in Kupang municipality ........................................................... 165 
Figure 5.4:  Announcement of the screening programme ............................................ 171 
Figure 5.5:  Diabetes community screening activities ................................................... 171 
Figure 5.6:  Prolanis teams (with the researcher) in the health centres that 
collaborated in the study ................................................................................... 172 
Figure 5.7:  Participant recruitment and allocation to the control and intervention 
groups ....................................................................................................................... 173 
Figure 5.8:  Physical activities conducted in the intervention group ....................... 179 
Figure 5.9:  Education sessions in the intervention group ........................................... 181 
Figure 5.10: The medication-taking card.............................................................................. 185 
Figure 5.11: Medication-taking card made by one participant .................................... 185 
Figure 5.12: Participants’ individual exercise activities ................................................. 187 
Figure 5.13: Role models’ education sessions .................................................................... 189 
Figure 5.14: Blood pressure measurement ......................................................................... 190 
Figure 5.15: Blood glucose measurement during the study period ........................... 190 
Figure 5.16: Collaboration with laboratory clinic of PT. Prodia Widyahusada for 
HbA1c measurement ........................................................................................... 193 
Figure 5.17: Participants involved in the questionnaire testing along with the 
researcher ................................................................................................................ 193 
Figure 5.18: Questions on socio-demographic and disease experiences ................. 197 
Figure 5.19: Questions for measuring self-management behaviours ........................ 201 
Figure 5.20: Research assistants involved in the study with the researcher ......... 202 
Figure 5.21: Baseline data completion .................................................................................. 203 
xix 
 
Figure 5.22: Data collection process at baseline ............................................................... 204 
Figure 5.23: Data collection process at follow up ............................................................. 205 
Figure 5.24: Torrential rain in Kupang ................................................................................. 206 
Figure 5.25: Follow up data completion ............................................................................... 208 
Figure 6.1:  CONSORT flow diagram of participants’ response and completion rate
 ..................................................................................................................................... 214 
Figure 6.2:  CONSORT flow diagram of HbA1c outcome completion ....................... 221 
Figure 6.3:  HbA1c changes of participants in the control and intervention groups
 ..................................................................................................................................... 222 
Figure 6.4:  Participants’ outcome at baseline and follow-up based on HbA1c 
range .......................................................................................................................... 223 
Figure 6.5:  Percentage of participants by the level of HbA1c change ..................... 223 
Figure 6.6:  Negative association between HbA1c at baseline and age ................... 225 
Figure 6.7:  CONSORT flow diagram of participants’ completion of knowledge 
questionnaire ......................................................................................................... 228 
Figure 6.8:  Changes of knowledge scores over time ..................................................... 229 
Figure 6.9:  Association of participants’ total knowledge score at baseline and 
education level and income .............................................................................. 231 
Figure 6.10: Descriptive plot of knowledge scores at follow up based on gender231 
Figure 6.11: Mean score of knowledge divided into categories at baseline ........... 233 
Figure 6.12: Mean score of knowledge divided into categories at follow-up ......... 233 
Figure 6.13: CONSORT flow diagram of data completion of medication adherence 
questionnaire ......................................................................................................... 238 
Figure 6.14: Association of medication adherence score at baseline with 
participants’ educational level and income ................................................ 240 
Figure 6.15: Association of medication adherence score at follow up with HbA1c at 
follow up .................................................................................................................. 241 
Figure 6.16: CONSORT flow diagram of data on dietary behaviour completion at 
baseline and follow up ........................................................................................ 244 
Figure 6.17: Change of days attending specific exercise programme by participants 
in the control and intervention groups ........................................................ 249 
Figure 7.1:  Indonesian people's health behaviours in child immunisation and 







List of abbreviations 
 
2-h PG  Plasma Glucose measured 2 hours after a 75 grams of 
anhydrous glucose intake 
ANCOVA analysis of covariance 
ANOVA analysis of variance 
BCG  Bacillus Calmette-Guerin 
BMI  Body Mass Index 
BPJS Badan Penyelenggara Jaminan Sosial (see glossary) 
CBT Cognitive Behavioural Therapy 
DFU Diabetic Foot Ulcer 
DHS Demographic and Health Survey 
DM Diabetes Mellitus 
DSME Diabetes Self-Management Education 
DTP  Diphtheria, Tetanus, Pertussis 
EDTA Ethylenediaminetetraacetic acid 
EPI  Expanded Programme on Immunisation (EPI) 
ES Elementary School 
FGD Focus Group Discussion 
FPG Fasting Plasma Glucose 
GDP  Gross Domestic Product 
HbA1c Glycosylated Haemoglobin  
HBM Health Belief Model 
HBsAg Hepatitis B virus surface antigen 
Hep B  Hepatitis B 
HiB Haemophilus influenza type b 
HPLC High Pressure Liquid Chromatography 
IDR Indonesian Rupiah 
IFCC International Federation of Clinical Chemistry 
IFG Impaired Fasting Glucose 
IGT Impaired Glucose Tolerance 
IPV Inactivated Polio Vaccine  
JHS Junior High School 
xxii 
 
LKC Layanan Kesehatan Cuma-Cuma (see glossary) 
MCV  Measles Containing Vaccine 
MMR Mumps, Measles, and Rubella 
MoH Ministry of Health 
MoU Memorandum of Understanding 
NGSP National Glycohaemoglobin Standardization Programme 
OGTT Oral Glucose Tolerance Test 
OPV Oral Poliovirus Vaccine 
PHC Primary Health Centre 
ProMAS Probabilistic Medication Adherence Scale 
SCT Social Cognitive Theory 
SD Standard Deviation 
SDG  Sustainable Development Goals 
SHS Senior High School 
TBA Traditional Birth Attendant 
UHC Universal health coverage 
UNICEF The United Nations International Children’s Fund 
USD The United States Dollar 





Adherence to medication The process by which patients take their 
medications as prescribed. 
Ajinomoto  Flavour enhancer, containing monosodium 
glutamate. 
Akar kuning Yellow root, (the root of Arcangelisia flava Merr.). 
Angin duduk Local term used by Javanese for symptoms related 
to heart disease.  
Askes Asuransi Kesehatan: health insurance for civil 
servants.  
Askeskin Asuransi kesehatan untuk rakyat miskin: a 
government-financed health insurance for the poor 
introduced in 2005.  
Badan Kependudukan dan Keluarga Berencana Nasional  
 The National Population and Family Planning 
board, the government agency at the central level.  
Badan Pengawasan Obat dan Makanan  
 Food and drug administration and control agency. 
Badan Penyelenggara Jaminan Sosial (BPJS) Kesehatan 
 The Social Security Agency, the government agency 
which manages the universal health coverage 
programme (Jaminan Kesehatan Nasional).  
Bahasa Indonesia  Indonesian National Language, the official language 
of Indonesia.  
Basic immunisation  Imunisasi dasar (Indonesian): immunisation 
programme for children before the age of one.  




Bhinneka Tunggal Ika  Indonesian national motto which is translated as 
‘Unity in Diversity’.  
Bidan desa Village midwife, a midwife who lives in a village and 
provides health services for the people in the 
village.  
Binahong Anredera cordifolia Steenis (Latin), its leaves are 
used as traditional medicines for diabetes. 
Booster child immunisation Imunisasi lanjutan: booster doses of immunisation 
for children over the age of one.  
Bosan  A word in Indonesian language that means not 
wanting to do it again because it has been done for 
too long, which is similar to ‘fed up’ or ‘bored’ in 
English. 
Buah pinang  Betel (Areca catechu) fruit. 
Community-based health workers  
 Voluntary health workers (kader), and village 
midwives. 
Corn rice  Corn that has been ground into smaller size. 
Cure Sembuh (Indonesian), means being free from the 
disease and its treatment. 
Decentralisation  Otonomi daerah (Indonesian) or ‘regional 
autonomy’, which means that the regional 
government including provinces, districts and 
municipalities has power to regulate themselves. 
District/municipality Administrative division of the province. The 
number of districts/municipalities in each province 
of Indonesia varies. 
Duwe  Syzygium cumini (Latin). Other local names: 
Jamblang hitam, duwet. 
xxv 
 
Elementary school Sekolah Dasar (Indonesian); a primary level of 
education comprises six years of education starting 
at 7 years old.  
Ethnic language Language spoken by people in certain ethnic 
groups. Ethnic languages are commonly used for 
everyday conversation with people within their 
group. 
Family Keluarga (Indonesian), in the Indonesian context, 
this word may include immediate family and 
extended family. 
Formal health providers Health facilities which provide medical services.  
Garam Salt. 
Gondongan ‘Swollen cheek’ literal translation in English, a sign 
of mumps.  
Gracia  A brand name of herbal medicines in Indonesia, 
containing powdered and encapsulated mangosteen 
fruit peel.  
Gula lempeng  Coin-shaped brown sugar made from neera (lontar 
palm nectar). 
Gula Sugar. Indonesian people commonly use the word 
gula for referring to white cane sugar. 
Gulai  Yellow curry. 
Gulai padeh Red curry. 
Haram  Forbidden by God, a word expressed mainly by 
Muslims.  
HbA1c Glycated haemoglobin. The HbA1c level reflects the 
average plasma glucose level over the previous 8 – 
12 weeks.  
xxvi 
 
Herbal medicines Traditional medicines which are mostly from plants 
or part of plants. People often use term herbal 
medicines and traditional medicines 
interchangeably.  
Immunisation coverage Percentage of children who have received one or 
more vaccines in relation to the population for their 
age.  
Incidence The number of new cases for specific period of time. 
Jamblang hitam Other local plant name for duwe (Latin: Syzygium 
cumini). 
Jaminan Kesehatan Nasional The national health insurance programme, a 
universal health coverage programme in Indonesia 
managed by a single agency Badan Penyelenggara 
Jaminan Sosial Kesehatan-BPJS Kesehatan. 
Jamkesmas Jaminan kesehatan masyarakat: government-
financed health insurance for the poor and near 
poor.  
Jampersal Jaminan persalinan: government-financed health 
insurance of Jamkesmas, which aimed specifically to 
cover birth delivery services.  
Jamsostek Jaminan sosial tenaga kerja: health insurance for 
industrial workers.  
Jamu Traditional medicines mainly from plants or part of 
plants. In some cases, mineral and animal sources 
might also be used. The word Jamu originally comes 
from the Javanese ethnic language, so the use of 
word Jamu is common among Javanese.  
Junior high school Sekolah Menengah Pertama (Indonesian) 
comprising three years of education after the 
elementary or primary level of education.  
xxvii 
 
Kader Posyandu Voluntary health workers for Posyandu: lay people 
who were chosen by the community to manage the 
Posyandu. Their work is commonly not paid, or low 
paid based on financial support from the 
communities.  
Kantor Pelayanan Terpadu Satu Pintu 
 The Integrated Office of Community Service. 
Katisen Term for malaria in some parts of Indonesia 
(Central Java). 
Kebal Immune (English): resistant to or not susceptible to 
getting diseases.  
Kersen  Singapore cherry, Muntingia calabura L (Latin). 
Kupang The capital city of East Nusa Tenggara Province. 
Lauk Side dishes mainly containing protein. 
Layanan Kesehatan Cuma-Cuma – LKC 
 Charity health centre privately owned by Dompet 
Dhuafa, a faith-based non-government organisation.  
Lemak Fat (English). 
Licenced drug stores Stores that have a licence to sell non-prescription 
medicines. 
Lontong  Rice cake wrapped inside banana leaves. 
Maneira  A brand name of herbal medicines containing a 
mixed of some powdered ingredients including red 
ginger, mangosteen fruit peel, cinnamon bark, black 
cumin, etc. 
Marungga Moringa oleifera Lamk (Latin), another local name: 
kelor.  
Masuk angin Local term for describing a mild sickness caused by 
indigestion or over exposure to wind.  
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Medicines Conventional, allopathic medicines. Indonesian 
people commonly refer to medicines as ‘obat’, the 
medicines they received from formal health 
providers.  
Minangkabau A large ethnic group in West Sumatera Province. 
The people of Minangkabau are called ‘orang 
Minang’ and look more like Malay people, and the 
language of Minangkabau is named ‘Bahasa 
Minang’. 
Missed opportunities A missed opportunity for vaccination defined as 
contact with health services by individuals who are 
eligible for vaccination, which does not result in the 
person receiving one or more doses of vaccination.  
Mungkin A word in Indonesian for describing uncertainty, 
similar to perhaps, or maybe in English.  
Nasi  rice. 
Non-formal health providers Health providers, including clinics or individuals, 
which provide traditional or alternative therapies. 
For example, traditional healers, herbal medicines 
practitioners, and spiritual healers.  
Non-state health centres Health facilities own by non-government 
organisations or individuals. These health centres 
includes both not-for profit health centres (for 
example faith-based hospitals) and for-profit health 
centres.  
Nusa Tenggara Timur East Nusa Tenggara. A province located at the 
eastern part of Indonesia, next to West Nusa 
Tenggara.  
Obat Medicines or drugs (English). In Indonesian 
context, people refer to medicines received from 
formal health providers as ‘obat’. 
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Olahraga  A word in Indonesian which is more related to 
‘sport’ in English, and often to related to a subject of 
physical education at schools. However, this word is 
also used to convey the concept of exercise, as there 
is no other word in Indonesian similar to ‘exercise’.  
Over-the-counter medicines Medicines that can be obtained without 
prescription. In Indonesia, this include Obat Bebas 
(medicines with green circled label), and Obat 
bebas terbatas (medicines with blue circled label).  
Pancasila The official philosophical and national symbol of 
Indonesia which embodies the five principles of the 
Indonesian state: Belief in absoluteness of God, 
Justice and civilised humanity, The Unity of 
Indonesia, democracy guided by inner wisdom in 
the unanimity arising out of deliberations amongst 
representatives, and social justice for all Indonesian 
people. 
Penyakit (sakit) kuning Literally translated as ‘yellow disease’ (jaundice in 
medical term). A local term for liver-related disease. 
Penyakit (sakit) lever Liver disease.  
Penyakit gula  Literally translated as ‘sugar disease’, a term used 
by lay people in Indonesia for diabetes.  
Penyakit gula basah Literally translated as: ‘wet sugar disease’. A lay 
classification of diabetes, describing people with 
diabetes who get fatter and experience unhealed 
wounds. 
Penyakit gula kering Literally translated as ‘dry sugar disease’. Another 
lay classification of diabetes, for when people with 
diabetes are getting thinner, and not experiencing 
diabetes wounds.  
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Penyakit kencing manis Literally translated as ‘sweet pee disease’, another 
lay term for diabetes.  
Pharmacy Apotik (Indonesia). Licenced places for obtaining 
medicines, including prescription and non-
prescription medicines.  
Pical Indonesian vegetable salad with peanut sauce. The 
main ingredients for the peanut sauce are ground 
fried-peanut, brown sugar, and spices. Pical is from 
Minang dialect, the same as pecel in Javanese 
dialect.  
Posbindu PTM Pos pembinaan terpadu penyakit tidak menular, an 
integrated health post for non-communicable 
diseases. This programme addresses people aged 
15 years and older for early detecting and managing 
risk factors of non-communicable diseases.  
Posyandu lansia Pos pelayanan terpadu lanjut usia, community-
based health post for the elderly. This programme 
focus on early detection of risk factors of non-
communicable diseases and improving general 
health of the elderly. 
Posyandu Community-based integrated health post for 
mother and child care. A government outreach 
programme managed by voluntary community 
members (kader), and monitored by Puskesmas. A 
Posyandu covers a quite small area within a village. 
The health services are commonly provided once a 
month, and include child growth monitoring, child 
immunisation, child-health education, and child 
supplemental nutrition.  
Prescription only medicines Medicines that can be obtained only with 
prescription. In the Indonesian context, this 
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includes Obat Keras (medicines with red circle label 
with letter K). 
Prevalence Proportion of people in a population who have a 
particular disease in some period of time. 
Prolanis club A club of people with diabetes and/or hypertension 
managed by the Prolanis programme at the health 
centres. 
Prolanis Program pengelolaan penyakit kronis. The health 
programme for managing chronic diseases, 
including hypertension and diabetes, which is 
currently under the management of universal 
health coverage (BPJS Kesehatan). 
Province Administrative division of the country. Indonesia is 
divided into 34 Provinces.  
Puskesmas Community health centres. Government-owned 
health centres located in sub-districts 
administrative level.  
Pustu Community health centres in village level. In a large 
sub-district, the Puskesmas might have sub-
ordinate Puskesmas named Puskesmas Pembantu 
or Pustu located in a village.  
Ramuan  A mixture of traditional medicines mainly 
containing dried leaves, barks, or roots. Each 
ramuan has specific mix of ingredients prepared by 
a traditional healer for a specific disease.  
Rendang Spicy meat dish originally from Minangkabau ethnic 
group in West Sumatera. It is like a dry curry made 
from beef which is cooked slowly with spices and 
coconut milk (santan). 
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Riset Kesehatan Dasar Basic health research. Nationally conducted health 
survey that has been done in 2007, 2010 and 2013.  
Rujuk balik  ‘Refer back’ policy, meaning referring back patients 
from secondary or tertiary healthcare facilities to 
primary care facilities after their condition 
improves.  
Salam  Bay leaves, Syzygium polyanthum (Latin). 
Santan  White coloured liquid obtained from the process of 
shredding coconut flesh and soaking it in water. 
Manually and freshly prepared coconut milk.  
Sei Smoked meat, a dish popular in East Nusa 
Tenggara. 
Self-efficacy Perceived capability to perform an action. 
Self-regulation A concrete skill that people should have to manage 
themselves. 
Senam A form of exercise done in a group where people 
move their bodies together with specific 
instruction, and often with music. The most popular 
form of physical activity in Indonesia.  
Senior high school Sekolah Menengah Atas (Indonesian). Comprises 
three years of education after junior high school.  
Sepat A taste like eating unripened banana, or unripened 
snake fruit. In this thesis this word is used to 
describe the taste of herbal or traditional 
medicines.  
Sinshe Chinese traditional medicines.  
Sirih merah  Piper crocatum (Latin). 




Stall or kiosk Warung or toko (Indonesian): small shops which 
sell everyday needs. Some kiosks also sell over the 
counter medicines. In some places, illegal 
prescription medicines might also be found.  
State-owned health centres Health centres own by the Indonesian government. 
This can be either the government at central, 
provincial or district levels. 
Sub-district Administrative division of districts/municipalities. 
Sumatera Barat West Sumatera. A province located in the Western-
central part of Sumatera Island.  
Terapi tertawa Literally translated as ‘laugh therapy’, a form of 
exercise involving moving the body while laughing.  
Traditional medicines Any medicines other than conventional medicines. 
Indonesians commonly use specific terms for 
specific types of traditional medicines, the most 
common terms: jamu, obat herbal, obat tradisional, 
and sinshe.  
Universal Health Coverage Defined by WHO as ensuring that all people have 
access to needed health promotion, preventive, 
curative and rehabilitative health services, of 
sufficient quality to be effective, while also ensuring 
that people do not suffer financial hardship for 
those services. In the Indonesian context this 
concept was implemented on 1st January 2014 in 
form of Jaminan Kesehatan Nasional, national 
health insurance programme, which managed by 
single agency of BPJS.  




Village midwife Bidan Desa. A government outreach programme of 
deploying a midwife to live in villages and provide 
health services particularly related to mother and 
child health, including immunisation. However, it 
often broadened into general health services for 
people in the entire village. 
Village The lowest administrative areas of Indonesia. Most 
villages are inhabited by about 2500 or fewer 
people. However, the size of a village varies 




Section A – Introduction and literature review 
1 Chapter 1: Introduction 
1.1 Background 
Indonesia is a developing country whose health system has been facing 
epidemiological transition from communicable diseases to non-communicable 
diseases for the last three decades [1]. Although the number of deaths from 
communicable diseases dropped from 70% in 1980 to 30% in 2001, such diseases 
remain a significant health problem [2, 3]. Indonesia has low immunisation 
coverage compared to most other countries in the Southeast Asia region. In 2015, 
the percentage of MCV1 (first dose of a measles containing vaccine) coverage in 
Indonesia was approximately 68%, far below the average within the Southeast 
Asia region which was 85%, while the percentage of DTP3 (third dose of 
diphtheria, tetanus, and pertussis) coverage in Indonesia was 81%, also below the 
regional average of 87% [4-6]. Moreover, the Indonesia Demographic and Health 
Survey 2012 revealed that only 37% of children aged 12– 24 months had received 
full basic immunisation. The percentage was lower in some provinces, such as 
West Sumatera where only 34.9% of children were fully immunised [7]. Aligned 
with low immunisation coverage, the incidence of vaccine-preventable diseases 
was high. In 2012, it was reported that measles was the cause of approximately 
5% of children’s deaths under the age of five. Diphtheria outbreaks were declared 
in some provinces during the period of 2011 – 2016 [8, 9].  
On the other hand, the prevalence of non-communicable diseases including 
cardiovascular diseases and diabetes is also rising, becoming major causes of 
deaths by 2012 [3, 9, 10]. In 2016, the prevalence of type 2 diabetes was 7%, an 
increase from 5.8% in 2014 [11, 12]. Although the diabetes prevalence in 
Indonesia was slightly lower than the average of other countries in the Southeast 
Asia region (7% compared to 8.6%, respectively), diabetes could be a serious 
health threat as it is strongly associated with tuberculosis [13, 14], undernutrition 
and stunting [15], the old health problems which remain prevalent in Indonesia. 
Recent studies including systematic review and meta-analysis confirmed that 
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people with diabetes have a two to three-fold higher risk for developing 
tuberculosis [16, 17]. About 10% of global tuberculosis patients live in Indonesia, 
with 399 incidences per 100,000 population in 2016. This tuberculosis incidence 
rate is far higher than the average incidence either in the Southeast Asia region or 
globally, which was 211 and 133 respectively [18, 19]. Research has also found 
that diabetes and its risk factors are associated with undernutrition and stunting 
in childhood [15]. Studies in Indonesia also suggest that childhood undernutrition 
and stunting increase the risk of obesity in later life [20, 21], further increasing the 
risk of diabetes. It was reported that in 2013 that the national prevalence of 
undernutrition and stunting in children under five was high, 19.6% and 37.2% 
respectively [22]. The existing problems of tuberculosis and stunting in Indonesia, 
therefore, may increase the number of people with diabetes.  
The problem of low immunisation coverage persists despite extensive 
governmental programmes providing greater access to health services. Since two 
decades ago, the Indonesian Ministry of Health has implemented the community-
based health post for mother and child care (Pos Pelayanan Terpadu - Posyandu) 
at the sub-village level. Posyandu is an outreach programme aimed at improving 
mother and child health by providing health services including immunisation [23, 
24]. Research showed, however, that the Posyandu was not well utilised [25, 26].  
Similarly, to promote chronic diseases management, including diabetes, the 
Ministry of Health also introduced community-based health care for the elderly 
(Posyandu lansia) in the early 21st century. This programme is aimed at early 
detection of risk factors and better management of non-communicable diseases. 
The programme is designed to involve active participation of community 
volunteers in managing the programme in collaboration with community health 
centres [27]. The implementation of the Posyandu Lansia, however, varied among 
regions depending on the level of support from the community [28, 29]. Following 
the implementation of Universal Health Coverage (UHC) on 1 January 2014, the 
government implemented the Prolanis Programme, a programme for managing 
chronic diseases, particularly hypertension and diabetes, under insurance 
management. The effectiveness of the programme has not yet been evaluated. If 
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there is no revitalisation or new initiative in the implementation of this 
programme, however, it could potentially have the same problems as other 
government programmes. Lack of availability of resources and facilities, and lack 
of people’s interest in the programmes were the common obstacles that may 
hinder the success of the programmes [29, 30].  
Increasing access to healthcare services is a key component of improving the 
nation’s health status. At an individual and community level, however, 
understanding people’s health-related behaviours iscrucial  in improving 
community health [31]. Greater understanding of people’s health-related 
behaviours might shed light on the problems that still exist in the community 
despite greatly increased access to health services. Gaining an understanding of 
people’s health behaviour is also an important step in establishing effective 
interventions aiming at improving people’s health [31, 32].  
In the Indonesian context, people’s health-related behaviour is more complex due 
to it being a multicultural, ethnically diverse country with a variety of health 
providers. These providers range from the formal, including public and private 
healthcare services, to non-formal, among which are traditional healers, herbal 
medicine practitioners, spiritual healers, and homeopaths. As a multicultural 
community, Indonesians often practise what they call ‘local wisdom’ related to 
health, such as taking traditional medicines, and conducting traditional 
ceremonies to chase away the bad spirits that are perceived to cause illnesses. 
Some people believe that some diseases are caused by supernatural powers [33, 
34]. Furthermore, this local wisdom ranges widely among different ethnic groups. 
Religious beliefs also play an important role in shaping people’s health-related 
behaviour. People would perform behaviour related to health, such as getting 
immunisation, if it is supported by their religious leaders or it is in line with their 
religious rules [35, 36]. 
Health seeking behaviours of people in Indonesia are also influenced by people’s 
perception of illness’ symptoms. People often delay treatment as they perceive 
their symptoms to be minor, so they choose to self-medicate or go to informal 
health providers as the first action. In contrast, when they perceive their 
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symptoms to be those of a more serious illness, they are likely to seek out formal 
health providers [37-40]. Self-medication is also supported by the fact that people 
can obtain most medicines including antibiotics without prescription from most 
pharmacies in Indonesia [41, 42]. People’s perception of diseases also influences 
their health-related action [39, 43, 44]. It is believed, for example, that diabetes is 
a disease of the wealthy, so the poor consider it impossible that they might get it 
[43]. Understanding people’s point of view in the Indonesian community, 
therefore, is an important step in establishing acceptable and effective health 
intervention.  
This thesis identifies underlying behavioural factors focusing on two health issues 
– child immunisation, and type 2 diabetes. Focusing on these two health issues 
may differentiate people’s behaviour related to different types of health problems: 
preventive behaviour and long-term disease related behaviour. This 
understanding is then applied to develop and implement a community-based 
intervention for diabetes patients, and the effectiveness of the intervention is also 
evaluated.  
1.2 Aims of the thesis 
This thesis focused on the problems of child immunisation and type 2 diabetes in 
Indonesia. The goal was to improve indicators or outcomes related to child 
immunisation or diabetes through implementing interventions that are based on 
understanding of health behaviour. In order to achieve that goal, the research was 
conducted in two stages: a qualitative study, followed by a quasi-experimental 
pilot study. The qualitative study focused on both child immunisation and 
diabetes, and the intervention pilot study focused only on diabetes.  
The qualitative study aimed to explore the perceptions, beliefs and behaviour of 
people in Indonesian communities related to child immunisation and diabetes. 
This understanding will have a significant impact on establishing more acceptable 
health programmes and increasing community participation in these programmes. 
Three research questions were addressed: 1) what are people’s perceptions, 
beliefs, and experiences relating to child immunisation and diabetes; 2) what are 
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the individual and social factors that may influence people’s behaviour related to 
child immunisation and diabetes; and 3) what are the health provider factors that 
may determine people’s behaviour in seeking care? 
Based on knowledge gained from the qualitative study, an intensive community-
based diabetes intervention was designed, and implemented. A quasi-
experimental study design was used to evaluate the effectiveness of the 
intervention compared to usual care that patients would receive. The intervention 
aimed to increase self-management knowledge and practices among diabetes 
patients, increase medication adherence, and improve patients’ outcomes. Three 
research questions that were also addressed for the intervention study were: are 
there any differences in: 1) knowledge and practices of self-management of 
diabetes; 2) medication adherence; and 3) clinical outcomes, between diabetic 
patients who receive a community-based intervention and those who receive 
usual care?  
1.3 The researcher’s personal motivation for the topic 
My personal interest on the topic of child immunisation and diabetes came from 
an unforgettable memory of my childhood. When I was a child, I remember that I 
got mumps, which is locally known as ‘gondongan’ or swollen cheek. At that time, 
a lot of my friends also got mumps. My mother and almost all my friends’ mothers 
applied blue-coloured bleaching powder to the swelling cheek. Thus, with that 
blue cheek you were easily recognised as having that disease. As I grew older, I 
noticed that some children still got that disease and their mothers still applied that 
blue-coloured bleaching powder. This led me to question why that blue-coloured 
bleaching powder was used for treating mumps, and from where they had 
acquired the idea that this was an appropriate treatment.  
The other unforgettable memory of my childhood is when one of my extended 
family members – the younger sister of my grandmother – died from a frightening 
disease, described by local people as an unhealed and disgusting wound that led 
her to have her limb amputated. Even after receiving an amputation, however, the 
disease did not go away. At that time, many people had no idea of what kind of 
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diseases existed: some believed that the disease was caused by supernatural 
power.  
Those memories had almost been forgotten until I began my Bachelor’s degree in 
Pharmacy and learnt about immunisation and diabetes. It was then that I 
understood that that blue-coloured bleaching powder had nothing to do with 
mumps, and that the unhealed wound was a complication of diabetes.  
After that, I felt that diabetes was really close to my life: my aunt died of diabetes, 
and my father also suffers from diabetes. These experiences have led me to 
consider the impact of behaviour on health. I recall one thing from visiting my 
aunt before she died: even after her condition had deteriorated greatly, she was 
angry when we told her to restrict certain kinds of food in her diet. Instead, she 
said something like: “We live to eat, so how come the disease comes from the food 
we eat. We all will die, whether or not we eat or do not eat that food, so it’s better 
to eat rather than restrict some kind of food and then still die”. In the case of my 
father, for some time my mother and I knew nothing about his symptoms; finally, 
my mother told me that my father had a sexual problem. He tried traditional 
medicines for improving this problem, but none were effective. Soon I 
remembered that diabetes can cause these types of symptoms. I asked my mother 
to take my father to the health centre to get his blood checked, which revealed that 
my father did indeed have diabetes.  
These experiences are the starting point of my interest in child immunisation and 
diabetes, particularly in relation to people’s behaviour around these two health 
issues.  
After graduating with a bachelor’s degree, I worked as a member of the academic 
staff at the university I graduated from. At that time, there was a transition of 
ideas within the pharmacy department, from a ‘product oriented’ to more ‘patient 
oriented’ way of thinking. Discussions with experts have led to the conclusion that 
new expertise has to be created: the pharmacist who has more skills in dealing 
with patients. To facilitate this, I was asked to learn more about public health as it 
relates to pharmacy. I took the opportunity to learn more about behavioural 
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aspects of health, completing a Master’s degree in Public Health. Being a lecturer, I 
also did research with my undergraduate students, mainly focusing on how people 
really take their medicines. The studies found that people’s behaviour in 
medication taking is an essential factor that affects the effectiveness of the 
medicines.  
My personal motivation with this PhD research was to do something that might 
change people’s health-related behaviour in diabetes and immunisation. I hope 
that the intervention can be applied widely so that there will not be a single 
person like my aunt who did not believe that the disease was caused by her eating 
behaviour; that there is nobody like my father who delayed in getting diagnosis 
with diabetes; and there is no child like me that is given a blue-coloured bleaching 
powder to treat an immunisation preventable disease.  
1.4 Indonesia 
1.4.1 Indonesia 
Indonesia, or officially the Republic of Indonesia, is a Southeast Asian nation 
situated between the continents of Asia and Australia, and between the Pacific and 
Indian Oceans. It is an archipelagic state consisting of more than 13,000 large and 
small islands, with a total land area of 1,913,578.68 square kilometres [45]. The 
five biggest islands are Sumatera, Java, Kalimantan, Sulawesi, and Papua. 
Kalimantan, Papua, and Timor islands share a land border with Malaysia, Papua 
New Guinea and Timor Leste, respectively (Figure 1.1). The most world famous 
island of Indonesia is Bali, which attracts foreigners to enjoy its white sandy 
beaches. Borobudur temple, Prambanan temple, Sangiran early man site, and 
Komodo National park are among properties of Indonesia listed as World Heritage 
Sites [46].  
Lying along the equator, stretching from 6°08' N latitude to 11°15' S latitude, and 
from 94°45' E to 141°05' E longitude, Indonesia is a tropical country with two 
seasons: dry and rainy [47]. The dry season usually occurs between May and 
September, and the rainy season occupies the rest of the year [48]. Other 
characteristics of a tropical country are that it is hot and humid. The temperature 
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commonly ranges between 230C, particularly in mountainous areas, and 330C in 
low land areas, while the humidity ranges from 60 – 90% [49]. Due to its 
geographical location, Indonesia is divided into three time-zones: Western 
Indonesia Time, which is seven hours ahead of Universal Time Coordinated (UTC 
+7), Central Indonesia Time, which is eight hours ahead of Universal Time 
Coordinated (UTC +8), and Eastern Indonesia Time, which is nine hours ahead of 
Universal Time Coordinated (UTC +9). Western Indonesia Time includes areas of 
Sumatera, Java, and western part of Kalimantan. Central Indonesia Time includes 
areas of eastern part of Kalimantan, Sulawesi, Bali, West Nusa Tenggara, and East 
Nusa Tenggara. Finally, Eastern Indonesia Time includes areas of Maluku and 
Papua [50].  
Administratively, the country is divided into 34 provinces. Each province is 
further divided into districts or municipalities, then sub-districts, and the lowest 
administrative areas, the villages [45]. Most villages in Indonesia are inhabited by 
about 2,500 or fewer people. The size of a village, however, varies depending on 
the provincial areas and local population density. On Java island, with population 
density of more than 1,000 person/km2, a village might incorporate only about 2.5 
km2, while outside Java island, a village might have a total area of more than 30 
km2 [45]. In 1999, the Indonesian government began to decentralise its political, 
administrative and fiscal functions from its formerly strongly centralised 
structure. This decentralisation programme is known in local term as ‘otonomi 
daerah’ or regional autonomy, which means that the regional government 
including provinces, districts and municipalities have their own power to regulate 
themselves [51, 52]. Since 2004, the Indonesian people have also elected the 








Figure 1.1: Map of Indonesia 
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Indonesia is home to more than 255 million people, and with an annual population 
growth of 1.38%, is recorded as the fourth most populous country in the world 
[54, 55]. The population is spread unevenly across the country, with more than 
half of the people inhabiting Java Island which occupies only about 6.5% of total 
land area of Indonesia [45, 56]. Indonesia is a culturally diverse nation with more 
than 1,300 ethnic groups. Some ethnic groups which share similar characteristics 
are further categorised as a single ethnic group, making just 31 groups of distinct 
ethnic populations. Javanese is the biggest ethnic group, accounting for 40% of the 
total Indonesian population. This is followed by Sundanese (15%), and the Batak 
ethnic group (3.5%) [57]. Each ethnic group has a different ethnic language, and 
almost 80% of Indonesian people use their local or ethnic language for daily 
communication [57]. The Indonesian Language or Bahasa Indonesia is the official 
and national language, therefore the majority of people also speak Bahasa 
Indonesia.  
In terms of religions, the Indonesian government recognises six official religions: 
Islam; Catholicism; Protestantism; Hinduism; Buddhism; and Confucianism. Islam 
is the predominant religion and accounts for about 87% of country’s population. 
In Bali, Papua, and East Nusa Tenggara, the predominant religions of the people 
are Hinduism, Protestantism and Catholicism, respectively [57]. Given this 
immense diversity, Indonesia has a strong national motto: Bhinneka Tunggal Ika, 
which is translated as ‘Unity in Diversity’. Moreover, the official philosophical and 
national symbol Indonesia is ‘Pancasila’ which describes five principles of the 
Indonesian state: belief in absoluteness of God; justice and civilised humanity; the 
Unity of Indonesia; democracy guided by inner wisdom in the unanimity arising 
out of deliberations amongst representatives; and social justice for all Indonesian 
people [58]. 
In the 21st century, Indonesia has developed significantly in its economy, 
education, and health indicators. The acceleration in economic growth is shown in 
an increase in gross domestic product per capita from IDR 6,569,760 (USD 780) in 
2000 to IDR 44,807,496 (USD 3,346) in 2015 [59]. This economic growth is fuelled 




classed as middle income [60, 61]. Some of the factors driving the rise of the 
middle-income group are rapid urbanisation, increased new job opportunities in 
the services and industrial sectors, and improving educational status [60]. In line 
with this economic growth, Indonesia has also experienced an enormous 
reduction in poverty. The percentage of people who live below the national 
poverty line, which is described as consumption outlays of IDR 372,114 (USD 28) 
per month per person in urban areas and IDR 350,420 (USD 26.3) per month per 
person in rural areas, almost halved from about 20% in 2000 to 10.7% in 2016 
[62, 63]. The percentage of poor is higher in the eastern part of Indonesia, 
including East Nusa Tenggara (22.01%), Papua Barat (25%) and Papua (28%) 
[64].  
The progress in the people’s education level has been similar. In 2010, about half 
of Indonesian people above 15 years of age had completed nine years of basic 
education, which was an increase from 39.08% in 2000. Coupled with this, the 
number of Indonesian people who had completed some form of tertiary education 
doubled from 3.77% in 2000 to 6.64% in 2010 [65].  
Indonesia has also made improvements in some health indicators mentioned in 
the Sustainable Development Goals (SDGs) related to health [6], as shown by 
decreasing infant mortality rates, and increasing life expectancy. The infant 
mortality per 1,000 live births dropped from 47 in 2000 to 13.5 in 2015, while life 
expectancy rose from 65.4 in 2000 to 69.1 in 2015 [6, 66]. These achievements 
were slightly higher than the average of other Southeast Asian countries, which 
saw an infant mortality rate of 24.3 and a life expectancy of 68.9 in 2015 [19]. 
Despite this progress, Indonesia still faces many challenges in other SDG health 
indicators, including low immunisation coverage, high incidence of tuberculosis, 
and increasing prevalence of and mortality rate due to non-communicable 
diseases [6].  
1.4.2 Health system in Indonesia 
The Indonesian health system consists of three levels: a central level Ministry of 
Health; the Provincial Health Departments; and the District or Municipality Health 




regulations and healthcare policy, and ensuring availability of healthcare 
professionals. The MoH manages health programmes addressing public health 
issues, such as immunisation, tuberculosis, malaria, and HIV/AIDS programmes. At 
the central level, there are also other government agencies that are closely related 
to health including the National Population and Family Planning board (Badan 
Kependudukan dan Keluarga Berencana Nasional), the Social Security Agency 
(Badan Penyelenggara Jaminan Kesehatan – BPJS Kesehatan), and the Food and 
Drug Administration and Control Agency (Badan Pengawasan Obat dan Makanan) 
[67].  
The Provincial Health Department has responsibility for managing provincial 
health services, monitoring and coordinating districts health services and 
addressing relevant health issues. Meanwhile, the District or Municipality Health 
Department is responsible for managing district or municipality hospitals and 
community health centres, and monitoring and coordinating sub-district health 
facilities. In 2001, however, following the implementation of administrative, fiscal 
and political decentralisation, the Indonesian health system, including 
responsibility for health services delivery was transferred from the central 
government to the district level. This means that the relationship between those 
three levels is no longer hierarchical, so that the provincial level of health care is 
now not subordinate to the MoH [67]. 
It was expected that with this decentralisation, each district would have better 
management of their budget and resources. Within the decentralisation era, the 
government health-related budget comes not only from direct funding from the 
MoH, but also from the provincial or district/municipality government budget, and 
from the health insurance fund. The national budget allocated for health, although 
quite low, increased from 2.0% in 2005 to 2.5% in 2014 [68]. More than a decade 
after its implementation, however, decentralisation has led to a wide variation in 
local health budgets, and the standard of health services across the country. The 
local provincial and districts or municipalities health budgets range widely from 
15.79% to 1.95% [10]. These variations have resulted in increasing inequities of 




of private health centres, while the performance of the health systems has not 
changed greatly [68-70]. These inequities of access and quality of health care can 
be seen in the wide range of health services indicators at the provincial level. In 
2014, the ratio of hospital beds per 1,000 population ranged from 2.9 to 0.6 
(Indonesia average 1.1), the ratio of general practitioner per 100,000 population 
ranged from 155.5 to 8.8 (Indonesia average 38.1), and the ratio of community 
health centres per 30,000 population ranged from 5.07 to 0.6 (Indonesian average 
1.17) [10].  
Meanwhile, health care in Indonesia is delivered by a mixed system in which 
government-owned health centres coexist with privately-owned health centres. 
The government-owned health centres consist of community health centres 
(Puskesmas-Pusat Kesehatan Masyarakat) at the sub-district level across the 
country, which are complemented by state hospitals at district and province level. 
Some villages are also supported by sub-community health centres (Pustu-
Puskesmas Pembantu) and maternity centres (Polindes-Poliklinik desa). These 
health centres not only deliver inpatient and outpatient services, but also perform 
promotive and preventive health activities [71]. While primary care is the main 
focus of services given at the Puskesmas, those needing secondary and tertiary 
care are usually referred to hospitals. Figure 1.2 illustrates the Puskesmas and 
Figure 1.3 illustrates typical health consultation at the Puskesmas. In 2015, the 
number of Puskesmas was 9,754, of which 3,396 had inpatient services. This 
number has grown to meet the expected ratio of one Puskesmas per 30,000 
population. By 2015, the number of government-owned hospitals in 2015 was 888 
[9].  
Privately-owned healthcare services range widely from not-for-profit religious 
charitable group-owned healthcare facilities and for-profit non-state healthcare 
facilities including ambulatory and out-patient care health centres, and hospital 
chains. Many medical staff who work at the government-owned health centres 
also open private clinics or work at other non-state health providers in the 
evening [72]. In some villages where there are not many medical doctors, village 




grew rapidly to about 1,600 hospitals, almost double the number of state hospitals 
[9]. These private health centres are regulated by local and central government 
through registration, licencing and accreditation [67]. The growth of the private-
for profit hospitals, however, may impact on commercialisation of health care 
[72].  
Despite its complex health system, Indonesia has experienced an increase in 
health insurance coverage. In 2005, the Indonesian government introduced a 
health insurance for the poor named Askeskin (health insurance for the poor); in 
2007, this scheme was renamed Jamkesmas to also cover the near-poor [73]. In 
2011, the government also expanded Jamkesmas to cover births, in a scheme 
which named Jampersal. Then, in early 2014 the government also introduced a 
Universal Health Coverage (UHC) programme: all Indonesians are expected to 
come under its umbrella by 2019 [74]. This universal health coverage programme 
is managed by single agency of BPJS Kesehatan, so that all other previous health 
insurance schemes are to be merged into this UHC, including the long-established 
health insurance for civil servants (Askes), and health insurance for industrial 
workers (Jamsostek) [75]. A year after it was introduced, the number of 
subscribers to the insurance programme had reached more than 150 million 
people or about 60% of total population [76]. Some studies suggested that 
increasing health insurance coverage correlates with an increase in health care 
utilisation [37, 77, 78].  
As in other developing countries, despite the wide availability of formal health 
providers, informal health providers or non-conventional health providers 
comprise a significant component of health services [79]. In Indonesia, these 
informal health providers range from traditional health providers to traditional 
birth attendants. The traditional health providers in Indonesia are divided into 
four categories: biologically based therapies – traditional therapies with 
substances from nature, for example herbal medicines; physical therapies with 
tools – for example acupuncture, acupressure, cupping therapy; physical therapies 
without tools – for example massage; and mind-body therapies – for example 





Figure 1.2: A community health centre (Puskesmas) in Kupang, East Nusa Tenggara 
 
 




With the wide availability of these traditional providers, the use of complementary 
and alternative medicines is also prevalent. The Indonesian government has 
recognised the importance of traditional medication in the society, and attempted 
to regulate these traditional providers [80]. Recently, in 2017, the government 
introduced an integration of traditional health services into the formal health 
services [81].  
Meanwhile, pharmaceutical products in Indonesia are regulated by the National 
Agency for Food and Drug Control (Badan Pengawasan Obat dan Makanan-BPOM). 
To ensure the quality of medicines, pharmaceutical companies must meet the 
Good Manufacturing Practice [82]. The medicines that are obtained legally from 
formal health providers, therefore, should meet the quality standards. However, 
evidence of substandard and counterfeit medicines has been found [83]. 
Medicines in Indonesia are classified into five categories, and each category can be 
identified by the colour of the label: over the counter medicines (green circle 
labelled known as Obat Bebas); limited-over the counter medicines (blue circle 
labelled – known as Obat bebas terbatas); prescription-only medicines (red circle 
labelled with letter K – known as Obat keras); psychotropic medicines (labelled 
the same as prescription-only medicines); and narcotic medicines (red labelled 
with a ‘plus’ sign) [84]. Both over the counter and limited over the counter 
medicines can be obtained from licenced places without prescription. Indonesia 
has separated the prescription and dispensing of medicines. Under regulation, 
medicines can only be obtained from licensed places, including pharmacies 
(apotik), and licensed drug sellers (toko obat berijin). Licenced drug sellers can 
only sell non-prescription medicines. Non-licensed drug sellers, however, 
including informal outlets (stalls, kiosks) are available widely across the country.  
1.5 Overview of study locations  
1.5.1 Justification of study locations 
The research was conducted in West Sumatera and East Nusa Tenggara, two 
provinces of Indonesia. Both provinces were chosen based on differences in their 




both provinces was almost the same: about 5.1 million people in 2015 [85]. The 
demographics of each province are markedly different, however. The majority of 
people in West Sumatera are originally from a single, large ethnic group, 
Minangkabau, who look more like Malay people (Figure 1.4). Islam is the 
predominant religion in West Sumatera [57]. In contrast, the people in East Nusa 
Tenggara have heritage from many different small ethnic groups, and most of their 
origin ethnically and culturally lay in a transition border from Asia to Australia 
and Micronesia (Figure 1.5). The predominant religion in this province is Catholic 
[57]. Therefore, gathering data in those provinces is likely to contribute rich 
information and insight about sociocultural influences on health related 
behaviour. 
Table 1.1: Characteristics and health-related indicators in West Sumatera and East Nusa Tenggara 
Characteristics / health 
related indicators 
West Sumatera East Nusa Tenggara National average 
Population 5,196,300 a 5,120,100 a 255,461,700 a 
Total area 42,012.89 km2 (b) 48,718.10 km2 (b) 1,913,578.68 km2 (b) 
Number of islands 391 c 1,192 d About 13,000 b 
Bed ratio per 1,000 
population 
1.34 e 0.88 e 1.21 e 
Community health centre 
ratio per 30,000 population 
1.52 e 2.17 e 1.15 e 
General Practitioner per 
100,000 population 
19.53 e 13.2 e 16.06 e 
GDP per capita USD 2,569 f USD 1,114 f USD 3,346 f 
Immunisation coverage 34.9% g 46.5% g 37.0% g 
Type 2 diabetes prevalence 1.8% h 3.3% h 6.9% h 
 
Notes:  a Statistics Indonesia [85] 
b Ministry of Home Affairs [45] 
c Statistics of West Sumatera Province [86] 
d Statistics of East Nusa Tenggara Province [87] 
e Indonesia Ministry of Health [9] 
f Statistics Indonesia [88] 
g Statistics Indonesia, et al. [7] 
h Department of Health Research and Development Ministry of Health of Indonesia [22] 
 
In terms of health services indicators, as presented in Table 1.1, people in West 
Sumatera generally have higher access to hospitals and general practitioners than 
those in East Nusa Tenggara, but people in East Nusa Tenggara have higher access 
to community health services. East Nusa Tenggara province consists of more 




more obstacles in getting to health facilities than their counterparts. In terms of 
their economy, people in West Sumatera are generally wealthier than those in East 
Nusa Tenggara, as shown by their GDP per capita.  
Given these conditions, it is interesting to note the fact that immunisation 
coverage in East Nusa Tenggara was higher than that of in West Sumatera. 
However, the prevalence of type 2 diabetes was higher in East Nusa Tenggara than 
in West Sumatera. These data of diabetes prevalence at provincial level were 
estimated based on a national survey of people with diagnosed diabetes or people 
who experienced diabetes symptoms in the last month [22]. This figure is likely to 
be even higher, given that most people with diabetes in Indonesia are 
undiagnosed, and people with diabetes often do not experience any symptoms 
[89].  
1.5.1.1 West Sumatera Province 
West Sumatera Province is located in the central eastern part of Sumatera Island 
(Figure 1.6). The Province is divided administratively into 12 districts and seven 
municipalities. In 2015, the population of West Sumatera was 5.1 million people, 
and it is estimated that 7.1% of these were living under poverty line [64]. The 
population consists of 31.9% children less than 15 years old, 62.4% adults and 
5.6% elderly people (more than 64 years old) [86]. The majority of people over 
the age of 15 work in the agricultural sector (39.3%), while 21.3% work in the 
business sector, and the remainder work mainly in industrial setting or in 
professional service areas such as teaching and health [86].  
West Sumatera Province has 64 hospitals, 260 Puskesmas and 896 Pustu [86, 90]. 
However, healthcare services utilisation was very low. The 2013 Basic Health 
Research survey estimated that about 6.9% of the total population utilised 
outpatient services in the last month preceding the survey, lower than the national 
percentage (10.4%). It was also lower than the West Sumatera population that 
self-medicated, which was 14.1% [22]. Of those who used outpatient healthcare 
facilities, the most common type used was Puskesmas (33.9%) followed by 





Figure 1.4: People of West Sumatera 
 
 






Figure 1.6: Map of West Sumatera Province (Provinsi Sumatera Barat) [91]  








Figure 1.7: Map of East Nusa Tenggara Province (Provinsi Nusa Tenggara Timur) [92] 




In terms of immunisation coverage, based on 2012 Demographic Health Research, 
the percentage of 12 – 23 months old children that received completed 
immunisation was only 34.9%, while 6.3% had not been immunised at all. This 
figure was lower than the average national immunisation coverage of 37% [7]. The 
immunisation with the highest uptake was BCG immunisation, which is given at no 
more than a month old, and the lowest rate was DTP-HB 3, the third dose of DTP-
HB [22]. This shows a high immunisation dropout rate. This low rate of 
immunisation coverage has led to a high incidence of vaccine-preventable 
diseases. In 2015, there was a diphtheria outbreak in West Sumatera with a total 
of 110 cases [9]. 
Another disease that has become a major problem in Indonesia including in West 
Sumatera is type-2 diabetes. Despite the low prevalence of only 1.8% in 2013, the 
figure represents an increase from 1.2% in 2007 [22]. 
1.5.1.2 East Nusa Tenggara Province 
East Nusa Tenggara Province is located in the eastern part of Indonesia, on the 
border of Timor Leste (Figure 1.7). It has 1,192 islands, of which only 43 are 
inhabited by about 5.1 million people [87]. The Province is divided into 21 
districts and one municipality, which is Kupang municipality, the capital city of the 
province [87]. 
In 2015, East Nusa Tenggara Province was recognised as the poorest province in 
the country as shown by the lowest regional GDP per capita, which was only IDR 
14,927,930 (USD 1114) compared to the national GDP per capita of IDR 
44,807,496 (USD 3,346) [88]. Furthermore, about a million or 22% of its 
population live below the poverty line [64].  
More than a half of people in East Nusa Tenggara are adults, and more than a third 
are children, while the remaining 5% of the population are the elderly. The 
majority of adults work in the agricultural sector (about 61%), services sector 
(13%), trades (7%), and industrial sector (7%). In terms of education, about 




another 31.07% have completed elementary school; and only a minority of this 
population (4.4%) have completed tertiary education [87]. 
In terms of healthcare services, the province has 43 hospitals, 368 Puskesmas and 
1,045 Pustu [87]. In general, health care utilisation is also low in East Nusa 
Tenggara. The 2013 Basic Health Research survey estimated that approximately 
20% of the population self-medicating in the previous month preceding the 
survey, and only 11% of the population utilised outpatient services [22]. Among 
those who self-medicated, 80.17% used modern/western medicines, another 
30.04% used traditional medicines, and the remaining 2.96% used another 
method of medicine/medication [22].  
The biggest health problem in East Nusa Tenggara is related to mother and child 
health. In 2010, the infant mortality rate was 39 per 1,000 live births and the 
maternal mortality rate was 387 per 100,000 live births. These rates were far 
higher than the national rates [93]. Prevalence of undernutrition and stunting 
were also reported to be the highest in the country. In 2013, more than 30% of 
children under five experienced undernutrition, and more than 50% of children 
under five were stunted [22]. 
Besides that, the percentage of children 12 – 23 months old who had completed 
the basic immunisation programme was only 46.5%, while 6.7% had not been 
immunised at all [7]. This low immunisation coverage leads to a high number of 
immunisation preventable disease cases. In 2012, 114 measles cases occurred, 
which was a decrease from 967 cases in 2011 [93]. 
In terms of non-communicable diseases, hypertension had the highest prevalence 
in East Nusa Tenggara followed by type 2 diabetes. In 2013, the prevalence of 
diabetes in adults more than 18 years old was 3.3%, 1.3% of which was diagnosed 
and the remaining 2% was undiagnosed [22]. Furthermore, diabetes is not only 
prevalent among people in urban areas, but also those in rural areas. One study 
showed that diabetes prevalence in Ende, a rural area of East Nusa Tenggara, was 
2% measured with fasting and post glucose load value and 2.83% with HbA1c 




1.6 Scope of the thesis 
The qualitative study explores the perceptions, beliefs, and behaviours of people 
in Indonesian communities in relation to child immunisation and diabetes. These 
perceptions, beliefs, and behaviours are investigated based on the actors of the 
health-related actions: the mothers of the children, and the diabetes patients. 
Although the perception, belief and behaviour related to child immunisation and 
diabetes in the community might also be investigated from wider community 
members other than the actors, their views are outside the scope of this study. The 
child immunisations referred to in this thesis are the basic childhood 
immunisations included in the National Immunisation Programme, which is 
intended for infants. Although the current child immunisation programme also 
includes booster doses for children older than one year, and booster doses for 
school-aged children, these are not included in the scope of this study.  
The intervention project aims to evaluate the effectiveness of community 
intervention compared to usual care. Evaluating intervention may be performed 
using two different types of study: an efficacy study; or an effectiveness study. An 
efficacy study evaluates performance of an intervention under ideal and controlled 
circumstances, while the effectiveness study evaluates performance of an 
intervention under real world or usual clinical practice setting [95, 96]. The 
evaluation of intervention in this thesis is an effectiveness study, which examines 
the intervention with less controlled conditions: a more heterogeneous patient 
population; and a less-standardised protocol, delivered by available health 
professionals in community settings. Moreover, an effectiveness study might also 
answer a wide range of questions including the impact of the intervention on 
clinical outcomes, and medical costs [96]. This thesis, however, only focuses on 
effectiveness in terms of participants’ clinical outcomes, so that a cost-
effectiveness analysis of the intervention is not included in the study. 
Furthermore, usual care is used as a comparison in evaluating the effectiveness of 
the intervention; however, this study does not evaluate the effectiveness of usual 
care. The intervention was also designed based on the results of the qualitative 
study done in the same community. Given the fact that the population of Indonesia 




communities should also involve careful assessment of the community’s 
characteristics. 
In developing the study, some theories on health behaviours are reviewed and 
implemented. This thesis, however, was not aimed to test the theory. Descriptions 
about theories are made based on their applicability in Indonesian context. This 
thesis also focused on type 2 diabetes, therefore the term ‘diabetes’ used in this 
study refers to type 2 diabetes.  
1.7 Structure of the thesis 
This thesis is organised into four sections. Section A is an introductory section. It 
includes Chapter 1 and Chapter 2. Chapter 1 presents the background of the thesis 
and healthcare delivery system in Indonesia. An overview of the study locations is 
also described in this chapter. Chapter 2 provides an overview of the literature 
related to the topic and key concepts related to the study. This chapter includes 
the topics of child immunisation and diabetes mellitus. The key concepts 
described in Chapter 2 are health behaviours and their social components 
including health beliefs and cultural characteristics that might influence health 
behaviour. The literature review on health seeking behaviour of people in 
Indonesia is also presented in this chapter. Lastly, Chapter 2 highlights the key 
findings from the literature review, the gaps observed, and how the thesis might 
contribute to the filling these gaps.  
Section B describes the process of understanding people’s health behaviours 
through a qualitative study exploring perceptions and experiences of Indonesian 
people related to child immunisation and diabetes mellitus. It is presented in 
Chapter 3. This chapter describes the methodology and methods of the study, and 
explains and discusses the result of the study. In the last part of this chapter, 
discussion and the introduction to the main study are also presented.  
Section C presents the development, implementation, and evaluation of an 
intervention pilot study for people with diabetes. The section consists of three 




related to diabetes interventions. This chapter describes the goals and the 
methods of diabetes interventions, then outlining diabetes intervention studies 
that have been done globally, in developing countries, and in Indonesia. Finally, 
this chapter details key findings from the review of the literature, identifies gaps, 
and presents the study’s contribution in the field. Chapter 5 presents the 
methodology and method for the intervention study. This chapter includes the 
rationale of the research, the theoretical framework, and research process. This is 
followed by explanations of the study design, sampling methods, and the 
instrument of the study. Lastly, Chapter 5 describes the data gained from this 
study: how the data were collected, managed and analysed. Chapter 6 explains the 
result of the intervention study, which is detailed in relation to each study 
outcome. Comparisons between control and experiment groups are also made, 
and a discussion related to the results of each outcome is also presented.  
Finally, Section D which is presented in Chapter 7 gives a summary of research 
findings, both of the qualitative and the intervention pilot study. These findings 
are then related to the literature. Based on this discussion, conclusions and 





2 Chapter 2: Literature review 
2.1 Introduction 
Chapter 2 reviews topics covered in this thesis. I identify and evaluate studies 
related to child immunisation programmes, diabetes, and health behaviours, 
particularly in the Indonesian context. This chapter is divided further into five 
subchapters. The first subchapter describes how the literature was collected, 
including key words and databases used in the process.  
The second subchapter looked at child immunisation. The review begins with the 
description of vaccination programmes in the global and developing countries’ 
scope, and then concentrates on Indonesia. This description is then followed by 
the epidemiology of vaccine preventable diseases in global and developing 
countries and followed by their epidemiology in Indonesia. This subchapter 
finishes with the challenges of the immunisation programme in Indonesia.  
The third subchapter focuses on type 2 diabetes mellitus (hereafter, diabetes). It 
starts with a short description about diabetes, followed by its epidemiology on a 
global scale, in developing countries and in Indonesia. The subchapter finishes 
with the description of challenges in managing diabetes in Indonesia. 
The fourth subchapter is about health behaviour: the importance of health 
behaviour studies; and health behaviour theories. This understanding of health 
behaviours is then used to review findings related to health behaviours in 
Indonesia. The fifth and final subchapter explains the key findings from this 
literature review, and highlights the identified gaps. 
2.2 Literature review strategy 
Different data sources and strategies were used to collect relevant literature. 
These included searching with specific keywords, the combination of those 
keywords with three Boolean operators OR, AND and NOT. Further, articles’ 
references lists were also searched for relevant literature. The keywords used in 




Table 2.1: Key words used in the literature search in each topic reviewed 








“type 2 diabetes mellitus” 














“health care utili*ation” 
“patient acceptance of health 
care” 







Using the keywords in Table 2.1, results were gathered from various databases 
including Ovid, PubMed, Scopus, Web of Science, Science Direct, ProQuest Central, 
and Google Scholar. A University of Otago library search was also used to find 
relevant literature. In addition, literature from Indonesian journals was also 
searched with the same keywords translated into Indonesian language. Google 
Scholar database is the main way to find articles in Indonesian journals. In 
addition, the grey literature was also searched, particularly to find information 
produced by the Indonesian government, such as health reports. 
The articles yielded from those literature-searching methods came from a wide 
range of peer-reviewed journals. Some relevant articles from Indonesian journals 
were also identified. These articles added further information which cannot be 
found from peer reviewed journals.  
2.3 Child immunisation  
2.3.1 Child immunisation programme 
2.3.1.1 Global child immunisation programme 
Following the success of the smallpox eradication programme in late 1960s, the 




Immunisation (EPI) in 1974, targeting six immunisation preventable diseases: 
diphtheria; pertussis; tetanus; measles; poliomyelitis; and tuberculosis [97, 98]. 
This EPI was the first coordinated action worldwide, and it was scheduled to be 
given to children before their first birthday [97]. The original EPI included one 
dose of BCG (Bacillus Calmette-Guerin) vaccine, three doses of OPV (Oral 
Poliovirus Vaccine), three doses of DTP (Diphtheria, Tetanus, Pertussis) vaccine, 
and one dose of measles containing vaccine (MCV). Since then, additional vaccines 
have been added. Currently, WHO recommends that all countries also provide six 
other vaccines in their immunisation programme: Hepatitis B virus; Haemophilus 
influenza type b; pneumococcus; rotavirus; rubella virus; and human 
papillomavirus [99]. Its implementation into national immunisation programmes, 
however, varies among regions and countries. Most countries, including low-
middle income countries have added Hepatitis B, and Haemophilus influenza type 
b vaccines in their national immunisation programme. A minority of them, 
particularly developed countries, have also introduced the other four vaccines into 
their national immunisation programme as well [5].  
To evaluate immunisation programme performance, the third dose of DTP (DTP3) 
is used globally as an indicator [98]. DTP3 coverage is also mentioned as one of 
the indicators of essential health services coverage in the Sustainable 
Development Goals for Health [19]. WHO/UNICEF estimate immunisation 
coverage based on official reports submitted by governments and supplemented 
by published and grey literature [100]. According to WHO and UNICEF estimation, 
global DTP3 coverage rose significantly from just 20% in 1980 to 74% in 1990, 
but then stagnated at about 80% until 2005 [101]. In 2015, the global DTP3 
coverage was 86%, but this achievement was less than the target of 90% DTP3 
coverage [4]. These figures varied widely among WHO regions and countries. 
During 2015, the lowest DTP3 coverage was recorded in the Africa region at only 
74%, and the highest DTP3 coverage was recorded in the Western Pacific region, 
which was 94% [102].  
The DTP3 coverage in the South-East Asia region was 87% in 2015, ranging from 




Indonesia in 2015, the DTP3 coverage was 81%, lower than the global and 
regional South-East Asia level. Moreover, Indonesia was also listed among ten 
countries which contribute to 60% of children globally who did not receive three 
doses of DTP at the age of one [102].  
Some studies also reported immunisation coverage based on demographic 
surveys. The immunisation coverage calculated based on demographic survey was 
commonly lower than that of reported data [103, 104]. Global DTP3 immunisation 
coverage calculated based on survey data showed gradual improvement, from 
65% in 1990 to 74% in 2006 [105]. Moreover, in low middle income countries, 
DTP3 immunisation coverage was under 80% in 2009 [104].  
2.3.1.2 Child immunisation programme in Indonesia 
Vaccines included in Indonesia’s National Immunisation Programme 
Indonesia adopted the Expanded Programme on Immunisation (EPI) in 1977. At 
that time the national immunisation programme was for children aged 3 – 14 
months, changing from 2 - 12 months in 1987. The vaccines included one dose of 
BCG, three doses of Oral Poliovirus (OPV) and diphtheria, tetanus, pertussis (DTP) 
containing vaccine, and one dose of measles containing vaccine (MCV) [106].  
Following the success of the Lombok Hepatitis B Model Immunisation Project in 
1987 – 1991 [107], the Indonesian Ministry of Health added Hepatitis B (HepB) 
vaccine into the national immunisation programme in 1997. During that time, a 
DTP and HepB containing vaccines combination (DTP-HepB) was also introduced, 
so that if the children received the combination of DTP-HepB vaccine, they would 
have 4 doses of HepB in total: one dose of HepB at birth, and 3 doses of DTP-HepB. 
If they received separate DTP and HepB vaccines, however, the HepB vaccine is 
given as three doses: at birth, at one month old, and at two months old [108, 109].   
In 2013, Haemophilus influenza type b (HiB) vaccine was also introduced into 
Indonesia’s national immunisation programme after a series of studies measuring 
incidence, disease burden, and the cost effectiveness of vaccination [110-112]. The 




and HiB. With this vaccine addition, the current basic immunisation in Indonesia 
includes one dose of Hepatitis B vaccine at birth; one dose of BCG vaccine; three 
doses of pentavalent vaccines containing DTP-Hepatitis B-Hib; four doses of polio 
vaccines; and one dose of MCV. All these vaccines are scheduled before the child’s 
first birthday (Table 2.2) [113]. In terms of the types of polio vaccine, the 
Inactivated Polio Vaccine (IPV) was introduced in one province in 2007, and it was 
then included in the routine national immunisation programme in July 2016 [114].  
Table 2.2: Indonesia's current basic immunisation programme 
Age (month) Vaccine given 
0 (at birth) HepB 0 
1 BCG, Polio 1 
2 Pentavalent 1 (DTP-HepB-HiB) 1; Polio 2 
3 Pentavalent 2 (DTP-HepB-HiB) 2; Polio 3 
4 Pentavalent 3 (DTP-HepB-HiB) 3; Polio 4 
9 Measles 
 
In 2013, the fourth dose of DTP-HepB-and Hib vaccines and the second dose of 
measles containing virus were also added as booster doses for children aged 18 
and 24 months respectively [113]. Further booster doses for measles, and 
diphtheria toxoid and tetanus toxoid containing vaccines in the form of DT and Td 
vaccines are also scheduled for older children in school-based immunisation 
programmes. Therefore, in addition to the basic immunisation programme for 
children before one year of age, these booster doses for older children are also 
part of routine immunisation programme [113].  
Other types of vaccines recommended for children by WHO such as rotavirus, 
pneumococcus, and a combination vaccine of mumps, measles, and rubella (MMR) 
are also available throughout the country, but these have not been included in the 
government’s programme of immunisation.  
The basic immunisation target and immunisation service delivery 
The population target for Indonesia’s basic immunisation programme in 2015 was 
4,749,791 children under one year old, and total population target for routine 




Indonesia’s population [9]. This child population is also distributed unevenly, with 
the majority of them living in the western part of Indonesia.  
In the Indonesian health system, the procurement of vaccines for the child 
immunisation programme remain centralised, so that the central government is 
responsible for procuring the vaccines through a national budget line. As with 
other health services, the sub-national and district government are responsible for 
operational cost and service delivery [115]. 
The basic immunisation programme in Indonesia is delivered through community-
based health posts for mother and child care (Pos Pelayanan terpadu-Posyandu), 
village maternity clinics (Poliklinik desa), community health centres (Pusat 
kesehatan masyarakat- Puskesmas), state hospitals, and private healthcare 
providers. The basic immunisation service is free of charge, except when provided 
by private health centres. 
The government established outreach programmes of Posyandu and ‘village 
midwife’ in an attempt to increase access to basic health services, particularly 
related to mother and child health. The Posyandu was introduced in 1983 [23]. In 
the first year of the Posyandu programme implementation, approximately 25,000 
Posyandus were established across the country, rising to 266,827 in 2009 with a 
ratio of about 3-4 Posyandu in each village [116]. A Posyandu covers a quite small 
area within a village. It is a community-based effort managed by voluntary 
community members (kader), and monitored by Puskesmas [23]. The Posyandu 
programme is designed to cover five basic health services including mother and 
child health, immunisation, family planning, improvement of nutrition, and 
prevention of diarrhoea [116]. The population target of the Posyandu services, 
therefore, includes neonates and children under five, mothers who are expecting 
or breastfeeding a baby, and people at their reproductive age. These health 
services are commonly held once a month. Figure 2.1 and Figure 2.2 illustrate 





Figure 2.1: Activity in a Posyandu: a nurse is preparing vaccine for a child 
 




The ‘village midwife’ (bidan desa) programme was first implemented in 1989, and 
aimed to deploy midwives to work and live in villages across the country [117]. 
Health services provided by the midwife mainly relate to mother and child health, 
including immunisation. It has often broadened into general health services for 
people in the entire village, however [118]. There is no research on the impact of 
this programme on child immunisation status, but some studies suggest that the 
programme has succeeded in improving child nutrition and development, with 
reduction in infant mortality [117-119]. 
Immunisation coverage in Indonesia 
Data on immunisation coverage in Indonesia can be found from WHO databases, 
the Indonesia health profile report from the Ministry of Health, results from 
demographic and health surveys, and results of basic health research. 
Demographic and health surveys in Indonesia have been conducted in 1991, 1994, 
1997, 2002, 2007, and 2012, whereas basic health research, which is a nationally-
conducted survey, has been done in 2007, 2010 and 2013. In terms of 
immunisation coverage, those four data sources present different rates of 
immunisation coverage: the survey-based data show a lower rate than that of 
reported data. These findings are consistent with other studies comparing 
reported data to survey-based data [103, 104]. 
During the 2012 – 2013 period, DTP3 immunisation coverage recorded by 
Ministry of Health data was approximately 99%, higher than the WHO estimation 
of DTP3 coverage of 85%. The survey-based result produced much lower 
estimates. The 2013 basic health research calculated 75.6% DTP3 coverage, while 
the 2012 demographic and health survey reported 70.6% of DTP3 immunisation 
coverage [22, 101, 120, 121].  
Based on government reported data, the full basic immunisation coverage also 
recorded reaching 89.9% in 2013, a decrease from 93.6 in 2010 [120]. In contrast, 
a nationally-conducted basic health survey done in 2013 calculated that 59.2% of 
children aged 12 – 23 months received full basic immunisation at any time before 




conducted in 2010 [22]. The demographic and health survey in 2012 showed that 
only 40.3% of children aged 12 – 23 months received full basic immunisation, with 
a percentage decrease to 36.8% of coverage of full basic immunisation given in 
accordance with schedule recommended, which is before 12 months [121].  
Explanations of differences between these data sources have been presented in 
comparison studies [100, 103, 105]. All the data sources have their own potential 
biases in collection of data. The reported data relied mostly on the health services 
report, and health services may have varying quality in their health information 
systems. In contrast, the survey-based data may have recall bias as some 
respondents could not show an immunisation record card, so the data then relied 
on mothers’ or caregivers’ recollection. In Indonesia’s case, however, the reported 
data showed far higher estimates compared to that of both surveys’ data 
(nationally-conducted health survey, and demographic and health survey). The 
accuracy of the higher estimate is questionable as there were diphtheria outbreak 
cases in some provinces during 2011 – 2016, and also a polio outbreak during 
2005 – 2006 [8, 9, 122, 123]. In 2012, the incidence of diphtheria and measles 
reported was also high, with 1,192 and 15,498 cases respectively, and also 
recorded as the second highest incidence of diphtheria and measles worldwide 
[124].  These outbreaks and high incidence rates suggest much lower coverage.  
Immunisation coverage varies widely among provinces in Indonesia. Based on 
both demographic and health survey and basic health survey data, Papua and 
Yogyakarta Provinces consistently showed the lowest and the highest rate for all 
type of immunisation coverage, respectively. Only about 20% children aged 12 – 
23 months in Papua Province received full basic immunisation, while more than 
80% of children in Yogyakarta Province received full basic immunisation [22, 
121]. The striking differences in these two provinces may be explained by 
geographical location, which influences access to and availability of health services 
[24]. Papua Province is situated at the most eastern part of Indonesia and shares a 
land border with Papua New Guinea. Topographical issues - it is mostly 
mountainous with vast forest areas - have limited both access to and the 




Jayawijaya Mountains, with their peaks at approximately 4,700 metres above sea 
level, are located in the centre of Papua province. Yogyakarta Province, a relatively 
small province compared to others in Indonesia, is located at the centre of Java 
Island, consisting most of lowlands. Yogyakarta is also a special region as it is led 
by a king, so that it is a kingdom within a country. It is also famous as an education 
centre, with a lot of accredited universities and schools located there. Thus, 
Yogyakarta Province has many recently graduated health professionals, enabling 
excellent access to and availability of health services, including immunisation.  
As described earlier, trends over time for individual vaccines and full basic 
immunisation coverage showed that immunisation coverage in West Sumatera 
Province was lower than national totals, while in East Nusa Tenggara Province, it 
was higher [108, 121, 125, 126].  
2.3.2 Epidemiology of immunisation preventable diseases 
2.3.2.1 Global burden of immunisation preventable diseases 
Immunisation has successfully improved public health through decreasing infant 
and child mortality from preventable communicable diseases. The higher the 
immunisation coverage, the lower the incidence of disease [127]. The number of 
reported cases of immunisation-preventable diseases dropped significantly within 
first decade of EPI implementation, and continued to decrease with increasing 
immunisation coverage. The number of reported measles cases, for example, 
dropped from 4.2 million in 1980 to 1.3 million in 1990, and in 2016 it was about 
110,000 cases [128].  
Polio is almost eradicated – some WHO regions have been freed from all type of 
poliovirus, leaving only one type of poliovirus to be eliminated [129, 130]. 
Currently, the world is also working toward measles elimination [131, 132]. This 
programme, however, is challenged by immunisation coverage gaps between 
developed and developing countries, and sub-national coverage gaps between 
rural and urban areas [133].  
Vaccination preventable diseases, therefore, remain the major cause of child 




than 8.7 million global deaths of children under five were caused by immunisation 
preventable diseases, with more than half of those deaths in Africa and South-East 
Asia [134]. Although measles, pertussis and tetanus were among the first vaccines 
included in the Expanded Programme on Immunisation in the mid-1970s, those 
immunisation preventable diseases are still causes of neonate and child deaths in 
2015 [135]. 
In South-East Asia, despite a significant increase in immunisation coverage, 
immunisation preventable diseases including measles, diphtheria, pertussis, and 
tetanus remain major public health problems. Reported cases of these diseases are 
prevalent. In 2015, with the average level of DTP3 immunisation coverage at 87%, 
there were more than 37,000 diphtheria, pertussis, and tetanus cases, and with 
85% of MCV1 coverage, 29,000 measles cases were reported [136]. Introduction 
of new vaccines within this region also lags behind its developed counterparts, so 
that disease burden from new vaccines-related diseases such as Hepatitis B, 
pneumonia, and rotavirus diarrhoea are still high [137-140].   
2.3.2.2 National burden of immunisation preventable diseases 
The incidence of diphtheria and measles in Indonesia remains high despite 
extensive government outreach programmes to improve immunisation coverage. 
Indonesia’s Ministry of Health declared diphtheria outbreaks during 2011 – 2016 
in some provinces, including East Java, West Sumatera, and West Java [8, 9]. 
Moreover, in 2012, 15,498 measles cases were reported, responsible for 5% of 
mortality in children under five [3, 124].  
In 1995, Indonesia was declared free from polio. The polio eradication programme 
suffered a setback ten years later, however, when a wild poliovirus originally from 
West Africa was found in West Java. More polio cases occurred in that period 
particularly in Sumatera and Java, and there was also a massive vaccine-derived 
poliovirus outbreak on Madura Island [122, 141]. To address these problems, 
national mass immunisation programmes were implemented, and the last 
poliovirus cases occurred in 2016. In 2014, the entire South-East Asia region was 




Prevalence of Hepatitis B infection in the population is indicated with Hepatitis B 
virus surface antigen (HBsAg). Studies have shown the prevalence of HBsAg 
between 4.0% – 7.1% in the general population [143]. This prevalence increases 
in high risk groups such as patients on haemodialysis, commercial sex workers, 
and health professionals [144]. A pilot mass Hepatitis B (HepB) immunisation for 
children in Lombok showed that three doses of Hepatitis B vaccine has 
successfully decreased HBsAg prevalence from 6.2% to 1.4% [107]. Recent 
studies, however, suggested that Indonesia still has low to moderately endemic 
areas of Hepatitis B virus, although a HepB vaccination has been included in the 
basic immunisation programme nationally since 1997. This may be an indication 
of low HepB immunisation coverage at birth [143, 145]. There is also a higher rate 
in young adults, as shown with HBsAg prevalence of 15.7% in Ternate, and 4.6% 
in Banjarmasin [146, 147]. This population group might have been born before the 
Hepatitis B immunisation programme was implemented or missed the Hepatitis B 
vaccination schedule.  
Pneumonia, an infectious disease that is caused by some types of bacteria 
including Streptococcus pneumoniae (pneumococcus), and Haemophilus influenza 
type b, is a leading cause of mortality in children under five worldwide [138]. 
About 60% of those deaths occurred in only ten countries, one of which is 
Indonesia [148]. The Indonesia 2013 basic health survey revealed that the 
prevalence of pneumonia in the general population was 4.5% [22]. In a 
Haemophilus influenza type b vaccine-probe study conducted in Lombok, 
Indonesia during 1998 – 2002, more than half of children under two included in 
the study developed clinical pneumonia [112]. This high burden of pneumonia, 
particularly in children, has led the government to include Haemophilus influenza 
type b vaccine in the national immunisation programme from 2013. This vaccine 
may also prevent children from contracting meningitis [111]. Since 2007, WHO 
has also recommended pneumococcal vaccines to be added into national 
immunisation programmes, but it has not been incorporated into Indonesia’s 




Another leading cause of child mortality in Indonesia is diarrhoea. In 2013, 
diarrhoea was responsible for 6% deaths in children under five, and more than 
half of acute diarrhoeal hospitalisation among children under five was caused by 
rotavirus [3, 150, 151]. Rotavirus vaccination is cost-effective and could 
potentially reduce the high burden of this diarrhoeal disease [152, 153], but it has 
not been introduced yet into the national immunisation programme.   
2.3.3 Challenge for immunisation programmes in Indonesia 
Challenges related to immunisation programme implementation in low and 
middle-income countries include health-system related factors on the supply side, 
and family and parental characteristics on the demand side [154, 155]. 
2.3.3.1 Supply side  
Health system related factors in Indonesia are made more complex due to its 
many islands, making physical access – geography and topography – the first 
barrier to delivering healthcare services, including immunisation. There are still 
remote and inaccessible areas with limited transportation. This has resulted in 
inequity of access and availability of immunisation services between rural and 
urban areas, and inequality of health services across the country [156, 157]. 
Implementation of governmental outreach programmes in the late 1980s has 
increased access to immunisation services. More than three decades after 
implementation of Posyandu, however, the achievement of immunisation coverage 
has not met the national target of 91% coverage, and there are wide geographical 
disparities across the country [7, 9]. Acknowledging this, in 2001, the government 
introduced a programme named ‘Posyandu revitalisation’ aimed at improving 
Posyandu performance, particularly for Posyandu which were inactive or located 
in low-income communities [116]. 
The decentralisation implemented in early 21st century, moreover, worsened the 
geographical disparities. Central government was responsible for vaccine 
procurement and distribution, whereas local government was responsible for cold 
chain maintenance and immunisation delivery services. With this decentralisation, 




central government also cannot control the immunisation delivery services. Health 
performance among districts, therefore, relies on the capacity and capability of 
local government in managing their budget and health related programmes. This 
decentralisation has led to a wide variation in funding availability for health 
among districts. During the first decade of decentralisation, immunisation 
coverage stagnated, and more disease outbreaks occurred [67, 158-160].  
Another practical obstacle in Indonesia is vaccine management, including 
distribution, handling and storage. Inappropriate vaccine management has been 
found in both government-owned health facilities and private facilities [161, 162]. 
Vaccines were properly stored and managed only at provincial level, and a wide 
variation of vaccine management occurred at district and primary health facility 
level. In Indonesia, vaccines are commonly stored in refrigerators and distributed 
with vaccine carriers. This storage relies on uninterrupted electricity supply. Most 
primary health centres do not have backup electricity generators even though 
total blackouts are still common. Some refrigerators are also not fitted with 
temperature monitoring [161]. A study conducted in Semarang, the capital city of 
Central Java Province, showed that more than half of private facilities managed 
vaccines inappropriately. It was found that there were no temperature monitors, 
and the refrigerators were not used solely for vaccine storage [162].  
2.3.3.2 Demand side 
On the demand side, child immunisation uptake is influenced by the community 
and the characteristics of their people, which are complex, and are country and 
region specific [154, 155]. Indonesian people comprise a number of distinct ethnic 
groups with different characteristics, cultures, and religions [116]. To improve 
immunisation coverage, therefore, more detailed information about people and 
community characteristics that influence vaccination behaviour is needed.  
Establishing outreach programmes to improve access to and availability of 
immunisation services is crucial. However, the communities’ acceptance of and 
participation in the programmes determine their success. Studies showed that 




Most Posyandu provide health services once a month during the morning of work 
days – a major barrier for working mothers. Other factors associated with 
Posyandu participation were mothers’ satisfaction and economic status. Mothers 
dissatisfied with Posyandu services less frequently attend the Posyandu, and 
higher income families also participated less frequently in Posyandu as they are 
able to take their children to other health facilities, including private clinics [25]. 
Taking the child to other health facilities was also found to be one of the reasons of 
not attending Posyandu [163].  
Further, the local community context needs to be acknowledged in delivering 
immunisation services. Administering the birth dose of the Hepatitis B vaccine 
(which has to be injected no more than 24 hours after birth), for example, is 
challenging particularly in rural areas where most mothers give birth at home. 
Although some of these home deliveries are attended by health professionals, 
unavailability of vaccine in the community, and people’s reluctance to inject babies 
less than seven days old has increased the number of missed opportunities, where 
there is contact with health professionals but the contact did not result in 
vaccination [164].  
Immunisation acceptance was also related to cultural values. People in the eastern 
part of Indonesia, Southeast Sulawesi and Maluku provinces, believe that babies 
must not be taken out from the house for 40 days after birth, so mothers would 
not take their babies to health facilities for immunisation [164]. Past studies on 
Java Island found that the dominant Muslim beliefs played an important role in 
vaccine acceptance [36, 165]. Some people refused immunisation as they believed 
that that vaccines were haram (prohibited according to Muslim ideology) as they 
are made with pig products [35, 165].  
Perceptions about disease also influence immunisation behaviour – mothers  who 
perceive that the diseases the vaccines prevent are not dangerous tended not to 
immunise the children [36]. In one polio outbreak area, the communities’ 
perception that vaccine could make children sick was found to be the most 




Some demographic characteristics including the mothers’ education level, her 
occupation, and maternal age have been also shown to influence immunisation 
acceptance [36, 156, 163]. The higher the mothers’ education level, the more likely 
they are to have their children fully immunised [121]. The mothers’ education 
status was also positively correlated to higher knowledge about vaccines and their 
associated diseases, which in turn influences their attitude toward immunisation 
[166]. Maternal education level also influenced whether or not mothers utilise 
antenatal and postnatal care [167, 168]. Studies have shown that maternal age 
influenced mothers’ behaviour in immunising their children, as the highest 
prevalence of having fully immunised children was for mothers in their thirties, 
and a lower maternal age was associated with not immunising their children [156, 
163].  
2.3.4 Summary of literature study on child immunisation 
Despite variations in the immunisation coverage reported by different data 
sources, the high prevalence of vaccine-preventable diseases and frequent 
occurrence of outbreaks demonstrates that immunisation uptake needs to be 
improved. The challenges reviewed showed that achieving target immunisation 
coverage in Indonesia requires a comprehensive strategy addressing both supply 
and demand sides. Merely improving access to and availability of immunisation 
services may not suffice in changing people’s behaviour. Community 
characteristics and their perceptions toward the services also influenced people’s 
acceptance of and participation in the programmes. It is thus important to 
understand community behaviour in child immunisation in order to maximise 
efforts by the health systems to improve the nation’s health. Acknowledging 
community behaviour and local context, therefore, enables interventions to be 
tailored to address specific factors influencing community behaviour related to 
immunisation.  
However, studies on social determinants of immunisation uptake in Indonesia are 
limited. Most available studies are conducted on Java Island, with fewer studies 
conducted outside Java, and no studies on social factors influencing immunisation 




previously described in Chapter 1, people in these two provinces are culturally 
different. Despite the better access to health facilities in West Sumatera compared 
to those in East Nusa Tenggara, the immunisation coverage was lower than that in 
East Nusa Tenggara. Gathering information in these two communities would 
therefore likely provide rich information regarding factors determining 
immunisation uptake in less developed areas.  
2.4 Diabetes mellitus 
2.4.1 Definition, diagnosis and treatment of Diabetes Mellitus 
Diabetes Mellitus (DM) is a metabolic disorder characterised by chronic 
hyperglycaemia as a result of impairment in insulin secretion, function, or both. 
Based on its underlying cause, diabetes is classified into four types: type 1 
diabetes, caused by ß-cells destruction that resulted in absolute insulin deficiency; 
type 2 diabetes, characterised mainly by inadequate insulin secretion or when the 
body becomes resistant to insulin; gestational diabetes, high blood sugar occurring 
during pregnancy; and other specific types of diabetes, such as caused by genetic 
defects of ß-cells, or drug-induced diabetes [169]. Type 2 diabetes accounts for 
approximately 90% of the total diabetes patients in the world [169]. This thesis 
focuses on type 2 diabetes; therefore the term ‘diabetes’ used throughout the 
thesis refers to type 2 diabetes mellitus.  
Symptoms of hyperglycaemia may include excessive urination, thirst, and hunger, 
weight loss, and blurred vision. Occurrence of these symptoms may vary, 
therefore diagnosis should be performed with diagnostic tests. According to the 
WHO, two main tests are recommended for diagnosing diabetes - fasting plasma 
glucose, and 2-h plasma glucose. Fasting plasma glucose (FPG) is plasma glucose 
level measured after at least eight hours of no food or drink other than water, and 
the 2-h PG is plasma glucose level measured two hours after a 75 grams of 
anhydrous glucose intake in oral glucose tolerance test (OGTT). Based on these 
two diagnostic tests, WHO also define two additional conditions where plasma 
glucose level is below the criteria for diabetes diagnosis, but the patient is at 
higher risk for developing diabetes. These are known as pre-diabetes: impaired 




the level of FPG and 2-h PG for diabetes, IGT, and IFG diagnosis. The term 
‘normoglycemia’ is used to describe people with a plasma level below these 
criteria. 
In addition, random plasma glucose levels might also be used for diabetes 
diagnosis in people experiencing acute symptoms of hyperglycaemia [170]. 
Random plasma glucose is a blood glucose measurement from a blood sample 
drawn at any time, regardless of whether fasting or not. A diagnosis of diabetes is 
confirmed for people with acute hyperglycaemia symptoms with the level of 
random plasma glucose of ≥ 200mg/dL (11.1mmol/L) [170]. A study has also 
found that the random plasma glucose level also has potential for detecting 
undiagnosed diabetes. A random plasma glucose level of ≥100mg/dL indicates the 
need for further diabetes screening [171].  
Table 2.3: Level of FPG and 2-h PG for diabetes, IGT, and IFG diagnosis 
Diagnoses Fasting Plasma Glucose 
(FPG) 
2-h PG 





<126 mg/dL (<7.0 mmol/L) ≥ 140mg/dl – <200mg/dl  
(≥ 7.8 mmol/L – 11.1 mmol/L)  
Impaired Fasting 
Glucose (IFG) 
110mg/dL to 125mg/dL <140mg/dL (7.8mmol/L) 
 
In 2011, WHO suggested that the HbA1c test can be used for diagnosing diabetes, 
provided the international standardised test is assured. The HbA1c (glycated 
haemoglobin) is formed through the non-enzymatic attachment of glucose to 
haemoglobin-a protein in red blood cells, so that the concentration of HbA1c 
depends on the concentration of glucose in blood and the life span of red blood 
cells (erythrocyte) [172]. The life span of red blood cells is approximately 120 
days, consequently the HbA1c level reflects the average plasma glucose level over 
the previous 120 days. Research has showed that the HbA1c concentration most 
accurately reflects the glycaemic control over the previous 8 – 12 weeks [173, 
174]. The measurement of HbA1c, therefore, provides long term assessment of 
glucose control which are free from daily fluctuation of blood glucose levels as 




measurement is easier to perform as the subject does not need to be fasting, and 
the blood sample can be drawn at any time [175]. HbA1c levels are commonly 
reported in two different values, the National Glycohemoglobin Standardization 
Programme (NGSP) unit of percentage, and the International Federation of Clinical 
Chemistry (IFCC) unit of mmol/mol [172]. The HbA1c level of 6.5%, equivalent to 
48 mmol/mol, is recommended as the cut off point for a diabetes diagnosis [176].  
Although diabetes is a chronic and progressive disease, people with diabetes can 
have a healthy life if the condition is detected early and is well managed. Key 
components to facilitate diabetes patients having a long and healthy life are access 
to early screening, comprehensive management including lifestyle modification, 
pharmaceutical intervention, patient education for self-care and monitoring, and 
regular screening for early detection of complications [177]. Diabetes 
management aims to improve clinical outcomes, including blood glucose, blood 
pressure and lipids control to reduce risk factors for diabetes-related 
complications [13].  
The high level of sugar in the blood of people with diabetes affects the vascular 
system. This increases the risk of microvascular (small blood vessel) damage and 
macrovascular (large blood vessel) complications [178]. The small blood vessel 
damage may lead to kidney disease, vision problems, diabetic foot ulcers, erectile 
dysfunction and periodontal disease. The large blood vessel complications may 
lead to stroke, coronary heart disease and other cardiovascular diseases [178]. 
Half of diabetic patients develop complications, mostly macrovascular. Individuals 
with diabetes have two-fold risk of developing fatal cardiovascular diseases, 
including coronary health diseases, and major stroke subtypes [179, 180]. 
Diabetes interventions include three layers of disease prevention - primary, 
secondary, and tertiary. Primary prevention focuses on decreasing the prevalence 
of modifiable risk factors, such as unhealthy diet and physical inactivity [181, 
182]. In addition to diet and physical activity, many also include smoking cessation 
programmes as a preventive strategy in diabetes, as there is evidence that most 




halting diabetes progression, and preventing complications; while tertiary 
prevention focuses on treating specific complications [182].  
2.4.2 Epidemiology and cost implication of diabetes 
The rapidly growing prevalence of diabetes worldwide, from 2.8% in 2000 to 
8.3% in 2013, has made diabetes into a global epidemic [184, 185]. Approximately 
382 million people were estimated to be living with diabetes in 2013, and more 
than half of them live in developing countries [184]. Moreover, almost half of all 
diabetes cases in adults were likely to be undiagnosed diabetes, mainly found in 
low and middle-income countries [186]. This diabetes epidemic, particularly type 
2 diabetes, is caused by a complex combination of genetic predisposition 
interacting with societal and environmental factors [187]. Risk factors for 
developing type 2 diabetes are classified into modifiable and non-modifiable. The 
modifiable risk factors describe any factor as a result of people’s lifestyle, included 
being overweight or obese, physical inactivity, sedentary behaviour, poor eating 
habits, smoking, high cholesterol, hypertension, and low birth weight due to 
malnutrition during pregnancy.  Non-modifiable risk factors include age, sex, 
ethnicity, family history and polycystic ovary syndrome [187].  
About 60% of total deaths globally and 71% of total deaths in Indonesia were 
caused by chronic diseases including diabetes [188, 189]. Diabetes itself is 
responsible for 2% of total deaths worldwide, and 6% of total deaths in Indonesia 
[12, 189]. However, the real figure is likely to be much higher, as the deaths of 
people with diabetes are usually recorded as being caused by cardiovascular or 
kidney diseases, which are complications of diabetes, rather than being recorded 
as diabetes itself [189].  
Diabetes has a large economic impact in addition to its impact on health. The 
direct impact is the cost of treatment [189]. Managing diabetes related 
complications is expensive, as most of the cases need hospitalisation. Research has 
shown that treatment costs for diabetic patients with macrovascular 
complications and microvascular complications is 2.7 and 1.5 times higher, 
respectively, than for those without complications [190]. This finding is similar to 




complications in Indonesia increased more than twofold compared to diabetes 
without complications (USD 774 compared to USD 336) [191]. The percentage of 
total health expenditure spent on diabetes was estimated at about 12% globally, 
and 7% in Indonesia [192].  
The indirect economic impact of diabetes is on lost productivity through 
premature death, illness and disability. It was found that in the United States the 
loss of productivity due to diabetes was USD 7.3 billion per year [193]. These 
direct and indirect economic burdens impact not only on family and community 
income, but also on national loss of Gross Domestic Product (GDP).It is estimated 
that in 2015, for example, the loss of national income caused by chronic conditions 
including heart diseases, stroke and diabetes in China and India is USD 131.8 and 
USD 54 billion respectively [189]. If there is no effective intervention, the financial 
impact of diabetes will continue to rise. An effective action that reduces the 
burden of diabetes will therefore bring enormous economic benefit.  
2.4.3 Diabetes in Indonesia 
2.4.3.1 Increasing prevalence and risk factors 
The increasing prevalence of diabetes, particularly in Asia and including 
Indonesia, has been attributed to lifestyle change as a result of rising income, in 
combination with a strong genetic predisposition [194]. Obesity has been 
suggested as the largest risk factor attributed to diabetes in Asia. Diabetes affects 
Asian people at a lower degree of obesity, and at younger age than in other parts 
of the world [195]. The WHO therefore recommended lower cut off points of 
weight classification by Body Mass Index (BMI) for Asia-Pacific people, with 
‘obese’ set at BMI ≥25 [196].  
These trends are also happening in Indonesia. Indonesia has the seventh largest 
diabetic population in the world, with a total of 10 million cases of diagnosed 
diabetes and an estimated 5.2 million cases of undiagnosed diabetes [197]. In 
2016, the prevalence of type 2 diabetes was 7%, which increased from 5.8% in 
2014 [11, 12]. This increasing prevalence of diabetes was a result of increasing 




circumference > 90 cm in men and > 80 cm in women), obesity, pre-diabetes, and 
smoking [20, 21, 198-205]. Diabetes in Indonesia affects more women than men 
(7.7% compared to 5.6%) as obesity is more prevalent among women than men 
(19.64% compared to 8.9%) [20, 206]. Metabolic defects were also detected 
earlier in the first-degree relatives of people with diabetes, implying a clear 
genetic component [207].  
Diabetes in Indonesia affects not only people in urban areas, but also those in rural 
areas, as the increasing obesity rate also affects people who live in rural areas with 
low-economic status [20]. A national survey conducted in 2013 showed that the 
diabetes prevalence in rural areas was slightly higher than that in urban areas 
(7% compared to 6.6%) [206]. One study showed that diabetes prevalence in 
Ende, a rural area of East Nusa Tenggara, was 2.83% based on HbA1c criteria [94]. 
A recent study has also found that the prevalence of diabetes in people aged 30 – 
65 years old living in rural areas of Yogyakarta, and of lower socioeconomic status 
was 9.5%, and more than half of the participants were obese [208]. A study in 
North Sumatera found that 68.5% of women aged ≥20 years were obese, and 
11.5% of them suffered from diabetes [199]. The highest prevalence (19.6%) was 
found in suburban areas of Ternate, eastern Indonesia [209]. Low socio-economic 
status is associated with high prevalence of diabetes [210], and this might be 
caused by increasing risk factors, such as a higher prevalence of smoking, lower 
fruit and vegetable intake, and lower physical activity in people with low and 
middle income [211]. With this condition, interventions in Indonesia should not 
only cover people in urban and wealthier areas, but also rural areas with lower 
economic status. 
While diabetes may be associated with an increasingly westernised lifestyle, this 
may be not the case in Indonesia. From the beginning of 21st century, Indonesia 
has had a remarkable increase in economic development [59], but for most 
Indonesian people, this increasing income has enabled them to practise culture-
specific behaviours that have been considered as prestigious in the traditional 
context [212]. For example, Fanany and Fanany [212] described that the ability to 




people can afford these. Increasing diabetes prevalence in Indonesia is therefore 
also associated with cultural beliefs. 
2.4.3.2 Poor glycaemic control and prevalent diabetes-related complications 
A national study in 2008 found that 97.5% of diabetes patients in Indonesia were 
categorised as having type 2 diabetes, with an average age of diagnosis 49.68 ± 
6.8 years old. The majority of diabetes patients experienced poor glycaemic 
control with HbA1c of 8.1 ± 2.0% [213]. Type 2 diabetes is characterised by slow 
onset of symptoms. Many people in Indonesia, therefore, do not realise they have 
diabetes until they get complications. One study suggested approximately 70% of 
diabetes patients were undiagnosed [198].  
Uncontrolled blood glucose has led many people with diabetes to experience 
diabetes-related complications [213-218]. A study in Yogyakarta showed that 55% 
of people with diabetes suffered from macrovascular complications, and 5% 
experienced microvascular complications [191]. Approximately 80% of diabetes 
patients experienced abnormal urinary excretion of albumin – a protein in the 
blood- which is a predictor of diabetic kidney disease, and approximately 36% had 
renal impairment [218]. Diabetic kidney disease caused approximately 18% of end 
stage renal disease in haemodialysis patients [219]. The prevalence of diabetic 
retinopathy, and vision threatening diabetic retinopathy found from a community 
based study in Yogyakarta was 43.1%, and 26.3%, respectively [220]. Diabetic foot 
ulcer (DFU) is the other most common complication found, with approximately 
55.4% of diabetes patients having DFU risk factors, and 12% of them experiencing 
DFU [216, 217]. Further, diabetes was also an important risk factor preceding 
stroke [221], and both stroke and diabetes caused premature mortality in Central 
Java [222].  
2.4.3.3 People’s perception and behaviour related to diabetes 
Another problem related to diabetes in Indonesia is people’s perception of the 
disease and its treatment. A study conducted by Pujilestari, et al. [43] found that 
people perceived diabetes to be a disease of the wealthy, and so it would not affect 




people with a family history of diabetes. They also thought that they were free 
from diabetes if they lived in a traditional way, and they did not perceive that their 
eating and smoking habits might lead them to have diabetes [43]. Some diabetes 
patients also consider that diabetes is not a serious illness because they can still 
perform everyday activities. Regardless of their religion, people with diabetes also 
believed that the disease is part of God’s will [223]. Yuniarti [224] explained that 
diabetes was believed to be something bad and inherited. Many diabetes patients 
were also unable to accept their illness, and the illness was the source of stress as 
they got tired easily [224]. It was also found that beliefs about treatments were 
associated with seeking care [225]. These perspectives, views, and beliefs all 
together may affect people’s behaviour in seeking care and treating the disease. 
However, research on diabetes patients’ behaviours and experiences in managing 
diabetes is limited [226]. 
Many people with diabetes have low adherence to medications, and also take 
alternative and complementary medicines [227, 228]. Traditional medicines are 
favoured because of people’s confidence in traditional healers, fear of the side 
effects of modern medicines, and the perception that they may not have been 
cured after taking modern medicines [229]. Although some of herbal-derived 
traditional medicines for diabetes have been extensively studied [230], their doses 
in the community are not standardised, resulting in unpredictable clinical 
outcomes [231].  
2.4.3.4 Diabetes is associated with tuberculosis, undernutrition, and stunting  
Diabetes is a risk factor for tuberculosis, and this evidence is confirmed by studies 
conducted both internationally [16, 232, 233], and in Indonesia [14]. People with 
diabetes, particularly with poor glycaemic control, have a two to three times 
higher risk of contracting tuberculosis than people without diabetes [16]. A recent 
study in Semarang showed that about one third of tuberculosis patients 
experienced uncontrolled blood glucose, and the majority of these patients with 
uncontrolled blood glucose had a history of diabetes [234]. This diabetes and 
tuberculosis comorbidity will result in further problems in managing those two 




recurrence and fatality [233]. Tuberculosis drug treatments reduce the 
effectiveness of diabetes drug treatment and vice versa, which then requires dose 
adjustment and/or longer therapy [235, 236].  
Diabetes, therefore, could be a serious health threat in Indonesia as approximately 
10% of global tuberculosis patients live in Indonesia. Tuberculosis incidence in 
Indonesia recorded in 2016 was 399 per 100,000 population. This rate was far 
higher than the average of tuberculosis incidence in the South-East Asia region 
and globally, which were 211 and 133 respectively [18, 19]. 
Furthermore, diabetes and its risk factors are associated with undernutrition and 
stunting in childhood [15], other health problems that remain in Indonesia. 
Children who are undernourished in the first two years of life and have rapid 
weight gain later in childhood, are at high risk of developing chronic diseases 
including diabetes [15]. Stunted children also have a higher risk of being 
overweight in adolescence and adulthood [237-239]. Moreover, low birth weight 
and nutritional deprivation during pregnancy correlate with increasing risk of 
diabetes in later life [187].  
In the case of Indonesia, the 2013 Basic Health Research survey reported that 
national prevalence of undernutrition and stunting in children under five were 
19.6% and 37.2%, respectively [22]. The highest prevalence of undernutrition 
(>30%), and stunting (>50%) was found in East Nusa Tenggara Province [22]. 
Usfar, et al. [21] and Roemling and Qaim [20] therefore suggested that increasing 
prevalence of obesity in Indonesia is related to other nutritional problems of 
undernutrition and stunting.  
2.4.3.5 National programmes and health delivery services for diabetes 
Diabetes management in Indonesia is also challenged by the capability of health 
providers in delivering services. Guidelines for diabetes management have been 
developed in Indonesia, but health professionals often do not follow them [240, 
241]. Studies also demonstrated that there is insufficient capacity of health 





In terms of national programmes related to non-communicable diseases, the 
government has introduced three different programmes: community-based health 
posts for the elderly (Posyandu lansia-Pos pelayanan terpadu lanjut usia); 
integrated posts for managing non-communicable diseases (Posbindu PTM-Pos 
Pembinaan terpadu penyakit tidak menular); and a programme for managing 
chronic diseases (Prolanis-Program pengelolaan penyakit kronis). The Posyandu 
lansia and Posbindu PTM programmes focus mainly on early detection of risk 
factors of non-communicable diseases and improving general health, while the 
Prolanis programme focuses on improving outcomes of people with diabetes and 
hypertension.  
The Posyandu lansia was first introduced in the early 21st century. This 
programme targeted the elderly, and aimed to detect early risk factors of non-
communicable diseases, and improve general health. As in the Posyandu for 
children programme, this programme invites voluntary participation of 
community members to manage the programme in collaboration with Puskesmas 
[27]. In 2010, the Indonesian Ministry of Health through its directorate of non-
communicable diseases control introduced a programme named Posbindu PTM. 
This programme targets people aged 15 years and older to detect early and 
manage risk factors of non-communicable diseases. Activities within this 
programme may include counselling for a healthy lifestyle, along with 
measurement of body mass index, blood pressure, blood glucose, and blood 
cholesterol levels [243]. Following the implementation of Universal Health 
Coverage (UHC) on 1st January 2014, the government also expanded Prolanis, a 
programme for managing chronic diseases, including hypertension and diabetes to 
also cover the patients under the universal health coverage scheme [244]. Before 
the implementation of UHC, the programme was managed by health insurance for 
civil servants (Askes), and would only cover patients under the Askes insurance 
(i.e. civil servants).  
Implementation of these programmes, however, particularly in the era of 
decentralisation, relies on local government capacity and commitment to 




across the country. The implementation of Posyandu lansia, for example, 
depended on support from voluntary community health workers within the 
community [28, 29]. Lack of resources and facilities, and lack of people’s interest 
in the programme are the most common obstacles that may hinder the success of 
the government programmes [29, 30]. Therefore, revitalisation or new initiative in 
the implementation of these national programmes for non-communicable diseases 
is needed to improve the performance of the programmes.  
In terms of healthcare services for diabetes patients in Indonesia, before the 
implementation of Universal Health Coverage (UHC), people could choose for 
themselves which health services they wanted to go to: either public or private 
facilities; and either primary health centres or directly to hospital. Diabetes 
speciality clinics are commonly located in hospitals, as they have more 
sophisticated laboratory facilities, specialist doctors, and a more complete range of 
medications. Following the implementation of UHC, everyone (including diabetes 
patients) is required to go to primary healthcare facilities first, either Puskesmas, 
or other private primary health centres that collaborate with the insurance 
management agency (BPJS). If the primary care facilities cannot provide services, 
patients are referred to the higher level of health services, which are hospitals - 
either public hospitals or private hospitals that have collaborated with the 
insurance management agency. This means that the patients cannot go directly to 
secondary or tertiary care facilities, except in case of emergency. In the UHC era, 
moreover, there is also a ‘refer back’ (rujuk balik) policy, where patients from 
secondary or tertiary healthcare facilities are referred back to primary care 
facilities after their condition improves. Continuing treatment is then provided by 
the primary healthcare facilities. In the case of chronic diseases including diabetes, 
the ‘refer back’ programme means that primary healthcare facilities are 
responsible for patients’ regular treatments. They are allowed into the secondary 
or tertiary health care once every three months or in case of emergency [67, 245].  
This new process of obtaining treatment is challenging. In terms of health systems, 
this new policy may be well implemented provided that primary care facilities 




medications. In some areas of Indonesia, however, the resources available in 
Puskesmas are lacking [246]. In terms of patients’ opinions of UHC, some find that 
UHC limits their ability to access the secondary and tertiary health facilities they 
could before [247]. They also showed a higher trust in physicians or specialists in 
hospitals compared to primary care doctors. Moreover, they also argued that the 
Puskesmas provided lower quality of services as shown by long waiting times, and 
short opening hours [247].  
2.4.4 Summary on literature study about diabetes 
The diabetes problem in Indonesia is alarming. Diabetes not only affects people in 
urban areas, but also in rural areas. Effective intervention is needed not only to 
improve patient outcomes, but also to reduce the national burden of costly 
medical treatment, particularly in the era of UHC. Addressing these problems, the 
government has implemented three different health programmes for non-
communicable diseases including diabetes. Variation in the resources of local 
government, and lack of community interest and participation in the programmes, 
however, has hindered the success of the programmes.  
On the other hand, diabetes patients’ behaviours in managing disease that 
impacted their outcomes have not been well explored yet. Understanding people’s 
behaviour and views are important in designing effective interventions that are 
well accepted by the targeted community. However, studies focusing on this in 
Indonesia almost do not exist.  
2.5 Health behaviour 
2.5.1 The importance of health behaviour study  
Health education and health promotion are essential in determining the success of 
public health programmes and medical interventions [32]. Health education is 
defined as “any attempts to close the gap between what is known about optimum 
health practice and that which is actually practiced” [248]. Moreover, Green, et al. 
[249] define health education as “any combination of learning experiences 
designed to facilitate voluntary adaptations of behaviour conducive to health”. 




information to people who lack it, but also facilitating behaviour change for those 
who have enough knowledge but have not been able to put it into practice. Health 
promotion is sometimes used interchangeably with health education, but with a 
slightly broader concept involving not only the individual, but also groups or 
communities [32]. These definitions imply that the central concern of health 
education is on health behaviour, so that the aim of providing health education is 
behaviour change.  
Health behaviour is a broad concept defined as “personal attributes such as 
beliefs, expectations, motives, values, and other cognitive elements; personality 
characteristics; including affective and emotional states and traits; and overt 
behaviour patterns, actions, and habits that relate to health maintenance and 
wellness, to health restoration, and to health improvement” [250]. This definition 
includes all three health-related behaviour terms described by Kasl and Cobb 
[251]: health behaviour; illness behaviour; and sick role behaviour. Health 
behaviour is any effort undertaken by people who consider themselves healthy for 
preventing or early detecting any diseases. Illness behaviour is any effort 
undertaken by a person who feels ill to find what illness he/she experienced. Sick 
role behaviour is any effort undertaken by a person who believes themself ill 
[251]. Health-seeking behaviour is another commonly used term which is “steps 
taken by an individual who perceives a need for help as she or she attempts to 
solve a health problem”[252]. This definition is also included in the broad concept 
of health behaviour defined by Gochman [250]. This thesis will apply the broader 
concept of health behaviour as it includes issues of disease prevention, such as 
immunisation, as well as action related to specific diseases, such as diabetes.  
After the implementation of the Expanded Programme on Immunisation (EPI) in 
1976, immunisation coverage rocketed within a decade. This trend stagnated, 
however, particularly in developing countries, and the problem of vaccine 
preventable diseases still exists. Nichter [253] argued that immunisation 
programmes are passively accepted by the community rather than actively 
demanded by the community. Passive acceptance indicates compliance where the 




demand describes adherence to the programme as a perceived benefit and need 
for the programme [253]. In order for the health programme to be sustained, 
therefore, it is important to understand social determinants that might influence 
uptake of the programme. Moreover, Nichter [253] argued there are three factors 
influencing vaccination acceptance: supply-service factors; social factors; and 
cultural perception of vaccinations and its related diseases. The last factor was 
suggested as the main factor influencing active demand of vaccination. Cultural 
values, and parental perception about the diseases were also key drivers of 
unvaccinated children [254].  
Decision making related to vaccine acceptance is complex and not only driven by 
scientific or economic evidence, but also by psychological, sociocultural, and 
political reasons [255]. Moreover, there are also specific local influences on 
vaccination programme acceptance including cultures, beliefs, perception about 
diseases, vaccines, and how vaccination programmes should be delivered [256-
258]. The success of vaccine programmes therefore depends on understanding 
behavioural and cultural values of the targeted population [258]. Streefland [259] 
further gave examples of how local culture influenced uptake of immunisation 
services. In India, social inequality based on caste was found to influence people’s 
access to immunisation services, so that people from a lower caste were reluctant 
to come to the services held in upper caste areas. In Bangladesh, the vaccinations 
were given by a male vaccinator to mothers through a curtain. As previously 
noted, religious beliefs are also associated with resistance to vaccination [256].  
Many interventions on immunisation focus on increasing services by bringing 
immunisation activity closer to the people. There is little attention to increasing 
demand for vaccination [260]. Andersson, et al. [261] demonstrated the success of 
structured community discussions done separately with male and female groups 
in increasing vaccine uptake without improving supply services in a low SES 
district in Pakistan. This community-based discussion was established based on 
previous studies on local community determinants of immunisation that derived 




Similarly, the success of diabetes management is closely related to people’s views 
related to the disease and its management, and their cultural beliefs and practices. 
This happens globally, not only in developing countries or where people lack 
knowledge about diabetes. Greenfield, et al. [263] reported that in Western 
Australia, despite having good knowledge about diabetes, diabetes patients 
experienced uncontrolled blood glucose levels as many of them did not put 
diabetes management as a high priority in their life. Other studies also explained 
different cultural beliefs and values related to diabetes that correlate with how 
people seek care and manage their illness [264-270]. Nguma [270], for example, 
described diabetes patients in Tanzania commonly delaying seeking care as many 
people tend to ‘wait and see’ if they perceive symptoms, and seek care only when 
they perceived their condition to be severe. They also commonly would go to 
traditional healers and herbalists first before going to healthcare services. The 
reverse condition has been observed in Uganda, however, where people would go 
to traditional healers when they perceived that the health care had failed [271].  
In order for diabetes programmes to be effective, therefore, people’s behaviour 
related to diabetes and its treatment needs to be understood. Other studies also 
demonstrate the effectiveness of community-based diabetes programmes tailored 
to people’s sociocultural and environment factors [272, 273]. Yazdanpanah, et al. 
[272], for example, set up nutritional education and physical activity intervention 
for diabetes patients and people at risk for developing diabetes based on a 
community needs assessment. Tucker, et al. [273] also gained success in diabetes 
intervention programmes that were set up in accordance with participants’ 
cultural backgrounds. The key element for a successful diabetes programme 
therefore is a good understanding of the community, including their health beliefs 
and cultures [274].  
2.5.2 Health behaviour theories 
Health behaviour theories explain why people perform health behaviours, identify 
factors that predict behaviours, and suggest targets for behaviour change 
interventions [32, 275]. Some theories focus more on determinants of individuals’ 




including community, and organisational context. These theories have guided this 
thesis. At the beginning, theories related to people’s behaviour in adopting health 
services and seeking care were used to understand factors influencing mothers’ 
immunisation behaviours, diabetes patients’ behaviours related to diabetes, and to 
develop questions for the qualitative research. Then, theories were also used to 
guide intervention development, based on determinants of health behaviours 
found in the qualitative research. Theories that were considered applicable in this 
thesis are discussed. However, this study does not, attempt to test these theories.  
The Health Belief Model (HBM) [276] is among the most popular theories in the 
study of people’s behaviour and behavioural interventions. This theory focuses 
primarily on individual health behaviours, and explains that they are influenced 
mainly by individual beliefs. These individual health beliefs are shaped by the 
major construct of the HBM: perceived threat – which is a combination of 
perceived susceptibility and perceived severity; perceived benefit; perceived 
barriers; and self-efficacy. These beliefs can be modified by individual 
characteristics and cues to actions (Figure 2.3).  
 
Figure 2.3: The Health Belief Model components and linkages [276] 
Stages in health seeking [277] or the Pathway Model, describes the logical process 




























making. Unlike the Health Belief Model which only focuses on the individual, the 
Stages in the health seeking model stressed the importance of society – family, 
relatives, and the wider social network – in the process of health seeking. The 
model suggests that disease is a social concept, as any disruption caused by a 
disease affects individuals’ social life and relationships with others. Significant 
others therefore also affect individuals in choosing treatments.  
 
Figure 2.4: Stages in health seeking [277] 
There are eleven sequential stages in the health seeking process that individuals 
might experience. The seeking process is started with symptom experience, 
followed by self-medication or self-treatment, communication to significant 
others, assessment of symptoms, assumption of sick role, expression of concern 
(by kin and close friends), assessment of probable efficacy or appropriateness of 
source of treatment, selection of treatment plan, treatment, assessment or the 
evaluation of the effects of treatment, and finally recovery and rehabilitation 
(Figure 2.4). All stages in this sequence may vary in duration and may sometimes 
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Other than the Stages in health seeking model, some theories focus on explanatory 
factors influencing people’s decisions in choosing certain healthcare resources. 
The Andersen Model [278] explains that health services utilisation is determined 
by three main factors: characteristics of health system delivery; changes in 
medical technology and social norms related to illness definition; and individual 
characteristics. The individual determinants are further categorised into three 
factors: predisposing; enabling; and illness level. This framework is designed 
mainly based on studies in developed countries.  
Kroeger [279] also proposed a framework explaining interrelated determinants of 
choices of healthcare resources in a developing countries context (Figure 2.5). 
This framework, therefore, is different from the previous model of Andersen and 
Newman [278]. The Anderson model explains the people’s behaviour in seeking 
care from formal health services available in the community, while the Kroeger 
Model includes people’s behaviours in seeking care from non-formal health 
providers. The Kroeger model also incorporates other factors that are better 
suited to the context of developing countries. In addition to predisposing and 
enabling factors in individual determinants described by Andersen and Newman 
[278], for example, Kroeger added anthropological concepts of people’s 
perceptions related to the disease they are experiencing. This includes whether 
the disease is chronic or acute, severe or trivial, has natural or supernatural 
causes, the expected benefit of modern or traditional treatment, and whether it is 
psychosomatic or a somatic disorder. These perceptions influence their choices in 
seeking care from a wide variety of options available in developing countries: 
traditional healer; modern healer; drug seller; self-treatment; or no treatment.  
Social Cognitive Theory (SCT) developed by Bandura (1986) is one behavioural 
model that describes broader factors influencing individual behaviour [280]. 
According to Bandura (1986) “human functioning is explained in terms of a model 
of triadic reciprocity in which behaviour, cognitive and other personal factors, and 
environmental events all operate as interacting determinants of each other”. With 
this model (Figure 2.6), the SCT not only attempts to understand factors that 
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Figure 2.6: The Social Cognitive Theory [280] 
 
Social Cognitive Theory concepts include psychological determinants, 
observational learning, environmental determinants, self-regulation, and moral 
disengagement. Psychological determinants of behaviour includes individual 
outcome expectation (perceived benefit of performing such behaviour), and 
individual belief in their own self-efficacy (perceived capability to perform an 
action). Self-efficacy has then been adopted into other behavioural models (such 
as the health belief model). Social Cognitive Theory emphasises that individual 
behaviour is also influenced through observational learning, such as learning from 
others, and learning through mass media. Peer modelling, therefore, is an 
important intervention that might be useful in altering people’s behaviour. 
Environment also shapes people’s behaviour, and vice versa, so that changing the 
environment has a powerful effect on behaviour. The environment can be changed 
through incentive motivation (rewards and punishment to modify behaviour) and 
facilitation (providing tools and resources to make new behaviours easier to 
perform). Social Cognitive Theory also includes self-regulation, a concrete skill 
that people should have to manage themselves. Increasing self-regulatory 
processes in SCT through self-monitoring, goal setting, feedback, self-reward, self-
instruction, and enlistment of social support have also been applied widely for 











2.5.3 Reflection on health behaviour theories 
The health behaviour theories presented above explain a variety of processes and 
determinants that may influence the way people behave, related to their health. 
These range from individual determinants including individual socio-demographic 
characteristics, and individual beliefs to the influence of other people, 
environment, and the wider health system factors. Although each model has a 
different focus, there are also overlapping factors that play a role in shaping 
people’s behaviour related to health. The Health Belief Model focuses on 
individual beliefs, and that the individual action depends on their perceived threat 
as compared to their perceived outcome and self-efficacy. This theory, however, 
does not incorporate the social aspects of individuals, or social aspects of the 
disease. That is, individual beliefs might not be enough to trigger action unless it is 
supported by their family, or society. In addition, that individuals’ illness may also 
influence their social role, therefore society also influences individuals’ decisions 
through social expectation norms. This social aspect of individuals and illnesses is 
important, particularly in context of people living in developing countries, in 
which most people are highly integrated in their family or community life.  
The other theories and models explain that people’s actions are influenced beyond 
the individual decision. Their behaviours are affected by significant others, their 
family, and social network. Igun [277] describes that the process of seeking 
treatment is also influenced by family, kin, close friends and other social networks. 
This theory focuses on the process of decision making, and does not include 
determining factors that influence the process of thinking about which behaviour 
people are choosing. Andersen and Newman [278] and Kroeger [279] then 
provide explanatory and interrelated factors that might influence people in their 
decision-making process about which health provider to seek help. These two 
theories go beyond individual determinants. They also include individual 
interaction with family, the influence of society, and health system factors as 
determinants of health behaviours. Given their use of studies carried out in the 
‘western cultural’ context, however, the Andersen and Newman [278] model 
emphasises the role of health professionals in the conventional health services. 




and contextual perception of diseases and disorders, and healthcare providers 
beyond western medical services. Kroeger [279] on the other hand, reviewed 
studies carried out in developing countries, so that the model also incorporates 
non-western cultural context, including non-biomedical concept of disease and 
disorders, and traditional health providers.  
This review of behavioural theories provided some direction around which my 
research was designed. I do not dwell much on the HBM as the HBM does not 
account for the role of the community, which is important in the Indonesian 
context. Although the pathway model proposed by Igun [277] emphasises the role 
of significant others in influencing behaviour, the theory does not provide an 
explanation of factors determining the choices of health providers. In the 
Indonesian context, with a wide variety of health providers - including formal and 
non-formal - the applicability of the Anderson model might be limited. The 
Kroeger model, therefore, is more relevant to be applied. 
While Kroeger [279] looked specifically at factors influencing people’s choices in 
seeking care, Social Cognitive Theory focuses on health related behaviour in 
general. The core concept of the Social Cognitive Theory is its interaction between 
cognitive, behavioural and environmental factors. Human behaviour is learnt from 
the environment through the process of observational learning. This theory, 
therefore, is widely used in behaviour change intervention that aims to modify 
people’s behaviour through peer modelling, facilitation, and other methods that 
enable them to learn a new desired behaviour from their environment. This model 
is applied in developing the intervention study explained in Chapter 4.  
All these theories led me to the summary that determinants of people’s behaviours 
should be understood based on people’s contexts, individually and socio-
culturally. Furthermore, in order to change the people’s behaviours, the 
behavioural intervention methods should be designed based on an understanding 




2.5.4 Indonesian people’s health behaviour, beliefs, and culture 
This section aims to document existing literature on health-seeking behaviour in 
Indonesia, identify areas and medical conditions that are under-studied, and 
highlight the major findings related to people’s behaviour in seeking care. To do 
this, a specific literature search was performed as outlined in subchapter 2.2, 
using the ‘Health behaviour’ keywords from Table 2.1. 
2.5.4.1 Description of relevant literature 
Fifty-six peer reviewed international articles were found from 1987 to 2017 [33, 
39-41, 44, 223, 281-330], and 19 articles from Indonesian journals from 2001 to 
2016 [331-349]. Looking at the publication dates, health-seeking behaviour in 
Indonesia drew little attention before 2000, with only six articles before that time. 
A complete list of literature included in the review of health-seeking behaviour of 
people in Indonesia can be seen in Appendix 1. 
2.5.4.2 Methodologies 
Quantitative cross-sectional designs (39 articles) were more frequent than 
qualitative designs (26 articles), with the same pattern for the Indonesian 
journals. Quantitative studies usually used an interviewer-administered 
questionnaire, possibly to reduce misunderstandings with self-administered 
questionnaires, due to literacy and language issues.  
Quantitative studies provide evidence of factors determining people’s behaviour, 
but are limited in their ability to explore the wider narrative of reasons for 
choosing specific care, which can be better explored in qualitative studies. There 
were also 10 studies applying mixed methods design [33, 285, 300, 312, 315, 323, 
324, 345, 346, 348]. Brooks et al., for example, explored secondary data from the 
Indonesian Demographic and Health Survey to quantify the effect of the insurance 
programme on maternity services, and explored barriers to the services utilisation 
qualitatively [285]. 
Most studies were community-based. Of those conducted in healthcare facilities, 




clinics. Clinic-based studies exclude people who never seek care [279]. Recruiting 
participants with a specific condition from the community means a large number 
of people need to be screened to find respondents. Some researchers, however, 
have conducted household surveys to study health-seeking behaviour related to 
acute respiratory illness, tuberculosis, and malaria [39, 289, 294, 303]. Some 
studies used secondary data from national surveys, revealing patterns of health 
care utilisation, and socio-demographic determinants [285, 307, 318, 337, 342, 
347, 349].  
One study asked about a hypothetical scenario [293], but hypothetical behaviour 
can differ from actual behaviour. Most of the other studies gathered retrospective 
information, from people who have a certain illness and asked them to recall what 
they have done to manage it [350]. This can lead to recall bias. To minimise this, 
some researchers set up inclusion criteria, for example, newly diagnosed, or 
having symptoms during the last month. In contrast, Utarini, et al. [315] used a 
longitudinal prospective design to explore people’s behaviour in seeking care for 
malaria over a one year period. They detected malaria cases in six endemic 
malarial villages and what people did during that period. Thus, prospective studies 
collect more accurate data health-seeking behaviour from the beginning of 
symptom experiences to the final stage of recovery. 
2.5.4.3 Medical conditions covered 
Many studies focused on infectious diseases such as malaria, tuberculosis, and 
leprosy. Maternity-related health was also common. Tuberculosis, malaria, and 
mothers’ and infants’ health are an important focus of the Sustainable 
Development Goals (SDGs) [6]. Despite low immunisation coverage, however, with 
wide gaps in the coverage at sub national level [121], and prevalent immunisation-
preventable diseases cases in Indonesia [3, 124], studies on people’s immunisation 
behaviour were scarce. One study was found on the social aspects of the 
immunisation programme, published in 1988 [351]. 
Non-communicable diseases studied included mental illnesses and cancer, but 




non-communicable diseases in Indonesia is rising and they became major causes 
of death in 2012 [3, 9]. The real figure is likely much higher, as most people in 
Indonesia with chronic diseases do not seek care until their health deteriorates 
[352]. Thus, more studies of health-seeking behaviour should focus on chronic 
diseases. Other diverse studies included health-seeking behaviour of infertility 
patients and transgender people related to HIV risk [299, 304]. 
2.5.4.4 Study location  
 
 
Figure 2.7: Coverage of geographical areas in the studies reviewed 
Blank map of the provinces of Indonesia by User:Golbez is licenced under CC BY-SA 3.0 
(https://commons.wikimedia.org/wiki/File%3AIndonesia_provinces_blank.png) modified 
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Most reviewed studies were on Java, the most populated island of Indonesia, 
which also includes the capital Jakarta (Figure 2.7). Java is the most developed 
region of the country. Within Java, most studies were in Yogyakarta and Jakarta. 
Beyond Java, some studies were performed in Aceh and Bali Provinces. Aceh is 
located on the far north of Sumatera, whereas Bali is an island to the east of Java. 
Socio-culturally, these provinces are different, as most people in Aceh are Muslim, 




2.5.4.5 Lay concepts of health and illness  
Concepts of health and illness are influenced by people’s socio-cultural 
background [353]. Indonesian people consider themselves healthy if they can 
perform their everyday activities without disruption. Thus, people generally 
sought help when symptoms hindered these [40, 44, 223, 281, 284, 294, 295, 297, 
301, 303, 319, 320, 324, 330]. Eeuwijk [324], for example, described that most 
older people sought care from health professionals for rheumatism, because it 
hindered their activities. In contrast, they did not seek professional help for 
problems with eyes, ears or teeth, because there was less impact on their daily 
lives. People thus delayed seeking care, until their diseases were severe.  
There is also a strong concept of ‘balance and harmony’, particularly among 
Javanese. Health is a physical status that cannot be achieved without an 
individuals’ spiritual wellbeing. Life in general should be balanced physically and 
spiritually, between individual and social life, so that a status of ‘harmony’ can be 
reached [223, 311]. Most Indonesians are also religious. Regardless of specific 
religion, people believe that health is God’s gift, and illness is their fate, and is 
sometimes viewed as God’s punishment [223, 284, 302]. 
2.5.4.6 Determinants of health provider choices 
Indonesian people’s choice of health providers is determined by complex and 
interrelated factors: socio-demographic characteristics; influence of significant 
others; socio-cultural beliefs; perception about diseases and their causality; and 
perception of medical services including accessibility and availability particularly 
in rural and areas, and its related cost [44, 223, 284-286, 290-292, 296, 298, 299, 
301, 302, 304, 305, 307, 309-311, 313, 314, 317, 318, 320, 325]. 
Socio-demographic characteristics 
Age, household size, education, and economic status determine people’s choices of 
health providers [318, 327, 347]. Poorer households were more likely to use 
traditional medicines for treating malaria [281]; older people and those in rural 
areas were also more likely to seek traditional and alternative treatment [337, 




symptoms [303]. Other studies, however, did not find a link between seeking care 
and socio-demographic characteristics [303, 308, 328, 331, 334], suggesting other 
factors may have greater impact in influencing people’s choices in health 
providers. 
Influence of significant others 
In most Indonesian communities, seeking care involves not only patients but also 
family, friends, and other community members [284, 286, 287, 290, 291, 296, 301, 
303, 310, 313, 317, 320, 325]. Recommendations from significant others were 
associated with visiting alternative healthcare providers for treating tuberculosis 
[303], and cancer [284, 301]. Religious leaders influenced tuberculosis patients’ 
choices [286]. The husband and older family members made decisions related to 
birth attendant choices [290]. 
Socio-cultural beliefs 
Most women chose to give birth at home, helped by a traditional birth attendant, 
despite the proximity of health facilities or health professionals, mainly because 
the birth attendant also performs prayers, and other traditional practices and 
ceremonies. People believe that birth is sacred and should occur in a way 
consistent with traditional beliefs [285, 290, 310]. 
Cultural beliefs also favoured traditional remedies or alternative treatments. 
These practices have been passed down for generations, and this embedded 
culture cannot be ignored. They are commonly used for treating most diseases, 
including malaria [33, 281, 315, 322], tuberculosis [40, 297, 303, 313, 320, 325], 
leprosy [302], rheumatoid arthritis [329], cancer [284, 296, 301], hypertension 
[346], stroke [44], and diabetes [348]. Traditional remedies are also used for 
promoting health and preventing disease. As an example, women took traditional 
herbal drinks in order to stay healthy during pregnancy and breastfeeding [282, 
306], and some people took bitter-tasting plants to prevent malaria [33, 39, 322, 




People perceived that conventional medicine was failing to cure illness. Fear of 
side effects, dependence on medication, and fear of medical procedures were 
other common reasons cited for using traditional or alternative treatments [284, 
288, 296, 345, 346, 348]. People view full cure as successful treatment. 
Conventional medicine was not believed to cure diabetes and hypertension, 
leading to the choice of traditional treatment [346, 348]. 
Indonesians regard traditional remedies as safe, because they are made from 
natural resources [340, 345]. People also perceived that traditional healers 
provided comprehensive services as they were also dealing with patients’ feelings 
[301], and in some cases, payment can be made in kind, for example with food 
[325]. 
Many forms of traditional remedies and alternative treatments are available in 
Indonesia. Jamu, a traditional herbal drink, is the most popular [230]. Other 
popular alternative treatments include traditional Chinese medicines, known as 
sinshe [340], treatment with animal media such as leeches [332], traditional bone 
setters [335], cupping therapy [339], and coin scratching [336]. 
Perception of causality  
Health-seeking behaviour was also influenced by perceptions related to diseases 
and causality. There were strong beliefs that mental illnesses have supernatural 
causes, so people first sought care from traditional, spiritual, or religious healers 
[291, 292, 317]. In some areas, tuberculosis and leprosy were also believed to be 
caused by black magic or bad spirits and so people sought help from traditional 
healers [302, 320, 325].  
Communities commonly have their own local term, description, and interpretation 
of illnesses or symptoms. Tuberculosis, for example, was believed to be caused by 
smoking, stress, sleeping on the floor, or other physical causes [313, 320, 325]. 
Thus, early symptoms of tuberculosis were not perceived as serious. People in 
Central Java did not recognise malaria, but the local term katisen has similar 
symptoms to malaria. Again, katisen is seen as a minor illness, leading to self-




(wind sickness), using the term angin duduk (sitting wind sickness) for heart 
disease. Masuk angin is a mild illness caused by over exposure to wind, and people 
treated it with coin scratching, so heart disease is treated in the same way [311]. 
Perception about healthcare systems 
Perceptions about medical services also influence health-seeking behaviour. Many 
people were reluctant to go to public health facilities as they experienced complex 
administrative procedures, one-sided communication style of health professional, 
and long waiting times [284, 285, 291, 298, 299, 320]. Thus, many people choose 
to go to private health providers [40, 289, 293, 294, 313, 318, 320]. Further 
reasons driving the choice of private providers include perceived quality of 
provider, availability of brand name medicines, and short waiting times [293, 313, 
319, 320].  
Health cost and people perception of health insurance 
Expanding health insurance alone was not enough to increase health care 
utilisation for people residing in rural areas [307]. Indirect costs of treatment, 
such as transportation are barriers to medical treatment [284, 290, 291, 301, 309]. 
In many cases requiring hospitalisation, family members accompanied the patient 
during their stay. Extended families were often a source of finance for extra costs, 
providing further burden [284, 290, 291, 301]. 
People experienced the insurance scheme as complicated and time consuming, 
and it was poorly socialised and understood [284, 285, 310, 312]. People therefore 
only applied once they perceived the need for help. People also perceived that 
health providers offered a low quality of service for the poor under the scheme 
[284, 285, 310, 312]. From the providers’ perspective, there has been incomplete 
reimbursement, and low payment [312].  
2.5.4.7 Care pathways 
After experiencing symptoms, people generally used self-care: taking rest; self-
medicating with medicines bought from drug stores or pharmacies; or taking 




seek help from formal health care. If that failed, they then would try other 
traditional or alternative treatments (Figure 2.8) [39, 284, 286, 296, 300, 301, 
313, 322, 325, 326, 341, 349]. Most then went to either formal or informal health 
providers, often combining or alternating medicines from different providers [40, 
320, 330, 331]. If the sick person is a child, however, going direct to formal health 
care is common [298, 321, 326, 341, 344, 349]. A strong belief exists that the 
effectiveness of treatment is a matter of being ‘suited to you’, so they would try 
alternatives to find one that suits [300, 322]. 
 
Figure 2.8: The pathway of seeking care 
1. General process of seeking care  
2. If the sick person is a child 
3. If the disease is strongly attributed to supernatural caused such as mental illness, or if they 
perceive that their symptoms have a supernatural cause 
4. Both providers, medical services providers and alternative providers, or type of 
medications, traditional and biomedicines are used as an alternate or in combination in 
order to find “fit” treatment to them.  
 
Another pathway, as mentioned before, was when people first went to any 
alternative treatments for illness attributed to supernatural causes, switching to 
formal health care when they perceived alternative treatments as ineffective [291, 
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Self-medication with biomedicines was common practice [349]. As with many 
developing countries, most prescription medicines are available illegally over the 
counter. People self-medicated with antibiotics for treating a common cold, 
headache and other minor symptoms [41, 283, 298]. People also self-medicated 
for malaria and tuberculosis [39, 40, 286, 297, 313, 315, 320, 322, 326, 333], and 
musculoskeletal pain [329]. Many observed self-medication practices are 
inappropriate [326]. 
2.5.5 Summary of health-seeking behaviour of people in Indonesia 
We found that studies were concentrated on Java. Moreover, most studies 
focussed on tuberculosis, malaria and maternity-related health. Without 
minimising the importance of these problems, it must be noted that the prevalence 
of non-communicable diseases is growing, which will increase costs and could 
hinder the newly implemented universal health insurance.  
Choices of care in Indonesia were influenced mainly by socio-cultural beliefs, and 
perceptions related to the disease and its causality, similar to other developing 
countries [354-359]. Traditional treatments were chosen when people perceived 
supernatural causes of the disease, and when they perceived that the biomedical 
system failed to cure their chronic diseases [356, 359]. The characteristics of the 
medical care provider, including availability and cost, were also relevant [360, 
361]. These factors influencing peoples’ choices align with the Kroeger’s 
framework [279].  
Traditional medicine systems are important in developing countries. People value 
their efficacy, and they are widely accepted. Thus, integrating these into formal 
health care may be more effective than discouraging them. Mothers’ preference for 
a traditional birth attendant, for example, has resulted in collaboration between 
village midwives and birth attendants in some areas of Indonesia [290]. The 
Indonesian government has also initiated efforts to ensure the safety and 
effectiveness of traditional herbal medicines [230]. In many cases, however, the 




questionable and not scientifically proven. Their existence, therefore, should not 
replace formal health care.  
Serious efforts should be made to address misconceptions related to diseases and 
perceived causality, which hinder people from seeking care. One study attempted 
to do this through implementing tuberculosis leadership groups within the 
community, who held meetings discussing peoples’ perceptions about 
tuberculosis and addressing any misunderstanding found, leading to greater 
engagement with formal health care [297]. This effort should be expanded to 
other communities and diseases.  
Negative past experiences with the public healthcare system have made people 
reluctant to engage. Improving availability and accessibility, therefore, might have 
to be balanced with improving quality of care. Another health system issue is the 
availability of prescription medicines over the counter, driving increased self-
medication.  
In summary, understanding people’s behaviour in seeking care is an important 
step for health intervention planning. This understanding would allow more 
evidence-based healthcare policy. 
2.5.6 Health behaviour of people in Indonesian communities: evidence of relevance 
of the Kroeger theoretical framework 
The Kroeger [279] model incorporates many factors that determine health seeking 
behaviour of people in Indonesia identified in the literature review. It models 
people’s choice within the wide range of health providers available being 
influenced by three major characteristics: characteristics of the person 
(predisposing factors); characteristics of disorders and their perceptions; and 
characteristics of the health services system.  
2.5.6.1 Characteristics of subject 
The characteristics of the person (predisposing factors) include age, sex, marital 
status, status in the household, household size, ethnic group, degree of cultural 




and community. Suswardany, et al. [281], for example, found that poorer 
households are more likely to take traditional medicines for treating malaria. 
Ahmad, et al. [303] also found that female patients are more likely to seek care for 
tuberculosis related symptoms. Older people, and those who are living in rural 
areas are also more likely to use traditional or alternative treatments [337, 342, 
362]. Many studies also suggested that individual interaction with significant 
others influence which providers they choose. Ahmad, et al. [303], for example, 
also found that recommendations from significant others were significantly 
associated with visiting alternative healthcare providers for treating tuberculosis. 
Fles, et al. [284], [301] also stated that people with a specific cancer of the nose 
started seeking care with traditional and alternative treatments with support from 
their family and friends. The use of traditional herbal remedies for tuberculosis 
was also generally recommended by family members or neighbours. 
2.5.6.2 Characteristics of the disorder and their perception 
Among factors determining the choices of health providers, characteristics of 
disorder and their perception seemed to be cited in most of studies of health 
seeking behaviour in Indonesia. People would seek help if they perceived that the 
symptoms were severe enough and resulted in impairment of their daily activities 
[40, 44, 223, 281, 284, 294, 297, 301, 303, 320, 324, 330]. Most people with 
tuberculosis, cancer, malaria, and other diseases delayed seeking treatment as 
they perceived that the symptoms to be harmless. Perceived causes of the diseases 
also clearly influence health seeking behaviour in the example of mental illnesses. 
Most people in Indonesia believe that mental illnesses are caused by supernatural 
power, so they will seek care from traditional or religious healers [291, 292, 317].  
2.5.6.3 Characteristics of health providers and their perception 
The characteristics of health providers include accessibility, appeal, acceptability, 
quality, communication, and cost. Women’s choices to give birth at home using a 
traditional birth attendant (TBA), for example, were also influenced by the 
accessibility, appeal and acceptability of the TBA [285, 290, 310]. The TBA mainly 
lived in their neighbourhood, so that they were available at any time. Although 




more sophisticated than the TBA, the appeal of the TBA was higher as the TBA 
conveyed not only birth related matters but also the mothers’ feelings and 
emotions. They therefore also provided comprehensive services including 
massage and performed prayer before the delivery process. Unless the delivery 
was complicated, many mothers preferred to choose the TBA over the formally 
trained birth attendant. Many people also complained about the methods of 
communication with professional health providers [284]. With the alternative 
healers, they often have much time to talk in a convenient home setting. Cost, 
particularly indirect cost, was also found to influence people’s choice of health 
care [284, 285, 290, 291, 301]. Although the government has implemented 
universal health insurance, the indirect cost of health care may therefore still be a 
key consideration, particularly for the rural poor living further from healthcare 
facilities.  
Apart from that, the Igun [277] model seems to also align with the Indonesian care 
seeking process. This process is started with the recognition of symptoms, 
including self-assessment of symptoms and whether or not they affect their daily 
activities. Then they first treated with self-medication, with traditional or over the 
counter drugs. If they then perceived that the self-medication failed, they then will 
seek care from other health providers after consulting with their significant 
others. Their significant others also recommend some other treatment perceived 
as a better way for the illness. If they felt that that choice also failed, they will find 






2.6 Key findings and gaps observed from the literature review 
The reviewed literature in this chapter examined an array of studies focused on 
the problems of child immunisation and diabetes, particularly in the Indonesian 
context. The key findings observed from the literature underlined that effective 
interventions should be developed to improve child immunisation uptake, and 
diabetes patients’ outcomes. It has been widely recognised that in designing an 
effective intervention, targeted people’s behaviours related to the health problem 
need to be understood. Numerous theories and models have attempted to explain 
the determinants of people’s health behaviours. The theories highlighted that 
people’s health behaviours are determined by individual characteristics, and their 
relationship within the socio-environmental context.  
Many studies on health-related behaviour have been conducted in the Indonesian 
context. Many of them, however, focused on a restricted range of health problems 
in Indonesia. Research on health behaviour on child immunisation has not been 
updated for a long time, and no studies on diabetes patients were found. 
Moreover, in terms of geographical areas, most studies in Indonesia were 
conducted within Java Island. Some studies outside Java were focused only in 
particular areas including Aceh and Bali Provinces. Limited studies were 
conducted in the eastern part of Indonesia.  
These key findings showed there are significant gaps in the literature. Although 
the gaps observed might include a wide range of health topics and locations given 
the wide variation of community characteristics in Indonesia, limited studies were 
observed from some areas of Indonesia, including East Nusa Tenggara and West 
Sumatera Provinces. This study, therefore, intends to fill some of those gaps. This 
current study was carried out in East Nusa Tenggara and West Sumatera 
Provinces, and aims to understand people’s health behaviour in relation to child 
immunisation and diabetes (Chapter 3). This understanding was then applied to 
establish, and implement an intervention to improve diabetes patients’ outcomes 










Section B – Understanding health-seeking behaviours of people in 
Indonesia in child immunisation and diabetes 
3 Chapter 3: Indonesian people’s perceptions and experiences related 
to child immunisation and diabetes: A qualitative study 
3.1 Introduction 
Chapter 3 presents the methodology, methods and findings of the qualitative 
study. The study was an attempt to understand health problems from the 
communities’ perspectives. Based on the literature study on health seeking 
behaviour in Indonesia detailed in Chapter 2, it was found that there are few 
studies on the topics of child immunisation and diabetes. It was, therefore, 
important to conduct a preliminary study to explore people’s beliefs and 
behaviours on these topics. Results from this study were then used to inform the 
design of the major study.  
Chapter 3 is divided into three major subchapters. The first subchapter describes 
the methodology and methods. It begins with the rationale for qualitative 
research, followed by the research process and description about recruitment of 
participants. The first subchapter ends with an explanation about instruments 
used, data collection and data handling processes. The second subchapter details 
the results of the study, including those related to child immunisation, and results 
related to diabetes. Discussions about the results are also presented. A short final 
subchapter concludes the findings and suggests future study directions.  
3.2 Methodology and methods 
3.2.1 Study design 
This qualitative study aimed to explore perceptions, beliefs and behaviours of 
people in Indonesian communities related to child immunisation and diabetes. It 
was therefore designed qualitatively to get a deeper understanding from the 
community [363]. Qualitative study enables a researcher to understand the reality 




enquiry [364]. Deeply rooted in social sciences, the qualitative design has been 
used widely in health research. Topics studied have ranged from healthcare 
organisation to social inequalities in health care [365]. 
In health behaviour studies, qualitative design enables researchers to reveal social 
aspects of health behaviours including people’s socio-cultural beliefs related to the 
condition, perceptions about the disease, and decision-making process preceding 
the action of seeking care. The qualitative enquiry has been applied to understand 
immunisation programme acceptance in Southeast Asia, and ethnic minorities in 
the United Kingdom [36, 257], and care-seeking behaviour of people with diabetes 
in Uganda, rural Australia, and ethnic minorities in the United States [263, 264, 
267, 366, 367].  
Within the qualitative design, this study applied a phenomenological perspective. 
The fundamental question in phenomenological study is “what is the meaning, 
structure, and essence of this phenomenon for this person or group of people” 
[363]. In health research, the phenomena studied might be related to people’s 
health or illness, health care, or health delivery services that are subjectively 
understood, practised or experienced [365]. In this research, the phenomena 
studied are mothers’ behaviour in child immunisation programmes, and people’s 
experiences in managing diabetes. 
The data were gathered using Focus Group Discussions (FGDs). A series of FGDs 
are an ideal method for obtaining people’s perspectives and their behaviour in a 
community. The FGD enables the researcher to explore the social context that 
influences people’s perspective and decision-making process in a community 
[363]. This discussion method is recommended particularly when the study 
involves people who are hard to reach or have a negative view towards medical 
services [365]. With the group discussion, those people might feel less threatened 
than when they are individually interviewed. In this qualitative study, potential 
participants may be people who are not willing to take part in child immunisation 
programmes, or may be diabetes patients who have negative views towards 




3.2.2 Theoretical framework 
The literature review of health seeking behaviour of people in Indonesia described 
in Chapter 2 revealed that the framework that aligns best with the Indonesian 
socio-cultural context is Kroeger’s framework [279]. Indonesian people’s 
behaviour is influenced by a number of complex interrelated factors including 
individual characteristics that interact within their society, perceptions about 
disease, and also perceptions about health services. The Kroeger framework, 
therefore, was applied in this qualitative study to develop the questions and 
interview guideline.  
3.2.3 The study location and justification 
The qualitative study was conducted in East Nusa Tenggara and West Sumatera 
Provinces. In each province, some regions were further purposively selected as 
study locations. The selection of these regions was done in order to represent 
rural and urban populations. Gathering data from urban and rural population 
groups provided rich information based on their socio-cultural context, and access 
to health care. The urban areas were characterised by high population density, 
whereas the rural areas are characterised by low population density. In term of 
health care access, the urban areas are also often characterised by higher 
availability and accessibility of healthcare facilities compared to their rural 
counterparts.  
In East Nusa Tenggara, the study was carried out in Kupang city, Kupang district, 
Manggarai district, and Manggarai Timur district (Figure 3.1). Both Kupang city 
and Kupang district are located on Timor Island, and Manggarai and Manggarai 
Timur district are located on Flores Island. Kupang city is the capital city of East 
Nusa Tenggara Provinces, and it represents the urban areas, whereas the other 
locations represent rural areas. Table 3.1 compares the population density and the 
number of healthcare facilities in study locations in East Nusa Tenggara Province.  
In West Sumatera, the study was firstly designed to collect data in Padang city, 
Pariaman city, and Solok district (Figure 3.2), as these three locations represent 




characteristics, i.e. population density and number of health facilities. Based on 
population density, both Padang and Pariaman city are categorised as urban areas. 
Padang is the capital city of the Province, and has a more sophisticated 
transportation system compared to other cities. Therefore, people in Padang city 
have greater access to healthcare facilities, compared to people in Pariaman city. 
 
Table 3.1: Population and healthcare facilities available in study locations in East Nusa Tenggara 
Province 
District/city Number of 
population 
(Population 












Kupang city 358,382 (2,296) 9 10 58 26 
Kupang 328,688 (60) 1 25 1 1 
Manggarai 309,614 (183) 2 21 9 10 
Manggarai Timur 264,979 (106) 0 20 3 0 
 
Notes: a Statistics of East Nusa Tenggara Province [87] 
b Indonesia Ministry of Health [368] 
c Indonesia Ministry of Health [369] 
 


















Solok 355,077 (95) 2 18 8 10 
Padang city 854,336 (1,229) 30 22 160 83 
Pariaman 80,870 (1,102) 1 7 25 5 
 
Notes: a Statistics of West Sumatera Province [86] 
b Indonesia Ministry of Health [370]  
c Indonesia Ministry of Health [369]  
 
During the time of data collection process, however, there was a severe haze 
problem which affected West Sumatera Province. In some areas, the haze was so 
thick that the local government recommended people not to go outside. With this 
situation, the data could only be collected in Pariaman city, and Solok district. 





Figure 3.1: Map of study locations in East Nusa Tenggara Province 
https://commons.wikimedia.org/wiki/File%3ALokasi_Nusa_Tenggara_Timur_Kota_Kupang.svg 
Ewesewes at id.wikipedia [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], from 
Wikimedia Commons, modified 
 
 
Figure 3.2: Map of study locations in West Sumatera Province 
https://commons.wikimedia.org/wiki/File%3ALokasi_Sumatera_Barat_Kota_Padang.svg 
Ewesewes at Indonesian Wikipedia [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-




3.2.4 Ethics approval and local government research approval  
Ethics approval for the qualitative study was sought through and granted by the 
University of Otago Ethics Committee New Zealand (Appendix 2.1). In study 
locations, local government approval was sought from the provincial government. 
The research approval letters were issued by Kantor Pelayanan Terpadu Satu 
Pintu (The Integrated Office of Community Service) (Appendix 2.2 – Appendix 
2.6). The documents required for obtaining approvals were a reference letter, 
which was the official letter requesting permission to conduct research from the 
head of the researcher’s institution, and a research proposal. The reference letter 
must be in the Indonesian language, so I requested the reference letter from the 
Dean of the Faculty of Pharmacy, Gadjah Mada University, the institution in 
Indonesia in which I work. As a result, research approval letters from local 
government offices included the Faculty of Pharmacy, Gadjah Mada University as 
the researcher’s institution.  
3.2.5 Study methods  
3.2.5.1 Sample, sample size, and sampling process 
Sampling strategy  
As appropriate for a qualitative study, the sample was recruited with non-
probability sampling techniques. A purposive sampling strategy, which is defined 
as selecting participants intentionally with predefined conditions [371] was 
applied. The selection criteria were set up in order to find people who have rich 
information about the topic studied.  
Sample description and eligibility criteria 
Because two different topics were covered, this study involved two groups of 
participants. The first group of participants were mothers aged at least 17 years 
who had a child or children under 3 years old. The second subject group involved 
participants who had been diagnosed with diabetes by formal healthcare 
providers; and were able to communicate clearly. The exclusion criteria for both 






Discussions were held with healthcare workers at the selected community health 
centres, and local community members to gather information on suitable methods 
for recruiting participants in the study locations. Most mother participants were 
recruited through the Pos Pelayanan Terpadu – Posyandu (community-based 
health post for mother and child care) programme. In some study locations, the 
invitation was announced to mothers who attended the Posyandu services. In 
some other study locations, the voluntary health workers in the Posyandu invited 
eligible participants by visiting their house, or calling them on the phone. Most 
diabetes participants were recruited from a list of patients at community health 
centres or the Prolanis programme (a programme for managing chronic illnesses) 
at the community health centre (Puskesmas). In study locations with limited 
patient data, the participants were sought by snowball sampling (asking people 
with diabetes, health professionals, or community health centres staff about their 
diabetic relatives, neighbours, or friends), and announcing the study after a 
Sunday service at a church.  
Sample size 
In the mothers group, a total of 53 mothers participated in six FGDs, with 3 – 12 
participants attending each FGD. Some mothers participating in the FGDs were 
also voluntary health workers (kader) in the Posyandu. There was one FGD which 
was attended by only three participants, as the other invited participants did not 
come. A discussion with a village midwife was also held after this FGD.  
In the diabetes group, 45 diabetes patients participated in six FGDs. Each FDG was 
attended by 6 – 10 participants. Some participants who were older or had 
problems in reaching the discussion sites (for example, could not ride a 
motorbike) came to the FGDs with one other family member – her/his daughter or 
his wife. The family members sometimes also helped the participants answer the 





3.2.5.2 Data collection 
The process of collecting data 
Participants who had been contacted and agreed to participate were invited to 
attend the FGDs. The FGD were conducted in the most convenient place for the 
participants. Among six FGDs with mother participants, three of them were in 
Posyandu, and the other three were conducted in one of participant’s or village 
midwife’s house. Among the six FGDs with diabetes participants, four of them 
were conducted in Puskesmas, and the other two were carried out at one of the 
participant’s house. Table 3.3 describes all the FGDs and the number of 
participants involved. Figure 3.3 and Figure 3.4 illustrate the data collection 
process involving diabetes and mother participants.  
Table 3.3: The focus group discussions conducted in the study 
Location Date Time 
Number of 
Participants 
FGD with mother participants 
Kupang municipality 10 September 2015 04.30PM 7 
Kupang district 12 September 2015 10.30AM 11 
Manggarai Timur district 16 September 2015 10.00AM 10 
Solok district 4 October 2015 01.00PM 12 
Pariaman municipality 8 October 2015 10.00AM 10 
Pariaman municipality 8 October 2015 01.00PM 3 
 
FGD with diabetes participants 
Kupang municipality 9 September 2015 04.30PM 6 
Manggarai district 19 September 2015 09.00AM 8 
Manggarai Timur district 20 September 2015 10.00 AM 7 
Solok district 4 October 2015 03.00PM 10 
Pariaman municipality 3 October 2015 09.00AM 7 
Pariaman municipality 8 October 2015 08.00AM 7 
 
During the FGDs, I was helped by local research assistants. I was the moderator for 
most of the FGDs, and the research assistants took notes. Before the FGDs started, 
I provided information about the study (Appendix 3.1 – Appendix 3.4), and invited 
them to ask any questions. After that, I provided them opportunities to consider 
whether or not they would continue to participate. Some of them asked further 
questions about the study, and all individuals who came gave consent to take part 
in the study, and signed the informed consent form (Appendix 3.5 – Appendix 3.8). 





Figure 3.3: Focus group discussion with diabetes participants in Manggarai Timur district 
 
 




The FGDs with mother participants lasted for about an hour, while the FGDs with 
diabetes participants lasted for about two hours. Personal conversation with 
participants was also held before and after the discussions. During the discussion, 
a lot of participants asked questions related to their personal conditions, and I 
answered the questions personally after the discussions.  
As an appreciation to participants for their time spent for the FGDs, souvenirs 
were provided after the discussion with mother participants. For the FGDs with 
diabetes participants, before the FGDs were performed, rapid blood glucose, 
cholesterol, and uric acid measurements were provided. In the study locations, 
people with diabetes have their blood measured when they visit health facilities 
and are advised by the health professionals. These measurements are commonly 
available at health centres. Some local pharmacies also provide blood glucose 
measurement services, but the people had to pay to get it. Based on observations 
in study locations, and participants expressions such as: “So, thank God, that I had 
my sugar level checked today and it’s 109 [mg/dL]”. They were pleased and 
wanted to have their condition checked.  
Language used 
Most people in Indonesia speak ethnic languages for everyday conversation. The 
majority of the population, however, understand and speak Bahasa Indonesia, the 
Indonesian national language. The Indonesian language is the formal language 
used in schools, and in healthcare settings. I originally come from Javanese ethnic 
group, which is different from the participants involved, so I do not speak the 
participants’ ethnic language. Bahasa Indonesia was therefore used as the main 
language in the FGDs. Before each FGD commenced, I explained to the participants 
that I would ask questions in Bahasa Indonesia, but they could answer in any 
language. In many cases, the participants answered in a combination of Bahasa 
Indonesia and their local language. I was helped by local research assistants who 
were native speakers of the participants’ language. During the research, I also 





In one FGD involving mother participants in Manggarai Timur district, East Nusa 
Tenggara, many participants answered in their local language, so the research 
assistant helped me moderate this FGD. People in this area rarely speak Bahasa 
Indonesia for every day conversation. All FGDs in West Sumatera were conducted 
in combination of Bahasa Indonesia and the Minang language. The Minang 
language is similar to Malay language, and it is almost the same as Bahasa 
Indonesia. The differences are in the word choices, pronunciation and dialect. I 
therefore understood the language even though I cannot speak in their dialect.  
The use of multiple languages poses a risk of losing meaning, and respondent 
validation is an important strategy to minimise this risk. During the process of 
discussion, when they answered with local language where I was not sure about 
the meaning, I repeated what they said in Bahasa Indonesia to check the meaning. 
After the discussion, I summarised the result of the discussion, and asked the 
participants to indicate whether or not the summary was consistent with what 
had been discussed. After each FGD, I also had a discussion with the research 
assistants, to make sure that I understood the conversation as a whole, and 
understood local words that were used. 
Study instrument  
The FGDs questions guides were developed in English, and translated into Bahasa 
Indonesia (Table 3.4 and Table 3.5). 
Table 3.4: Focus group discussions guide for child immunisation topic in English 
Number Questions 
1 What do you think makes your children healthy? 
2 What do you do to keep your children healthy? 
3 What are your views about immunisation? 
4 Do you have any experience, or have you heard about the experience of 
your family or friends, about immunising children? 
5 How do you make the decision about whether or not to immunise your 
children? 
6 Do you face any challenge in immunising your children? If so, what are 
they? 
7 What do you think about the immunisation services given by Posyandu 






Table 3.5: Focus group discussion guide for diabetes topic in English 
Number Questions 
1 How were you first diagnosed with diabetes? 
2 What do you think about diabetes? 
3 What do you think is the cause of diabetes? 
4 Could you please tell us your experiences in managing your 
diabetes after being diagnosed? 
5 In terms of medicines, what type of medicines are you taking? 
6 Is there any medicine that you are taking other than medicines 
from your doctors?  
 
3.2.5.3 Data management and analysis 
All the Focus Group Discussions were recorded, and transcribed verbatim in 
Bahasa Indonesia. Words or sentences in local languages were also translated into 
Bahasa Indonesia with the help of research assistants. Some words or phrases that 
do not have the same meaning were recorded in the local language without any 
translation. Due to time constraints, the process of transcription could not be 
completed in the study locations. Contact with the research assistants, however, 
continued until all the transcription process was finished.  
These transcripts were then translated into English. In doing this, I was assisted by 
a person who was fluent in both languages. After the translation process, 
discussions were made to indicate sentences, phrases, and words that might have 
different meaning in each language. Some words that were specific to Indonesian 
or the local languages were left without any translation.  
These translated transcripts were analysed using inductive qualitative content 
analysis as there was no previous research that had been published describing this 
phenomenon [372]. The analysis involved three stages: a preparation stage, 
including selecting of a unit of analysis and understanding the data as a whole; 
followed by an organisation stage, including coding, grouping and categorising 
data; and finally, a reporting phase in which the results are reported in the form of 
a model and conceptual system [372]. Nvivo software (Nvivo Pro edition version 




To increase the trustworthiness of the findings, the content of categories was 
checked by supervisors. Discussions involving all supervisors and myself were 
also made to finalise the coding process. The results of data analysis are presented 
from the themes that emerged, and detailed with some quotes. 
3.2.5.4 Ethical issues 
Several ethical issues were considered while undertaking the study. First, the 
research was conducted in accordance with the Ethical Guidelines of the 
University of Otago. The information sheet for the study was read and explained to 
the participants. Written informed consent was sought before the process of 
collecting data. The participants were also informed that their participation was 
voluntary, and that they might withdraw from participating at any time without 
any consequences.  
Secondly, during the Focus Group Discussions, I tried to uphold the participants’ 
cultural practices. As an example, I showed respect towards all participants by 
acknowledging them in accordance to their cultural practices. Instead of 
addressing them with their formal title from Bahasa Indonesia, I addressed them 
with titles in their local language. I also prepared drinks and snacks in all the 
FGDs. This is part of the culture of inviting others. Before asking questions related 
to the study, I also made personal conversation, for example, by asking them 
anything related to everyday life. Personal conversation in Indonesia increases 
personal relationship among people.  
Lastly, participants’ names were not mentioned anywhere in the research report, 
including the thesis and publications. The respondents’ names were coded. Some 
photographs were also taken after the FGDs, and verbal consent was sought for 
including some of the photographs in the thesis. The participants’ names, 




3.3 Results  
3.3.1 Results related to the topic of child immunisation 
3.3.1.1 Socio-demographic characteristics of the participants. 
In total, 53 mothers participated in six Focus Group Discussions related to the 
topic of immunisation. Table 3.6 shows demographic characteristics of the 
participants. 
Table 3.6: Socio-demographic characteristics of participants in mother group 
Socio-demographic 
characteristics 
Categories Number of 
participants 
Age 20 – 29 20 
30 – 39 24 
40 – 50 9 
Education Elementary school 13 
Junior high school 10 
Senior high school 26 
Tertiary education 4 
Occupation Housewives/ no formal 
occupation 
52 
Civil servant 1 
 
As seen in the table, the majority of participants were in their twenties and 
thirties. In terms of education, the majority of them graduated from senior high 
school, and only four of them had tertiary education. Almost all participants were 
housewives. Because participants were recruited through Posyandu services, 
which are held in the morning of work days, they are attended mostly by mothers 
who have no current paid occupation. 
3.3.1.2 Knowledge and perception related to child health and immunisation 
The discussions were started by asking participants about general child health, 
and common childhood illnesses. Discussion on this topic revealed participants’ 
knowledge and perceptions related to child health and immunisation (Figure 3.5). 
Participants mentioned that good food and a clean environment were essential in 
keeping the children healthy. Most respondents breastfed their children 




children, including regular showering twice a day, and cleaning their hands before 
eating, were also regarded important to maintain child health.  
Keep their clothes clean. Have our kids to take shower (FGD Kupang 
district, East Nusa Tenggara). 
To keep them healthy, the key is eating regularly, and paying attention 
to our kids’ activity (FGD Pariaman 1, West Sumatera). 
[take them] go to Posyandu regularly, manage their diet, and monitor 
their weight (FGD Kupang city, East Nusa Tenggara). 
 
 
Figure 3.5: Participants’ knowledge and perception related to child health and immunisation 
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Discussions about this topic also revealed mother’s care-seeking behaviour for 
childhood illnesses. The most common childhood illnesses were fever, cold, and 
cough. In dealing with these, most mothers took the child to medical services, 
either to village midwives, the village level community health centres (Pustu), or 
to the community health centres (Puskesmas). Self-medication, either with 
medicines bought from a drug kiosk or traditional medicines, was rarely used. In 
villages with a village midwife living there, most people first sought care from the 
midwife for child illnesses. The midwives would refer to Puskesmas if they could 
not handle it.  
Hardly do kids suffer from diarrhoea, cough and cold are the most 
common they get (FGD Kupang district, East Nusa Tenggara). 
If it’s fever, we give a warm compress [to our kid] [by putting warm wet 
napkin on baby’s forehead], [and give them] medicines from the 
midwife (FGD Manggarai Timur, East Nusa Tenggara).  
I’m just afraid [to buy from the stall, kiosk], not like when we were kids. 
At that time, we bought the medicine from the stall, but now we don’t 
(FGD Pariaman 1, West Sumatera). 
Moreover, some participants believed that taking their children regularly to 
Posyandu, and having their children immunised was also an action for keeping the 
children healthy. Most participants related immunisation to the immune system, 
so that the injection was believed to increase immunity and keep them healthy. 
Lay people refer to ‘immune’ in Indonesian as ‘kebal’ which means resistance from 
or insusceptibility of contracting diseases. Only a few participants, however, said 
that immunisation was for preventing specific diseases. Some participants also 
thought that immunisation was related to child growth. Some participants 
explicitly said that they did not really understand immunisation – what it is and 
what it is for – but they kept immunising their children anyway.  
To improve our kids’ immune system, to keep our kids healthy, to 
preserve the immune system of our baby (FGD Manggarai Timur, East 
Nusa Tenggara). 
It will, if we don’t give our kid the immunisation, it will affect our kid’s 
growth (FGD Kupang city, East Nusa Tenggara). 
Although I don’t really understand what immunisation is, I just do what 




Further discussions also revealed that participants did not understand the 
diseases related to the vaccines. This came up when the discussion went to the 
topic of the diphtheria outbreak that happened in West Sumatera in 2014. They 
also did not understand why an outbreak happened to their areas.  
Is it [diphtheria] the same as typhoid? Diphtheria is like itchy [on skin] 
(FGD Pariaman 1, West Sumatera). 
No, we don’t know, it was an outbreak, but thank God there’s no [cases] 
anymore (FGD Solok, West Sumatera). 
 
3.3.1.3 Mothers’ experiences in immunising their children 
This second topic discussed related to mothers’ experiences in immunising their 
children. This topic generated two themes: Posyandu and the important roles of 
community-based health workers – including voluntary health workers and 
village midwives –; and factors influencing mothers’ acceptance of immunisation. 
In this thesis, the term ‘community-based health workers’ is referred to voluntary 
health workers (kader) and village midwives.  
Posyandu: the important roles of community-based health workers 
As the participants were recruited by community-based health workers involved 
in the Posyandu programme, most of them went to Posyandu for child 
immunisation. Gathering data from these participants, however, enabled us to get 
information about the Posyandu programme implementation (Figure 3.6). The 
Posyandu is a community-based initiative, and self-managed by the community. In 
most places, the Posyandu health services are organised by community-based 
health workers, in collaboration with and monitored by Puskesmas. 
In all study locations, the Posyandu health services were held once a month, either 
in the village administrative office, or in the community-based health worker’s 
house. The main activities included weight measurement, vitamin A 
supplementation, and immunisation. Sometimes, there were education sessions 
related to mother and child health. In some places, contraception services for the 




Injection [immunisation], body weight, family planning [contraception] 
(FGD Manggarai Timur, East Nusa Tenggara). 
We have Posyandu service every month…to check their health, give 
them vitamin A, polio injection or BCG all are provided here (FGD 
Pariaman 1, West Sumatera). 
 
Figure 3.6: Posyandu: activities, problems and implementation 
The main problem with Posyandu was targeting community attendance to the 
designated time and place of Posyandu services. Some participants reported that 
mothers lacked motivation to attend Posyandu services.  
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Nusa Tenggara).  
I asked them to take their children to the Posyandu, but they said that 
they are lazy [to take them] (FGD Kupang city, East Nusa Tenggara). 
Solutions depended on the capacity of community-based health workers. Some of 
them invited mothers a day before the Posyandu services door to door. However, 
this approach might not work everywhere.  
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Yes, they are. We don’t even have to go to the Posyandu [before the 
day], they are the one who come to our place asking us to come. (So, 
each of you are being informed before the day, like that?). Yes (FGD 
Manggarai Timur, East Nusa Tenggara). 
The Posyandu is held on the 4th of every month. On the 3rd, the day 
before we [the cadres] come to all houses in the neighbourhood that 
have kids. But, they don’t come. They are lazy to come though we’ve 
already informed them (FGD Kupang district, East Nusa Tenggara). 
In some other locations, the community-based health workers implemented food 
supplementation for children, and this increased mothers’ attendance at the 
Posyandu. Lack of funding, however, hindered the sustainability of this food 
programme. Overcoming this, some community-based health workers 
implemented a ‘donation for Posyandu’ programme. The community-based health 
workers asked each community member, each household, or each Posyandu 
member to donate a certain amount of money for the Posyandu Programme.  
Yes, we also have additional food for kids programme in the Posyandu, 
in order to attract people. So, every month we come to every house to 
ask them [to donate] money for the programme. (FGD Solok, West 
Sumatera).  
But, because I’m really busy with working, then, that programme, the 
additional food programme, is now ended… we [should] collect IDR 
1000 (USD 0.07) each people again, to provide additional food for kids, 
hence they could come here vigorously (FGD Kupang district, East Nusa 
Tenggara). 
During discussions in Kupang district and Kupang city, participants also 
mentioned aid they received from non-government organisations. The aid helped 
them to provide better services. However, the aid was given only for a specific 
period.  
In 2007, there was also aid from UFP, an NGO for 6 years. During that 
time, health services in this Posyandu were great. (I see, the problem is 
the fund, right?). Yes, something like that. There has been no other NGO 
since then, we have been managing it by our self (FGD Kupang district, 
East Nusa Tenggara). 
In the past, the aid from overseas, was delivered directly to the 
community, and didn’t go through the Puskesmas. They held an 
educational program, then everyone only had to come, and everything 
and everyone were ready, it was great to be like that (FGD Kupang city, 




Posyandu is a community-based programme, so although the vaccines are 
supplied by the government for free, other financial support to facilitate the 
programme implementation comes mainly from the community. Therefore, health 
services included in the programme differed in each location, depending on 
community participation and financial support. 
(Don’t you get any help [funding] from the Puskesmas?) None. (How 
about from the district government?) Nothing (FGD Kupang district, 
East Nusa Tenggara). 
I [kader] have already asked the government to give such aid, they said 
they would try to help, but nothing has happened until today. We also 
need a proper scale to weigh kids… (FGD Kupang city, East Nusa 
Tenggara). 
 
Basic immunisation services for children are available in Posyandu. The vaccines 
are stored in Puskesmas, and they are distributed to the Posyandu on the day of 
Posyandu services by village midwives or health professionals in the Puskesmas. 
However, because the Posyandu health services are only once a month and cover 
quite small areas, participants reported often encountering practical problems. 
These included the child’s immunisation schedule not matching with the day of 
Posyandu service, children who were sick at the time of Posyandu service, and 
concerns about vaccine wastage. Many mothers reported delayed immunisation or 
having to go to other immunisation services because their children were sick on 
the day of Posyandu services. The vaccine wastage concern was particularly for 
multi-dose vial vaccines that will only be opened provided a minimum number of 
children were gathered together. The concern about vaccine wastage was 
reported by participants in East Nusa Tenggara. When these problems were 
encountered, the children then were referred to other immunisation providers. 
This would potentially increase missed opportunities.  
If the immunisation date in the Posyandu don’t fixed with our kids’ 
immunisation schedule, we take them to the Puskesmas to have the 
immunisation (FGD Kupang city, East Nusa Tenggara). 
The immunisation programme is scheduled, if the children suffer from 
fever at that time, they are referred to have the immunisation in the 




[I think] the BCG vaccine is hard to get, isn’t it? Yes, it is, it’s because it 
needs 3 kids gathered beforehand, otherwise the immunisation will be 
postponed, and we have to get it from the Puskesmas. But then, the 
problem is sometimes the mothers forget about it, then they become 
lazy [to come back] to get the immunisation (FGD Kupang city, East 
Nusa Tenggara). 
 
Some participants mentioned that they then took their children to village level 
community health centre (Pustu), community health centres (Puskesmas), village 
midwife, or private doctors for immunisation. However, private immunisation 
services are not free. Some participants also mentioned that health services 
provided by Pustu outside working hours were not free. These may further 
increase the number of children missing out on immunisation. 
Yes, I have had, for measles. Because my kid suffered from cough and 
cold when he was supposed to get the measles immunisation [in 
Posyandu] that time… So, my kid had measles immunisation in the 
private clinic. (Did you have to pay for it?) Yes, I did, it was 150 
thousand [IDR] (USD 11) (FGD Kupang city, East Nusa Tenggara). 
We take them to the Pustu if it’s cough and cold. (Do you need to pay for 
the medical treatment there?) It’s free of charge. We don’t have to pay 
the treatment during 7 am to 12 pm. From 12 pm to 5 pm, it’s not free of 
charge anymore is it? yes, it’s the off hours. (FGD Kupang district, East 
Nusa Tenggara).  
 
The success of immunisation programme in Posyandu also depended on the active 
and collaborative work of community-based health workers. Community-based 
health workers spread the information about the importance of immunisation to 
the community. Moreover, community-based health workers often visited mothers 
with children who did not come to the immunisation services, and gave the 
vaccines at home.  
Yes. We come to their house, give them the immunisation at their house. 
If they don’t show up, the midwife come to their house eventually. (Such 
great cadre you are) (FGD Kupang district, East Nusa Tenggara). 
If we couldn’t make to the Posyandu, we called village midwife to come 
to our house, she would come eventually and brought the vaccine with 





Factors influencing mothers’ behaviour related to child immunisation  
Most participants in the study stated that they had their children immunised 
completely, and only a few of them had not immunised their children. Some 
participants also mentioned that they had their youngest children immunised 
completely, while their older children were partially immunised or did not have 
the immunisation at all. Information about reasons for refusing immunisation, 
therefore, was gathered by asking participants about their relatives or neighbours 
who refused immunisation, or asking participants why they did not immunise 
their older children.  
In the past, there weren’t any information about immunisations, were 
there? Yes, I have 4 [children]. To be honest, 3 of them didn’t get any 
immunisations, only one got complete immunisation (FGD Pariaman 1, 
West Sumatera). 
My second child had all the immunisations, but the eldest one didn’t get 
complete immunisation, this kid [the third one] had complete 
immunisation as well (FGD Pariaman 1, West Sumatera).  
Factors influencing mothers’ behaviour of child immunisation found in this study 
are described in Figure 3.7. The main factors are shown in bold: fathers as a 
decision maker; and interaction with community-based health workers. These two 
factors were frequently mentioned and observed in almost all study locations. The 
other factor was related to individual characteristics including religious beliefs 
and knowledge about immunisation. These factors were less frequently 
mentioned or found only in some study locations. They may therefore be specific 
to certain locations or they may not strongly influence behaviour. 
The father as a decision maker 
The most important factor influencing mothers’ behaviour in child immunisation 
found in this study was the role of the father as the decision maker within the 
family. This emerged in discussions in almost all study locations. Participants 
mentioned that the main reason mothers refused to take their children to the 
immunisation programme was that they were not allowed to do so by the father. 
In some cases, they did not know the father’s reason. In other cases, participants 




sick instead of being healthy. This belief might come from their children’s previous 
experiences of adverse reactions after immunisation.  
I asked her to come, but [she couldn’t do it since] her husband wouldn’t 
allow her, he thought that the immunisation made their kids got sick 
instead of being healthy (FGD Kupang city, East Nusa Tenggara). 
My husband said that if [our kids] got immunisation, they would get 
sick, become this and that, so he told me not to give it. But, for my 
youngest child, I took him here once a month [to have immunisation], I 
always had it here from the beginning till the last one (FGD Pariaman 1, 
West Sumatera). 
Yes, there are some. They are not allowed to do that by their husband, 
but we don’t know the reason why (FGD Pariaman 2, West Sumatera). 
Yes, there are husbands do that. The mothers just can’t do if their 
husband doesn’t allow them to do so. (why is it like that?) [their reason 




Figure 3.7: Factors influencing mothers’ behaviour in relation to child immunisation 
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Another case, there is also wife and husband arguing at their house. [I 
asked] why did you have an argument yesterday? [she said] My kid got 
fever, he [the husband] didn’t allow me to go to the Posyandu, but I 
went there, and our kid got fever (FGD Kupang district, East Nusa 
Tenggara). 
Sometimes we lied to our husband…I said no though our kid did get 
injection, [we did that] just so we didn’t have to argue... But he would 
know if our kid got sick, eventually (FGD Pariaman 1, West Sumatera).  
 
Relationships with community-based health workers 
Relationships with community-based health workers also influenced mothers’ 
decisions on child immunisation. Some participants mentioned that they had a 
good relationship with village midwives. The mothers trusted them, therefore they 
regularly immunised their children despite limited understanding about 
immunisation. They describe this relationship as not one of authority but of trust. 
With this trust, a belief that immunisation is good for their children’s health was 
enough to encourage them to do so.  
It’s good if the midwife can help us to recover [from any sickness]. If the 
midwife tells us something, we do so. Yes, we just trust her [the 
midwife] and let her treat us. Yes, true, true… (FGD Pariaman 1, West 
Sumatera). 
The key role is the midwife, if she’s not active, doesn’t approach the 
cadres, it [the Posyandu] doesn’t work. If there is a rumour that she [the 
midwife] is going to move out [from the village], we protest 
immediately (FGD Solok, West Sumatera). 
Participants in this study also demonstrated positive attitudes toward health 
services, as shown with their engagement with health services, including 
immunisation and other medical services for childhood illnesses. Some 
participants also mentioned that they went to midwives for birth delivery, and 
maternal health services. The relationship with village midwives also showed 
their availability at any time to help the community. Participants therefore 
acknowledged the importance of village midwives’ role in the community health.  
(Is there any traditional birth attendant here mam?) Yes, there is, a 
traditional birth attendant. She does massages. [but] people come to see 
her not to give birth anymore, but only to have the massages (FGD 




(If your kids suddenly get sick in the night time, how do you get the 
medicine?) Yes, we immediately visit the midwife. [once] It was at 2 or 
3 am since our kids were babies (FGD Solok, West Sumatera).  
This finding showed that interaction between health professionals and community 
influenced people’s attitude to, and acceptance of, health programmes. 
Establishing a good relationship between health professionals and the community 
increased people’s trust, and this led to the community accepting health 
intervention. Moreover, the capacity of village midwives in solving the problems 
might also increase people’s acceptance of immunisation. In Pariaman, for 
example, the village midwife shared her experience when she gave the mothers 
paracetamol to be taken to the children, not after the children had the injection, 
but before they received the vaccines. She did this to prevent fever from 
happening, and reduce parents’ anxiety of having adverse events after the 
injections. 
For preventing [fever], I give them medicine before giving the 
immunisation, so the mothers don’t worry afterwards, they were given 
the medicine first, then they have the immunisation after that. So, we 
give them medicine first before having that immunisation (personal 
communication with a village midwife in Pariaman, West Sumatera). 
 
Individual characteristics  
Personal characteristics including religious belief and limited understanding about 
immunisation and prevention concepts were also found to influence immunisation 
acceptance. Religious beliefs were only found as a reason to refuse vaccines in 
West Sumatera, in which the dominant religion is Islam.  
They think the immunisation is haram [forbidden by the God]. We give 
more explanations about it, that [the vaccines] are produced in 
Indonesia now, they still can’t buy the idea (personal communication 
with a village midwife in Pariaman, West Sumatera). 
They say that immunisation is haram [forbidden by God], [so] it is 
forbidden to be injected into our body. So many reasons, like, the 
immunisation is made from pork (FGD Solok, West Sumatera). 
A lack of understanding about the concept of prevention was mentioned as the 
effect of immunisation is not obvious, and some mothers prefer to treat illness 




My younger sister has 4 children, ever since the first kid was born, she 
never gives them immunisation. I asked her once to come to the 
Posyandu, and she said “no, there is no difference [whether or not 
taking the children for immunisation], I would take them to the doctor if 
they get sick” (FGD Kupang city, East Nusa Tenggara). 
They said that there are still many other medicine than the 
immunisation (FGD Pariaman 2, West Sumatera). 
 
3.3.1.4 Discussion. 
Themes generated in the current study suggest that mothers’ immunising 
behaviour for their children is influenced mainly by external factors: their 
interaction with community-based health workers; and their husband as a 
decision maker within the family. Therefore, although they commonly had limited 
knowledge related to vaccines and the diseases vaccination prevents, their 
behaviour was strongly driven by those external factors. Studies about 
immunisation in other Indonesian communities also showed that mothers had 
limited knowledge about immunisation [36, 166, 351, 373]. Poor understanding of 
what vaccinations do and what diseases they protect against, however, did not 
always mean that mothers had negative attitudes towards it. Participants accepted 
the immunisation programme as they trusted the community-based health 
workers. Mothers trusted the community-based health workers as the health 
workers were able to integrate with and became an important part of the 
community. It has been widely acknowledged that the patients’ and health 
professionals’ relationship influence patients’ acceptance and adherence to health 
intervention, which further improves patient outcomes [374]. Trust in health 
professionals in particular, has been shown to encourage people to utilise medical 
services, and further indirectly improve patient outcomes through increased 
adherence, and continuation [375, 376]. Further, LaFond, et al. [377] also found 
that integration of health workers in the community has been able to increase 
people’s trust and participation in immunisation programmes in some districts in 
African countries.  
Interaction of mothers with community-based health workers found in this study, 




health instructions shown in this study is, however, somewhat different from 
compliance as a result of social pressure or from a higher authority. Previous 
studies found that external factors, such as interaction with health professionals 
and authority created social pressure that forced people to comply with the 
instruction [253, 351].  
This study also showed that the presence of a village midwife increased health 
services utilisation. The village midwife programme is a programme to deploy 
midwives to serve and live in villages. This strategy has succeeded in decreasing 
socioeconomic inequalities in accessing skilled birth attendants dramatically, and 
improving child nutrition status [118, 378]. There is, however, inequity in the 
distribution of midwives between remote and urban areas, with low retention 
rates of midwives in remote areas [117, 379].  
Mothers’ action whether to immunise their children or not is also strongly 
influenced by the fathers’ decision. In all study locations, participants mentioned 
that the fathers’ refusal stopped children being immunised. Indonesia has a strong 
patriarchal culture, so that the father is the leader and the main decision maker for 
the entire family. A study also showed that the husband was a decision maker for 
family planning use [380]. This inequitable distribution of power within the 
family, particularly in decision making of health services utilisation, however, may 
shift according to the women’s ownership of household assets, women’s 
education, and social status. Beegle, et al. [381] argued that the more the women 
have shared assets, the more educated, and from higher social status, the more 
power they had in influencing family decisions. More educated women also tended 
to have fewer children, and utilised reproductive health services [382]. Most 
participants in this study were housewives. This may suggest that they have less 
power in decision making in the family, as they have less shared assets. In the 
community where women have less power in decision making, the fathers should 
be involved to increase immunisation uptake.  
Further, the rationale behind the fathers’ decision of immunisation refusal showed 
that they also had limited understanding about immunisation. It was widely 




vaccines made the child sick were also found as the major reason for vaccine 
refusal in one polio outbreak area of Madura [122]. This perception was 
commonly based on past experiences of adverse effects after immunisation. The 
experience of adverse effects challenged what people commonly believed - that 
the vaccine would make the children healthy. Perception that the immunisation 
would make the children healthy might also be interpreted as a curative action – 
an action intended for sick children – so that they would not take the children to 
be immunised if they are healthy [36]. Reasons related to parental attitude and 
knowledge including the perception that vaccines could cause harm, questioning 
the impact of vaccines, and other family member refusal of vaccines were also 
commonly found in studies of immunisation acceptance in other developing 
countries [254, 262]. 
Therefore, although limited knowledge may not always lead to vaccine refusal, 
education programmes to improve people’s understanding about immunisation 
and the disease they protect against are also important in shaping people’s 
understanding of immunisation as preventive action. While in some cases, it might 
be difficult to deliver complex messages about immunisation, relevant information 
should be given appropriately. Misunderstandings about immunisation may lead 
to misperceptions, and unrealistic expectations, that may then further develop 
negative attitudes to vaccination [253]. It was found also that having correct 
knowledge about vaccination affected immunisation uptake by people in Pakistan 
[383]. 
This study also highlights issues related to the implementation of Posyandu. The 
backbone of the programme was the work of community-based health workers 
including community volunteers (kader) and village midwives, and their 
partnership with the whole community. Lack of community participation and lack 
of funding were found in this study to hinder implementation of the Posyandu 
programme. Previous studies also found irregular participation of mothers in 
Posyandu [25, 26]. The active and collaborative work of community-based health 
workers with the whole community is important in solving these problems. 




participation. However, this programme was challenged by lack of funding, which 
was overcome by some Posyandu that could build collaboration with the whole 
community by creating a ‘donation for Posyandu’ system, for example. 
Consequently, there is inequality of services given by each Posyandu depending on 
the community-based health workers’ capability and the level of community 
support for the programme. These findings align with the result of a study by 
LaFond, et al. [377], who investigated why some districts performed better in 
immunisation coverage than the others despite similarities in basic health system 
resources. They found that direct drivers of immunisation coverage improvement 
were the work of community-centred health workers in partnership with 
community volunteers that were capable of tailoring strategies to specific setting 
and community needs. 
Another key finding is that there were noticeable cases of missed opportunities in 
Posyandu. There was a concern about vaccine wastage, particularly in East Nusa 
Tenggara, and delayed vaccination services because the children were considered 
ill. In order to minimise these missed opportunities, a clearer procedure related to 
vaccines with multi-dose vials, and to assess and monitor sick children has to be 
implemented.  
Although interventions to increase immunisation coverage from the demand side 
have been poorly investigated, some have shown their effectiveness in 
empowering the community and increasing immunisation acceptance [260, 384]. 
The findings from this study suggest some interventions that should be 
implemented. Firstly, for improving skills of community-based health workers, 
regular training is needed. A study conducted in Maluku has shown that peer-
training of immunisation nurses improved immunisation coverage [385]. 
Secondly, increasing people’s contact with community-based health workers may 
increase people acceptance of immunisation. Ethnographic studies found that 
people’s relationship with health professionals and their personal contact largely 
determine their willingness to immunise their children [386]. This type of 




systematically visit mothers at home, and encourage them to attend immunisation 
services, and this is effective in increasing immunisation uptake [387].  
Lastly, in order to increase knowledge and understanding of immunisation for not 
only mothers, but also fathers and the wider community, discussion involving 
community members could be an effective intervention. This type of intervention 
has been done, for example, in Pakistan [261]. This community discussion is not 
only effective in increasing people’s understanding about immunisation and 
willingness to immunise the children, but also created community initiatives to 
overcome barriers to getting the services without improving the services [261]. 
This type of intervention could improve community involvement with the 
Posyandu programme, and increase community initiatives to improve the 





3.3.2 Results related to diabetes mellitus 
3.3.2.1 Socio-demographic characteristics of respondents 
In total, 45 diabetes patients participated in six FGDs. Each FDG was attended by 6 
– 10 participants. Characteristics of participants are described in Table 3.7  
Table 3.7: Characteristics of participants involved in focus group discussions about diabetes 
Demographic characteristics Categories Number of participants 
Age (year) 20 – 39 2 
40 – 59 34 
60 – 79 9 
Gender Female 31 
Male 14 
Education Elementary school 5 
Junior high school 7 
Senior high school 15 
Tertiary education 18 
Occupation Housewives 23 
Entrepreneurs  3 
Civil servants 14 
Retired 5 
 
As seen in Table 3.7, the majority of participants were aged between 40 and 59 
years old, nine participants aged more than 60, and only two participants aged 
less than 40 years old. The youngest participant was aged 26, and she experienced 
gestational diabetes. Participants were predominantly female, and housewives. 
Participants’ socio demographic characteristics were similar to other studies of 
diabetes patients in Indonesia, and in Asia. The prevalence of diabetes is higher in 
females than males, and starts rising sharply from 40 years of age [89]. The 
highest prevalence of diabetes in Asia is in the 40 – 59 age group [388]. A previous 
study also demonstrated that housewives had the highest prevalence of diabetes 
of any occupational category [89]. In terms of education, more people had 
completed tertiary education, and the majority of participants who completed 
tertiary education worked as civil servants in the formal sector. The table also 
shows that participants came from a wide range of socio demographic 
backgrounds. Education level often represents economic capacity. People who 





3.3.2.2 Lay perception about diabetes  
During the discussions, participants shared their view about diabetes, which 
included local terms for diabetes, beliefs about its causality, and common local 
knowledge related to diabetes.  
Local terms and lay knowledge of diabetes 
Although the term diabetes was often used in clinical settings, lay people referred 
to diabetes as ‘penyakit gula’’ literally translated as ‘sugar disease’, or ‘penyakit 
kencing manis’’ literally translated as ‘sweet pee disease’. These terms are an easy 
way to describe diabetes. Sugar disease referred to diabetes causality: the disease 
is caused by too much sugar in the body. Participants therefore also used the term 
‘blood sugar level’ instead of ‘blood glucose level’. ‘Sweet pee disease’ is an easy 
description of diabetes symptoms: having sweet pee is the symptom of diabetes. 
Some participants observed having sweet pee as indicated by ants gathered 
around it.  
When I saw my urine attracted ants, and it was brown, I checked. It 
[blood sugar level] was 318 [mg/dL] (17.7 mmol/L) at that time (FGD 
Pariaman, West Sumatera). 
During the discussions, participants often mentioned their blood glucose level, 
although they often did not remember whether it referred to fasting or random 
blood glucose measurements. The healthcare facilities in Indonesia commonly 
provided fasting and random blood glucose measurements for diabetes patients. 
All units of blood glucose level mentioned by participants were in mg/dL. 
Other than local terms, participants in all study locations classified diabetes into: 
‘penyakit gula basah’, literally translated as ‘wet sugar disease’; and ‘penyakit gula 
kering’, literally translated as ‘dry sugar disease’. People differentiated these two 
types based on patients’ characteristics. People suffered from wet sugar disease if 
they were getting fatter after contracting the disease, and experienced unhealed 
wounds. In contrast, people suffered from dry sugar disease if they were getting 




I have a family member in Jakarta, he experienced extreme weight loss. 
He is getting thinner and thinner. Is that true that he suffered from dry 
sugar disease? (FGD Kupang city, East Nusa Tenggara). 
Yes, somebody in my neighbour also have sugar disease, but she could 
not come here, her feet got wounded… Yes, that’s wet sugar disease. It’s 
really difficult condition if you got wet sugar disease (FGD Solok, West 
Sumatera). 
Moreover, participants in West Sumatera were confused between diabetes and 
liver-related disease. The local term for liver-related disease is ‘sakit kuning’, 
literally translated as ‘yellow disease’ (jaundice in medical term), or ‘sakit lever’, 
literally translated as liver disease. Participants in Pariaman considered that 
diabetes was the same as sakit kuning. The other participants explained that 
diabetes was different from sakit kuning, and that sakit kuning was related to 
haemoglobin level. Meanwhile, participants in Solok assumed that sakit kuning 
was caused by sugar deficiency. One other participant explained that people with 
sakit kuning had to eat sugar to ease their liver in digesting.  
So, is it [sakit kuning] different from sugar disease? Sakit kuning is 
different from sugar disease. Sakit kuning is caused by the haemoglobin 
level. Sakit kuning is a symptom of liver disease. So, sakit kuning is 
different from sugar disease, isn’t it? Yes, it’s different (FGD Pariaman 2, 
West Sumatera). 
Is it true that sakit kuning is caused by sugar deficiency? No, sakit 
kuning is liver disease, so that in order for easing the liver in digesting 
sugar, (the patient) should eat sugar. It doesn’t mean that sakit kuning 
is caused by sugar deficiency (FGD Solok, West Sumatera).  
 
Beliefs about diabetes causality 
Participants attributed diabetes to genetic factors, eating habits, and lifestyle 
changes. They however elaborated these causal beliefs further with their own 
personal explanation, based on their illness and treatment experiences. In some 
cases, where they could not find personally relevant explanations, they started 
questioning why they got the disease, and in the end, they made their own unsure 
conclusions about that. As can be seen in quotes below, they often use word 





But sometimes I think why I got the disease, what’s the symptoms of 
diabetes, that’s my questions… I work in training department, and my 
job is to prepare food for the training programmes, so perhaps 
[because] I always taste the food (FGD Kupang city, East Nusa 
Tenggara).  
I’ve suffered from sugar disease for about 15 years. [my sugar level] 
was 387 [mg/dL] (21.5 mmol/L), and it increased to 400 [mg/dL] (22.2 
mmol/L). Yes, even though I have taken medicines … I didn’t eat meat 
anymore, I [also] do exercise. I still teach. Perhaps, it’s inherited, have 
run in our family blood (FGD Manggarai Timur, East Nusa Tenggara).  
Participants who mentioned heredity as a cause also had other family members 
with diabetes. In the Indonesian context, term ‘family’ or ‘keluarga’ include 
extended families and other relatives. Some participants who experienced failure 
of treatment despite their behavioural change efforts eventually believed heredity 
was a cause. As described by participants:  
But, we got these diseases, sugar disease and high blood pressure, from 
our ancestors, it is inherited, all of my family, my grandmother, my aunt, 
all of them died of this disease. So, I have got the disease for more than 4 
years, but in the last 3 years I take medicines. Then, just recently, about 
2 months, I have given injection … insulin. but everything just the same, 
my sugar never goes down. Ya, perhaps that because my eating habit, 
but I have tried to control diet, my weight has decreased from 105 kg to 
93... (FGD Kupang city, East Nusa Tenggara). 
I am taking it [the medicines] till now, and I already have had 2 times 
insulin injection, but still, [the sugar level] has never dropped… [It has 
been] 21 years, it’s genetic, my mother as well (FGD Pariaman 1, West 
Sumatera). 
Further, notions that diabetes is inherited also led people to feel vulnerable to the 
disease if they have a family history of it. They also questioned the risk of diabetes 
for future generations.  
I don’t have sugar disease, but I also want to check it, because my mum 
has sugar disease. So that I don’t want to have dinner (FGD Solok, West 
Sumatera).  
I have a question though, if our parents suffer from [sugar disease], do 
their children will definitely also suffer from it? All of their children? 
(FGD Manggarai, East Nusa Tenggara).  
In terms of diet as a cause, participants explained their own experiences which 
they thought contributed to their dietary habits. As described in Table 3.8, some 




past which encouraged them to eat a lot. Further, participants also said that their 
dietary habits were part of their culture. Diet in the participants view, therefore, is 
not only an individual choice, but is also influenced by their community. This 
implied further, that their efforts to change their diet were also problematic, as it 
is not only depended on their own choices. Moreover, some participants also put 
the increasing number of people with diabetes into a historical perspective of 
community eating habits. They compared recent generations’ eating habits to 
those in the past. It is believed that there were no diabetes cases in the past as 
people ate a lot of different kinds of food, while today’s generation only depended 
on white rice as a staple food. 
Table 3.8: Participants narrative concept of diet causality 
Past life events triggering unhealthy diet 
[I had sugar disease] Since I stopped exercising. Then, I worked as a plastic seller, many 
customers come in the morning. In the afternoon, almost no one come, so what I’ve done 
was only eating and eating again… (FGD Solok, West Sumatera).  
For me, I got sugar disease because in the past, I had suffered from another 
disease which made me eat a lot in the morning, and I bought [food] in a big box 
(FGD Manggarai Timur, East Nusa Tenggara). 
Eating habit as part of culture 
I have a cousin died of sugar disease, her toes were amputated, because of sugar. 
People in his village usually drink coffee or tea [with sugar] in the morning 
before going to farmland for working. Then, at 10am and 4pm they will drink it 
[coffee or tea] again… Afterwards, they will also eat cassava, if they also have 
corn or banana, they will eat again, then they will also eat rice (FGD Kupang city, 
East Nusa Tenggara). 
Yes, we will have a lot of parties in wedding or school season. Sometimes, there 
are a lot of families in one neighbourhood who do the feast at the same time. 
Yeah…we will eat a lot, because we can have 10 or perhaps 100 invitations, so, 
we will eat 10 times or 100 times in a day. That’s why we have high sugar level 
(FGD Manggarai Timur, East Nusa Tenggara).  
 
We rarely eat vegetables here. What could we do. We are the biggest producers of coconut; 
everyday coconuts fall down from the tree. If we don’t use it to make gulai [yellow curry], 
we think it’s a waste. We have no choice, it’s like something missing if we don’t make gulai. 
(FGD Pariaman 1, West Sumatera). 
Dietary habits influenced by community changing 
In the past, we are, people in Manggarai have a wide range of food diversity. But, 
all changed when our Governor, humiliated us, if you not eat rice, you… Actually, 
it means to encourage people to grow rice, but our people interpreted it literally. 
After eating rice become more usual, the other food products are left behind. It 




Other than heredity factors and diet, participants also attributed the increase in 
diabetes to a modernised lifestyle. With the development of transportation 
systems, people were no longer walking as a form of transport. Interestingly, some 
participants also mentioned that diabetes was associated with a change from the 
traditional way of cooking rice to the modern one. They perceived that their sugar 
level in rice cooked with a rice cooker is higher than that in rice cooked 
traditionally. Before rice cookers were popular, people in Indonesia commonly 
cooked rice slowly in two steps. First, the rice grain was boiled until it was half-
cooked. In this first step, people often took out the water used for boiling. In the 
second step, the half-cooked rice was then steamed for about 30 minutes. 
Participants argued that as the sugar is dissolved in the water, taking out the 
water used for boiling the rice grain, and steaming the rice reduced the amount of 
sugar in it. In contrast, they argued that the modern rice cooker eliminated those 
steps, and consequently, the sugar in rice was believed to be higher. 
Long before now, people cooked using the fire woods, then they took 
the water out, the water was thick. Therefore, many people suffer from 
sugar disease because of the modern way of rice cooker (FGD Pariaman, 
West Sumatera). 
The doctor told me that that it’s better to cook the rice by steaming it 
than using rice cooker, since if we steam it, the water will fall down, it 
[the water] contains sugar. On the other hand, the rice cooker preserves 
the water, so the water will be absorbed [by the rice], thus more people 
suffer from diabetes nowadays (FGD Pariaman, West Sumatera).  
 
3.3.2.3 Participants’ illness experiences 
This theme was generated from participants’ experiences from the first time they 
were diagnosed until recently. Participants’ illness experiences are presented in 
Figure 3.8. Most participants in the study reported almost the same illness 
experiences. They were first diagnosed when their blood glucose reached a very 
high level that resulted in dramatic consequences such as stroke, eye surgery, and 
stillbirth. After being diagnosed, they experienced uncontrolled blood glucose, had 






Figure 3.8: Participants' illness experiences 
 
Diabetes diagnosis 
Participants shared their experiences of how they were first diagnosed with 
diabetes. Some of them found out that they had diabetes unexpectedly when they 
went to healthcare facilities for another health complaint, including blurred vision, 
gastritis, asthma, and stroke. These health problems could be signs and symptoms, 
or complications of having high blood glucose level. Because of limited knowledge 
prior to diagnosis, however, they had not realised this. Generally, participants’ 
blood glucose levels when they were first diagnosed were very high, more than 
300 mg/dL (16.7 mmol/L). Some participants had blood glucose levels of 500 
mg/dL (27.8 mmol/L) or more. Most of them remembered their blood glucose 
level at diagnosis, although they did not mention whether it referred to fasting or 
random blood glucose measurements.   
Last year, 2014, I got blurred vision, cataract, so I visited a doctor, …So, I 
checked my blood glucose level, and it was 200 [mg/dL], no, 374 
[mg/dL] (20.8 mmol/L). I was confused, I was told to fast at night 
before the checking day, and my sugar level was 374 [mg/dL] (FGD 
Kupang city, East Nusa Tenggara). 
Yes, indeed, in the past I suffered also from gastritis, yes, then I often 
vomited, and then I was hospitalised. [When I was hospitalised], I just 
knew that I suffered from sugar disease. It was told by the doctor that 
[my sugar level] was 300 [mg/dL] (16.7 mmol/L) (FGD Manggarai, East 
Nusa Tenggara). 
First diagnosed: 
Late, blood glucose level at 




 Unexpected when visited medical 
services for another health complaint 
which in might relate to diabetes 
symptoms, or complication 
 Dramatic consequences of late 
diagnoses: stroke, stillbirth 
 Felt the symptoms and went to health 
facilities to find out 
 Period of having diabetes mostly 
2 – 7 years 
 Showed uncontrolled blood 
glucose level 
 Diabetes complications 






I did medical check because of asthma. Ya, I had asthma and I didn’t get 
better for a quite long time. Ya, the asthma didn’t get better, and I 
checked, and (it was found that) I had sugar disease (FGD Manggarai, 
East Nusa Tenggara).  
I just knew that I have sugar when I had stroke. It [sugar level] was 307 
[mg/dL] (17.1 mmol/L). I’ve had it [stroke] twice…but thank God, [I got 
cured] because I took sinse (Chinese traditional medicines) (FGD 
Pariaman, West Sumatera). 
Others experienced symptoms, and went to health providers to find out what 
disease they suffered from. The symptoms they mentioned including urinating 
frequently, tingling on tips of the fingers, often feeling hungry, dizziness, and 
always thirsty.  
It was in 2008, and at that time, I didn’t know, I didn’t understand about 
sugar disease and the symptoms. I just felt exhausted, always feeling 
hungry and eating a lot. Not more than 1 hour [after eating], [I was] 
hungry again, thirsty even though I’ve drunk 2 big bottles of water…I 
went to have a complete medical check, including blood sugar, and it 
almost reached 500 minus 2, so 498 [mg/dL] (27.7 mmol/L). The 
doctor shook his head, and I asked, “is it not good?” (FGD Kupang city, 
East Nusa Tenggara).  
Yes, I’ve, it was 300, almost 400 [mg/dL] (22.2 mmol/L), it was in 2014 
when I was in Cancar. I just felt dizzy, and I felt tingling in tip of my 
fingers and toes, it was like pins and needles in my legs (FGD Manggarai 
Timur, East Nusa Tenggara).  
I felt dizzy in my head, I felt that I had no energy, I kept eating yet I felt 
drowsy after that, I took pee so many times as well. Then, I went to 
village midwife, and my sugar level was above 500 [mg/dL] (27.8 
mmol/L)… (FGD Pariaman, West Sumatera). 
Only one participant was aware of the symptoms, and knew that it was diabetes. 
I felt that my condition deteriorated, I lost weight from 63 to 56 in a 
week, and it was 7 kilos drop. Then, I felt something wrong happening, I 
was always thirsty at night, often urinating, and feeling so weak... So, I 
told my-self that I have to check my blood glucose, and it was 375 
[mg/dL] (20.8 mmol/L), the blood glucose before meal. So, I know that I 
must have got sugar disease… (FGD Manggarai, East Nusa Tenggara).  
Two participants experienced gestational diabetes. One participant found out 
about this when she was about to give birth, and the baby was stillborn. She also 
had diabetes during her second pregnancy, but because of her previous 




Three years ago, I got pregnant, and in the ninth month, I went to 
private clinic because I felt that there was no movement in my bump, 
and I was referred to a hospital. At that time, I was ok, only feeling so 
weak…and the doctor told me that the baby need to be delivered 
through surgery. That I had sugar disease was just known after that 
surgery, and it [sugar level] was 600 [mg/dL] (33.3 mmol/L). The baby 
was stillborn. After that, I did medical treatment... but after 40 days, my 
sugar level came back to normal. Yes, it happened also in my second 
pregnancy. but I went to the doctor and got early treatment… (FGD 
Manggarai, East Nusa Tenggara). 
When I was pregnant my youngest kid, I felt the [sugar disease’s] 
symptoms… I just let it [diabetes symptoms] happened, and I didn’t take 
any medicines, but thanks God, now my sugar level is normal (FGD 
Solok, West Sumatera). 
Most participants in the study were diagnosed late when they had experienced 
very high blood glucose levels. They commonly sought medical care when they 
perceived any symptoms. This behaviour has resulted in dramatic consequences 
such as stroke, eye surgery, and stillbirth. Prevention behaviour including regular 
medical check-up was uncommon. People were commonly, as expressed by one 
participant in this study, afraid of getting medical check-ups as they were afraid of 
knowing that they suffered from any disease.  
Somebody told me to do medical check. He/she said that you were pale, 
getting thinner, but at that time I was afraid, afraid to go to the doctor 
because [I was] afraid to know that I suffered from any disease [that I 
haven’t known before]…(FGD Kupang city, East Nusa Tenggara). 
 
Uncontrolled blood glucose level 
Most participants suffered from diabetes for between two and seven years, but 
two participants had it for fifteen and twenty-one years. During this time, they 
experienced uncontrolled blood glucose levels. Many participants also had high 
blood glucose levels when it was measured with a rapid test as part of the study. 
Some participants expressed frustration in controlling their blood glucose level.  
My fasting blood glucose level can be as high as, now it, 270, 280 
[mg/dL] (15.6 mmol/L) and sometime 300-ish, and it is, of course, 
higher after eating, I’m stress, [thinking of my blood glucose level after 
eating]. I have a rapid blood glucose check tool… So, after checking 
fasting blood glucose level and knowing the result, I don’t want to check 
again after eating, because I’m afraid, I’m stressed (FGD Kupang city, 




(Your sugar level is 181 [mg/dL] (10.1 mmol/L). Have you eaten?). Not 
yet. I have been fasting, didn’t eat anything since 12 last night. I once 
had 250, 300 (FGD Pariaman 1, West Sumatera). 
 
Diabetes complications and other comorbidities 
Uncontrolled blood glucose level increases risk of diabetes related complications. 
One participant developed kidney complications, and needed haemodialysis. Foot 
problems also affected diabetes patients, as told by participants about their 
relative or neighbour who had diabetes but could not come to the discussion 
because they could not walk. Optical problems of blurred vision, cataract, or 
requiring eye surgery, were experienced by some participants before knowing 
that they had diabetes, and after being diagnosed with diabetes.  
He suffered from kidney failure for about 3 to 4 months…Yesterday, the 
doctor told me that he had to be haemodialysed. I answered, “I don’t 
know what I have to do”, but the doctor said again, yes mum, he need 
haemodialysis… (FGD Manggarai, East Nusa Tenggara).  
Yes, my neighbour also have sugar disease, but she could not come here 
as his feet got wounded. Her/his sugar level is high, and it is inherited 
(FGD Solok, West Sumatera). 
Yes, I was worried, I had [eyes] surgery in Penang (a city in Malaysia), 
[a couple of months ago]… (FGD Pariaman 1, West Sumatera). 
Hypertension and hypercholesterolemia were the most common comorbidities 
suffered by participants. These diseases may also increase risk of developing 
diabetes related complications. 
However, I also suffered from stomach disease [gastritis], also 
hypertension, so it may be different from the others. So, I’ve suffered 
from sugar disease, hypertension, urinary tract infection. In a year, I 
was hospitalised several times, 3, 4, or even 5 times, and in the last year 
6 times, and even in this year I have hospitalised 4 times… (FGD Kupang 
city, East Nusa Tenggara).  
 
3.3.2.4 Participants’ medication experiences 
Participants discussed their experiences of any medicine – including conventional 
and traditional medicines – they took for managing diabetes, why they chose those 




people use the word ‘medicines’ or ‘drug’ which are translated in Indonesian as 
‘obat’ to refer to conventional medicines. On the other hand, people will use term 
‘obat tradisional’ (traditional medicines) or ‘obat herbal’ (herbal medicines) to 
refer to any medicines other than modern medicines. People also use specific 
terms such as ‘sinse’ (traditional Chinese medicines), for describing other specific 
types of medicines or medication. In this thesis, therefore, the term ‘medicines’ 
refers to conventional medicines, and specific terms such as ‘traditional 
medicines’, ‘herbal medicines’, or ‘traditional Chinese medicines’ are applied to 
distinguish the meaning.  
Participants’ medication taking behaviours and their reasons for these 
Generally, after being diagnosed at healthcare facilities, participants started taking 
the medicines prescribed by healthcare professionals for some period. Diabetes 
patients were commonly prescribed with medicines for a one-month course, and 
they were instructed to refill after it finished. From this point then, the 
participants’ medication taking behaviours varied based on their individual 
perception and the influence of significant others. These variations in medication 
taking behaviour can be grouped into three patterns: participants who 
discontinued taking medicines; participants who also tried other types of 
medicines; and participants who continued taking only medicines (Figure 3.9).  
Discontinued taking medicines 
Some participants stopped taking medicines and either did nothing, only 
exercising, and controlling diet, occasionally bought medicines from the drug store 
or pharmacy without prescription, or changed to traditional medicines.  
After finishing the medicines for a month, I don’t take medicines 
anymore. To be honest, I don’t take medicines anymore, but I control 
my diet and drink more water (FGD Kupang city, East Nusa Tenggara). 
(What medicine do you take?) Nothing, I just do exercise, I drink goat 
milk every day (FGD Pariaman 1, West Sumatera).  
[I took] metformin. [I got it] from Java. (Are you still taking it until 
now?) Yes, sometimes I take, but sometimes I don’t take it. (If it all gone, 
where do you usually buy?) In drug store. It also available in 





Figure 3.9: Participants' patterns of and reasons for medication taking behaviour 
The most common reason mentioned by participants who discontinued taking 
medicines was that they got fed up with taking the medicines. Participants 
expressed in the Indonesian language as ‘bosan’. The word ‘bosan’ in Indonesian 
means do not want to do it again because it has been done for too long. In English 
translation, it might refer to ‘fed up’ or ‘bored’. In the discussions, participants 
related the word bosan with some other explanatory notions. Some participants 
said that they got fed up with taking modern medicines, as they did not perceive 
them to be effective in curing the disease. Other participants referred bosan to 
hassles they experienced in taking medicines, such as taking a large number of 
medicines at the same time, and taking medicines that were big in size.  
Me? What medicines? I’ve been fed up to take medicines, because more 
and more medicines, but I’ve never been cured, so now I gave up and 
did nothing (FGD Manggarai Timur, East Nusa Tenggara). 
Stopped: 
- Did nothing 
- Only exercise or diet 
- Occasionally bought medicines 
from drug store or pharmacy 
without prescription 






- Wanted to be cured 
- Experienced side effect or any 
discomfort after taking modern 
medicines 
- Perceived ineffectiveness of 
modern medicines 
- Back to nature 








- Got bored 
- Medicines are 
expensive. 
- Did not know that the 







- Traditional medicines 
have no specific doses 
- Fear of side effect of 
traditional medicines 








Given medicines for a month is really bored. Especially if the medicines 
are in big size. If it’s small, it’s easy (FGD Kupang city, East Nusa 
Tenggara). 
Yes, me too. I took medicines only for three months, and I got fed up 
(FGD Kupang city, East Nusa Tenggara). 
Other issues related to availability and accessibility of medicines also emerged. 
Two participants preferred taking the medicines they got from hospitals to the 
medicines from the Puskesmas, as they experienced or believed that the medicines 
from the hospitals were more effective. One participant mentioned that her blood 
glucose level decreased if she took Acarbose, which was not available at the 
Puskesmas. Acarbose was available at hospitals but it was expensive. One other 
participant believed that the quality of medicines available at the Puskesmas was 
not as good as those in hospitals. However, she also mentioned that the medicines 
at the hospitals were expensive. For these reasons, these two participants 
discontinued taking medicines.  
I found Glucobay is good for me, it is acarbose, half of it, it’s good. It’s 
expensive, the Puskesmas doesn’t have it and glimepiride as well. [the 
Puskesmas] only have Gliben [glibenclamide]. (Where did you buy it?) 
[I got] from the doctor in the hospital. (Are you still taking it?) No, I am 
not, that’s why my sugar level becomes high (FGD Pariaman 2, West 
Sumatera).  
It has been about 4 years. She only took medicine from the hospital, the 
medicines were expensive, 500 thousand rupiah (USD 36), it was taken 
a half of tablet. (Does she take any medicine now?) No, the medicines 
are expensive. She refused to be taken to Puskesmas, she said that the 
medicines there was not good (FGD Solok, West Sumatera). 
Some participants stopped taking medicines after they were finished because they 
did not know that the medicines for diabetes should be taken continuously.  
(Mum, your sugar level is high, 595 [mg/dL] (33.1 mmol/L), do you 
take any medicine?) Yes, I take, what the name… metformin. Should I 
take it continuously? (FGD Solok, West Sumatera). 
 
Tried traditional medicines 
After taking medicines for a period, some participants discontinued them and 




in combination with traditional medicines. The use of traditional medicines was 
mostly based on a significant others’ recommendation.  
My father also [take herbal medicines]. He had wound on his legs, lots of 
wound [like his legs were] burned, and somebody informed us to take 
bark … duwe bark [Java plum, Syzygium cumini bark]. It is boiled and he 
drink the water. After that, all the wound dried and cured. Yes, and his 
sugar level also decreased. (Does he still take it until now?) Yes, he is 
still taking it, combined with medicines (FGD Manggarai, East Nusa 
Tenggara). 
I take Betel fruit [pinang, Areca catechu], the dried one, [I take it] after 
having breakfast, I soak it and drink the water, every day. I also still take 
glicose [metformin] (FGD Manggarai Timur, East Nusa Tenggara). 
Gliben [glibenclamide], and another one that taken 3 times a day, I 
forget the name of it. (Metformin?) yes, yes. [I take] some leaves, the 
bitter [leaves] twice a week. yes, those bitter leaves (FGD Pariaman 1, 
West Sumatera). 
Participants tried traditional medicines or accepted other people’s 
recommendations to take traditional medicines for various reasons. Some of them 
experienced side effects or discomfort after taking medicines, and some others 
perceived that the medicines could not cure the disease. Some participants 
believed that the medicines were ineffective. On the other hand, they also believed 
that traditional medicines were more natural, have been used for generations, and 
gave other benefits such as an increase in their energy and strength.  
Yes, I just do what people recommend because I want to be cured. But 
after taking herbals for a quite long time, I got gastritis, and then, 
urinary tract infection, then, I stopped again, but someone recommend 
this and this, I just want to try, only want to try (FGD Kupang city, East 
Nusa Tenggara).  
Just imagine, [I’ve taken] metformin, but it doesn’t work (FGD 
Manggarai Timur, East Nusa Tenggara). 
[My sugar level dropped] from 360 [mg/dL] (20 mmol/L) to 260 
[mg/dL] (14.4 mmol/L). By taking Gracia [brand name of herbal 
medicines], it is mentioned on [its box] for preventing diabetes (FGD 
Pariaman 2, West Sumatera). 
Herbal [medicines] don’t make the sugar level drops, it gives us more 
energy so we feel fresh. I had taken herbal for more than 2 years. I felt 




After taking traditional medicines for some period, they self-evaluated its 
effectiveness, and made a decision afterwards. Some participants stopped taking 
medicines, and continued taking only the traditional medicines.  
[I took] Maneira [brand name of herbal medicines] … (So, now are you 
still taking prescribed-medicine?) No, I don’t take it again (FGD 
Manggarai Timur, East Nusa Tenggara). 
A month after checking the blood sugar level, every time I took 
medicines I always vomited, got a headache, so that then I [only] take 
traditional medicines. After taking traditional medicines, my condition 
is getting better (FGD Manggarai, East Nusa Tenggara). 
I don’t take [any other medicine] anymore, I only take mangosteen fruit 
peel for almost 1 year (FGD Pariaman 1, West Sumatera). 
Some other participants did the reverse, and discontinued taking the traditional 
ones and went back to the medicines. The reasons for doing this include perceived 
ineffectiveness of traditional medicines, and side effects of the traditional 
medicines. One participant shared that she had another disease which emerged 
because of the traditional medicines. 
What I’ve tried that made me almost die were cinnamon bark, and Java 
plum (Jamblang hitam Syzygium cumini) bark, I got severe gastritis 
until I got difficulty in breathing. Because, those are really sepat [the 
taste like eating unripened banana]. Then… Singapore cherry leaves, 
soursop leaves, java plum bark, cinnamon bark, I’ve tried all of those, 
yes, I want to be cured, but, instead of being cured, another disease 
emerged. I got another illness, so I’m back to medicines from the doctor 
(FGD Kupang city, East Nusa Tenggara). 
Then I also took yellow roots [the root of Fibraurea chloroleuca], I took 
it at night and in the following morning my sugar level dropped, from 
400 [mg/dL] to 48 [mg/dL] … Yes, so I don’t take it anymore, so now, I 
only take medicines from hospital (FGD Kupang city, East Nusa 
Tenggara). 
In this process of evaluation of both traditional and modern medicines, the 
participants mentioned that effectiveness of medicines is a matter of the 
medicines being suited to you. They therefore often argued about the types of 
traditional medicines they took, and came to a conclusion that it is a matter of the 
medicines being suited to the individual.  
It’s because it works on her, but it doesn’t work on me. It varies. I took 2 
sets [of traditional medicines], yet nothing happened to my sugar level, 




Continued taking medicines 
After initiating taking medicines, some participants continued taking it. There 
were also various reasons related to this. Some participants believed that 
traditional medicines have no specific doses, and did not take them because they 
were not recommended by the doctor. Meanwhile, some others were fearful of 
having side effects from traditional medicines.  
Only medicines from the hospital, because if it is traditional medicines, I 
don’t understand its dosage (FGD Pariaman 1, West Sumatera). 
[I] fear of [traditional medicines’ side effect] to kidney (FGD Kupang 
city, East Nusa Tenggara). 
In taking medicines, however, some participants also modified doses based on 
their experiences without consultation with health professionals. One participant 
did not take the night time dose of medicines, and only took one of the two 
medicines she had been prescribed. This participant mentioned that she 
experienced low blood glucose level if she took the medicines as prescribed.  
At first, I was [also] given Glibenclamide in combination with metformin 
to be taken before meal, and then I experienced weakness and sweating, 
the doctor instructed me to take it [metformin] 3 times a day. [But] I 
only take it twice a day, only in the mornings and afternoons. The 
doctor asked me, did you finish the medicines? [I answered], yes, even 
though I never took the evenings dose, because I’m afraid if the sugar 
level drops at night. So, I [also] never take the glibenclamide (FGD 
Kupang city, East Nusa Tenggara). 
 
Types of medicines used 
Medicines from formal health providers 
Oral antidiabetics were the most common medicines prescribed. Metformin was 
mentioned often, followed by glibenclamide. Few participants mentioned other 
oral antidiabetics including glimepiride and acarbose. Four participants had also 
been prescribed insulin. 
For me, I have suffered from diabetes for 4 years, but for about the last 
3 years I take medicines, metformin and glibenclamide… Then, just 
recently, about 2 months, yes in the last 2 months I was given injection, 




So, just in the last one month I was prescribed with insulin, the 300-unit 
insulin pen to be injected 10 unit once a day before bed. And, my sugar 
level decreased. After that, the doctor prescribed me insulin combined 
with metformin 3 times a day, and my blood glucose level dropped to 68 
(FGD Manggarai, East Nusa Tenggara). 
Traditional medicines 
The most common traditional medicines mentioned were parts of plants, 
including leaves, bark, or root which were dried. These are also known as herbal 
medicines. The dried parts of plants were soaked in hot water, or boiled. By doing 
this, people believed that the medicinal ingredients dissolved in the water, so then 
they drank the water. The most common sources of leaves mentioned by 
participants were kersen (Singapore cherry, Muntingia calabura L), sirsak 
(soursop, Annona muricata), salam (bay leaves, Syzygium polyanthum), and sirih 
merah (Piper ornatum). Bay leaves were quite popular, and they were mentioned 
by participants both in East Nusa Tenggara and West Sumatera Provinces. The 
most common barks were cinnamon bark, Java plum bark, and kersen (Singapore 
cherry, Muntingia calabura L) bark. Other traditional medicines mentioned for 
diabetes were buah pinang (betel nut), and akar kuning (the root of Fibraurea 
chloroleuca).  
Some participants also took readily available branded herbal medicines, including 
Gracia (encapsulated powdered mangosteen fruit peel), and Maneira (contains a 
mixture of some powdered ingredients including red ginger, mangosteen fruit 
peel, cinnamon bark, black cumin, etc.). These branded herbal medicines were 
available at local shops or pharmacies. 
For me, I take bay leaves, so I boil 9 bay leaves, yes, only 9, with 2 
glasses of water, and boil it until it become one glass. Then, I drink it, 
and my sugar level and blood pressure will definitely decrease (FGD 
Manggarai, East Nusa Tenggara).  
One participant in Manggarai, East Nusa Tenggara got the traditional medicines 
from a traditional healer living in Manggarai Timur. The FGD in Manggarai Timur 
also mentioned the traditional healer, who had a lot of different kinds of ramuan, a 
mixture of traditional medicines. Each ramuan has a specific mix of ingredients 
prepared for specific diseases. The ingredients mainly contained dried leaves, 




Eh, I’m not sure [the name and ingredients], I got it from Manggarai 
Timur. Yes, it contains leaves and bark, I got it from Borong. (How do 
you take it?) Yes, it’s boiled. People said that the doctor [traditional 
healer] there is trusted by many people and the ramuan I bought can 
lower the sugar level… (FGD Manggarai, East Nusa Tenggara). 
Ya, he has 76 kinds of ramuan, he is head of our village. For all kind of 
diseases. Specific ramuan for specific disease. Each has specific dose 
instruction. He has a lot of patients, perhaps, thousands… (FGD 
Manggarai Timur, East Nusa Tenggara).  
Two participants, one in East Nusa Tenggara and one in West Sumatera stated that 
they drank goat milk as a supplement that they believed maintained their health 
and their sugar level.  
Another time in the past I couldn’t remember the year, it (the blood 
glucose level) was 165 [mg/dL] (9.2 mmol/L). But now, perhaps 
because I often drink goat milk and thanks God, now it slightly 
decreases with that milk. I drink the goat milk, yes, the goat milk. (FGD 
Kupang city, East Nusa Tenggara). 
It was 265 [mg/dL] (14.7 mmol/L). (what medicine do you take?). 
Nothing, I just do exercise, I drink goat milk every day, and.. yes, I feel 
good (FGD Pariaman 1, West Sumatera). 
 
3.3.2.5 Participants experiences of self-managing diabetes 
Other than taking medicines, participants also frequently discussed controlling 
diet as part of managing diabetes. Some participants reported doing exercise, and 
checking their blood glucose level regularly. The participants’ experiences of 
diabetes self-management are described in Figure 3.10.  
Controlling diet 
Methods of controlling diet 
The view that eating behaviour contributed to diabetes led people to discuss 
controlling diet as part of managing diabetes. However, they reported diverse 
opinions about methods of controlling diet. Some participants demonstrated 
substantive knowledge about reducing rice portions, and eating more vegetables. 
Others believed that reducing meat and fatty food consumption, skipping main 
meals, and also reducing sweet food or using non-calorie sweetener were methods 




I eat only a small portion of rice, more portion of vegetables, without 
oily food. I don’t eat meat, it has been several days… but I eat eggs two 
times in the time between 15 September until today (FGD Manggarai, 
East Nusa Tenggara). 
Reduce eating food contains coconut milk (FGD Solok, West Sumatera). 
Mummy often eat pical [Indonesian vegetable salad with peanut mixed 
with palm sugar sauce], its sauces contains peanut and sugar, it contains 
sugar. So, you should not eat pical. Pical contain sugar, palm sugar (FGD 
Solok, West Sumatera).  
 
 







 Some had awareness the importance of exercise. 
 A few participants practised regular exercise. 
Blood glucose measurement: 
 Some participants measured blood glucose once a 
month at the community health centres (Puskesmas). 
 A few of them had their own tool for blood glucose 
check. 
 Some did not regularly check. 
Methods: 
 Reducing rice portion, and eating more 
vegetables.  
 Eating diverse food sources 
 Reducing meat and fatty food 
consumption. 
 Skipping main meals, particularly 
dinner 
 Reducing sweet food consumption 
 Using non-calorie sweetener. 
 Eating boiled food, and limiting fried 
food 
 Not adding flavour enhancer (MSG) in 
cooking 
 Eat cold rice 
Barriers: 
 Community feasts 
 Family members’ support.  





Some participants also stated that they ate diverse carbohydrate sources, such as 
taro, sweet potato, corn or cassava, as they believed that it was good for their 
health. The others substituted rice with corn rice (corn that has been ground into 
smaller size), and brown rice.  
We, who has got [this] illness, must eat a lot kind of food. The food 
should be diverse. [for example] we eat cassava or other tubers at 
noon… (FGD Manggarai Timur, East Nusa Tenggara). 
People also regarded methods of cooking as being important in controlling diet. 
Fried food was considered as bad, and boiled food as good. Not using any food 
additives in cooking was also stated as a method of good eating behaviour. A few 
of them also argued that eating cold rice is better than the warm rice, as cold rice 
contains less sugar.  
I boiled papaya leaves, potatoes, taro, cassava [for my uncle who 
suffered from diabetes], yes, he really persistent in controlling the diet. 
Yes, it’s better boiled food (FGD Kupang city, East Nusa Tenggara). 
But, my brother has really controlled his diet, he never put ajinomoto 
[flavour enhancer containing monosodium glutamate] in his food, 
never, even in a little amount, but… [he still got this disease] (FGD 
Kupang city, East Nusa Tenggara). 
The diversity of common knowledge and opinions related to proper diet for 
diabetes resulted in confusion. Some participants asked whether or not some 
dishes were good for diabetes.  
Does it affect [the sugar level] if I eat lontong [rice cake wrapped inside 
banana leaf]? (FGD Pariaman, West Sumatera). 
Do the snacks also have an impact? Does eating snacks, such as biscuits 
also have an impact? (FGD Kupang city, East Nusa Tenggara) 
Moreover, the wide range of local food, and diverse methods of cooking in 
Indonesia has made controlling diet much more complicated. Some participants 
self-evaluated the impact of local food on their blood glucose, and came to their 
own conclusion whether or not the food was good for them. 
I ate jackfruit, and no… I experienced weakness at night, so we, diabetic 
patients, cannot eat a lot of jackfruit, yes, the ripen jackfruit. [My blood 
sugar level increased] to 400 [mg/dL] (22.2 mmol/L), and [I 





Barriers to controlling diet 
Participants also identified barriers to controlling their diets. The main perceived 
barriers came from social supports, either from the community or family. 
Participants, particularly those living in East Nusa Tenggara expressed difficulties 
in controlling their diet because they had a lot of ethnic and religious feasts. 
Socially, they were not able to refuse to eat in those feasts. Eating food provided 
showed respect, and providing enough food for the guests showed honour. These 
ethnic or religious ceremonies were commonly held in a specific time period 
which was culturally regarded as a good time. Many people, therefore, held feasts 
at the same time.  
Just like what I’ve said before, we have a lot of feasts, and in the feast all 
people eat, so it looks weird if we do not eat … Sometimes, if we do not 
eat, people will say that we are arrogant, … So, even in small portion, we 
have to take a bite, but later on, we will have its effects (FGD Kupang 
city, East Nusa Tenggara). 
Yes, we often have feasts, too often. For lay people, feast is like a chance 
for having good food, so they eat a lot. That’s also applied for calculating 
the need of rice. The lower the economic class of the guests, the higher 
amount of rice we need to prepare. This calculation is important, as it is 
shameful if we prepare less food for guests (FGD Manggarai Timur, East 
Nusa Tenggara). 
On the other hand, participants in West Sumatera did not mention feasts as a 
barrier to controlling diet. However, they considered that their cultural cuisine 
might damage their health.  
We rarely eat vegetables here. What could we do, we are the biggest 
producers of coconut, and every day coconuts fall down from the trees. 
If we don’t use it to make gulai [yellow curry], we think it’s a waste. We 
have no choice, it’s like something missing if we don’t make gulai. 
Besides, the vegetables are added with the coconut milk as well. But, 
because of that coconut milk, it tastes delicious (FGD Pariaman, West 
Sumatera). 
What a coincidence, we are about to cook squid. My children love eating 
squid or cuttlefish [sotong]. Then we eat it along with jengkol [the beans 
of Archidendron pauciflorum], it is so delicious. That’s why we [Minang 
people] have a high cholesterol level, because of those food, our food 
contains too much fat. yes, rendang…. gulai padeh [red curry], gulai 
[yellow curry], we add the coconut milk in it (FGD Pariaman, West 
Sumatera).  
In Indonesia, cultural diversity within the country has made dietary control for 




Sumatera identified their cultural cuisine as a barrier for controlling diet, while 
people in East Nusa Tenggara identified frequently attending cultural or religious 
ceremonies as the main barrier to controlling diet. The traditional cuisine in West 
Sumatera is rich in coconut extract or coconut milk, or ‘santan’ in the Indonesian 
language. Santan is white coloured liquid obtained from the process of shredding 
coconut flesh and soaking it in water. It is widely used in cooking, including for 
cooking meat, fish, and vegetables. People commonly cook these dishes slowly 
until the santan become thick enough or sometimes until it becomes oily. The 
most popular dish in West Sumatera is rendang, which is slowly cooked meat 
combined with spices and santan. Their dishes, therefore, are generally high in fat. 
In contrast, participants in East Nusa Tenggara did not identify a type of cultural 
dish as a barrier in adopting a healthy diet. People in East Nusa Tenggara do not 
use coconut milk a lot. The method of cooking in East Nusa Tenggara is also much 
simpler than that in West Sumatera. The most popular dish in East Nusa Tenggara 
is sei, which is smoked meat. The traditional cuisine in East Nusa Tenggara is 
therefore lower in fat. Frequent cultural and religious feasts, however, were 
mentioned as the main barrier in controlling diet. Culturally, people in East Nusa 
Tenggara are different from people in West Sumatera. The dominant religion in 
East Nusa Tenggara is Catholicism, while in West Sumatera it is Islam. People in 
East Nusa Tenggara mentioned that they often had sacrament ceremonies, which 
are specific to Christianity. People attending the feast are supposed to eat to show 
respect. In both places, however, as is also common in Indonesia in general, people 
eat a large portion of white rice in every meal.  
Another barrier to controlling diet was support from family members. Participants 
expressed that they found it difficult to have a different type of food from other 
family members.  
Eating boiled food is not easy, because we cook the food for all family 
members. And they said it is tasteless. So, it’s difficult (FGD Kupang city, 
East Nusa Tenggara). 
Yes, mum yes, we say that we cook it but then we divided our food into 
two [one mostly boiled for the diabetic, and the other for other family 
members… Yes, this one is delicious, but another one is tasteless (FGD 




The discussion about eating habits revealed that participants were aware of the 
impact of eating habits on diabetes. However, their opinion on proper diet for 
diabetes varied, and they also expressed barriers to implementing it.  
Exercise 
Some participants were aware of the importance of exercise in controlling blood 
sugar level, but only a few of them exercised regularly. Some barriers to doing 
exercise were also reported, including lack of time.  
For me, I have never had more than 200 [mg/dL], because I also join 
lenting [specific type of exercise], three times in a week every 5.30 AM, 
so I leave home after Subuh prayer (FGD Kupang city, East Nusa 
Tenggara). 
Yes, me too, I always go up and down the hill every day (FGD Manggarai 
Timur, East Nusa Tenggara). 
Yes, it’s hard to do exercise, as we are mothers. Will we go out for 
walking or cooking for the whole family? Because we don’t only think 
about our self, but also the other family members, so it’s quite difficult 
(FGD Kupang city, East Nusa Tenggara). 
 
Regular blood glucose measurement 
The majority of participants measured their blood glucose level once a month at 
the primary health centres. A few of them had their own rapid blood glucose 
measurement tool.  
Usually the Puskesmas held regular sugar checking on date 15 every 
month… (FGD Pariaman 1, West Sumatera). 
Once a month, at minimum, but if I feel that sugar level is likely going up 
or down, it’s better to check it again (FGD Manggarai, East Nusa 
Tenggara).  
I have a rapid blood glucose check tool. Doctor recommended me to 
have it, because [I have] high sugar level (FGD Kupang city, East Nusa 
Tenggara).  
The blood glucose measurement at the primary health centres was free of charge. 
At the hospitals, however, participants said that they had to pay for measuring 




If we do medical check in hospital, we have to pay 325 thousand rupiah 
(USD 24), and 25 thousand rupiah (USD 1.8) for sugar level check (FGD 
Solok, West Sumatera). 
 
3.3.2.6 Coping response and the meaning of diabetes 
In coping with the disease at the early stage, some participants denied having 
diabetes, as they sought second opinions from various health professionals. Others 
questioned why they got the disease, as they did not experience any symptoms.  
I went to village midwife, and [it was found that] my sugar level was 
above 500 [mg/dL] (27.8 mmol/L), I was told to take medicines. But I 
didn’t trust the result, so I went to another place, [but] it was the same, 
and I was asked to be hospitalised, but I refused it. Then, I went to the 
Puskesmas and had my sugar level checked. I had to fast before 
checking my sugar level (FGD Pariaman 2, West Sumatera).  
But sometimes I think why I got the disease, what’s the symptoms of 
diabetes, that’s my questions. What are the symptoms, I really don’t 
know … I felt nothing (FGD Kupang city, East Nusa Tenggara).  
Some of them also expressed frustration about having uncontrolled blood glucose 
levels despite the efforts they have made.  
My fasting blood glucose level can be as high as, now it, 270, 280 
[mg/dL] (15.6 mmol/L) and sometime 300-ish, and it is, of course, 
higher after eating, I’m stress, (thinking of my blood glucose level) … 
(FGD Kupang city, East Nusa Tenggara). 
Last Saturday I checked my blood sugar, it [blood sugar] used to be 
normal. However, it increased to 320 [mg/dL] (17.8 mmol/L) after I 
had lontong. It (blood sugar) can’t be stable, it always fluctuates, we 
can’t make it balance… (FGD Pariaman 2, West Sumatera).  
Participants commonly knew ways to manage the disease, including controlling 
diet, taking medicines regularly, and exercising, although to some extent this 
knowledge is misunderstood. However, they also reported barriers which were 
beyond their individual control. These included personal barriers such as lack of 
self-efficacy, and social environmental barriers, such as lack of social supports. 
Despite the knowledge they had, therefore, they found it difficult to apply this 
knowledge to their personal lifestyle.  
Then, we had an event for the elders, they held activities like a light 
exercise to move our body. Having done that, my sugar level dropped to 
121 [mg/dL] (6.7 mmol/L). But I still have to take medicines for the rest 




An attitude of fatalism was also found. This view was commonly expressed by 
participants with strong religious beliefs, shown by frequent references to God 
during the discussions. These participants, however, acknowledged that their 
diabetes was affected by their own unhealthy behaviours, and they also 
emphasised the importance of controlling diet, and exercising as ways to manage 
the disease. In this case, fatalism constructed in their narrative did not mean a 
passive acceptance to fate. Rather, it reflects their submission to God, after all 
efforts they have made.  
I’m sorry, a pastor in a church said to me “the healthy will die, the sick 
will also die, the professors will die, the rich will also die, so don’t 
stress”. The pastor also said that we are, the 50 years people or older, 
have to avoid LGG (Lemak, Gula, Garam) fat, sugar and salt. Fat for 
preventing from cholesterol, sugar for diabetes, and salt for 
hypertension. That’s all… (FGD Kupang city, East Nusa Tenggara).  
So, the summary is, don’t think too much about that, stay calm. God has 
arranged our life (FGD Manggarai Timur, East Nusa Tenggara). 
Most participants acknowledged that being stressed might worsen their condition, 
so that they believed that controlling their mind is an important part of managing 
the disease. The words ‘jangan dipikir’, ‘jangan terlalu penat pikiran’, ‘jaga pikiran’, 
which can be translated as ‘don’t think too much’, or ’controlling mind’, were often 
used as expressions for minimising stress. These expressions may imply both 
denial or acceptance of their condition. In this study, however, those words were 
often combined with other expressions, such as ’God has arranged our life’, which 
might be interpreted as acceptance and resignation to a Higher Power. The 
expression is more relevant to the lay concept of health as a balance of physical 
condition and spiritual well-being. With this belief, although they experienced 
uncontrolled blood glucose level, their emotional burden was minimised. This 
shows a positive method of coping response.  
Yes, so don’t stress, if we are sick and stress, it can deteriorate our 
condition… (FGD Kupang city, East Nusa Tenggara). 
Calm mind is a medicine, just relax, don’t worry, it’s a medicine. If we 







Lay perceptions of diabetes 
Findings from this study emphasised that diabetes patients constructed illness 
concepts into their own narratives based on their experiences. The use of local 
terms and common lay knowledge about diabetes classifications were also found 
in other areas of Indonesia [43, 223]. The use of local terms, however, may also 
lead to misconceptions of the disease. The term penyakit gula (sugar disease) 
narrows people’s perception to white cane sugar or any sweet food as being the 
cause of diabetes. The term ‘sugar’ was also often used by diabetes patients in 
many countries [389-392]. Association of diabetes and having ‘sweet pee’ was also 
found in people in Bangladesh and Thailand [390, 393]. This may also diminish the 
understanding of other symptoms of diabetes. On the other hand, medical terms 
are often too complex to understand. Given the impact on communities’ vague 
conceptualisation, avoiding use of lay terms particularly by healthcare 
professionals may be beneficial to improving people’s understanding.  
This study also found that participants connected their beliefs about causality into 
their own narratives to make sense of why they got the disease. When they could 
not find a personal explanation, or failed to succeed after any efforts they have 
done, they began questioning and found another logical reason. This finding is 
similar to a study in Tanzania, where diabetes patients questioned and felt unsure 
about diabetes causality when they could not relate it to their personal 
experiences [270]. Although it seemed that participants in this study further 
related diabetes causality to something beyond their control, no participant stated 
that their disease is a matter of chance, luck, fate, or caused by a supernatural 
power. This finding, however, may be limited by the characteristics of people with 
diabetes involved in the study, and the methods of gathering data through group 
discussions. All participants in this study had received a diabetes diagnosis from 
health professionals, and this might imply that they have received information 
about diabetes from the health professionals. Further, with FGDs, some 
participants might feel ashamed to mention an individual opinion which differs 
from the group opinion. Studies in Sri Lanka, Thailand, and India found that 




or bad karma when they could not identify a personal reason for contracting 
diabetes [354, 392, 394-396].  
Findings on lay concepts of disease and its causality showed that these narratives 
are important in conceptualising the disease into their own logical and accepted 
explanation. As described by Hunt, et al. [397], this personal concept of disease 
causality gave meaning to the individual about their own role in the disease 
process and its treatment. This further implied that having a personalised diabetes 
narrative is important to empower an individuals’ role in managing it. Further, 
Anderson, et al. [398] suggest that in order to empower diabetes patients, the first 
and second steps of the counselling model involve personalising the diabetes 
problem into the patients’ perspectives. A study comparing Arabic-speaking 
migrants and Caucasian English-speaking patients in Australia found a significant 
relationship between participants’ illness and treatment perception, and 
adherence to self-management practices [399].  
Moreover, participants in this study also related diet causality into a broader 
concept of cultural practices. In this view, however, they did not seem to blame 
their culture for them getting the disease, but they recognised their disease in 
their cultural context and understood barriers to practising healthy diet in a 
broader perspective. Consequently, the wider community needs to be involved in 
any action for managing diabetes. In behavioural change theory, individuals would 
be more likely to adopt behaviour if they perceive that it is accepted by their 
community, and they have enough self-efficacy, or confidence to do so in a 
challenging environment [400, 401].  
As part of developing a lay account of diabetes, participants also tried to explain 
why the number of people with diabetes is increasing. They believed that less 
walking, and changing eating habits such as moving towards dependence on white 
rice, contributed to diabetes. Improving economic conditions have meant that 
more people in Indonesia can afford a motorbike, and these have also changed 
eating habits. In the Indonesian context, changes in eating habits have not seen a 
move towards westernised food, but instead an increased ability to eat food which 




to findings from other studies in the Indonesian context [212]. Interestingly, some 
participants blamed the rising diabetes on modernised ways of cooking rice. This 
has not been found in other literature. Regardless of the anecdotal evidence, this 
shows that the participants tried to make sense of their communities’ experience 
of diabetes.  
Illness experiences 
Most participants in this study were diagnosed late, and similar situations were 
also observed in Iran, and India [402, 403]. Type 2 diabetes has a long 
asymptomatic preclinical stage, with metabolic abnormalities possibly occurring 
four to six years before symptoms of retinopathy appeared [404]. Moreover, the 
health seeking behaviour of people in Indonesia, where they would not go to 
health facilities unless they experience any symptoms – as described in Chapter 2 
– further delays diabetes diagnosis. This situation is complicated by limited 
knowledge about diabetes prior to diagnosis. Intervention to increase community 
awareness about diabetes is urgently needed. 
This shows the importance of screening for early detection of diabetes. In 
Indonesia, a guideline for diabetes screening and treatment has been developed, 
and was last revised in 2015 [405]. A study revealed that health professionals in 
Indonesia, however, showed low adherence to the guideline including for 
detecting risk factors and early screening. The doctors tended not to advise their 
patients to be screened for diabetes unless several cardiovascular risk factors had 
emerged [241].  
Most participants in this study had suffered from diabetes for a long period of 
time, and most of them had poor glycaemic control, which eventually led to 
complications. These problems can be seen from two perspectives: the patients’; 
and the health providers’ perspective. From the patients’ perspective, the problem 
might be a result of limited skills in self-managing the disease. Meanwhile, from 
the health providers’ perspective, this problem might be caused by limited 
diabetes management by health professionals. These are discussed further in the 




Medication experiences  
Analysis of medication taking behaviour in this study highlights the concept of 
people’s resistance to medicine taking [406] and a therapeutic decision model 
[407]. Resistance to medicines taking is defined as “considerable reluctance to 
take medicine and a preference to take as little as possible” [406]. Both the 
concept of resisting medicines and a therapeutic decision model stressed the 
process of lay evaluation, which shows that people are concerned about taking 
medicines, particularly for a long period of time [406, 407]. Only a few 
participants in this study accepted taking medicines passively without question as 
they trusted in health professionals, and no participants rejected the regimen 
completely. The majority of them evaluated the impact after taking medicines for 
some period, both subjectively and objectively. The lay evaluation process 
included: evaluation of its effectiveness; adverse effects; cost; and acceptability of 
regimen. With the availability of alternative medicines, many participants 
compared modern medicines to other alternative medicines. They compared both 
medicine types by actually testing and evaluating objective and subjective impacts 
on their body, or by comparing both treatments’ characteristics.  
This process was influenced by significant others, as people also observed and 
received information from others:  other family members or friends with diabetes. 
This finding is similar to a study involving diabetes patients with an Arabic 
cultural background, demonstrating that their medication taking was heavily 
influenced by the diabetic patients’ peers and family members [408]. Participants 
also evaluated their acceptability of medicines including the psychosocial burden 
resulting from the daily routine of taking them. Cost was also another 
consideration. Medicine taking behaviours found in this study were described in 
Figure 3.11. Based on this lay evaluation, participants then divided into three 
groups: participants who remained committed to medical treatment; participants 
who also tried traditional treatment; and participants who were medically 
inactive, who discontinued taking any medicines. These findings are similar to a 





Figure 3.11: Participants’ behaviour in medicines taking in Model of medicines taking described by 
Pound, et al. [406] 
After initiation, the first group of participants discontinued taking medicines. A 
key factor in this behaviour was the psychosocial burden of the daily routine of 
drug taking. Participants reported being fed up with taking medicines regularly. 
Long-term medicine use is reported as creating psychosocial burden on the 
patients, and impacts on their quality of life [409]. The notion of being fed up was 
also commonly stated by patients taking long term medication [410]. Some 
participants experienced side effects or discomfort from the medicines, and a few 
others also stopped taking medicines as they could not afford them. The second 
group of participants were active modifiers, with most of them taking both 
prescription medicines and traditional medicines as an alternative or a 
combination. A few participants modified the dose of the prescribed medicines, or 
took them occasionally. Finally, the third group of participants were active 
acceptors, accepting the medicines after evaluating them. Some participants in this 
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group decided to go back to medicines, after trying some other alternative 
treatments and experiencing perceived ineffectiveness or side effects from the 
traditional medicines. Other participants in this group believed that the traditional 
medicines have no specific doses, and may have adverse events so that they 
committed to only taking medicines prescribed by their doctor.  
Many participants took traditional medicines as they believed that traditional 
medicines are more natural, and have been used since previous generations. The 
use of different sources of treatment, both from medical and traditional systems as 
an alternative or in combination, is prevalent in countries with pluralistic medical 
systems, and in communities with strong socio-cultural beliefs [265, 391, 392, 
394, 395, 408, 411]. Other than cultural beliefs, some participants chose 
traditional treatment because they experienced adverse effects or discomfort after 
taking medicines, and some others perceived medicine to be ineffective. This 
needs to be explored further as these may relate to problems from the medicines 
themselves. Some participants shared that their blood glucose level has never 
decreased although they have taken medicines. One other participant also stated 
that her blood glucose level will decrease if she takes Acarbose, but it was not 
available at the Puskesmas. Further questions emerged: did the patients receive 
medication appropriate to their clinical needs; and did the patients receive 
medicines which meet the quality standard? 
The main type of traditional medicines taken by most respondents in this study 
was plant-based or herbal medicines. Studies have been conducted to analyse 
chemical content and efficacy of frequently used plants for treating diabetes [412-
416], and found that they had potential antidiabetic effect. The main problem 
related to the use of traditional medicines, however, is that they are commonly 
taken based on anecdotal evidence without any specific information about dose. 
Because of this, some participants experienced side effects including 
hypoglycaemia, and having other diseases emerge after overusing herbal 
medicines. Further research about traditional medicines for diabetes is needed.  
Furthermore, it is important to note that the main aim of diabetes treatment is to 




of the disease, prevent complications and improve patients’ quality of life. This 
needs to be highlighted because some participants reported frustration with 
medicines because they did not provide a cure. They took traditional medicines in 
search of a cure for the disease. Another study also confirmed the reason 
frequently mentioned by participants who choose traditional therapy for diabetes 
was to search for a cure for the disease [229]. Perception of ineffectiveness of 
medicines, and searching for a cure with traditional therapies was also found in a 
study involving communities in Nepal [417]. The notion of ’cure’ described is 
being free from the disease and its treatment. Another reason for trying other 
traditional medicines was to find those which they perceived to be suited to them. 
Similar findings were also gathered from previous studies done in Indonesia as 
detailed in Chapter 2. Strong belief that the effectiveness of medicines is a matter 
of being ‘suited to you’ also encouraged people to try any available alternatives to 
find the best fit medicines for them.  
Self-management experiences 
The majority of participants believed that controlling their diet was essential in 
managing their blood glucose level. Although some respondents also mentioned 
exercise, for most of them, it remained a missing ingredient. Misconceptions about 
the proper diet for diabetes were prevalent, however, which was also complicated 
by wide variation in local food and methods of cooking. Moreover, cultural 
practices including social events and traditional cuisine were regarded by 
participants as the main barrier to controlling diet. These findings were also 
observed in other studies conducted mainly in developing countries [390-392, 
394, 395, 402, 418-421]. A systematic literature review of research involving 
people in South Asian countries suggested that limited availability of culturally-
specific tailored diets, traditional food habits, and misconceptions related to 
diabetic diet were barriers to adopting dietary changes for diabetics [418]. In 
places where people eat rice as main dishes, limiting portion size was regarded to 
be difficult [390, 394, 395, 420, 421]. These findings suggest that dietary 
guidelines for diabetes which are tailored to cultural practices and availability of 




Participants had diverse opinions related to proper diet for diabetes, and showed 
confusion about which food is good or bad for diabetes. Rice was commonly 
believed as bad for diabetes, so reducing portions, or substituting brown rice or 
corn for white rice was regarded as good for managing diabetes. Discussion about 
the effect of local fruits on blood glucose level also emerged. Studies on the effect 
of certain food on blood glucose levels have been widely conducted. Tables of 
glycaemic index, defined as the ranking of carbohydrate in food in affecting blood 
glucose level, of numerous food types have been established [422]. It has been 
suggested also that eating food with low glycaemic index could be beneficial for 
diabetes patients [423, 424]. Glycaemic index of the same food, however, for 
example rice, varies widely depending on botanical differences in rice species 
across the globe. Moreover, lists of glycaemic index are developed based on food 
available in western countries. The types of food available, such as fruits, vary 
widely from country to country. Unfortunately, although the glycaemic index of 
some local food available in Indonesia has been studied a lot [425-432], the results 
have not been integrated yet. Moreover, the methods of determining the glycaemic 
index also differ among those studies, and publications of the results in many 
cases are also limited. It is therefore important to integrate research about local 
food in Indonesia and publish it widely.  
Interestingly, some participants, as they said they were told by their health 
professionals, also argued that eating cold rice, or cooking rice traditionally might 
reduce the sugar level in rice compared to eating freshly cooked rice, or rice 
cooked in a rice cooker, respectively. Studies have also been conducted on 
modifying the rate of starch digestion to glucose through altering the processing 
conditions [433, 434]. Slowly digestible starch could be potentially useful in 
decreasing absorbable glucose rates in the small intestine [434]. Wang, et al. [433], 
Svihus and Hervik [434] suggested that one method that could potentially lower 
the rate of digestibility of starch-contained food is through modifying storage 
conditions after cooking. It is explained that storing freshly cooked starch-
containing food for prolonged time in cooler temperatures may potentially lower 
its digestion rate [433, 434]. In practice, therefore, storing cooked rice in a cooler 




rate. More research needs to be done in this particular area to understand its 
implications in the Indonesian context.  
However, Evert, et al. [435] suggested that both glycaemic index and starch 
modification strategies showed moderate effects and variability of results 
between individuals. These strategies may potentially be used as guidelines, but 
where there is no specific data, the general principal of healthy eating should be 
recommended to diabetes patients. Further, it is stated that an eating plan for 
diabetes should be individualised based on the patient’s clinical needs and 
condition, and that eating pattern is not a ’one size fits all’. Further, it is evident 
that carbohydrate plays an important role in blood glucose level. Modifying intake 
of carbohydrate-containing food, therefore, both in quantity and type is 
recommended [435]. Healthy eating strategies for people with diabetes include 
nutrient-dense, and high-fibre carbohydrate-containing foods, high saturated fats, 
leaner protein, no sugar-sweetened drinks, and limiting alcohol consumption. In 
the Indonesian context, with wide variation of education level and socio-economic 
status of people with diabetes, a simple recommendation of eating pattern, such as 
reducing portions, and choosing types of food which are recommended or not 
could be the best strategies. It is also suggested that for people with lower literacy 
or older age, a simple healthy eating plan should be recommended [435].  
In terms of exercise, some participants acknowledged its importance in managing 
diabetes. However, only a few of them practised regularly. Indonesian’s refer to 
olahraga to convey the concept of exercise. The term ‘olahraga’ is, however, more 
related to ’sport’, and often relates to the subject of physical education at schools. 
The most popular form of physical activity in Indonesia is called ’senam’ which is a 
form of exercise done in a group where they move their body together with 
specific instruction, and often with music. Individual exercise is uncommon in 
Indonesian culture. Moreover, in the Indonesian context, with the current, more 
modernised situation and the development of rapid transportation systems, more 
people can afford a motorbike. For people who do not have a motorbike, the 
motorbike taxi is available everywhere, even in remote areas. Even in rural areas, 




are safe enough for people doing exercise. With this cultural context, encouraging 
people to do exercise regularly is quite challenging.  
Limited access to blood glucose measurement is also found to complicate the 
practise of self-managing diabetes. A rapid blood glucose measurement tool is 
relatively expensive, so people cannot afford it. Under the universal health 
coverage programme, diabetes patients who register as members have access to 
blood glucose measurement at the primary health centre, and usually the health 
centres organises the measurement once a month.  
Coping response and meaning of diabetes  
Based on participants’ experiences during their illness, at the early stage after 
being diagnosed, a denial response was common, followed by frustration at not 
being able to decrease their blood glucose levels. Diabetes is a chronic disease that 
needs persistent effort to manage. Diabetes-related distress may come from its 
treatment, which includes changing diet pattern, and taking medicines regularly, 
often viewed as burdens that interrupt normal life [436]. As found in this study, 
the notion of being fed up with taking medicines can strongly affect willingness to 
adopt it into the patient’s regular routine. Moreover, changing diet can seem to be 
impossible, with the barriers from socio-cultural environment. Research has 
shown that diabetes patients are at risk of depression, and other emotional 
problems [437, 438]. Furthermore, diabetes-related distress has been found to 
affect the patients’ clinical outcomes, and quality of life [436, 439-441].  
The ways diabetes patients deal with these life stressors, known as coping, also 
affects their clinical outcomes and quality of life [442, 443]. This study found that 
religious belief played an important role in the participants’ coping strategy. From 
this coping strategy, it seems that participants showed a fatalistic attitude, that 
they perceived themselves as not having much control over their health status 
[444]. Fatalistic beliefs among people with chronic diseases has been suggested as 
the major cause of patients’ non-compliance with healthy lifestyle change, as they 
viewed that their health and illness resulted from their destiny, fate, or luck [444]. 




chronic diseases, for example it became a barrier for cancer screening [445], and it 
is also associated with poor management of diabetes [446].  
In this study, however, fatalism was not always associated with a negative coping 
response. Spiritual belief does not always mean passive acceptance of fate, but was 
often a way of finding support in facing stressful life events. This finding is similar 
to research involving diabetes patients in Java, Indonesia. People with religious 
belief showed a more fatalistic view, but this did not mean a passive resignation, 
instead it is an attitude of submission to God [223]. Studies involving communities 
with different spiritual beliefs have shown that despite being more fatalistic, 
individuals with a strong religious belief appeared to have more positive coping 
responses, as seen by not being frustrated over difficulties as a result of having 
diabetes [447-450]. People perceived religion as a means of coping, and a support 
in the struggle with diabetes [448]. As described by Moos and Holahan [451], 
seeking guidance and support including religious support is one strategy of 
coping.  
Spiritual belief is also an important element in shaping people’s lay concept of 
health and illness. Health is often viewed as a balanced condition of physical and 
spiritual wellbeing, and illnesses might emerge as a result of pursuing only 
physical health, and ignoring spiritual health, or vice versa. This concept might be 
rooted in eastern traditional medical philosophy, which emphasised balance, 
energy systems, and holistic integration of the body and mind [452], but it is also 
shown in people living in the  Pacific Islands [453].  
These findings further suggest that involving religious leaders may potentially 
support diabetes patients to better manage the disease. Religious practices may 
further encourage patients to implement a healthier lifestyle. In one discussion in 
Kupang city, one participant also mentioned that a pastor also gave advice on 
healthy lifestyle: “A pastor in a church said to me: we are, the 50 years people or 
older, have to avoid LGG (acronym for Lemak, Gula, Garam) fat, sugar and salt. 
That’s all. Fat for preventing from cholesterol, sugar for diabetes, and salt for 




acknowledge the concept of balance and harmony, so that a more holistic 
approach could be implemented in health practices. 
Diabetes patients’ behaviours in managing the disease and recommended 
intervention focus  
Diabetes patients’ behaviour in managing the disease is synthesised further from 
findings described previously (Figure 3.12). Individuals’ behaviour in managing 
the disease was mainly a result of a lay evaluation process of their disease and its 
treatment. With the nature of diabetes as long-term disease, lay evaluation is a 
continuing process over time. Diabetes patients perceived the disease in their own 
narrative explanation of an aetiological model and expected benefit of treatment. 
Participants started to question the dietary cause of diabetes, for example, after 
experiencing a negative result from controlling diet. Participants discontinued 
taking medicines, and chose the traditional medicines as they perceived 
ineffectiveness or side effects from medicines, in contrast to perceived 
effectiveness of traditional medicines. The process of lay evaluation, however, was 
limited by misconceptions and lack of knowledge about diabetes and its 
treatment.  
 
Figure 3.12: Factors influencing diabetes patients' behaviour in managing the disease 
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Moreover, input from significant others was crucial in determining behaviour. 
Significant others may influence behaviour through the process of lay evaluation 
or direct suggestion of behaviour. The significant others mentioned by 
participants were mainly the other diabetic family members or friends with 
diabetes. The participants commonly contacted and interacted with other diabetic 
peers for sharing their experiences. For example, people chose to take traditional 
medicines based on success stories of other family members or friends with 
diabetes. 
Perceptions about health providers also influence diabetes patients in managing 
their disease. The lay evaluation process of the disease and its treatment 
effectiveness may further influence appeal and acceptability of specific health 
services. As an example, patients who perceived positive experiences after using 
the medicines from the hospital would prefer to get their medicines from the 
hospitals instead from Puskesmas.  
Cultural beliefs and practices also influenced people’s behaviour in managing the 
disease. Diabetes participants in the study saw the disease in a broader cultural 
context. In practising dietary control, for example, they were challenged by types 
of local food available, as well as cultural practices. These conditions reduced 
people’s self-efficacy – a belief about individual capability in performing 
behaviour.  
These findings suggest that the interventions for diabetes patients in Indonesia 
should focus on assisting participants in a lay evaluation process and providing 
social support from significant others and the community. In assisting a lay 
evaluation process, knowledge about diabetes and its recommended treatments, 
and skills in practising the recommended treatment need to be improved. 
Providing support would likely improve the patients’ self-efficacy in practising the 





3.4 Conclusion and further study direction 
This qualitative study explored knowledge, perception, and experiences of 
mothers in relation to immunisation, and diabetes patients in managing the 
disease. This study adds substantial value to existing literature and fills gaps in 
previous research. The findings provide substantial understanding of health-
related topics from the people’s perspectives. Understanding the problems from 
the participants’ perspective enables researchers to design more effective 
interventions in order to improve people’s health status.  
On the topic of immunisation, it can be concluded that mothers’ behaviour in 
regard to child immunisation is mainly influenced by external factors: their 
relationship with community health workers; and the fathers as the decision 
makers. Without ignoring the importance of proper education programmes to 
improve understanding about immunisation, efforts should be made to 
acknowledge the important role of community-based health workers and involve 
fathers in the immunisation programme.  
Further, the mothers’ immunisation behaviours were also affected by their 
attitude towards health services, which may be influenced by the quality of 
immunisation services in the Posyandu programme. Lack of support, both from 
the community and government were found to be the main barriers in Posyandu 
programme implementation. This further suggests that it is important to empower 
the community and involve them in the management of the programme. A simple 
community discussion about immunisation intervention has been shown to 
improve people’s interest in the immunisation programme. This could be 
potentially adopted into the Indonesian context, where community gatherings are 
common. This intervention may further increase community belonging in the 
programme. Barriers to implementation of the Posyandu programme may be 
different from place to place, and from community to community. Community 
discussions therefore have the potential to identify specific barriers in their 
community context. Because of inequality in the distribution of socioeconomic and 




struggle more to better implement the programme. At this point, external 
influences, such as government authority, are needed to overcome the situation.  
Aforementioned findings in the topic of diabetes revealed more complex situations 
which contributed to participants’ illness experiences including late diagnosis, 
uncontrolled blood glucose level, and prevalent diabetes related complications. 
Diabetes participants’ behaviour in managing the disease was influenced by 
interrelated factors of the individual and their interaction with significant others 
and their community, the continuing process of lay evaluation of the disease and 
its treatment, and cultural practices. Findings on participants’ medication and self-
management experiences revealed that self-management practised by participants 
was not sufficient, as shown by misunderstanding, limited knowledge, self-
efficacy, skills, and motivation for practising the recommended behaviour 
regularly. Participants’ medication taking behaviour varied based on their 
subjective and objective evaluation of the treatment on their disease state. In the 
Indonesian context, with availability of traditional medicines and other alternative 
therapies, the process of lay evaluation became much more complex. Participants 
compared medicines to the other types of traditional medicines available. In 
practising dietary behaviour, limited information on proper diet for diabetes led 
participants to evaluate for themselves the effect of particular food, and methods 
of cooking on their disease.  
This implies that interventions for diabetes are urgently needed. Without proper 
management, diabetes severity and risk of complications increases over time. This 
impacts not only on people’s health status, but also increases the financial burden 
of diabetes. In the universal health coverage era, this burden from diabetes could 
affect the whole country. New initiatives, therefore, should be established to also 
reduce this financial burden from diabetes. The only way of doing this is making 
efforts to prevent, detect diabetes early, and improve patients’ outcomes. Without 
ignoring the importance of the child immunisation topic, therefore, the rest of this 
study focuses only on an intervention for diabetes. Furthermore, as the financial 
burden of diabetes may be higher in lower socioeconomic communities, the 




Section C – Developing, piloting and evaluating a culturally appropriate 
intervention for people with diabetes 
4 Chapter 4: Literature review of diabetes interventions 
4.1 Introduction 
The qualitative study findings presented in Chapter 3 underline the urgent need 
for an intervention study aimed at improving diabetes patients’ outcomes. The 
main study, therefore, focused on establishing, piloting, and evaluating an 
intervention for people with diabetes in Kupang, East Nusa Tenggara. The results 
of this study contribute not only to filling the literature gaps on diabetes 
interventions in Indonesia, but also to informing health professionals, the health 
system, and policy makers in designing an effective intervention. The results of the 
study also direct future research in this area. 
Chapter 4 describes the process of developing an intervention study through a 
literature review covering diabetes interventions that have been successfully 
implemented worldwide and in developing countries. The main objective of this 
chapter is to identify relevant studies of type 2 diabetes interventions and 
evaluate these on their relevance and applicability in the Indonesian context. This 
information, together with the results of the qualitative study reported in Chapter 
3, were used to design an intervention study aiming at improving outcomes for 
people with diabetes.  
4.2 Approach 
The review was limited to publications from peer-reviewed journals. Different 
data sources and strategies were applied to locate relevant literature. Key words, 
and a combination of key words with three Boolean operators OR, AND and NOT 
were applied. Further, relevant literature from the articles’ references was also 
hand-searched. The key words used are listed in Table 4.1. 
Using the key words in Table 4.1, literature was gathered from various databases 




and Google Scholar. Searches were also performed in the University of Otago 
library database. In addition to this, literature from Indonesian journals was also 
searched with the key words translated into the Indonesian language. Google 
Scholar database was the main source of articles in Indonesian journals. The 
articles yielded from those searching methods come from a wide range of peer 
reviewed journals. Some relevant articles were also found in Indonesian journals. 
Table 4.1: Keywords applied for locating relevant literature 
Keywords 









4.3 Diabetes intervention 
4.3.1 Goals of diabetes management 
As described in Chapter 2, diabetes is a chronic and progressive disease, and much 
of its morbidity and mortality is associated with long term complications [179]. 
The main goal of diabetes management, therefore, is to reduce or delay 
microvascular and macrovascular complications by controlling blood glucose and 
blood pressure close to normal range [454, 455]. Intensive glucose control of 
HbA1c of less than 7%, and blood pressure less than 140/80 mmHg has been 
shown to be associated with reduced risk of diabetes complications [454, 456].  
The key for managing type 2 diabetes and maintaining glycaemic control is 
patients’ adherence to a daily treatment regimen, which includes recommended 
lifestyle changes, and in many cases is combined with pharmacological treatment. 
Interventions for diabetes worldwide have therefore been focused on diabetes 
self-management education programmes (DSME) [457-459]. Diabetes self-
management education programmes are defined as “ongoing process of 
facilitating knowledge, skill, and ability necessary for prediabetes and diabetes 




4.3.2 Diabetes interventions worldwide 
Diabetes self-management education (DSME) interventions have been intensively 
studied in developed countries. The intervention approach differed in types, 
teaching methods, mode of delivery, educational providers involved, content, and 
contact time. Outcomes measured also varied, and have included biomedical, 
behavioural and psychological outcomes [457-459]. The types of interventions 
were categorised based on their objectives into educational, behavioural, 
psychological, and mixed. Educational interventions focus on providing 
information to improve patients’ knowledge; behavioural interventions aimed at 
improving patients’ self-management skills and implementation; and the 
psychological interventions focused on improving patients’ coping strategies and 
emotional status [457]. Teaching methods can be divided into didactic, which 
focus only on conveying messages, and interactive, which involves active 
participation of patients [457]. The mode of delivery varied from individual 
education, group education, a combination of individual and group sessions, and 
with technological help for delivery including online or telephone [457, 458]. A 
diverse range of health professionals, including physicians, registered dietitians, 
nurses, and pharmacists [461], and also lay educators [462-464] have been 
involved as educational providers in the intervention studies. Differences in 
outcomes and effect size of DSME interventions were also observed. With this 
heterogeneity, there is no specific formula for the intervention to be effective 
[459]. 
Larger effect sizes were found in interventions that applied a combination of 
group and individual one-on-one sessions, which focused on behavioural skills, 
had a higher number of interactions, and were delivered with more interactive 
teaching methods [457, 458]. There is also a strong suggestion that self-
management programmes should be tailored to specific populations, taking into 
consideration population characteristics, including culture and socio-demographic 
characteristics. Culturally tailored interventions have been widely developed and 
shown to be accepted, and improve patients’ outcomes [462-467]. These culturally 
tailored interventions were commonly delivered by community health workers, or 




educational materials were also designed in the targeted people’s language [462-
467]. Furthermore, it is also suggested that community-based interventions are 
the most ideal form for type 2 diabetes education programmes, compared to 
clinical or worksite based interventions [468, 469]. Community gathering places 
are often culturally relevant, and more convenient, especially for those living in 
more rural areas. Church-based interventions have also been conducted [470-
472]. Most of those studies, however, were conducted in Western communities. 
The culturally tailored studies found were commonly performed for ethnic 
minorities living in developed countries. 
4.3.3 Diabetes interventions studies in Asian countries 
In Asian countries, diabetes self-management education interventions have been 
performed in China [473-475], Korea [476], India [477], Malaysia [478-480], and 
Thailand [481]. Studies conducted in Asian countries also varied in types, content, 
delivery methods, and intervention doses. Most studies showed positive outcomes 
for diabetes participants after the interventions. All but one study focused on 
knowledge and lifestyle modification. A study in Malaysia by Alvani, et al. [478] 
focused on a psychological intervention designed with cognitive behavioural 
therapy (CBT), conducted in eight group sessions spread over three months.  
In terms of delivery methods, a combination of group sessions and individualised 
counselling were applied in some studies [473, 481-483]. Community-based [478, 
481-483], clinic-based [473, 475, 476, 480, 484], and worksite-based [474] 
deliveries were also applied. The community-based studies in India utilised 
community health workers and trained trainers as the education providers, and 
they also involved a wider community - not only the diabetes patients - in a 
lifestyle intervention, [482, 483]. Clinic-based studies involved various health 
professionals, including pharmacists [479]. The workplace-based intervention was 
implemented in collaboration with the companies’ health clinics, and involved 
diabetes participants who worked in those companies [474].  
In terms of study design, the intervention studies conducted in Asian countries 




experimental [478], quasi experimental with wait-list design [475], and 
randomised controlled trial [474, 476, 479-481].  
Lifestyle intervention studies aimed at preventing diabetes have also been 
developed in Asian countries, including three large randomised controlled trial 
diabetes prevention studies in India (Indian Diabetes Prevention Programme, 
IDPP) [485], China (The Da Qing IGT and diabetes study) [486], and Japan (A 
Japanese Trial in IGT males) [487]. A quasi-experimental study for diabetes 
prevention has also been performed in Malaysia (Community-based healthy 
lifestyle intervention programme, Co-HELP) [488].  
These studies show that diabetes intervention programmes can be adapted to 
specific country contexts and cultural settings. People living in Asia and 
developing countries commonly have a great variation of cultures, religions, and 
customs which affect their lifestyle behaviours, including eating and physical 
activity behaviours. Intervention programmes aiming at modifying lifestyle 
behaviours should therefore be built based on a good understanding of the 
community and socio-cultural characteristics [489]. As an example, Balagopal, et 
al. [483] in India and Ibrahim, et al. [488] in Malaysia built a partnership with the 
community, and utilised community health workers or community volunteers as 
education providers. This method increased acceptability of the lifestyle change 
programme. Those two studies also focused on changing to more healthy eating 
habits based on local food available.  
Specific diabetes care programmes have also been developed in three low and 
middle-income countries. Van Olmen, et al. [490] described Kin-réseau, MoPoTsyo 
and FiLDCare programmes for diabetes care and self-management support in the 
Democratic Republic of Congo, Cambodia, and the Philippines, respectively. Kin-
réseau is a network of primary care centres which deliver diabetes care. The Kin-
réseau has not been formalised into an organisation, but two religious 
organisations are responsible for most facilities, and health services. MoPoTsyo is 
a community-based peer educator network who worked actively in screening the 
community and providing health services including diabetes education. FiLDCare 




self-management support from a community health worker [490, 491]. After 
studying these three programmes, Van Olmen, et al. [490] further suggested that 
health outcomes depended not only on individuals and their behaviours, but were 
also influenced by the people around them including family, community and larger 
social context. Diabetes patients’ outcomes also depended on the support from the 
health systems through diabetes-specific programmes. This further suggests that 
it is possible to establish and maintain a diabetes care programme with self-
management support in low resource settings.  
4.3.4 Diabetes intervention studies in the Indonesian context 
Studies about diabetes in Indonesia have been widely conducted, but mostly focus 
on establishing diabetes prevalence [89, 198, 209, 492-494], risk factors [201-204, 
207, 494, 495], and diabetes related complications [213, 215-218, 220, 496-505]. 
Some studies focused on diabetes management from the health providers’ 
perspective [214, 240-242, 506]. Studies have also been conducted to investigate 
the role of pharmacist in managing diabetes patients [214, 506].  
A few studies have investigated diabetes patients’ behaviours including 
medication adherence [227, 507], smoking behaviour [508], dietary habits [509], 
and factors predicting those self-management behaviours [510]. Diabetes patients’ 
coping strategy [511], and quality of life [507, 512, 513] have also been studied. 
Findings of the studies emphasised that patients’ medication adherence is 
correlated with their quality of life. Most diabetes patients, however, showed low 
adherence to diabetes medications, some of them combining medicines with 
traditional or alternative treatment [227, 228, 507]. Further, patients’ self-
management behaviours needed to be improved, particularly by improving their 
knowledge, self-efficacy, and social support [509-511]. Smoking behaviour was 
prevalent in male diabetes patients, so that smoking cessation programmes should 
also be implemented in diabetes clinics [508].  
However, studies focused on interventions for improving diabetes patients’ 
outcomes were limited. A study has attempted to analyse factors influencing 
glycaemic control by comparing poorly controlled diabetes patients to well-




to age and sex, but duration of illness and dietary habits [514]. Three intervention 
studies have been implemented. One study was a hospital-based study conducted 
in Banten Province. This study focused on improving patients’ adherence to 
medication by providing them with a medication booklet and a 30-minute 
counselling session focused on adherence [515]. This study was designed with a 
pre-and post-test single group, and analysed patients’ medications adherence and 
clinical outcomes of HbA1c after 10 weeks of the intervention. Diabetes 
participants experienced a huge reduction of HbA1c (3.19 ± 2.42%), and there 
was a significant correlation between medication adherence and HbA1c level 
[515].  
Another study was a community-based study in Yogyakarta Province that aimed at 
improving diabetes patients’ quality of life through an interactive education 
programme [516]. This study was designed quasi-experimentally, comparing an 
intervention group to a diabetes club (an existing diabetes programme) and usual 
care. The intervention activities were done in one two-hour session, with the main 
activities of active facilitated self-learning in groups. The participants’ quality of 
life outcomes were measured repeatedly: at baseline; after one month; at three 
months; and six months following the intervention [516]. The result indicated that 
the patients’ quality of life in the intervention group increased significantly over 
time, however this increase was smaller compared to the diabetes club control 
group [516]. The diabetes club is a regularly-conducted programme for diabetes 
patients. This implied that, consistent with the findings above, health education 
should be repeated to maximise the positive outcomes.  
One other intervention study for diabetes patients was found; however, the full 
text article could not be retrieved [517]. Wardhani, et al. [517] has investigated 
the effectiveness of community-based intervention with pre-and post-
experimental design. Interventions included continuous education programmes 
for diabetes patients delivered by community health workers in the community 
health promotion posts. From the study, it was suggested that empowering the 
community in diabetes programmes can be applied in an Indonesian context, and 




Because so few studies of diabetes interventions in Indonesia were found, the 
literature search was expanded into the broader context of non-communicable 
diseases. By doing this, two studies focused on reducing non-communicable 
disease risk factors were found: one study was conducted in Depok, West Java 
Province [518]; and one other study was performed in Yogyakarta Province [519], 
These two studies focused on building community-based programmes for 
healthier lifestyle change in order to decrease the risk of cardiovascular disease 
and non-communicable diseases. The studies emphasised that the success of a 
community-based programme depended on its sustainability, and the result might 
not be seen in a short period of time. The programme needed to be reiterated so 
that the expected outcome could be achieved [519].  
 
4.4 Key findings and recommendations for diabetes intervention in the 
Indonesian context 
The literature review provided valuable input into how to design a diabetes self-
management intervention in the Indonesian context. A large body of literature 
suggested that intervention programmes should be specifically tailored to the 
population target, based on understanding of the specific culture and socio-
environment characteristics. A community-based type of intervention is more 
relevant with this type of culturally tailored programme. Furthermore, it has also 
been found that interventions focused more on skills with interactive 
communication could have a more positive impact. In overcoming the challenges 
of limited health resources in a low and middle-income country setting, 
partnership with the community, and involving wider community members was 
beneficial. With limited studies on diabetes intervention in Indonesia, it is difficult 
to compare the effectiveness of different types of intervention programme. 
Findings from the available studies suggest that improving diabetes patients’ 
outcomes is feasible, and community-based intervention is strongly recommended 




The qualitative study described in Chapter 3 was an attempt to understand the 
problem of diabetes from the patients’ perspectives, and to explore their 
experiences in managing the disease. Findings from the qualitative study 
underlined that diabetes patients’ behaviours in managing the disease are 
influenced by interrelated factors of individual lay evaluation of the disease and its 
treatment, significant others, and cultural practices. The findings suggest that an 
intervention for diabetes patients in Indonesia should focus on assisting 
participants in the lay evaluation process, and providing social support from 
significant others and the community. In assisting the lay evaluation process, 
knowledge about diabetes and its recommended treatments, and skills in 
practising the recommended treatment need to be improved. Although diabetes 
patients accepted a medical perspective of diabetes causation, their personal 
narratives were diverse based on their personal condition. There is also a wide 
variation of opinions, lay knowledge, and misconceptions about diabetes and its 
management. Although some studies showed that there is no consistent 
relationship between knowledge and diabetic control [520-522], proper 
knowledge about diabetes self-management is essential for people to be able to 
manage their disease [523, 524]. As a simple example, some participants believed 
that diabetes is caused by modern ways of cooking rice. With this knowledge, they 
considered that the traditional way of cooking rice is a way for preventing or 
managing the disease. Improving diabetes patients’ understanding about the 
disease by relating the explanation to their condition and experiences is therefore 
essential in diabetes interventions.  
Findings from the qualitative study also underlined that cultural beliefs and 
practices, and family and community support challenged diabetes patients in 
managing the disease. This emphasised the role of social support, either from the 
family, or the community in diabetes management. Social support has been widely 
acknowledged as influencing diabetes management behaviour [525, 526]. Limited 
social support was often perceived as a barrier that further undermined self-
efficacy, and the belief in the ability to perform the recommended behaviour. 
Limited support from other family members in controlling diet has made 




Sarkar, et al. [527] emphasised that perceived barriers negatively affect self-
efficacy, so these should be addressed in the intervention. Self-efficacy belief was 
associated with diabetes patients’ self-management behaviour, including in people 
with low health literacy, and across a wide range of ethnicities [523, 525, 527].  
Other than social support, limited self-efficacy might also relate to perceived 
failure after doing the recommended behaviours. Negative experiences resulted in 
low self-efficacy which further reduces motivation, affecting behaviour in 
managing the disease [528, 529]. Some participants shared that they did not 
experience any difference in their disease state although they had tried to 
implement the recommended actions. These negative experiences in patients’ 
perspective might relate to their lack of skills in implementing the recommended 
behaviour. This should, however, be studied further as many factors may 
contribute to the success of managing diabetes.  
The main components of diabetes intervention therefore included knowledge, 
social-support, self-efficacy, skills and motivation (Figure 4.1). These components 
for behavioural change aligned with the Social Cognitive Theory (SCT) described 
in Chapter 2. The SCT concept explains that behaviour change is not only mediated 
by knowledge, but it also requires self-efficacy, skills, and social support [280, 
530]. In health promotion programmes, the theory can be translated into 
interventions addressing determinants of behaviours: psychological determinants 
of self-efficacy; observational learning; environment support; and self-regulatory 
processes [280, 528, 530]. Based on the principle of observational learning, peer 
modelling is an important intervention that might be useful in improving people’s 
self-efficacy, and facilitating behavioural change. Moreover, the other important 
concept of SCT is self-regulation, a concrete skill that people should have to 
manage themselves. Increasing self-regulatory processes in SCT through self-
monitoring, and feedback can also potentially change behaviour [280]. 
Environmental support through facilitation, and incentive motivation can also 







Figure 4.1: Design of the intervention study based on qualitative study findings and literature review 
Based on information gathered, we therefore developed an intervention with 
several elements (Figure 4.1):  
1. The intervention was conducted with the patient group outside their usual 
interaction with health professionals. The patient group provided social 
support through frequent contact with friends with the same condition. 
The group also enabled people to learn from others through observational 
learning, and peer modelling.  
2. Educational content focused on addressing misconceptions about the 
disease, and improving patients’ skills in self-management. Education 
sessions were delivered through interactive communication, with 
educational material that was designed to be simple and clear. 
3. For improving self-regulatory processes, self-monitoring and feedback 
were implemented  
4. To increase motivation and support, facilitation through demonstration, 
and providing tools, and incentive motivation through providing rewards 
for performing behaviour were also applied. Demonstration improved 




























In terms of intervention programmes, the government has introduced three 
distinct programmes aimed at early detection and management of non-
communicable diseases including diabetes. The programmes are Pos pembinaan 
terpadu penyakit tidak menular - Posbindu PTM (integrated health posts for non-
communicable diseases), targeting people aged 15 or more for early detection for 
risk of developing chronic disease; Pos pelayanan terpadu lanjut usia - Posyandu 
lansia (integrated health posts for the elderly), aimed at managing illnesses in the 
elderly; and Program pengelolaan penyakit kronis – Prolanis (Programme for 
managing chronic diseases), a programme for managing hypertension and 
diabetes for people under the government health insurance scheme. The 
implementation of these programmes, however, differed across the country, 
depending on the capacity and capability of health professionals, and there is no 
such evaluation yet related to their effectiveness in achieving goals.  
The intervention study in this project was therefore conducted in collaboration 
with these existing government programmes. With this collaboration, the 
intervention project made use of available resources in the study location. This 
collaboration and use of existing resources improved the sustainability of the 
intervention because it could easily be adopted, and continued after the research 
project was ended. Collaboration with the existing programme also emphasised 
empowerment, using the available resources for improving the performance of the 
programme. This collaboration also enabled the intervention to be implemented 




5 Chapter 5: Methodology and methods 
5.1 Introduction 
Chapter 5 describes the methodology and method of the pilot intervention study. 
This chapter presents the design of the study, details the research process, 
describes the participants involved in the study, and explains the intervention 
sessions. Chapter 5 also explains the outcomes measured including HbA1c, and 
knowledge, medication adherence, and self-management behaviours. This 
explanation is then followed by description about data collection process. The 
chapter is finished with description about data management and analysis. 
5.2 Study design 
5.2.1 Rationale for quasi-experimental research 
A quasi-experimental study design with a control, a pre-test and a post-test non-
equivalent group was chosen for diabetes intervention in this study. Although 
randomised-controlled trial is the gold standard for determining the ‘true 
experiment’ effect, there are many contextual situations in practice-based and 
public health areas where individual randomisation is not possible [531]. As an 
example, randomisation might be considered impossible because the health 
providers or policy makers have decided that the interventions have to be 
conducted in the most needy areas or individuals, or when having control groups 
is considered as unethical as the practitioners believe that the intervention is 
generally beneficial and should not be restricted to certain individuals [531]. In 
behavioural interventions, individual randomisation might also increase cross-
contamination bias, in which the participants in the experimental group share the 
experiment to participants in the control group [532]. A quasi-experimental 
design enables the researcher to undertake an experiment in these situations 
[531, 533, 534].  
Given the social nature of the community and the contextual situation in the study 
location, randomisation of participants to intervention and control groups was 




people with diabetes interacted each other to find support and treatment 
recommendations. This interaction would likely increase for those who visit the 
same health providers, those who have familial relationship, or those who are 
living near each other. People in the study locations are highly sociable and are 
closely connected to their community. The researcher, therefore, was concerned 
about spreading the intervention through word of mouth from participants in the 
intervention group to those in the control group. This could potentially increase 
cross-contamination bias. Although cluster randomisation would be appropriate 
in a larger sample, to avoid contamination we opted to run the intervention in 
geographically distinct communities.  
 
 
Figure 5.1: Main transportation methods in Kupang, motorbikes, and ‘bemo’ a public transport 
 
The intervention study was designed to include a community-based patients 
group. Participants in the intervention group were invited to attend group 
activities regularly. The intervention was therefore performed in the most 
convenient and accessible place closest to the participants’ homes, to improve the 




performed if the participants were randomised. In the study location, the main 
transportation method is motorbike (Figure 5.1). Bemo, the public transport in 
Kupang, is only available for connecting people living near the main city roads. In 
suburban and rural areas, motorbike taxi is the main transportation method for 
those who do not have a motorbike. The costs for taking a motorbike taxi, 
however, are more expensive, which is often an issue for people of low socio-
economic status.  
 
5.2.2 Experimental design 
In this quasi-experimental study, the effect of the intervention was evaluated and 
compared with usual care. The experimental group included people with diabetes 
who were involved in a group-based intervention, while the control group 
involved diabetes patients who received usual care provided by healthcare 
facilities. The intervention consisted of ten sessions conducted within three 
months. Baseline and follow-up data were collected in both groups (Figure 5.2). 
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5.3 The research process  
5.3.1 Ethics, and local approvals 
Ethics approval for the intervention study was sought through and granted by the 
University of Otago Human Ethics Committee, New Zealand (Appendix 4.1). In the 
study locations, local government approval was sought from the provincial 
government. The research approval letters were issued by Kantor Pelayanan 
Terpadu Satu Pintu (The Integrated Office of Community Service) (Appendix 4.2). 
The documents required for getting the approvals were a reference letter, which 
was the official letter asking permission to conduct research from the head of the 
researcher’s institution, and a research proposal. The reference letter must be in 
the Indonesian language, so I requested the reference letter from the Dean of the 
Faculty of Pharmacy, Gadjah Mada University, the institution in Indonesia in which 
I work. As a result, research approval letters from local government offices 
included the Faculty of Pharmacy, Gadjah Mada University as the researcher’s 
institution. 
The approval letters from the provincial government were then submitted to the 
Kupang municipality government (Appendix 4.3) and the health department office 
(Appendix 4.4). The letters of approval from the municipality government and 
health department office were then submitted to the primary health centres 
(PHCs).  
5.3.2 Study locations and justification 
The qualitative study exploring diabetes patients’ perceptions and experiences 
was performed in West Sumatera and East Nusa Tenggara. In this following 
intervention study, the study was conducted in Kupang, the capital city of East 
Nusa Tenggara Province. As detailed in Chapter 1, diabetes prevalence in East 
Nusa Tenggara was higher than in West Sumatera. Further, with lower socio-
economic status, the financial burden of diabetes in East Nusa Tenggara is higher 
than the other regions in Indonesia. Kupang, the capital city and the most urban 
area of the province was chosen as the study location. The population density in 
Kupang is higher than in other areas of the province. The city also has more health 




study was conducted in collaboration with healthcare facilities, and the HbA1c 
outcome was measured in collaboration with the local clinical laboratory.  
Kupang is situated on Timor Island. With a total land area of 180.27 km2, Kupang 
has a population of 402,286 people in 2016 [535]. The city is divided into six sub-
districts and 51 villages (Figure 5.3). The six sub-districts in Kupang include Alak, 
Kota Raja, Kota Lama, Kelapa Lima, Oebobo, and Maulafa sub-districts [535]. 
Kupang city has 11 state-owned and private hospitals, 11 community health 
centres (Puskesmas), 29 private clinics, and 39 village level community health 
centres (Pustu) [535]. Table 5.1 describes the number of healthcare facilities in 
each sub-district in comparison with the population.  
 
 
Figure 5.3: Sub-districts in Kupang municipality 
https://commons.wikimedia.org/wiki/File:Peta_Timor_Barat_-_Kabupaten_dan_Kecamatan.png 
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Table 5.1: Population and healthcare facilities in sub-districts in Kupang city [535] 









Alak 62,090 1 3 2 
Maulafa 75,459 2 2 3 
Oebobo 97,696 4 2 11 
Kota Raja 53,953 2 1 9 
Kelapa Lima 78,850 0 1 3 
Kota Lama 34,238 2 2 1 
 
5.3.2.1 Languages used in the study location 
As the biggest urban city in East Nusa Tenggara Province, Kupang is the melting 
pot where people from rural areas of the province and other surrounding 
provinces come and live together. Culturally, therefore, the people of Kupang come 
from diverse ethnic groups, both from within the province and from outside the 
province. Because of this, ethnic languages are rarely used for everyday 
conversation, particularly in public places. The people mainly use the Indonesian 
national language (Bahasa Indonesia) as their everyday language.  
Local cultures, however, have influenced the Bahasa Indonesia, so that local 
dialect and local word choices are commonly applied. People in Kupang commonly 
speak more loudly and faster than the people from the western part of Indonesia. 
Because of the speed of speech, they often only say the first syllable of words. They 
also often change the word order in their dialect from the common word order in 
the Indonesian language. 
Culturally, I am Javanese, which is different from the study participants. Bahasa 
Indonesia was therefore used throughout the study process. Modification with 
local dialect and word choices were made. During the research process, I lived in 
the houses of local people in Kupang. Subsequently, I also learnt about the local 




5.3.3 Establishing collaboration with health professionals and the community 
The first stage in conducting the study was establishing collaboration with health 
professionals and communities in Kupang. During this stage, I invited health 
professionals in primary healthcare facilities – including community health 
centres (Puskesmas) and private health centres – and academic communities to 
collaborate in the study. I approached the head of eight primary health centres 
(PHCs), and discussed the possibility of implementing the project. Based on the 
discussions, we decided to implement the project in four PHCs:  
1. Puskesmas Sikumana, located in Maulafa sub-district.  
2. Puskesmas Oepoi located in Oebobo sub-district. 
3. Puskesmas Oebobo, located in Oebobo sub-district.  
4. Layanan Kesehatan Cuma Cuma – LKC - Charity health centre privately 
owned by Dompet Dhuafa, a faith-based non-government organisation, 
located in Alak sub-district.  
The eight primary health centres approached welcomed and appreciated the 
project. Some of them, however, expressed lack of capacity and capability of health 
professionals who might be involved in the programme. Health professionals in 
Puskesmas are often overburdened with clinical and administrative tasks, so that 
they have limited time for additional tasks.  
During this stage, I also approached academic staff at the Faculty of Public Health, 
Nusa Cendana University, and Kupang Health Polytechnic (Politeknik Kesehatan 
Kupang) to collaborate in the project. Eight research assistants were recruited 
from undergraduate students at the Faculty of Public Health, Nusa Cendana 
University. The research assistants were involved in data collection processes as 
interviewers. Some academic staff at Kupang Health Polytechnic agreed to take 
part as providers in some educational activities.  
5.3.4 Existing diabetes related programmes at the healthcare facilities who 
collaborated in the study 
Most Puskesmas in Kupang have implemented Posyandu lansia and Posbindu 




programmes are designed for early detection of risk factors for non-
communicable diseases. The programmes, therefore, invite participation from the 
general population, and not specifically for those who have been diagnosed with 
non-communicable diseases.  
In mid-2015, health centres in Kupang started implementing Prolanis, a 
programme focused on people with diabetes and hypertension, aimed at 
improving their outcomes. The Prolanis programme was managed by the 
Universal Health Coverage (UHC) scheme; therefore, the programme is 
implemented not only by government-owned healthcare facilities but also private 
healthcare facilities which collaborated with insurance management. Based on 
observation and communication with health professionals, however, 
implementation of the Prolanis in health centres depended on the availability of 
resources and capability of the health centres. In some Puskesmas, the Prolanis 
programme is integrated with the Posyandu Lansia. The main activity of the 
Prolanis programme is establishing a Prolanis club. The members of the Prolanis 
club are people with diabetes and/or hypertension registered in the healthcare 
facilities under the UHC scheme. Activities within the club are mainly light exercise 
and health status measurements. Education sessions were also sometimes 
provided. The four health centres involved in the study have implemented the 
Prolanis programme. The frequency of activities, and the number of people with 
diabetes registered to the clubs, however, differed. 
Initial discussions were held with the head of the health centres involved in the 
study. As the intervention targeted diabetes patients, the head of the health 
centres agreed that the intervention would be conducted in collaboration with the 
Prolanis programme. They also agreed that the activities within the Prolanis 
would be modified according to the research project agenda.  
Table 5.2 shows that there are considerable differences in the number of diabetes 
patients involved in the Prolanis club in the four health centres involved in the 
study. Based on Table 5.1 described previously, the population in Oebobo sub-
district, in which Puskesmas Oebobo and Oepoi are located, is higher than that of 




district has more health centres, however, including private clinics. Consequently, 
diabetes patients in Oebobo sub-district may also be distributed over those health 
facilities as people commonly registered to a health centre closest to their home. 
The number of the patients registered in Puskesmas Oebobo and Oepoi, therefore, 
was fewer than that in Puskesmas Sikumana. The LKC health centre is a non-
government faith-based health centre. This health centre provides health services 
only for its members, and specific criteria are applied for people to become 
members. This health centre therefore has the fewest diabetes patients.  
Table 5.2: Prolanis programme implementation in the healthcare facilities that collaborated in the 
study and the number of diabetes patients in the Prolanis club 
Health facilities involved in 
the study 
Frequency of Prolanis club 
activities 
Number of diabetes patients 
in the Prolanis club 
Puskesmas Oepoi Once a week 16 
Puskesmas Oebobo Once in two weeks 16 
LKC health centre Once a month 8 
Puskesmas Sikumana Once a month 59 
 
5.4 Participants 
5.4.1 Eligibility criteria 
Eligibility criteria were applied to ensure that the participants were capable of 
doing intervention activities. Inclusion criteria included: diagnosed with type 2 
diabetes mellitus at a healthcare facility or by healthcare professionals; taking 
diabetes medication; and able to understand and comprehend information. The 
exclusion criteria of participants included having major organ complications of 
diabetes, or being pregnant.  
5.4.2 Sample size calculation 
Currently, there is no published literature on similar interventions conducted in 
the Indonesian context, so it was difficult to estimate an effect size for 
interventions conducted in similar settings. Therefore, we estimated the sample 
size for the study based on Lifestyle Over and Above Drugs in Diabetes (LOADD) 
study conducted in New Zealand [536]. The sample size calculation used a 
standard deviation of HbA1c of 1.4%, and a correlation between measures of 0.74. 




0.5% in HbA1c using the analysis of covariance (ANCOVA) method, with power of 
80% and at 5% level of significance, allowing for a 10% dropout rate. 
 
5.4.3 Participant recruitment 
5.4.3.1 Finding potential participants 
Data about potential participants were gathered from the list of diabetes patients 
registered in the four health centres involved in the study, and screened for 
eligibility by the researcher and health professionals at the health centres. 
Attempts were also made to increase the number of potential participants through 
a community screening programme. The community screening enabled us to find 
undiagnosed diabetes patients. Two community screening sessions in Oebobo sub-
district were performed. The screening programmes were conducted in 
collaboration with Puskesmas Oepoi.  
Invitations to attend a health check were announced to the community using a 
portable loudspeaker with an ambulance going around the areas (Figure 5.4). 
After conducting two screening programmes (Figure 5.5), we found that the 
screening activities were ineffective in finding potential participants. Only a few 
people were detected to have high blood glucose levels. The likely explanation for 
this might relate to the Indonesian people’s health seeking behaviours explained 
in Chapter 2. Most Indonesians would not seek care unless they experience 
symptoms which hinder their everyday activities. The people who were detected 
with high blood glucose level were invited to the Puskesmas for diagnosis 
confirmation, and were also invited to attend the Prolanis activities. Only one 
person detected from the community screening process came to Puskesmas and 







Figure 5.4: Announcement of the screening programme 
 
 




5.4.3.2 Participants recruitment 
A total of 72 eligible potential participants were contacted through short 
messages, and phone calls to attend information sessions about the study. The 
information sessions were conducted at the same time as Prolanis club activities 
in the health centres. Sixty-eight diabetes patients came to the designated place at 
the time. The information sheet (Appendix 5.1 and Appendix 5.2) about the 
project was explained, and time to ask questions and think about whether or not 
to continue participating was provided. Those who agreed to participate were 
then provided consent forms to sign (Appendix 5.3 and Appendix 5.4). All 68 
potential participants who came to the sessions agreed to participate and signed 










Figure 5.6: Prolanis teams (with the researcher) in the health centres that collaborated in the study 
Notes: Left above: Puskesmas Sikumana, Left below: Puskesmas Oebobo,  
Right above: Puskesmas Oepoi, Right below: LKC health centre 
 
 
5.4.4 Intervention and control group allocation 
Further discussions were conducted with Prolanis programme managers, and 
decisions were made about allocation of participants into the control and 
intervention groups. The decision about how participants in each health centre 




the health centres to be involved in managing the intervention activities. The 
Prolanis team at the health centres consist of one health professional, mainly a 
nurse, as the leader of the team, and other supporting health professionals, 
including physicians and nurses. Puskesmas Sikumana had the fewest health 
professionals involved in the Prolanis team, compared to other health centres 
(Figure 5.6). Participants registered in Puskesmas Sikumana were therefore 
allocated to the control group, and the participants registered in Puskesmas 
Oebobo, Puskesmas Oepoi, and LKC health centre were allocated into the 
intervention groups. 
 
Figure 5.7: Participant recruitment and allocation to the control and intervention groups 
 
Initially, 68 participants were recruited: 32 participants in the control group; and 
36 participants in the intervention group. After the baseline data collection 
process, however, one participant from the control group was excluded. This 
participant was not confirmed to suffer from diabetes based both on HbA1c 
72 eligible potential participants registered at 
four health centres were contacted 
68 agreed to participate and signed the 
consent form 
32 participants registered in 
Puskesmas Sikumana were 
allocated to control group 
36 participants were 
allocated to intervention 
group 
16 participants registered in 
Puskesmas Oebobo as the 
first intervention group 
12 participants registered in 
Puskesmas Oepoi as the 
second intervention group 
8 participants registered in 
LKC health centre as the 
third intervention group 
1 participant was excluded 





measurement and questionnaire responses. This participant was originally 
enlisted on the basis of being registered as a diabetes patient in the health centre. 
In total, therefore, 67 participants were involved in the study: 31 participants in 
Puskesmas Sikumana were assigned into the control group; and 36 participants in 
Puskesmas Oebobo, Puskesmas Oepoi, and LKC health centre were assigned into 
the first, second, and third intervention groups, respectively (Figure 5.7).  
Participants in the intervention group received an intensive group-based 
intervention conducted in collaboration with the Prolanis club, and the 
participants in the control group received usual care provided by Puskesmas 
Sikumana. Apart from the intensified activities, participants in the intervention 
group also received usual care provided by their physician. The usual care 
provided in the Puskesmas Sikumana may include care by a physician at the 
Puskesmas, and may also include usual activities in the Prolanis club in the 
Puskesmas. The study did not prohibit self-management education recommended 
by usual care providers or sought by study participants.  
 
5.5 The intensive group-based intervention 
5.5.1 Initial meeting and discussion with providers of the intervention 
Separate meetings were conducted with the health professionals in the Prolanis 
team in each health centre. During the meeting, details of the project were 
explained. Schedules, content, and education material were also discussed and 
explained. The educational materials were prepared by the researcher. The 
content of the educational material and method of delivery were also explained.  
5.5.2 Content and new initiatives 
The intervention designed in the study was an intensification of the usual Prolanis 
club activities with new initiatives added. Development of these new initiatives 
was guided by the results of the qualitative study described in Chapter 3, and the 
literature study about diabetes interventions described in Chapter 4. Table 5.3 




Table 5.3: New initiatives in the Prolanis implementation 
Activities New initiatives 
Frequency of activities During the intervention study, the frequency of activities was 
intensified: ten sessions conducted within three months. To 
increase participation, a friendly short message was sent by health 
professionals reminding them a day before each session. 
Educational session  Educational sessions focused on improving self-efficacy and skills. 
Interactive communication: The education activities were 
delivered interactively in a group.  
Literacy tailored education material: Leaflets were developed by 
the researcher in simple language. Pictures were used for 
illustrating the explanations. 
Peer modelling: Some participants were invited to tell their story 
in managing diabetes in the group.  
Incentive motivation: Focus on encouraging people to implement 
the intended behaviour: after some educational sessions, they 
were encouraged to implement an individual task during the next 
week. On the following session, they were invited to share their 
experiences in implementing the task. Small rewards were 
provided for those who implemented the task well. 
Physical activity Culturally tailored: some physical activity sessions incorporated 
traditional dance with traditional music. 
Health and medication 
check 
 
Self-regulation: Two health cards were provided along with a 
small bag for participants to keep the education material and the 
cards. The cards included: 
 A health card, on which their blood pressure or 
blood glucose level were written. With this card, 
they were able to monitor their disease.  
 A medication taking card: a card on which the 
participants put a mark after taking medicines. This 
card was designed as a tool to improve adherence to 
medicines taking, and minimise forgetfulness when 
taking the medicines.  
Feedback: Feedback was also provided in line with the results 
after health check.  
Snack programme Healthier snacks for diabetics were introduced in some sessions.  
 
5.5.3 Intervention sessions 
5.5.3.1 Timing  
Intervention sessions in Puskesmas Oepoi and Oebobo were conducted every 
Saturday morning at 6.00 AM to 8.00 AM. In Puskesmas Oepoi, the intervention 
activities were performed in the Puskesmas, while in Puskesmas Oebobo, the 
activities were conducted in the sub-district government office. Meanwhile, in the 
LKC health centre, the agreed times for intervention activities were two different 
schedules: on Saturdays of the first week of the month; and on Fridays for the rest 
of the month. Timing was the same for both schedules, from 7.30 AM to 9.30 AM. 




5.5.3.2 Intervention schedule and participants’ attendance  
The intervention sessions were conducted in collaboration with Prolanis club 
activities. The members of the Prolanis clubs were people with diabetes, people 
with hypertension, and people with both hypertension and diabetes. Based on 
discussions with health professionals in the Prolanis team, separating them into 
two groups was not practical as some participants suffered from both diabetes 
and hypertension. Furthermore, health professionals also argued that it was a 
good idea to involve patients with high blood pressure for activities focused on 
diabetes, as having high blood pressure is a risk factor for developing diabetes. 
The intervention sessions were therefore attended by not only diabetes patients, 
but also the club members with hypertension. 
Ten sessions were conducted within three months starting from 15 October 2016 
to 13 January 2017 (Table 5.4). Attendance rate of participants in each session 
varied from 43% to 100%.  
Table 5.4: Intervention sessions in each group and percentage of participants attending each session 
Sessions First intervention group 
(Puskesmas Oebobo) 
Second intervention group 
(Puskesmas Oepoi) 
Third intervention group 
(LKC health centre) 
Date  Participant 
attendance 
Date  Participant 
attendance 
Date  Participant 
attendance 
1 22 Oct 2016 100% 15 Oct 2016 83.3% 21 Oct 2016 100% 
2 29 Oct 2016 100% 22 Oct 2016 100% 28 Oct 2016 100% 
3 5 Nov 2016 87.50% 29 Oct 2016 75% 5 Nov 2016 87.5% 
4 12 Nov 
2016 
75% 5 Nov 2016 75% 11 Nov 
2016 
75% 
5 19 Nov 
2016 
68.75% 12 Nov 2016 75% 18 Nov 
2016 
25% 
6 26 Nov 
2016 
75% 19 Nov 2016 66.67% 25 Nov 
2016 
75% 
7 10 Dec 
2016 
62.50% 26 Nov 2016 83.33% 9 Dec 2016 75% 
8 17 Dec 
2016 
81.25% 10 Dec 2016 66.67% 16 Dec 
2016 
75% 
9 7 Jan 2017 43.75% 17 Dec 2016 83.33% 7 Jan 2017 50% 
10 14 Jan 2017 75 7 Jan 2017 58% 13 Jan 2017 75% 
 
Table 5.5 describes the percentage of sessions attended by each participant in the 
intervention groups. It shows that two participants in Puskesmas Oebobo group 
only attended two sessions and two participants in LKC health centre group 
attended only three sessions or less. The two participants in Puskesmas Oebobo 




come regularly. The two participants in LKC health centre who attended only 
three sessions or less did not provide a reason for non-attendance.  
Table 5.5: Percentage of sessions attended by each participant in the intervention groups 
Percentage of sessions attended by each participant 
First intervention group 
(Puskesmas Oebobo) 
Second intervention group 
(Puskesmas Oepoi) 
Third intervention group 
(LKC health centre) 
Participant 1: 60% Participant 1: 80% Participant 1: 90% 
Participant 2: 100% Participant 2: 70% Participant 2: 30% 
Participant 3: 90% Participant 3: 70% Participant 3: 90% 
Participant 4: 100% Participant 4: 70% Participant 4: 90% 
Participant 5: 100% Participant 5: 80% Participant 5: 90% 
Participant 6: 60% Participant 6: 60% Participant 6: 90% 
Participant 7: 90% Participant 7: 90% Participant 7: 20% 
Participant 8: 100% Participant 8: 60% Participant 8: 90% 
Participant 9: 70% Participant 9: 90%  
Participant 10: 80% Participant 10: 100% 
Participant 11: 20% Participant 11: 70% 
Participant 12: 60% Participant 12: 80% 
Participant 13: 90%  
Participant 14: 90% 
Participant 15: 20% 
Participant 16: 100% 
 
5.5.3.3 Intervention activities 
There were four main activities in each intervention session: physical activity; 
education; health check; and healthy snacking. Prayers led by a participant or 
health professional were also conducted, either for opening or closing the 
sessions. The order of these activities differed in each intervention group.  
Physical activities 
The physical activities were done mostly in the form of ‘senam’ - light aerobic 
dance exercise with music. Foot exercise, and ‘laugh therapy’ (terapi tertawa) 
were also conducted (Figure 5.8). The laugh therapy was introduced by academic 
staff at Politeknik Kesehatan Kupang. The therapy has never been practised before 



















Figure 5.8: Physical activities conducted in the intervention group 
a. Senam – light aerobic dancing exercise 
b. Laugh therapy (terapi tertawa) 
c. Foot exercise 


















Figure 5.9: Education sessions in the intervention group 
a. Education session in the first intervention group, participant answering the question 
asked by the education provider.  
b. Education session in the second intervention group, participants asking questions. 
c. Education session in the third intervention group.  





The types of dance in each health centre and each session were varied, based on 
the creativity of the facilitators. In some sessions, traditional dancing with music 
was also performed. People in Kupang love dancing, and they often have dancing 
sessions in cultural or traditional feasts. The exercise activities lasted for about 
half an hour. 
Educational activities 
As discussed previously, the new initiatives of educational activities focused on 
improving self-efficacy – confidence about the ability to perform recommended 
behaviours – and skills. The educational content was delivered with an interactive 
teaching style. Educational materials were developed by the researcher, 
considering people’s literacy and general understanding about diabetes explored 
in the qualitative study. The materials were leaflets with big font and many 
pictures and diagrams (Appendix 6). A small bag was also provided to each 
participant for them to keep the education materials in, so that the leaflets could 
be read again at home, or read by other family members.  
The educational providers involved in the study were mainly the researcher, and 
the health professionals in the Prolanis team. In one session, the education was 
also provided by academic staff from Politeknik Kesehatan Kupang. Figure 5.9 
illustrates some education sessions conducted in the intervention group. 
Observational learning through peer modelling was also applied by inviting some 
participants to share their positive experiences in managing diabetes. Incentive 
motivation was also applied by providing an individual task to be completed 
during the following week. The participants recorded their achievement in the 
leaflets provided. On the following session, they were given opportunities to share 
their experiences in implementing the task. Small rewards were provided for 
participants who implemented the task well.  
The educational sessions covered seven topics of diabetes including: 
understanding diabetes; the meaning of blood glucose level; diabetes medicines 
and medication adherence; diet for diabetes; physical activity; foot care; and 




adherence, and diet for diabetes were delivered in two sessions. One education 
session was storytelling, in which one participant in each intervention group was 
invited to share his or her experience in managing diabetes. 
Mengenal diabetes (understanding diabetes) 
This topic presented basic knowledge related to diabetes including early 
symptoms and risk factors. During the explanation, participants were invited to 
share common understandings about diabetes. Misconceptions encountered were 
addressed. Misconceptions encountered were related to diabetes classification, 
and the lay terms for diabetes. Participants mentioned that diabetes was classified 
into two types: penyakit gula basah (wet sugar disease), and penyakit gula kering 
(dry sugar disease). Local terms describing diabetes were penyakit gula (sugar 
disease), and penyakit kencing manis (sweet pee disease). The use of term 
penyakit gula often misunderstood that gula or sugar is the main cause of 
diabetes. Participants associated gula with white cane sugar. Many participants 
therefore questioned about a local type of sugar, known as gula lempeng. Gula 
lempeng (coin-shaped brown sugar) is made from neera (lontar palm nectar). 
Some of them believed that gula lempeng would not cause diabetes. Some 
participants also asked about honey from bees; they also believed that honey 
would not cause diabetes.  
Apa arti hasil kadar gula darah anda? (What is the meaning of your blood glucose 
level?) 
This topic covered types of blood glucose measurements, including fasting blood 
glucose, random blood glucose, HbA1c, and their meanings. After the explanation, 
the copy of the HbA1c test result at baseline was provided to the participants. 
They were then asked to write the result in the table provided on the leaflet, and 
evaluate the result by themselves. They were also encouraged to write down 
results of the last blood glucose measurements, and evaluate them. Many 
participants wanted to know more about the results, and individual consultations 
were provided afterwards.  
The HbA1c test was a new type of blood glucose measurement for the vast 




provided by the health centres were commonly the fasting or random blood 
glucose, measured mainly with a point of care device. In this session, the topic of 
pre-diabetes was also introduced.  
Tahukah anda obat diabetes atau hipertensi yang anda minum? (Do you know 
about diabetes and/or hypertension medicines you are taking?) 
This topic was delivered in two sessions. The first session was an explanation 
about the medicines for diabetes and hypertension: how they work; and why they 
need to be taken regularly. Medicines for hypertension were included in this 
session, as some diabetes patients experienced co-morbidity with hypertension. 
This medication session particularly stressed the problems encountered by 
participants in taking the medicines regularly. Participants mentioned that 
forgetfulness was the main problem in taking medicines. Some participants 
mentioned that they did not know the name of the medicines they were taking, 
and some of them described it based on the medicines’ characteristics, for 
example, ‘the small white tablets’.  
After the first session of about diabetes medication, the participants were 
encouraged to practise some individual tasks including: 
 Recognising the name of the medicines they were taking. The participants 
were encouraged to have a look at the medicines they had, and read or 
have their family members read for them the names of each medicine.  
 Filling in a ‘medication taking card’ (Figure 5.10). This medication taking 
card was developed to improve adherence to medication. After 
recognising the name of the medicines, the participants were encouraged 
to write the name of the medicine and its dosage instruction on the card. 
The rows of the table are for the date of the month, and the columns of the 
table are for the dosage, 1st dose, 2nd dose, and 3rd dose. After taking each 
dose of the medicine, the participants were encouraged to put a mark in 
the relevant row and column. Explanation of how to fill in the card was 






Figure 5.10: The medication-taking card 
 
 




The second session of the topic about medication was a sharing session about the 
participants’ experiences of practising the individual tasks. Participants found that 
the medication taking card was helpful for minimising forgetfulness in taking the 
medicines. Interestingly, one participant made his own medication taking card 
based on all the medicines he was taking.The medication taking card provided was 
intended for one medicine, so that if the participants received three medicines, 
they would have three cards. So, this one participant made his own card and 
combined the three medicines in one card (Figure 5.11). 
Diet sehat, bagaimana caranya? (Healthy diet, how to do that?)  
Diet for diabetes was also delivered in two sessions. The first one explained about 
the plate method, and the second one was a discussion about local foods available 
and their impact on diabetes. The participants shared that controlling diet, 
particularly in reducing the rice portion, was the most difficult part of managing 
diabetes. They said they did not feel full if they had not had enough rice in their 
meals. After the explanation session, participants were also encouraged to write 
about what they ate during the following week.  
In the second session, participants were invited to share efforts they have made 
for managing diet. Discussion about diet revealed some misunderstanding about 
proper diet for diabetes. Participants questioned about whether the way of 
cooking rice impacted on the amount of sugar in it, and what food sources should 
be restricted for diabetes patients and why.  
Sudahkah anda berolahraga hari ini? (Have you been exercising today?) 
The education about exercise aimed at encouraging participants to practise 
individual physical activity. Walking, particularly, was encouraged as it is the 
cheapest and easiest form of exercise. Some participants asked about walking 
barefoot on gravelly surfaces. They believed that walking on gravel may improve 
blood circulation to their foot, like a foot massage. Some pedestrian paths in 
Kupang are designed with gravel on them. This may imply that participants were 
not aware of the risk of foot injury as a result of walking barefoot. After the 
explanation session, an individual exercise task was also provided. The 




upcoming week in the table provided on the leaflets. Some participants did this 
well, as illustrated in Figure 5.12. 
  
Figure 5.12: Participants’ individual exercise activities 
Perawatan kaki untuk diabetes (Foot care for diabetes) 
Education about foot care aimed to increase participants’ awareness about foot 
complications of diabetes, and encouraged the diabetes participants to practise 
daily inspection of their feet. This topic was presented along with a foot exercise 
programme.  
Storytelling 
One education session focused on providing role models for the diabetes 
participants (Figure 5.13). The role models were chosen from diabetes 
participants in each intervention group who experienced better control of 
diabetes than the others. These role models were invited to share their 
experiences in managing the diabetes. In the first intervention group (Puskesmas 
Oepoi), the role model was a participant who had suffered from diabetes for 21 
years. He explained that he managed the diabetes with controlling diet, exercising 
regularly, and taking medicines. He mentioned that it was not easy at the 
beginning, and being persistent and patient was the key to successfully managing 




aged 70 had experienced diabetes for around four years. She also had her diabetes 
well-controlled and had an active life. She shared that the key point was to always 
have a happy life. She actively participated in activities for diabetes patients.  
In the LKC health centre, one participant had diabetes for 10 years, and her blood 
glucose level was also well-controlled. She shared that her success in controlling 
diabetes was mainly because of very supportive health professionals at the health 
centre. She mentioned that the health professionals sometimes home-visited the 
patients. One other participant also shared that he experienced a diabetes wound 
on his limb. Because of the wound, he could not come to the health centre, but the 
health professional home-visited him to take care of his feet regularly.  
Komplikasi, apa dan bagaimana mencegahnya? (Diabetes complications, what and 
how to prevent them?)  
This topic was provided in the last intervention session. This final session aimed 
to remind and encourage the participants to practise the recommended actions for 
managing diabetes explained at the previous sessions, and explain the diabetes-
related complications. This topic was delivered interactively with a question and 
answer session. The majority of participants responded well to the questions 
asked. Some of them, however, commented: “it’s bit easy for answering questions, 
but actually it’s difficult to practise. Often after we got home, we still did what we 
usually did, although we knew that we should not do those things, not eat those 
things. But … it’s hard, but … at least we know”. 
5.5.3.4 Measurement of blood pressure and blood glucose 
During the intervention sessions, blood pressure was measured in each session, 
and fasting or random blood glucose measurements were provided twice (Figure 
5.14 and Figure 5.15). The measurements were conducted as part of routine 
assessment for the members of Prolanis club, and these data were not included as 
part of the research. This was because different measurement tools were used in 
each group, therefore, the chance of having variability of result because the 
variability of measurement tools was high. Participants’ attendance at the sessions 
















Figure 5.14: Blood pressure measurement 
 
 





5.5.3.5 Healthy snacking 
In some sessions, a healthy snacking programme was also introduced.  The 
researcher and Prolanis team prepared snacks suitable for diabetes participants. 
We ordered snacks with specific instructions. For example, low sugar bread, green 
bean porridge with low-calorie sweetener, and rissoles with vegetables inside. 
Although the participants enjoyed the snacks, some of them complained about the 
taste, that it was not the proper way of serving it, for example, the snacks were not 
as sweet as they should be. 
5.5.4 Participants’ and health professionals’ perspectives related to the 
implementation of the intervention programme 
After the intervention session finished, four individual interviews and a focus 
group with participants involved in the intervention group were conducted. 
Individual interviews with two Prolanis team leaders in the intervention groups 
were also conducted. The interviews and focus group aimed at gathering 
participants’ and health professionals’ opinions related to the implementation of 
the intervention. 
5.5.5 Safety consideration 
During the intervention sessions, participants’ conditions were closely monitored. 
Individual assessment was conducted before each group session to ensure that the 
participants were capable of doing exercise. No adverse events were encountered 
during the study. 
5.6 Outcomes measured 
Outcomes of this experimental study were collected at baseline, and at follow-up – 
approximately three months after baseline data collection. The outcomes 
measured were HbA1c, knowledge, medication adherence, and self-care 
behaviours. The clinical outcome of HbA1c was gathered in collaboration with a 
local clinical laboratory. The socio-demographic characteristics, knowledge, self-
care behaviour, and medication adherence were collected using interviewer-





The clinical outcome measure HbA1c, and its measurement was conducted by the 
local clinical laboratory, PT. Prodia Widyahusada (Figure 5.16). After discussion 
with the marketing manager in the laboratory, a Memorandum of Understanding 
(MoU) was signed. The laboratory analysed HbA1c level from venous blood 
samples with an Ion Exchange High Pressure Liquid Chromatography (HPLC) 
method which has been standardised by the National Glyco-haemoglobin 
Standardization Programme. The blood samples were drawn by qualified 
laboratory staff. It was also agreed that the laboratory staff came to the health 
centres at the time of baseline and follow up data collection. Venous blood 
samples were taken and stored in a tube containing anticoagulant 
Ethylenediaminetetraacetic acid (EDTA). These blood samples were then brought 
to the laboratory for analysis.  
5.6.2 Questionnaires  
The questionnaire for collecting socio-demographic, knowledge, medication 
adherence and self-care behaviours was administered orally. According to 
academic staff in Nusa Cendana University, based on their experiences of 
conducting surveys, lay people in Kupang commonly have difficulty in filling 
questionnaires by themselves, particularly when the questions are in formal 
Indonesian language. The questionnaire was therefore administered orally to the 
participants by research assistants. The research assistants were native speakers 
of the participants’ language, so that they were able to modify questions to a more 
conversational style to improve participants’ understanding of the questions.  
The questionnaire was originally developed to include 14 questions on socio-
demographic and diabetes experiences, 10 questions on knowledge, 18 questions 
on medication adherence, and 14 questions on self-management behaviours. After 
testing the questionnaire, however, it was modified. The knowledge section was 
changed to include 38 questions. Explanation on this in detail is provided in the 













5.6.2.1 Questionnaire translation 
The questionnaires were developed in English, and translated into the Indonesian 
national language (Bahasa Indonesia) with a forward and backward translation 
process. The English version was translated into Indonesian, and the Indonesian 
version was back translated into English by different translators. This process 
involved four translators who were fluent in both languages, two of them as 
forward translators, and the other two as backward translators.  
After the forward and backward translation process, the backward translated 
version was compared to the original version by the researcher’s supervisors. No 
major differences were found between versions. Different word choices found 
were synonyms, and can be used interchangeably without altering the meaning. 
Some issues related to words with specific meaning in the Indonesian language 
were encountered and resolved.  
As an example, in the English version, there were technical terms in questions 
about dietary behaviour: carbohydrate; and protein. For lay people in Indonesia, 
these terms were not commonly used. Carbohydrate was therefore translated into 
nasi or rice, and protein was translated into lauk, which in English, literally 
translated as ‘side dish’. Nasi or rice is the staple food mostly eaten in every meal, 
and lauk is referred to a side dish mainly as a source of protein which is eaten with 
rice. People referred lauk to meat, chicken, fish, tempeh, or tofu.  
Another example was related to the translation of the word ‘exercise’. In one back 
translated version, the translator used the term ‘sport’, which in English has a 
different meaning from exercise. In the Indonesian language, both words ‘exercise’ 
and ‘sport’ are translated into the same word in Indonesian: olahraga. In this case, 
more explanation was given in translating the word exercise by including 
examples of activities in the meaning of exercise.  
There was also an issue related to the use of word ‘herbals’. One translator used 
‘alternative medicines’ for herbals. In the Indonesian language, the word herbal is 
often used interchangeably with alternative medicines, or traditional medicines, 




The Indonesian people refer to medicines as ‘obat’, which means conventional 
medicines.  
5.6.2.2 Questionnaire testing  
The translated version of the questionnaire was tested before the data collection 
process. The participants involved in the questionnaire testing were people with 
diabetes who were registered in a health centre which was not included in the 
experimental study. They were recruited with snowball sampling, in which one 
diabetes participant who agreed to be involved in the trial invited his or her 
diabetic friends registered in the same health centre. The trial involved seven 
participants and was performed on 1st October 2016 at 09.00 AM to 12 PM (Figure 
5.17). Two research assistants who had been previously trained were involved in 
the process of questionnaire testing as interviewers. After the interview process, 
discussions were held with respondents to get feedback about the questions. The 
discussions pointed out two important points of the questionnaire:  
1. The multiple choice questions in the knowledge section were difficult to 
administer orally as the participants needed to remember the choices 
before choosing the best option. Remembering the choices took more time, 
and the interview process often went back and forward to the choices 
several times. Finding this problem, the participants answered one by one 
of each choice after it was read to them. At the end, however, we sometimes 
found no clear final answer to the questions, as they answered ‘true’ for 
more than one option. The multiple choices questions, therefore, were then 
changed into dichotomous – true and false – questions. Consequently, the 
10 multiple choice questions about knowledge were changed into 38 true 
and false questions.  
2. In the self-management behaviour section, questions about dietary habits 
were found to be the most difficult part, particularly in the questions about 
the ‘plate portions’ [537]. Some participants shared that the ways they put 
food on the plate was different, so that it was difficult to approximate the 
portion compared to the whole plate. As an example, they usually put the 




this problem, we then decided to elaborate more on the plate portion 
questions in an easier way. If, therefore, the participants were confused in 
answering the plate portion questions, they were asked which part of their 
meal was the largest. If they answered the largest portion was the rice, we 
assumed that the rice portion would be more than a quarter part of their 
plate, and the vegetable portion would be less than the recommended 
portion of half of the plate.  
5.6.2.3 The final version of the questionnaire  
The final version of the questionnaire included 14 questions about socio-
demographic characteristic and disease experiences, followed by 38 questions 
about diabetes knowledge, 18 questions related to medication adherence, and 14 
questions on self-management behaviours (Appendix 7).  
Socio-demographic characteristics and diabetes experiences 
Socio-demographic data included age, gender, income per month, marital status, 
and completed education level. These socio-demographic characteristics were 
asked at the beginning of the questionnaire followed by questions about diabetes 
experiences such as diabetes duration, medication taking, and other diabetes 
management experiences, including attending diabetes programme, and visiting a 
dietitian (Figure 5.18). 
Knowledge 
The questions on diabetes knowledge were developed based on the results of the 
qualitative study. Findings of the qualitative study indicated that peoples’ basic 
knowledge about diabetes symptoms, risk factors, causes, complications and 
management were limited. As previously mentioned, the knowledge outcome was 
first designed to be collected with 10 multiple choice questions. After the 
questionnaire testing, these 10 multiple choices knowledge questions were 
changed into 38 dichotomous questions (Table 5.6). The 38 questions consisted of 
nine positive questions, and 29 negative or reverse questions. The reverse 
questions were coded with (R) in the Table 5.6. The questions asked participants’ 




diabetes risk factors (questions numbers 5-7; and 23), diabetes medication 
(questions numbers 8-11), diabetes-related complications (question numbers 12-
15), diabetes symptoms (question numbers 16-19), diet for diabetes (question 
numbers 20, 21, and 27-34), and exercise and smoking (question numbers 22, and 
35-38). 
 
Your name     : ………………………………………………… 
What is your age?     …………………. Years 
What is your gender?    □ Male   □ Female 
How long have you had diabetes?  …….. years or ...…. months or ……. days 
Do you take medicines from doctors for your diabetes?  □ Yes    □ No 
If yes, what type of your medicines from doctors?  □ Tablets    and/or □ injection  
If you use injection, how many injections per day? 
□ 1 □ 2 □ 3 □ 4 □ other, please specify ……………..  
If you use tablets, how many different tablets? 
□ 1 □ 2 □ 3 □ other, please specify …………….. 
Do you also take herbals for your diabetes?  □ Yes    □ No 
Have you ever attended specific diabetes programme?  □ Yes    □ No 
Have you ever seen a dietitian?    □ Yes    □ No 
 
Income per month (in IDR): 
□ < 500,000 
□ 500,000 – 1,499,999 
□ 1,500,000 – 2,499,999 
□ 2,500,000 – 4,999,999  




□ Not married 
□ Widowed 
 
Highest education level 
□ Elementary school 
□ Junior high school 
□ Senior high school 
□ University 
 
Figure 5.18: Questions on socio-demographic and disease experiences 
 
Medication adherence 
Medication adherence was measured with a Probabilistic Medication Adherence 
Scale (ProMAS) developed by Kleppe, et al. [538]. It consists of 18 yes/no 




Table 5.6: Questions on knowledge outcome 
Number Statement True False 
1 Diabetes is a condition that can be cured by adopting a healthy 
lifestyle (R) 
  
2 Diabetes is a condition that can be cured with medicines (R)   
3 Diabetes is a condition that currently not curable   
4 Diabetes is a disease that cannot be prevented (R)   
5 Diabetes is only suffered by people who have family history with it. 
(R) 
  
6 Diabetes is only suffered by obese people (R)   
7 Diabetes is a disease only suffered by older people (R)   
8 If your blood sugar levels are normal or if you feel better, you can 
stop taking medicines from your doctor (R) 
  
9 Long-time use of medicines from the doctors may cause kidney 
damage (R) 
  
10 Regular medical check-ups are necessary to assess whether to 
adjust diabetes medicines 
  
11 People taking diabetes medicines from doctors do not need to 
worry about healthy eating (R) 
  
12 If your diabetes is getting worse, you might get cancer (R)   
13 If your diabetes is getting worse, you might get rheumatoid 
arthritis (R) 
  
14 If your diabetes is getting worse, you might get lung problems (R)   
15 If your diabetes is getting worse, you might get heart disease   
16 Feeling weakness is early symptom of diabetes   
17 Headache is early symptom of diabetes (R)   
18 Feeling pain at the back of your neck is early symptom of diabetes 
(R) 
  
19 Always feeling sleepy is early symptom of diabetes (R)   
20 Avoid carbohydrates food is part of managing diabetes (R)   
21 Taking food supplement is part of managing diabetes (R)   
22 Stop smoking is part of managing diabetes   
23 Having high blood pressure makes you more likely to get diabetes   
24 Having contact with unhealed wound of diabetic patients makes 
you more likely to get diabetes (R) 
  
25 Sharing your food, eating equipment or clothing with diabetes 
patients makes you more likely to get diabetes (R) 
  
26 Unhealthy environment makes you more likely to get diabetes (R)   
27 People with diabetes must not eat anything sweet (R)   
28 Potato is a vegetable, so it is carbohydrate free (R)   
29 Taro, sweet potato, and corn cannot substitute white rice (R)   
30 Diet recommendations for people with diabetes are the same as 
healthy diet recommended for general people 
  
31 Skipping dinner is as part of healthy diet for people with diabetes 
(R) 
  
32 Eat specific food product designed for diabetes is as part of healthy 
diet for people with diabetes (R) 
  
33 Reduce the rice portion in every meal is as part of healthy diet for 
people with diabetes 
  
34 No meat diet is as part of healthy diet for people with diabetes (R)   
35 Exercise for diabetes patients has to be done in a specific exercise 
class with an instructor (R) 
  
36 Walking regularly is a form of exercise for diabetes patients   
37 Exercise for diabetes patients should be avoided in people with 
high blood sugar and hypertension (R) 
  




Table 5.7: Questions on medication adherence  
The following questions ask about how you usually take your medicines from your doctor for 
diabetes.  
Number Statements Yes No 
1 It has happened at least once that I forgot to take (one of) my 
medicines (R) 
  
2 It happens occasionally that I take (one of) my medicines later 
than usual (R) 
  
3 I have never (temporarily) stopped taking (one of my) medicines   
4 It has happened at least once that I did not take (one of) my 
medicines for a day (R) 
  
5 I am positive that I have taken all the medication that I should 
have taken in the previous year 
  
6 I take my medicines exactly at the same time every day   
7 I have never change my medicine use myself   
8 In the past month, I forgot to take my medicine at least once (R)   
9 I faithfully follow my doctor’s prescription concerning the time I 
take my medicines 
  
10 I sometimes take (one of) my medicines at a different time than 
prescribed (e.g., with breakfast or in the evening) (R) 
  
11 In the past, I once stopped taking (one of) my medicines 
completely (R) 
  
12 When I am away from home, I occasionally do not take (one of) 
my medicines (R) 
  
13 I sometimes take less medicines than prescribed by my doctor. 
(R) 
  
14 It has happened (at least once) that I changed the dose of (one 
of) my medicines without discussing this with my doctor (R) 
  
15 It has happened (at least) once that I was too late with filling a 
prescription at the pharmacy (R) 
  
16 I take my medicines every day   
17 It has happened (at least once) that I did not start taking a 
medicine that was prescribed by my doctor (R) 
  





The self-management behaviour outcome was assessed with 14 questions 
addressing eating, exercise, foot care and smoking behaviours (Figure 5.19). The 
questions asked participants to recall their behaviour within the last week: the 
number of days during the last week on which they performed intended 
behaviours. If the participants mentioned any number of days, they were 
questioned further about the frequency of doing the behaviour within a day. If the 
participants responded that they never performed such behaviour within the last 
week, the zero (0) was circled, and the questioning process was continued to the 




The following questions ask about what you usually do for managing your diabetes 
 
1. How many days in the last week did you eat a meal where rice filled at least a quarter of 
your plate?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat a meal where rice 
filled at least a quarter of your plate? ……………………. 
2. How many days in the last week did you eat a meal where vegetables and fruits filled at 
least half of your plate?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat a meal where green 
vegetables and fruits filled at least half of your plate? ……………………. 
3. How many days in the last week did you eat a meal where protein-containing food filled at 
least as much as a quarter of your plate? 
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat a meal where 
protein-containing food filled at least as much as a quarter of your plate? ……………… 
4. How many days in the last week did you have food in your plate like this picture? 
 
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you have food in your plate 
like the picture above? ………………………………… 
5. How many days in the last week did you substitute white rice with another type of 
carbohydrate? 
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you substitute white rice 
with another type of carbohydrate? …………………………….. 
6. How many days in the last week did you eat fried snacks?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat fried snacks? 
……………….. 
7. How many days in the last week did you drink coffee or tea with sugar?  
0  1 2  3 4 5 6 7    
When you did that, on average, how many cups a day did you drink coffee or tea with 
sugar? …………… 
8. How many days in the last week did you eat cookies and sweet snacks?  
0 1 2  3 4 5 6 7 








9. How many days in the last week did you exercise on your own (including walking)? 
0 1 2  3 4 5 6 7 
When you did that, on average, how long did you exercise on your own per day? …….. 
10. How many days in the last week did you attend specific exercise programme such as 
“senam” or other group exercise?  
0 1 2  3 4 5 6 7 
11. How many days in the last week did you exercise (including walking) for about 30 minutes 
a day?  
0 1 2  3 4 5 6 7 
12. How many days in the last week did you take care of your feet, including washing, soaking 
and drying your feet? 
0 1 2  3 4 5 6 7 
13. How many times in the last month did you visit your health professional for checking your 
diabetes? ………… 
14. Do you smoke cigarettes?  
How many days in the last week did you smoke a cigarette – even one puff? 
0 1 2  3 4 5 6 7 
How many cigarettes did you smoke on an average day? ……………… 
 
Figure 5.19: Questions for measuring self-management behaviours  
The questions about diet were developed based on the plate method dietary 
recommendation, carbohydrate substitution, and food restrictions. The plate 
method has been suggested as a simple alternative meal planning method using a 
visual plate, on which the portion of food is depicted [537]. This plate method is 
recommended for teaching diabetes patients, particularly those with low literacy 
levels [539]. The questions about carbohydrate substitution and food restriction 
were also developed based on local eating habits and conditions. 
5.6.2.4 Training of the interviewers 
The interviewers for the questionnaire were eight study assistants who were 
recruited from undergraduate students at the Faculty of Public Health, Nusa 
Cendana University (Figure 5.20). The criteria for their selection were: had 
experiences of interviewing the public, or conducting a survey; and were able to 
speak the local language for daily conversation. The selection process was helped 
by a lecturer from the Faculty of Public Health, Nusa Cendana University. The 
selected study assistants were provided with a half-day training. The training 
included explanation about the study, the process of collecting data, their roles, 




of each question was explained, and acceptable ways of modifying the questions 
into local dialect or wording were also discussed.  
After each data collection session, discussions with study assistants were also 
made to check the completeness of the data, and discuss their experiences in 
interviewing participants. As an appreciation for their time and covering travel 
cost, the study assistants were paid after each stage of data collection was 
completed.  
 
Figure 5.20: Research assistants involved in the study with the researcher 
 
5.7 Data collection 
5.7.1 Baseline data 
Baseline data of participants in both intervention and control groups were 
collected in four timeslots. During the data collection process, the researcher, the 
Prolanis team, the laboratory staff, and the research assistants, gathered at a 
designated place and time. The place and time selected were the usual place and 




attending) (Table 5.8). The blood sample was drawn from the participants by the 
laboratory staff. After having their blood sampled, the participants were 
interviewed by the research assistants. The amount of time needed for data 
collection process differed across participant groups. It depended on the number 
of participants, and the time of their attendance. In some places, the participants 
did not attend the data collection process at the same time, so we waited for them 
to come, as they had agreed to be involved.  
Table 5.8: The timing and the number of participants who attended baseline data collection 
Group of participants Time and date of baseline data collection Number of 
participants attended 
the session 
Control group  Saturday, 8 October 2016, at 8 AM to 11 AM 32 
First intervention group  Saturday, 15 October 2016, at 6 AM to 9 AM 16 
Second intervention 
group  
Saturday, 8 October 2016, at 6 AM to 8 AM 12 





Figure 5.21: Baseline data completion 
One participant involved in the third intervention group could not attend the data 
collection session as she had another activity on the date of data collection. This 
participant, however, agreed to come to the laboratory to get her blood sampled 
the day after. This participant therefore only completed the clinical outcome, and 
missed the questionnaire data. The researcher, along with the Prolanis team made 
attempts to contact her to have the questionnaire data collected, but we could not 
manage this until the intervention sessions were started. The number of 
participants who completed baseline data collection is described in Figure 5.21. 
Figure 5.22 illustrated the data collection process at baseline.  
67 participants attended 
designated time and place of 
baseline data collection 
1 participant has her blood 
sampled at different time 
but missed the interview 
Total number of data collected at 
baseline: 
 68 participants had their blood 
sampled 





















5.7.1.1 Follow-up data collection 
The follow-up data were collected approximately three months after the baseline 
data collection (Figure 5.23). As described previously, one participant in the 
control group was excluded after baseline data collection. A total of 67 
participants, therefore, were invited to the follow-up data collection. Scheduled 
timing and participants’ attendance are listed in Table 5.9.  
Table 5.9: Follow-up data collection 
Group of 
participants 




attended the session 
Number of participants 
who had data collected 
at different time  
Control group  Saturday, 14 January 2017, 




Saturday, 21 January 2017, 
at 6 AM to 8 AM 
10 4 
Second 
intervention group  
Saturday, 21 January 2017, 




Friday, 20 January 2017,  








The process of collecting follow-up data was the same as the baseline data. The 
researcher, the Prolanis team, the research assistants, and the laboratory staff 
were gathered at the designated time and place. Participants in the intervention 
group were informed of the schedules for follow-up data collection at the last 
intervention session. The participants were also reminded about the session a day 
before by the researcher and/or the Prolanis team through a short message 
and/or a phone call. The participants in the control group were contacted through 
a short message and/or a phone call by the researcher and/or the Prolanis team a 
week before. For some of them who could not be contacted through phone, the 
Prolanis team asked the other participants who lived close to them to invite them. 
During the follow-up data collection, however, a practical problem mainly caused 
by bad weather was encountered. The follow-up data were collected in January, 
the time of the year with the highest intensity of rainfall (Figure 5.24). This made 
it difficult for participants to come to the session.  
Four participants involved in the control group did not attend the session: one 
participant went out of town; one was unwell; one had something else to do at the 
same time; and one did not offer a reason. The researcher along with the Prolanis 
team then made attempts to contact them and asked whether or not they were 
willing to have their data collected at other times. We finally managed to get the 
data collected from three out of four of the missing participants in the control 
group within two weeks after the data collection session: all but the one with no 
reason. These three participants agreed to come to the laboratory for blood 
sampling, and had the interview conducted at their house.  
The follow-up data collection in the first and second intervention groups were 
conducted on the same day but different times. It was a heavy rainy day. Nine out 
of 12 participants in the first intervention group, and ten out of 16 participants in 
the second intervention group, attended the session. Three participants in the first 
intervention group did not come to the session because of the rain. Six 
participants in the second intervention group did not come: two went out of town; 
one was unwell; and the other three did not come because of the rain. Addressing 




missing participants. We informed them that if they were willing to have their 
follow-up data collected, they may go to the laboratory or have the laboratory staff 
collect their blood at their home. Within a week after the scheduled data collection 
sessions, all three participants in the first intervention group agreed to have their 
blood sample collected at their home, and four participants in the second 
intervention group agreed to come to the laboratory to have their blood sampled. 
For the questionnaire data, all seven participants were interviewed at their homes 
by research assistants. This left two missing participants from the second 
intervention group: the one participant without any reason; and the one who was 
still out of town. All participants in the first intervention group had their data 
collected. 
In the third intervention group, two participants did not come to the follow up 
data collection session: one without any reason; and one who had haemoglobin 
variant which could not be measured for HbA1c. An attempt has also made to 
contact the missing participants. Both of them, however, were not willing to have 
their follow-up data collected. This resulted in a total of 62 participants who 




Figure 5.25: Follow up data completion 
 
52 participants attended 
designated time and place of 
follow-up data collection 
10 participants had their 
blood sampled and been 
interviewed at different time  
Total number of data collected at 
follow up: 
 62 participants had their blood 
sampled 
62 participants completed the 
interviewed questionnaire 
5 participants lost to follow 
up: 1 from the control group, 





5.8 Data management and analysis 
5.8.1 Data management 
During the study, all data collected were managed by the researcher, and securely 
stored in a locked filing cabinet and on a password-protected laptop. The HbA1c 
outcome results were collected by the researcher from the laboratory, and stored 
securely. Copies of these results were also distributed to the relevant participants 
and their health providers. The completed questionnaire files were also managed, 
compiled, and stored by the researcher. Although the study assistants interviewed 
the participants, the compilation of this data was done by the researcher, and the 
results were only known to the researcher.  
After the research was completed, all primary data files including the original copy 
of HbA1c laboratory test results and the filled paper questionnaires were brought 
to New Zealand and stored in a locked container, and only the researcher and the 
supervisors had access to this data.  
Health information generated from this study will be retained for at least five 
years in secure storage. Any personal information may be destroyed at the 
completion of the research even though the raw data derived from the research 
will, in most cases, be kept for much longer or possibly indefinitely.  
Although the completed questionnaires have the participants’ names on them, for 
data analysis, they were de-identified. The participants’ names were also not 
presented in the thesis and publications derived from the thesis.  
5.8.2 Data analysis 
The outcomes data were recorded into Excel in their original language. The 
recorded data were checked and re-checked by the researcher. After inputting the 
original version of the data into Excel, this was then translated into English. The 




5.8.2.1 HbA1c outcome  
The HbA1c test provided the results in two units: The National Glycohemoglobin 
Standardization Programme (NGSP) unit of percentage; and the International 
Federation of Clinical Chemistry (IFCC) unit of mmol/mol. However, only the 
NGSP unit of percent is presented in this thesis.  
5.8.2.2 Socio-demographic and disease experiences data 
Information about participants’ demographic characteristics and disease 
experiences was presented as given. No scoring was applied in analysing this data.  
5.8.2.3 Knowledge outcome 
As described previously, the 38 questions for measuring knowledge were divided 
into seven categories, and the questions consisted of nine positive and 29 negative 
types of questions. The positive questions were scored 1 for the ‘true’ answer, and 
0 for the ‘false’ answer. In contrast, the negative or reverse questions were scored 
1 for the ‘false’ answer, and 0 for the ‘true’ answer. In cases where respondents 
responded, ‘do not know’ the score given was 0. This scoring process provided ‘the 
raw score’. The raw scores were processed further for data analysis.  
From the raw score, the total composite score was calculated by dividing the raw 
score of each participant by the number of total questions (38), and multiplying by 
100. The total scores therefore ranged from 0 to 100. For comparing the 
knowledge score in each knowledge category, the raw score in each knowledge 
category was divided by the number of questions, and multiplying by 100. By 
doing this, the mean scores in each knowledge category are comparable.  
5.8.2.4 Medication adherence outcome 
The participants’ medication adherence outcome was measured with ProMAS 
developed by Kleppe, et al. [538]. It consists of 18 yes or no questions. The 
guideline for scoring these questions was also based on Kleppe, et al. [538], of 
which ‘yes’ is coded with 1, and ‘no’ is coded with 0 for the positive questions, and 




5.8.2.5 Self-management behaviours outcome 
The self-management behaviours outcomes were measured with 14 questions 
divided into two types of questions. The first type included ten questions 
(question number 1 - 9, and 14) which have two different questions for each 
number. These nine questions asked participants about how many days in the last 
week did the participant practised a specific behaviour. When the participants 
responded with a specific number of days, they were asked further about the 
frequency within a day of them doing the behaviour. In scoring this type of 
question, participants’ answers of the number of days were multiplied by the 
frequency within a day of doing the behaviour. This calculation provided the score 
for behavioural activities.  
Meanwhile, for the second type of question (question number 10 – 13) the 
participants were only asked about how many days in the last week. In scoring 
this type of question, the participants response of the number of the days were 
used as the final score of behaviour.  
5.8.2.6 Statistical analysis 
Descriptive statistics were applied to characterise participants in terms of 
demographics, and diabetes experiences. Statistical analyses using independent t-
test, X2 test and Mann-Whitney U test were applied to compare socio-demographic 
and diabetes experiences of participants between the control and the intervention 
group. Independent sample t-tests were performed to compare the differences 
between the control and intervention group at baseline.  
To test our intervention, we used analysis of covariance (ANCOVA) for detecting 
differences in the outcomes measured between participants in the control and 
intervention groups. The ANCOVA analysis used the follow-up data as dependent 
variables and baseline data as covariates. Statistical analysis of correlation matrix 
and analysis of variance (ANOVA) were also performed to assess association of 
outcomes with participants’ characteristics. Correlations were used for analysing 
the relationship of two continuous variables, while the ANOVA was performed for 




Validation of the Indonesian translation of the ProMAS questionnaire was done 
with Rasch scaling using the eRm package in R [540, 541]. Details of validity of the 
Indonesian transation of this measure are included in Appendix 8. In dealing with 
some missing data, the principle of intention to treat analysis was applied. 
Therefore, the missing data at follow up were replaced with the last measurement 
carried forward [542]. The significance level for all tests was set at p < 0.05. 





6 Chapter 6: Results of the intervention study 
6.1 Introduction 
This chapter presents the results and discussions of the diabetes intervention pilot 
study including participants’ response and completion rates, demographic 
characteristics and diabetes experiences, clinical outcomes (HbA1c), and 
knowledge, medication adherence and self-management behaviour outcomes. 
Both participants’ and health professionals’ perspectives related to the 
implementation of the intervention programme are also explored. Lastly, this 
chapter also presents the discussions of the overall results of the intervention 
pilot study.  
6.2 Participants’ response rate and completion rate 
A total of 72 diabetes patients met the eligibility criteria for the intervention 
study: 32 potential participants registered in a health centre which was allocated 
to the control group; and 40 potential participants registered in three health 
centres which were allocated to the intervention group. These 72 potential 
participants were contacted and invited to attend the information session 
followed by baseline data collection. In the intervention group, four potential 
participants did not attend the information and baseline data collection sessions, 
leaving 36 participants who attended the session, signed the consent form, and 
completed baseline data. All 32 participants in the control group attended the 
information session, signed consent forms, and completed baseline data collection. 
A response rate of 94% was therefore calculated. After analysing the baseline data, 
however, one participant in the control group was excluded. This participant did 
not suffer from diabetes confirmed by HbA1c test result at baseline and 
interviewer-administered questionnaire. A total of 67 participants were therefore 
included in the study: 36 participants in the intervention group; and 31 
participants in the control group.  
At the follow up, one participant in the control group, and four participants in the 
intervention group did not complete data collection. A total of 30 participants in 




completed baseline and follow up data collection (Figure 6.1). Based on this, the 
drop-out rate was 7.5%. 
 
Figure 6.1: CONSORT flow diagram of participants’ response and completion rate 
 
6.3 Demographic characteristics and diabetes experiences 
6.3.1 Demographic characteristics 
Demographic characteristics of participants are presented in Table 6.1. Despite 
some minor variation between groups, no significant differences were observed at 
baseline.  
In 2008, the Indonesian government declared that education would be 
compulsory for nine years, which included six years of elementary school and 
three years of junior high school [544]. All participants in the study had completed 
some form of formal education, and overall most participants were relatively well-
educated.  
72 eligible diabetes 
patients were contacted 
and invited to participate 
Control group: 32 Intervention groups: 40 
32 participants signed form 
and completed baseline data 
1 excluded: did not 
suffer from diabetes. 
36 participants signed form 
and completed baseline data 
36 participants included 
4: Lost to follow up 
30 participants at post-
intervention data collection 
32 participants at post 
intervention data collection 
31 participants included 




Table 6.1: Demographic characteristics of participants 
















Age (mean ± SD in years) 58.8±7.98 55.9±6.30 0.101 b 
Education level 
Elementary School (ES) 
Junior High School (JHS) 
Senior High School (SHS) 












Monthly income IDR               (USD) 
1. < 500,000  (< 36) 
2. 500,000 – 1,499,999 (36 - 106) 
3. 1,500,000 – 2,499,999 (107 - 178) 
4. 2,500,000 – 4,999,999 (179 - 358) 














Married 89% 93% 0.801 a 
Notes: a determined by X2 test 
 b determined by Welch’s t test 
 c determined by Mann-Whitney U test 
 
 
6.3.2 Diabetes experiences 
During the interview process we asked participants about their experiences of 
diabetes, including duration, medication taking, participation in diabetes 
programmes, and visiting dietitians (Table 6.2). Age at diagnoses was calculated 
by subtracting duration of diabetes from participants’ age.  
Table 6.2: Participants' diabetes experiences 
Diabetes experiences Intervention group Control group Between-Group p-
value 
Duration of diabetes c 
mean ± SD (year) 
5.06 ± 5.10 4.04 ± 3.37 0.336 a 
Age at diagnosis  
mean ± SD (year) 
53.9 ± 7.82 51.8 ± 6.74 0.257 a 
Taking medicines 83% 87% 0.632 b 
Prescribed with oral 
antidiabetics 
90% 89% 0.222 b 
Taking traditional 
medicines 
46% 36% 0.399 b 
Participating in diabetes 
programme 
66% 48% 0.155 b 
Consulting dietitian 51% 65% 0.283 b 
 
Notes:  a determined by Welch’s t test;  
b determined by X2 test 
c data on duration of diabetes was missing for one participant. At baseline, this participant 
did not answer the question about duration of having diabetes in a specific time frame, 




6.3.2.1 Duration of diabetes and age at diagnosis 
Most participants in both groups suffered from diabetes for less than five years 
(Table 6.2), but the mean duration was relatively similar, the mean being pulled 
up by participants who had diabetes for longer. There was also more variation in 
the duration of diabetes in the intervention group, with two participants newly 
diagnosed, and two other participants having suffered from diabetes for 18 and 21 
years. Most participants were diagnosed between the age of 50 to 59 years, and 
the mean age of diagnosis did not differ between groups.  
6.3.2.2 Medication taking  
Around 85% of participants were taking medicines, with no statistically significant 
variation between groups. Four participants in the control group and five 
participants in the intervention group reported that they did not take medicines. 
Among participants who did not take medicines, two of them said that they 
discontinued taking medicines in the last three months, and one other participant 
said that she took medicines for only a month, and discontinued taking them.  
The majority of participants were prescribed oral antidiabetic medicines. Four 
participants were prescribed insulin, and two participants were prescribed both 
oral antidiabetics and insulin.  
The questionnaire also asked about the number of types of tablets prescribed. In 
many cases, however, participants could not differentiate which medicines they 
got for diabetes, or for other comorbid conditions. This information was therefore 
missing in many cases, and if the information presented, we could not confirm its 
reliability. Metformin was mentioned by a number of participants as a medicine 
they were taking, followed by glibenclamide, and glimepiride. Addressing this 
problem, I tried to obtain access to patients’ medical records at the health centres. 
However, the medical records were often incomplete and poorly written. 
Information about the number of medicines taken by participants could not 




Somewhat less than half of participants were also taking herbal or traditional 
medicines. It appears that some participants took these traditional or herbal 
medicines either as an alternative to, or in combination with, medicines. The most 
commonly mentioned traditional medicines mentioned in the interviews were 
from leaves, such as the leaves of sirsak, salam, airnona, binahong, and marungga, 
trees or unspecified bitter leaves.  
6.3.2.3 Lifestyle interventions 
As can been seen in Table 6.2, although the number of participants attending 
specific diabetes programme and visiting a dietitian varied between the 
intervention and control groups, the differences were not statistically significant. 
Some participants also explained further that they attended a diabetes programme 
managed by the health centres, or community health education provided by health 
professionals. In contrast, slightly more participants in the control group than the 
intervention group reported that they had visited a dietitian.  
6.3.3 Discussion of demographic characteristics and diabetes experiences  
Overall, the demographic characteristics and diabetes experiences of participants 
in both groups did not differ statistically. More female than male participants were 
involved in the study, similar to other diabetes studies conducted in Indonesia 
[213, 217, 218, 505, 507, 509, 515, 545, 546]. This finding might be because the 
prevalence of diabetes in Indonesia is higher in women than men, and this has 
been consistent over time. In 2009, the prevalence of diabetes in women was 6.4% 
compared to 4.9% in men, and in 2013 it increased to 7.7% compared to 5.6% [89, 
206, 547]. The higher prevalence of diabetes among women was also found in 
rural areas of Indonesia [493]. Further, Christiani, et al. [548] reported that risks 
factors for non-communicable diseases in Indonesia were higher in women [548]. 
Women have a higher prevalence of overweight, obesity, hypercholesterolemia 
[20, 548], and hypertension [205], which further led them to have a higher 
prevalence of pre-diabetes, and diabetes [202, 203] than their male counterparts. 
The higher prevalence of diabetes and its risk factors among women are also 




In terms of age, the mean age of participants was 57. The majority of diabetes 
studies in Indonesia also involved participants with mean age between 50 – 60 
years old [209, 213, 215, 216, 218, 220, 497, 507, 509, 510, 545, 546, 552]. Most 
participants were diagnosed between 40 and 60, similar to a previous study which 
also demonstrated that the mean age of diabetes diagnosis was 49.68±6.8 years 
[213]. This figure is similar to the age distribution of diabetes prevalence in other 
Asian countries [549-551]. Diabetes affects people in Asia at a younger age than 
people in developed regions, with the highest prevalence in the 40 – 59 age group 
[194, 195, 388]. With the increasing prevalence of obesity at a younger age, 
diabetes prevalence in people aged 30 – 39 is also increasing [195]. Two 
participants in this study were diagnosed with diabetes at less than 40 years of 
age. Some previous studies about diabetes also involved participants aged less 
than 40 [516, 552]. 
The 2013 Basic Health Research survey reported that prevalence of diabetes was 
1.1% for people aged 15 – 24 years old, and it rose dramatically to 11.5% for the 
age of 55 – 64 years, and peaked at 13.2% for people aged 65 or more [206]. A 
study on pre-diabetes in Indonesia also showed that pre-diabetes has been found 
in people aged 18 – 27 years old, and this increased along with increasing age, 
with the highest proportion in 38 – 47 age group [202]. The implication of these 
findings is that interventions for prevention or early detection of diabetes and its 
risk factors should target people before the age of 40. 
In terms of income, less than 20% of participants had a very low monthly income 
(less than IDR 500,000/USD 36.65), and very few a had very high income (> IDR 
5,000,000/USD 366.5). The Indonesian national poverty line is IDR 400,995 (USD 
29.5) per month in urban areas and IDR 370,910 (USD 27.2) per month in rural 
areas [63]. The poverty line, however, differs among regions and districts within 
the country. In Kupang, the poverty line was set at IDR 482,857 (USD 35.5) [535], 
so less than 20% of participants in this study were below the poverty line. Most 
participants were in the middle-income bracket.  
Since the beginning of the 21st century, there has been rapid socioeconomic 




to the increasing prevalence of diabetes [194, 195, 388]. This socio-economic 
development was shown by the increasing proportion of people within the 
middle-income bracket [553]. Although the definition of middle-income class 
varied, Chun [554] defined it as people with daily expenditure of USD 2 – 20. This 
daily expenditure range is divided further into near poor (USD 2 - 4), lower 
middle-income class (USD 4- 10), and upper middle-income class (USD 10 - 20). 
Kupang is the biggest urban area of the province in which rapid urbanisation has 
occurred and there are increased job opportunities, and more tertiary education 
facilities available. These have further fuelled the economic growth of the city. 
These three factors have led to the rising number of people with mid-level 
incomes [60].  
The distribution of participants by income is similar to the distribution of 
participants by level of education. Only a few participants had completed only the 
lowest level of education. Most participants had completed secondary education, 
and some of them attended tertiary education. Educational level often correlates 
with income, with the higher the education, the higher the income. In contrast to 
some developed countries, Balinese women who are wealthier and had a higher 
education level tended to be overweight and obese [555]. Moreover, risk factors of 
hypertension and obesity were found mostly among people residing in urban 
areas and among wealthy people living in more rural areas [200]. This is also 
similar to other studies which reported that diabetes was found more in people 
with a higher level of education and income [493]. This information may imply 
that diabetes in Indonesia affected more people with higher income and 
educational level. The disease burden for the poor is, however, higher than that for 
the wealthier counterparts.  
In terms of medication taking behaviour, this intervention study reported similar 
findings to the qualitative study: the majority of participants reported taking 
medicines, with many of them combining or alternating the medicines with other 
herbal or traditional medicines. This finding is similar to other studies in 
Indonesia [227-229]. A high prevalence of complementary and alternative 




[556, 557]. The results of the qualitative study described in Chapter 3 explain 
diabetes patients’ behaviour in medication taking, including the patterns and the 
reasons for their behaviour.  
Furthermore, some participants also reported that they had attended diabetes-
specific programmes and dietitian consultations conducted at the healthcare 
facilities where they were registered. This implies that many participants have 
been exposed to information about diabetes, which further relate to the results of 
the knowledge, medication adherence, and self-management behaviour outcomes, 
which are described in a separate section of this chapter. 
6.4 Outcome measures: HbA1c  
6.4.1  HbA1c data completion 
A total of 67 participants completed HbA1c measurement at baseline. As can be 
seen in Figure 6.2, one participant in the control and one in the intervention group 
had a haemoglobin variant which interfered with HbA1c analysis, as described in 
Chapter 5. Their HbA1c level could therefore not be measured, leaving data for 65 
participants at baseline. Post-intervention, five participants were lost to follow up: 
one participant in the control group; and four participants in the intervention 
group. The participant in the intervention group who had a haemoglobin variant 
that interfered with HbA1c analysis at baseline was also lost at follow up. The 
HbA1c data for 61 participants was therefore obtained at follow up. Results of 
HbA1c measurement of participants in the intervention and control groups are 
included in Appendix 9. 
The HbA1c levels at baseline and follow up were analysed using the intention to 
treat principle, and missing data were replaced with the last measurement carried 
forward. One participant who was lost at follow up had HbA1c measured in a time 
between baseline and follow-up data collection. The other three participants did 
not have their HbA1c level measured in between, however. During the study 
period, in December 2016, people with diabetes in Kupang who registered under 
the universal health insurance scheme were offered a complete biological 




by the insurance; HbA1c analysis had never been done in Kupang prior to the 
study period. In analysing the HbA1c outcomes, therefore, four missing data at 
follow up were replaced by the baseline values for three participants, and HbA1c 
value measured in between for one participant.  
 
Figure 6.2: CONSORT flow diagram of HbA1c outcome completion 
6.4.2 HbA1c outcomes  
As shown in Table 6.3, HbA1c did not differ between groups at baseline. To test 
the effectiveness of the intervention, ANCOVA analysis was performed with HbA1c 
at follow up as an independent variable, and HbA1c baseline as a covariate. There 
was no difference between the control and intervention groups F (1,62) = 0.02, p 
= 0.9 (Table 6.3). As can be seen in Figure 6.3, the intervention did not provide 
statistically significant difference in HbA1c outcome compared to the control 
(usual care). 
Table 6.3: Statistic tests of HbA1c outcome 
Groups  Baseline 
Mean ± SD 
Between 





group p value 




Intervention  8.26 ± 1.89 0.872 a 7.84 ± 1.82 0.839 a 0.897 b 
Control  8.35 ± 2.60 7.95 ± 2.53 
Notes:  a determined by Welch’s t test; 
b determined by ANCOVA test 
67 participants involved in the 
study 
Control group: 31 Intervention groups: 36 
1 participant had 
haemoglobin variant 
interfered with HbA1c 
29 HbA1c data at follow up 
30 HbA1c data at baseline 
1 lost to follow up 
1 participant had 
haemoglobin variant 
interfered with HbA1c test 
35 HbA1c data at baseline 
4 lost to follow up, 
including participants who 
have haemoglobin variant 
interfere with HbA1c test 





Figure 6.3: HbA1c changes of participants in the control and intervention groups 
 
6.4.2.1 Exploratory analyses 
However, as Figure 6.3 makes obvious, participants in both groups made 
improvements in HbA1c outcome as shown in decreasing trends of HbA1c over 
time. Further statistical analysis using paired independent t-test (Table 6.4) 
comparing the HbA1c level of all participants at baseline and follow-up shows 
groups improved significantly from baseline. Similarly, a Bayesian t-test provides 
strong evidence that HbA1c had decreased at follow-up.  
Table 6.4: Paired t-test comparing HbA1c at baseline and at follow up 
   





Student's t 2.91 
 
64.0 0.005 0.361 
Bayes factor₁₀ 6.31 1.05e-8 
   
 
Although my planned analyses revealed no evidence of an effect for the 
interaction, I further looked to see whether there was any information in the data 
that could be useful for guiding future interventions. In Figure 6.4, participants 
HbA1c levels were categorised based on cut points at 7.0 and 8.0. The percentage 
of participants in the control group at each specific range of HbA1c at baseline and 
follow-up did not differ. In contrast, in the intervention group, the percentage of 
participants with poorly controlled glycaemic level of 8% or more dropped from 
51% to 40%, and the participants achieving HbA1c value of less than 7% 
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Deteriorated by 1% or more
Deteriorated by ≥0.5 to <1%
Deteriorated by up to 0.5%
Remain the same
Improved by up to 0.5%
Improved by ≥0.5 to <1%
Improved by 1% or more




Further, across both groups, the HbA1c levels of most participants improved: 63% 
of participants in the control group, and 71% of participants in the intervention 
group. A few participants experienced no change in their HbA1c value, and 
glycaemic control deteriorated in some participants. The level of HbA1c change of 
participants can be seen in Figure 6.5. 
More participants in the intervention group than those in the control group 
achieved a decrease in HbA1c value of 0.5% or more, 43% compared to 30%, 
respectively. More participants in the intervention group, however, also 
experienced a high increase in their HbA1c value of 1% or more, 11% compared to 
3%. These participants attended the intervention sessions less frequently 
compared to the others.  
 
6.4.3 Association of HbA1c outcomes and socio-demographic characteristics of 
participants 
 
Table 6.5: Statistical tests associating HbA1c at baseline with demographic characteristics 
 HbA1c at baseline HbA1c at follow-up 
Gender a F (1,63) = 0.411  
p-value = 0.524 
F (1,59) = 0.330  
p-value = 0.568 
Age b Pearson’s r = -0.390 
p-value = 0.001* 
Pearson’s r = -0.279 
p-value = 0.030* 
Education level a F (3,61) = 0.520 
p-value = 0.670 
F (3,57) = 1.23  
p-value = 0.308 
Income a F (4,60) = 0.490 
p-value = 0.743 
F (4,56) = 0.619 
p-value = 0.651 
Duration of diabetes b Pearson’s r = -0.087 
p-value 0.495 
Pearson’s r = 0.022 
p-value = 0.869 
 
Notes:  a determined by ANOVA  
b determined by correlation matrix analysis with Pearson’s r 
* statistically significant (p-value <0.05) 
 
Statistical tests were performed to analyse associations between HbA1c outcome 
at baseline and follow-up, and change in HbA1c with participants’ characteristics 
including gender, age, education level, income, and duration of diabetes. 




variables of age and duration of having diabetes, and ANOVA test was applied for 
analysing the correlation between HbA1c and categorical variables of gender, 
educational level, and income. Table 6.5 and Figure 6.6 show that HbA1c level 
decreased with increasing age, about both baseline and follow-up. There were no 
other statistically significant associations between HbA1c and demographic 
variables. 
 
Figure 6.6: Negative association between HbA1c at baseline and age 
 
6.4.4 Discussion of HbA1c outcome 
Participants in both study groups experienced a very similar level of HbA1c 
improvement. This is surprising because typically people with diabetes tend to 
stay the same or get worse with time, as discussed below. Although more 
participants in the intervention group experienced an improvement of HbA1c 
level of equal to or more than 0.5% than those in the control group (44% 
compared to 31%), statistically the change of HbA1c in both groups did not differ. 
Baseline condition of participants – their demographic characteristics, diabetes 
experiences, and clinical outcome – did not differ statistically. This suggests that 
the project might have indirectly triggered more intensive diabetes management 




The literature review (Chapter 4) showed that there have been few intervention 
studies for diabetes patients in Indonesia. This study was the first experimental 
study with control measuring the effect of intensive group-based self-management 
education, conducted regularly for three months, on participants’ clinical 
outcomes as well as knowledge, medication adherence and behavioural outcomes. 
An intervention study evaluating the effects of a single session of counselling and 
providing a medication booklet on diabetes patients’ medication adherence and 
HbA1c outcomes was conducted in Banten Province [515]. The study applied pre- 
and post-test a single group design, and reported a huge improvement of HbA1c 
from 11.3±2.95% to 8.1±2.79% after 10 weeks. The mean of baseline HbA1c level 
from 30 participants involved in the study by Presetiawati, et al. [515] was higher 
compared to that of the participants in this study. A systematic review showed 
that interventions involving poorly controlled diabetes participants with HbA1c 
levels of over 9.5% resulted in a greater effect [558].  
The result that HbA1c outcomes of participants in both groups improved also 
contrasted with similar studies conducted in developed and developing countries. 
Systematic reviews evaluating the effectiveness of similar diabetes intervention 
studies demonstrated favourable outcomes of HbA1c improvement compared to 
control or usual care services [457, 458, 467, 468, 559-562]. As an example, 
Chrvala, et al. [458] reported that among 118 diabetes self-management 
interventions, about 62% of them demonstrated significant changes in HbA1c with 
an absolute improvement of 0.57%. A systematic review conducted by Fan and 
Sidani [457] published in 2010 reported a lower reduction of HbA1c value of 
0.36%. The possible explanations for the findings of this study are presented in 
the final section of this chapter. 
Our participants’ baseline HbA1c level (8.30 ± 2.23%) was similar to two national 
Indonesian studies published in 2010 and 2009 that found uncontrolled blood 
glucose means of 8.1 ± 2% [213], and 8.1 ± 2.1% [218]. The participants in our 
study were selected based on inclusion criteria of having no diabetes related 
complications. Studies involving diabetes patients with complications showed 




profile of diabetes patients with foot ulcers admitted to a hospital in Central Java 
and found that the mean HbA1c was 11.3 ± 2.8%. Yusuf, et al. [217] also showed 
that diabetes participants with diabetic foot ulcers had a considerably higher 
HbA1c compared to those without complications, 8.95 ± 2.07% compared to 7.86 
± 2.61%. Rianita, et al. [503] also found a mean of HbA1c of 9.1 ± 2.4% in diabetes 
patients with vision complications. A study by Pranoto, et al. [552] who 
specifically recruited diabetes patients with uncontrolled blood glucose found a 
mean HbA1c of 11.60 ± 2.03%. Newly diagnosed diabetes patients also tended to 
have higher levels of HbA1c with a mean value of 10.5 ± 4.9% [563].  
Further, the majority of participants had uncontrolled glycaemic levels with 
HbA1c levels of more than 7%. A study that recruited diabetes participants from 
three hospitals in three different cities in Indonesia showed that 49% of their 
participants had uncontrolled blood glucose, i.e. more than 7% [499]. Soegondo, et 
al. [218] found that 60% of diabetes patients did not reach the target of a HbA1c 
less than 7%. Markum and Galastri [505] found 73% of diabetes patients had 
HbA1c levels more than or equal to 7%.  
In our study, participants were recruited from lists of diabetes patients registered 
at primary care facilities. Most studies on diabetes in Indonesia also recruited 
participants from healthcare facilities. This implies that the people with diabetes 
involved in studies have reached medical care and are being treated by health 
professionals. Most of them, however, still experienced uncontrolled blood glucose 
levels. This finding is similar to studies conducted in other developing countries: 
although the diabetes patients have been treated by healthcare professionals, the 
majority of them had uncontrolled glycaemic levels [549, 564]. An implication of 
this finding is that management of diabetes patients in healthcare facilities should 
be evaluated and monitored.  
This current study also found interesting points related to the participants’ HbA1c 
outcome in association with their characteristics. The statistical analysis revealed 
that the HbA1c level was not correlated with duration of having diabetes. Previous 
studies in Indonesia have found that HbA1c levels are correlated positively with 




of HbA1c [213, 514]. Furthermore, the current study demonstrated a negative 
correlation between HbA1c measured both at baseline and follow up with the 
participants’ age: the older the age, the lower the HbA1c level. This result differs 
from that of another study in Indonesia which reported that HbA1c level was not 
associated with participants’ age [514].  
 
6.5 Outcome measures: knowledge 
6.5.1 Knowledge questionnaire data completion and scoring 
 
 
Figure 6.7: CONSORT flow diagram of participants’ completion of knowledge questionnaire 
Knowledge was evaluated with a 38 item yes-or-no interviewer-administered 
questionnaire. From a total of 67 participants involved in the study, one 
participant involved in the intervention group missed the baseline interview. As a 
result, we have baseline knowledge data from 66 participants: 31 from the control 
group; and 35 from the intervention group. At follow-up, one participant in the 
control group and four participants in the intervention group were lost to follow 
up. This leaves a total of 61 participants; 30 in the control group and 31 in the 
67 participants involved in the 
study 
Control group: 31 Intervention groups: 36 
30 completed knowledge data 
collected at baseline and at 
follow up 
31 knowledge data at baseline 
1 lost to follow up 
1 missed baseline 
interview  
35 knowledge data at baseline 
4 lost to follow up 
31 completed knowledge data 





intervention group who had a completed knowledge outcome measured at 
baseline and at follow up (Figure 6.7).  
6.5.2 Knowledge scores at baseline and follow-up 
There were no differences in baseline knowledge of participants between groups 
(Table 6.6). 
Table 6.6: Statistical tests of knowledge outcome 
Groups  Baseline 
Mean ± SD 
Between 





group p value 




Intervention  56.6 ± 9.03 0.394 a 58.9 ± 11.8 0.507 a 0.544 b 
Control  54.3 ± 12.1  56.8 ± 13.9   
 
Notes:  a determined by Welch’s t test;  
b determined by ANCOVA test 
 
To evaluate differences in knowledge changes of participants in the control and 
intervention groups, ANCOVA was conducted with knowledge score at follow up 
as the independent variable, groups as fixed factor, and knowledge score at 
baseline as covariate. As Figure 6.8 shows, both groups experienced a similar 
increase in the total knowledge score from baseline. This increase was confirmed 
with a paired t-test, t (65) = -2.02, p = 0.047. 
 





6.5.3 Association of knowledge score with demographic characteristics of 
participants 
Statistical analysis was also performed to explore associations between 
knowledge with participants’ characteristics and HbA1c outcome. The ANOVA test 
showed that there was significant association of knowledge score at baseline and 
follow up with participants’ education level, and income (Table 6.7). This 
association demonstrated that the higher the education level and income, the 
higher the mean knowledge score (Figure 6.9). Knowledge scores at baseline did 
not, however, correlate with participants’ gender, age, duration of having diabetes, 
or HbA1c. 
Table 6.7: Statistical analysis of association of total knowledge score and participants’ demographic 
characteristics and HbA1c outcome 
 Total knowledge score 
at baseline 
Total knowledge score at 
follow-up 
Gender a F (1,64) = 0.144   
p-value = 0.706 
F (1,60) = 8.93 
p-value = 0.004* 
Age b Pearson’s r = 0.051 
p-value = 0.684 
Pearson’s r = 0.143 
p-value = 0.269 
Education level a F (3,62) = 6.35   
p-value = <0.001 * 
F (3,58) = 8.27  
p-value = <0.001 * 
Income a F (4,62) = 2.70   
p-value = 0.039 * 
F (4,57) = 4.09  
p-value = 0.006 * 
Duration of diabetes b Pearson’s r = 0.119 
p-value = 0.345 
Pearson’s r = 0.199 
p-value = 0.120 
HbA1c b Pearson’s r = - 0.023  
P-value = 0.856 
Pearson’s r = 0.094 
p value = 0.471 
 
Notes:  a determined by ANOVA  
b determined by correlation matrix analysis with Pearson’s r 
* statistically significant (p value < 0.05) 
 
At follow-up, knowledge scores were significantly associated with gender. Male 
participants had significantly higher knowledge level at follow up than their 
female counterparts (Figure 6.10). 
Further association analysis of knowledge change also revealed that the change in 
knowledge was significantly associated with gender. The male participants 
experienced a notable improvement in their level of knowledge (mean change of 
score of 6.82) while their female counterparts did not experience an improvement 







Figure 6.9: Association of participants’ total knowledge score at baseline and education level and 
income 
 




6.5.4 Participants knowledge scores based on knowledge categories 
Statistical analysis showed that the knowledge outcome for participants in the 
intervention group did not differ statistically from participants who received usual 
care in the control group. The knowledge level of participants in both groups 
improved. We then analysed this further by breaking down the scores into 
categories of diabetes knowledge: causes; risk factors; medications; complications; 
symptoms; and diabetes self-management, including diet, exercise and smoking. 
We wanted to get a better understanding of participants’ knowledge in each 
category. This information will be useful in designing future studies aiming at 
improving diabetes knowledge.  
Figure 6.11 illustrates the mean scores of participants’ knowledge based on 
knowledge categories at baseline. It shows that mean scores in each knowledge 
category of participants in both groups were quite similar. The highest score was 
on knowledge about risk factors, followed by knowledge about exercise and 
smoking for diabetes management. Knowledge about diet was the lowest. 
Knowledge scores were similar at follow-up (Figure 6.12). There was no evidence 
of change between experimental groups, F (1,64) <2.8, p>0.1.  
On average, about half of the questions about causes of diabetes were answered 
correctly. Most participants (78%) understood that diabetes is not transmitted 
through sharing food, eating equipment or clothing. A lot of participants (67%) 
also understood that diabetes can be prevented. About half of participants 
responded that having contact with unhealed wounds of participants and 
unhealthy environments increased their risk of getting diabetes, however, and 
only about 30% of participants believed that diabetes is a disease that currently 
cannot be cured. This implies that most participants were still confused about the 
causes of diabetes.  
Knowledge about risk factors had the highest mean score compared to other 
categories. The vast majority of participants understood that diabetes is not only 
suffered by people who have family history, are obese, and older people. About 
two third of participants were also aware that having high blood pressure 





Figure 6.11: Mean score of knowledge divided into categories at baseline 
 
 
Figure 6.12: Mean score of knowledge divided into categories at follow-up 
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Participants’ score on knowledge about diabetes medication was also relatively 
high. Most of them were aware that regular check-ups are important to assess 
effectiveness of the medications. Most participants were also aware that they had 
to apply a healthy diet although they were on diabetes medications. Some 
participants, however, believed that long-term use of medicines may cause kidney 
damage, and more than a half of them also believed that they could stop taking 
medicines if their blood sugar was normal or if they were feeling better. This 
provided evidence that some participants had limited understanding of the role of 
medications in diabetes management, and the importance of continuation of 
taking medications. The belief that taking medicines for a long time increased the 
risk of kidney damage needs to be addressed.  
In terms of knowledge about complications, mean scores at baseline and follow up 
were similar. Most participants understood that heart disease is a complication of 
diabetes. About half of them, however, also thought that diabetes might increase 
their risk of cancer, rheumatoid arthritis, and lung problems.  
In recognising diabetes symptoms, most participants acknowledged that feeling 
weakness is an early symptom of diabetes. Almost all participants also responded 
that always feeling sleepy was also a symptom of having diabetes. This lay 
knowledge might come from the participants’ experiences of fatigue which was 
interpreted as sleepiness.  
Knowledge about diet for diabetes had the lowest mean score compared to the 
other categories. This showed that most participants had limited knowledge 
related to diet for diabetes. The term ‘sugar disease’ let them think that diabetes is 
caused by any sweet food so that they believe anything sweet was restricted for 
diabetes patients. Most of them also had limited knowledge in recognising the 
sources of food containing carbohydrate. Most of them responded that potato was 
free from carbohydrate. Some of them also thought that taro, sweet potato and 
corn also could not substitute for white rice as a source of carbohydrate. 
Furthermore, although the majority of them recognised that reducing rice portions 
is part of managing diabetes, most of them believed that skipping dinner is part of 




Moreover, related to diabetes management, more than two thirds of participants 
acknowledged that stopping smoking is part of managing diabetes. In terms of 
exercise, most participants were aware that walking regularly is recommended for 
diabetes patients, and recognised the importance of a combination of exercise and 
a healthy diet for managing diabetes. 
 
6.5.5 Discussion of knowledge results 
This current study showed that participants in both groups experienced an 
improvement in their knowledge scores. The improvement, however, was not 
remarkable, only an increase of 3.06 from the total score of 100, or about one 
question item. Furthermore, ANCOVA analysis confirmed that the change of 
knowledge scores of participants did not differ between groups. These findings 
contrasted to other studies assessing the impact of diabetes interventions. A 
systematic review of diabetes self-management interventions showed that the 
most notable improvement was on knowledge outcomes, followed by clinical 
outcomes, and the least was on behavioural outcomes [457].  
A likely explanation of these findings might be that participants in both groups had 
relatively high knowledge scores at baseline. The mean knowledge scores at 
baseline was 55, which means that most participants had an average level of 
knowledge. Only a few participants had knowledge scores of lower than 20. The 
participants were recruited from selected healthcare facilities in the study 
location, so that most of them had reached medical care. During the usual 
consultation with health professionals, information and education were often 
provided. Some participants had also attended specific diabetes related 
programmes. Most participants had therefore already gained a better 
understanding about diabetes. This finding is similar to other studies assessing 
diabetes patients’ knowledge, attitudes and practice in Dhaka, Bangladesh [565, 
566]. Studies focused on knowledge of diabetes patients in other developing 
countries reported a variety of levels of participants’ knowledge. A limited 
knowledge about diabetes was reported in studies conducted in Pakistan [567], 




of knowledge was also reported in some other settings including Sri Lanka [570], 
Bangladesh [564], and Iran [571]. It is difficult, however, to compare the results to 
those studies because the nature of the study population and the instruments used 
were dissimilar.  
This study found that participants’ knowledge about diabetes was associated with 
their education level and income, with the higher the education level and income, 
the more knowledgeable the participants. Most participants involved in this study 
were relatively well-educated and had a better income, with only about 20% 
participants in the lowest education and income levels. This might also explain 
why most participants had an average knowledge about diabetes. It is highly 
recognised that knowledge level of diabetes patients is associated with education 
level [564, 565, 568-570, 572, 573]. Other studies have also found an association 
of knowledge with income [564, 565, 569].  
The knowledge scores of the participants in this study were not associated with 
age, and duration of diabetes. Age and duration of diabetes have often been 
reported to be associated with knowledge [564, 568, 571, 572]. Herath, et al. [570] 
also found that there was no association between knowledge and age, however. 
Interestingly, our study revealed that the participants’ knowledge score at follow 
up was associated with gender, which was not shown at baseline. Further analysis 
showed that the change of knowledge was also associated with gender, with male 
participants experiencing some increase in their knowledge scores, while the 
knowledge scores of female participants were unchanged. Some studies conducted 
in Bangladesh, the Democratic Republic of Congo, and the United Arab Emirates 
also reported an association of knowledge and gender with the males significantly 
better than females [564, 565, 569, 573]. Those studies did not evaluate the 
association of change of knowledge with gender, however, but may provide 
evidence that the learning abilities of male participants were higher than their 
female counterparts. Another likely explanation for this is that the women tended 
to receive false information from lay sources. Studies found that women more 
actively sought health-related information [574, 575]; however, women also 




including relatives, or friends [575]. This may imply that the women learnt as 
much false information from others as information from trusted health 
professionals.  
It was widely acknowledged that a sufficient level of knowledge was a pre-
requisite for a better attitude to, and outcomes of diabetes management. In the 
Indonesian context for example, Adriono, et al. [546] found that lack of knowledge 
about the vision complications of diabetes was associated with less practice of eye 
examination, and Primanda, et al. [509] reported that there was a positive 
correlation between knowledge related to diet and dietary behaviour.  
This current study, however, found no correlation between knowledge scores and 
the clinical outcomes of HbA1c. Similar findings were also observed in studies 
conducted in Bangladesh [564] and the United Arab Emirates [573]. It was also 
suggested that knowledge level did not predict self-management behaviours of 
people with diabetes in East Java Province, Indonesia [510], and knowledge did 
not associate with attitude and the practice of diabetes patients in Sri Lanka [570]. 
This finding implies that improving knowledge may not be enough to improve 
outcomes.  
In terms of knowledge categories, this study revealed that most participants had a 
relatively good understanding of diabetes risk factors, and exercise and smoking 
cessation for managing diabetes. Most participants, however, seemed to be 
confused in terms of knowledge related to diet and medications. This further 
implies areas of diabetes education that should be strengthened: knowledge that 
relates to behaviours including diet and medications. Participants’ medicine taking 
was hindered by their belief that long term use of medication might cause kidney 
damage, and that the medication taking could be stopped when their condition 
improved. Participants’ dietary behaviour might also be affected by their limited 





6.6 Outcome measures: medication adherence 
6.6.1 Data completion on medication adherence questionnaire 
A total of 67 participants completed baseline data collection. In medication 
adherence outcome, however, nine participants reported that they did not take 
any medicines for diabetes, so that they were not able to answer questions related 
to medication adherence. Some of them mentioned that they discontinued taking 
medicines for diabetes. Another participant missed being interviewed at baseline. 
Data on medication adherence outcome at baseline were therefore gathered from 
57 participants.  
 
 
Figure 6.13: CONSORT flow diagram of data completion of medication adherence questionnaire 
67 participants involved in the 
study 
Control group: 31 Intervention groups: 36 
4 participants reported 
not taking medicines at 
baseline.  
28 medication adherence data at 
follow up 
27 medication adherence 
data at baseline 
1 lost to follow up 
2 participants reported 
not taking medicines at 
follow up 
1 missed baseline interview 
5 participants reported not 
taking medicines at 
baseline 
30 medication adherence data 
at baseline 
4 lost to follow up 
2 participants reported not 
taking medicines at follow 
up 
 
30 medication adherence 
data at follow up  
25 participants completed data 
on medication adherence at 
baseline and follow up 
25 participants completed data on 
medication adherence at baseline 




At follow up, the medication adherence data were completed by 58 participants. 
Five participants were lost at follow up. Two participants, who reported taking 
medicines at baseline, reported not taking medicines at follow up. Seven 
participants, who reported not taking medicines at baseline, took medicines at 
follow up. Meanwhile, two participants reported not taking medicines both at 
baseline and follow up. Because of the differences in participants’ medication-
taking behaviour at baseline and follow up, 50 participants completed medication 
adherence questionnaire both at baseline and follow up (Figure 6.13).  
6.6.2 Medication adherence 
The medication adherence outcome was assessed with the Probabilistic 
Medication Adherence Scale (ProMAS) [538]. Table 6.8 shows that there were no 
differences in medication adherence scores between groups at baseline or follow-
up.  
Table 6.8: Statistical analysis of medication adherence outcome 
Groups (N) Baseline 
Mean ± SD 
Between 





group p value 




Intervention  9.97 ± 3.54 0.628 a 10.4 ± 4.24 0.569 a 0.928 b 
Control  10.4 ± 3.84  10.9 ± 3.26   
 
Notes:  a determined by Welch’s t test;  
b determined by ANCOVA test 
 
Both groups experienced a similar increase in the medication adherence score 
from baseline; however, this increase was not statistically significant as shown by 
the ANCOVA analysis.  
6.6.3 Association of medication adherence score with demographic characteristics 
and other outcomes 
Associations between medication adherence score and participants’ 
characteristics and other outcomes were also explored. As can be seen in Table 
6.9, the medication adherence score at baseline was associated with education 
level and income. Interestingly, these associations demonstrated that the higher 
the education level, and the higher the income, the less adherent participants were 




Table 6.9: Association of medication adherence with sociodemographic characteristics and other 
outcomes 
 Medication adherence score 
at baseline 
Medication adherence score at 
follow-up 
Gender a F (1, 55) = 1.52 
p-value = 0.223 
F (1,56) = 0.087 
p-value = 0.769 
Age b Pearson’s r = 0.023 
p-value = 0.865 
Pearson’s r = 0.193 
p-value = 0.146 
Education level a F (3,53) = 6.06 
p-value = 0.001 * 
F (3,54) = 1.07 
p-value = 0.370 
Income a F (4,52) = 3.60 
p-value = 0.012 * 
F (4,53) = 1.84 
p-value = 0.135 
Duration of diabetes b Pearson’s r = -0.104 
p-value = 0.444 
Pearson’s r = 0.110 
p-value = 0.413 
HbA1c b HbA1c at baseline 
Pearson’s r = -0.113 
p-value = 0.410 
HbA1c at follow up 
Pearson’s r = -0.343 
p-value = 0.009* 
Knowledge score b Knowledge score at baseline 
Pearson’s r = -0.108 
p-value = 0.426 
Knowledge score at follow up 
Pearson’s r = -0.091 
p-value = 0.498 
Notes:  a determined by ANOVA  
b determined by correlation matrix analysis with Pearson’s r 





Figure 6.14: Association of medication adherence score at baseline with participants’ educational 




At follow-up, higher HbA1c was associated with lower medication adherence 
(Figure 6.15), which suggests that poorer self-reported adherence is associated 
with poorer glycaemic control. The medication adherence scores both at baseline 
and follow up were not associated with other participants’ characteristics and 
outcomes (Table 6.9).  
 
Figure 6.15: Association of medication adherence score at follow up with HbA1c at follow up 
 
6.6.4 Discussion of medication adherence 
Our study found that although participants in both groups experienced a similar 
improvement in medication adherence, we could not detect statistically significant 
differences in medication adherence scores between groups over time. A 
systematic review assessing the impact of interventions for people with diabetes 
on medication adherence, conducted by Sapkota, et al. [576], revealed that among 
fifty-two studies reviewed, only twenty-two studies showed improvement in 
medication adherence. Similarly, Williams, et al. [577] also systematically 
reviewed twenty-seven studies of diabetes interventions, and thirteen of them 
showed statistically significant change in medication adherence. Although the 
results might be incomparable as the instruments used for measuring adherence 
varied, these findings indicated that the effect of diabetes interventions on 
participants’ adherence to medication might be limited.  
Adherence to medications in chronic diseases is a complex phenomenon. The 
results of the qualitative study described in Chapter 3 showed that medication 




medicines taking, which means that the people try to take the medicines as little as 
possible. With the availability of other alternative therapies, people compared the 
effect of both types of medications. Numerous qualitative studies have also been 
conducted to identify factors influencing diabetes patients’ medication taking 
behaviour. It was found that reluctance to initiate therapy was prevalent, as they 
believed that once they started taking it, they could not stop doing it [557, 578, 
579]. Beliefs about traditional medicines, stigma, and relationship with doctors 
also influenced adherence to medicines [579-581]. Moreover, with the 
asymptomatic nature of the disease, patients often adjusted dosage and timing of 
taking medicines [578]. These findings suggested that patients have a key role in 
making decisions related to their medication. It is therefore suggested that the key 
step to improving adherence to medication is to identify individual barriers to 
medication taking and develop personalised strategies [577, 582]. Inconsistent 
results among studies implementing similar strategies were also found, however, 
suggesting that there is no specific formula for the interventions to be effective in 
improving adherence to medications [576, 583].  
On the other hand, measuring adherence to medication is also challenging. In our 
study, some participants reported that they discontinued taking medicines for a 
long time, therefore they were not able to answer the questions on adherence to 
medications. Most of these participants, however, reported taking medicines at 
follow up. The study has therefore triggered the participants to start taking the 
medications they discontinued before, but we could not detect this change 
statistically. Furthermore, in measuring adherence we relied on self-reported data. 
Various methods are available to measure adherence to medications [584]; 
however, most studies applied self-report tools [576, 577, 585]. There is no gold 
standard of methods in measuring medication adherence; however, triangulation, 
or using a combination of methods, is suggested to increase validity of the results 
[584, 585].  
No association was found between medication adherence score and HbA1c level at 




preliminary evidence for the validity of the translated ProMAS in an Indonesian 
diabetes population.  
From the studies reviewed by Sapkota, et al. [576], only nine out of 52 studies 
reported improvement in both adherence score and HbA1c. This may suggest that 
adherence to medication is not the only contributor to glycaemic control [577]. 
Poor glycaemic control of diabetes patients is, however, associated with poor 
adherence to treatment [586, 587]. Poor adherence to diabetes medication 
increased disease progression [588], and led to higher healthcare costs [589]. A 
current systematic review of type 2 diabetes medicines adherence revealed that 
only 22% of studies reported adherence of ≥80% among their study participants 
[590]. Studies in Indonesia also found that only about 30% of diabetes patients 
showed high adherence to diabetes medications, and they also frequently took 
alternative and complementary medicines [227, 228]. Strategies to improve 
medication adherence need to be developed [582]. Other studies found that the 
interventions led by pharmacists and focusing on medication, led to an 
improvement in adherence to medications [577, 591]. This may imply that 
pharmacist involvement in diabetes interventions is crucial, particularly for 
improving adherence to medications.  
6.7 Outcome measures: self-management behaviours 
In measuring self-management behaviours, the participants were asked about 
their diet, exercise, foot care, visits to health professionals and smoking behaviour 
within the last week. Dietary behaviour was assessed with four questions about 
portion control, one question about carbohydrate substitution, and three 
questions about food restriction. Exercise behaviour was measured with three 
questions: total minutes of exercising; days of attending an exercise programme; 
and days of exercising for 30 minutes or more. Foot care and smoking behaviours 
were gathered with one question each: number of days in the last week of taking 
care of feet; and whether or not they had smoked in the last week. The number of 




Some data about self-management behaviours were missing as the participants 
found it difficult to answer the questions. A few participants, for example, could 
not answer the questions about portion control because their way of putting food 
on a plate was different – they did not put vegetables on the same plate but in a 
separate bowl. In another example, they mentioned that they never calculated the 
time they spent doing exercise. Some of them also found it difficult to recall what 
they had done during the last week. The number of participants who provided 
data about each behaviour is described in each section below. 
6.7.1 Dietary behaviour 
6.7.1.1 Data completion 
 
Figure 6.16: CONSORT flow diagram of data on dietary behaviour completion at baseline and follow 
up 
At baseline, from the total of 67 participants, completed data were gathered from 
63 participants. Three participants were unable to respond to the questions. 
Although the study assistants tried to elaborate the questions, some participants 
A total of 67 participants 
Control group: 31 
30 completed data at baseline:  
 1 participant could not 
answer the questions as 
expected 
29 completed data at follow up:  
 1 participant could not 
answer the questions as time 
constraint,  
 1 participant lost to follow up 
28 participants with completed 
data at baseline and follow up 
Intervention group: 36 
33 completed data at baseline:  
 2 participants could not 
answer the questions as 
expected 
 1 participant missed to be 
interviewed 
32 completed data at follow 
up:  
 4 participants lost follow 
up, including one 
participant who had 
missing data at baseline 
30 participants completed answer 




remained unable to answer them. One other participant missed the baseline 
interview. At follow up, three of those participants who had missing data at 
baseline, responded to the questions as expected. One participant could not 
answer the questions on self-management behaviour because of time constraints: 
she was about to go out of town (this participant responded to knowledge and 
medication adherence questions). Five other participants were lost to follow up, 
leaving 61 participants who completed questions on self-management behaviour 
at follow up. A total of 58 participants completed dietary behaviour questions at 
baseline and follow up (Figure 6.16). 
6.7.1.2 Dietary behaviour analysis 
Dietary behaviour was divided into two categories: portion control and 
carbohydrate substitution; and food restriction. A higher score for portion control 
and carbohydrate substitution is desirable, which means that the participants 
applied desirable behaviour more frequently. In contrast, the higher score for food 
restriction is undesirable, because it means that participants more frequently 
consumed food which should be restricted.  
Table 6.10: Statistical test of dietary behaviour scores 
  Intervention group 
(N = 36) 
Control group 





Mean ± SD 
Between group p-value 
 
39.5 ± 24.5 
 
46.2 ± 24.8 
0.282a 
Follow up 
Mean ± SD 
Between group p-value 
 
45.8 ± 24.6 
 
43.3 ± 25.1 
0.683 a 
P-value between group 
difference over time 
0.815 b 
Food restriction Baseline 
Mean ± SD 
Between group p-value 
 
6.88 ± 9.08 
 
4.97 ± 4.89 
0.291a 
Follow up 
Mean ± SD 
Between group p-value 
 
5.17 ± 5.72 
 
4.71 ± 9.42 
0.814 a 
P-value between group 
difference over time 
0.869 b 
 
Notes:  a determined by Welch’s t test;  





No differences were however found between intervention and control at baseline, 
or following the intervention (Table 6.10). This meant that dietary behaviour of all 
participants at baseline was similar to that at follow up, and that the intervention 
did not change participants’ behaviour. 
6.7.1.3 Description of dietary behaviour of participants 
No differences were found for dietary behaviour. We further explored the 
participants’ dietary behaviours by looking at the mean score of questions asking 
the number of days within the last week they were practising the recommended 
behaviour at baseline. This better describes the behaviours that have been applied 
by the participants, and this may be important in designing future projects. We 
included eight questions on dietary habits: portion control (question 1 - 4), 
carbohydrate substitution (question 5), and food restriction (question 6 – 8) 
(Table 6.11).  
Table 6.11: The mean number of days within the last week the participants applied dietary 
behaviours at baseline 
 The mean number of days within the last week the participants applied the 
behaviours 
  Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 
Mean 4.49 4.65 3.48 3.60 1.85 1.20 1.86 1.69 
Median 7 6 3.00 3 1 1 0 1 
Standard 
deviation 
3.01 2.68 2.78 2.90 2.12 1.72 2.81 1.98 
Minimum 0 0 0 0 0 0 0 0 
Maximum 7 7 7 7 7 7 7 7 
Q1 = how many days in the last week they had meals with about a quarter portion of rice 
Q2 = how many days in the last week they had meals that were half vegetables and fruit 
Q3 = how many days within the last week the participants had meals that were a quarter lauk 
Q4 = how many days within the last week the participants had meals with combination of those 
three portions 
Q5 = how many days within the last week the participants substituted rice with other type of 
carbohydrate 
Q6 = how many days within the last week the participants ate fried snacks 
Q7 = how many days within the last week the participants drink coffee or tea with sugar 
Q8 = how many days within the last week the participants ate cookies or sweet snacks 
 
 
In portion control, many participants reported that they had reduced the amount 
of rice, and added more vegetables in their meals. As can be seen in Table 6.11, on 
average, within the last week, participants had their meals with a quarter of rice 




participants, respectively, reported that they had not applied the recommended 
portion of rice, and vegetables and fruit portion within the last week. Some 
participants, however, added some comments on the vegetables and fruit 
question. They said that they ate fruits less frequently than the vegetables. Some 
said that they only had fruit once a day and some also said that they had fruit only 
some days of the week. Meanwhile, for the protein or ‘lauk’ portion (Q3), the mean 
number of days that participants had meals with protein for one quarter of their 
plate was less than the rice and vegetable portions. This meant the number of days 
within the last week that the participants had a combination of previous three 
questions (Q4) was similar to the protein portion. In this case, some participants 
added comments that ‘lauk’ was less than a quarter portion of what they ate.  
Although this information in some cases may not be accurate (as many 
participants said that it was difficult to answer the question as the way they plated 
meals was different), it does show that many participants were aware about 
controlling portions of their meal, particularly by reducing the rice portion and 
adding more vegetables. 
The question about carbohydrate substitution (Q5) had a lower mean of the 
number of days than the portion control (only about 1.8 days). This implies that 
carbohydrate substitution was less frequently applied by participants than portion 
control as part of dietary management for diabetes.  
The questions about food restriction (Q6 – Q8) are negative, which means that the 
higher score was undesirable. Table 6.11 shows that the mean of days within the 
last week of food restriction behaviours was about two days, with Q6 (eating fried 
snacks) having the lowest mean days (1.2 days). This implies that many 
participants restricted eating fried snacks. Some participants also mentioned that 






6.7.2 Exercise behaviour 
Exercise behaviours were measured with three main questions: the number of 
days during the last week the participants exercised independently; attended a 
specific exercise programme; and exercised for 30 minutes or more. At baseline, 
one participant missed being interviewed as explained previously, while at follow 
up five participants were lost.  
At baseline, as can be seen from Table 6.12, the mean scores of exercise 
behaviours of participants in the control group were similar to those of 
participants in the intervention group. At follow up, for the number of days 
attending specific exercise programme, participants in the intervention group had 
a higher mean score than those in the control group, as confirmed by ANCOVA and 
depicted in Figure 6.17. No other effects of the intervention were observed for 
exercise.  
Table 6.12: Statistical test of exercise behaviour scores 
Exercise 
behaviours 
Statistics Intervention group 
(N = 36) 
Control group 
(N = 31) 




Mean ± SD 
Between group p-value 
 
3.69 ± 3.03 
 
3.81 ± 3.22 
0.876 a 
Follow up 
Mean ± SD 
Between group p-value 
 
4.17 ± 2.77 
 
4.03 ± 3.04 
0.852 a 
P-value between group 
difference over time 
0.714 b 




Mean ± SD 
Between group p-value 
 
0.686 ± 0.676 
 
0.677 ± 0.653 
0.960 a 
Follow up 
Mean ± SD 




0.548 ± 0.506 
0.035 a * 
P-value between group 
difference over time 
0.042 b * 
Number of days 
doing exercise for 
30 minutes or 
more 
Baseline 
Mean ± SD 
Between group p-value 
 
2.94 ± 2.79 
 
3.39 ± 3.21 
0.553 a 
Follow up 
Mean ± SD 
Between group p-value 
 
3.03 ± 2.90 
 
2.87 ± 3.11 
0.833 a 
P-value between group 
difference over time 
0.939 b 
Notes:  a determined by Welch’s t test;  
b determined by ANCOVA test 





Figure 6.17: Change of days attending specific exercise programme by participants in the control and 
intervention groups 
6.7.2.1 Description of participants’ exercise behaviour 
Most participants exercised for some days during the last week (Table 6.12). 
Following the question about the number of days that the participants did 
independent exercise, the participants were also asked for ‘how long they did the 
independent exercise for’. Most participants, however, failed to answer the second 
question. 
Some of them mentioned that they did not calculate the time spent exercising. 
Others said that they exercised on random days and at random times, so they 
could not recall the duration. At baseline, 40 participants - 21 in the control group 
and 19 in the intervention group - responded to this question, while at follow up, 
49 participants - 23 in the control group and 26 in the intervention group - 
responded to this question. A total of only 29 participants - 14 in the control group 
and 15 in the intervention group - responded to the question about duration of 
doing independent exercise. These data showed a variety of duration of exercise, 
with most doing exercise for about 30 minutes. Some participants elaborated 
further: they did gardening as part of their daily routine; or they walked regularly 
in the morning. 
In terms of attending a specific exercise programme, at baseline, some participants 
reported that they attended exercise programmes held by health facilities. At 




improvement in attending a routine exercise programme compared to the 
participants in the control group. The intervention has encouraged the 
participants to attend the exercise programme regularly.  
6.7.3 Other self-management behaviours 
Other self-management behaviours included the number of days that the 
participants took care of their feet within the last week, visits to health 
professionals within the last month, and smoking behaviour (Table 6.13).  




Statistics Intervention group 
(N = 36) 
Control group 
(N = 31) 
Number of days 
taking care of feet 
Baseline 
Mean ± SD 
Between group p-value 
 
1.56 ± 2.84 
 
1.90 ± 2.90 
0.631 a 
Follow up 
Mean ± SD 
Between group p-value 
 
1.74 ± 2.79 
 
1.00 ± 2.38 
0.248 a 
P-value between group 
difference over time 
0.264b 
Number of visiting 
health professionals 
within the last 
month 
Baseline 
Mean ± SD 
Between group p-value 
 
0.794 ± 0.641 
 
1.39 ± 1.61 
0.062 a 
Follow up 
Mean ± SD 
Between group p-value 
 
1.43 ± 1.22 
 
1.74 ± 1.41 
0.342 a 
P-value between group 
difference over time 
0.918 b 
Smoking behaviour Baseline 
Percentage YES/NO 















Notes:  a determined by Welch’s t test;  
b determined by ANCOVA test;  
c determined by X2 test 
 
 
6.7.3.1 Foot care 
Foot care behaviour was measured with one question about the number of days in 
the last week they cared for their feet including washing, soaking, and drying. 
Table 6.13 shows this did not differ at baseline, with participants taking care their 




practised foot care elaborated further, that they always drain their feet when they 
got wet. Some others said that they took care of their feet when they became itchy. 
The participants who reported not taking care of their feet said that they had no 
wounds on them, so they thought that foot care was not needed. At follow-up, the 
mean number of days decreased for the control group, and remained almost the 
same for the intervention group. However, this change was not significant 
statistically. 
6.7.3.2 Health professional visits 
The majority of participants had visited their health professionals at least once 
within the last month, and this did not differ between groups (Table 6.13). The 
health facilities in the study location commonly scheduled patient visits once a 
month. Only a few participants visited their health professionals more than once a 
month. Some participants mentioned further that they visited a physician at 
Puskesmas (community health centres), or came to Posyandu Lansia (community-
based health services for the elderly). Two participants also mentioned that they 
were visited at home by health professionals. Some participants – five in the 
control group and eleven in the intervention group – did not visit a health 
professional within the last month. Two of them said that they had not had their 
diabetes checked in the last four and two months respectively.  
At follow up, more participants in both groups reported visiting health 
professionals at least once within the last month. Only nine participants - three in 
control and six in the intervention - reported that they did not visit health 
professionals within the last month. At follow up, the number of participants who 
visited their doctors more than once in a month increased. These changes were 
not statistically significant, however. 
6.7.3.3 Smoking behaviour 
The majority of participants reported that they did not smoke at both baseline and 
follow-up data collection. The participants who reported smoking were all male. 
Only four participants – two in the control group and two in the intervention 




group who previously reported smoking stated that he had not smoked within the 
last week at follow up. Moreover, one participant who reported not smoking at 
baseline mentioned that he smoked at follow-up. One other participant in the 
control group mentioned that he smoked at both baseline and follow up with an 
increased number of cigarettes on an average day from 10 to 20. In the 
intervention group, one participant who reported smoking at baseline was lost at 
follow up, and one other participant reported not smoking at follow up. Smoking 
status did not differ statistically at baseline or follow-up. 
 
6.7.4 Combined score of self-management behaviours and its association with 
demographic characteristics and other outcomes 
The combined scores of self-management behaviour were calculated by adding the 
scores of all behaviour categories, except for the dietary behaviour on food 
restriction. The score for food restriction behaviour was subtracted as the 
questions were negative. Table 6.14 shows statistical tests of total behavioural 
score of participants in the control and intervention groups at baseline, and at 
follow up. There were no differences at baseline or follow-up. 
Table 6.14: Statistical test of total self-management scores 




Groups  Mean ± SD Between group 
p-value 
Mean ± SD Between 
group p-
value 
Intervention  41.1 ± 28.3 0.131 a 51.9 ±29.0 0.761 a 0.926 b 
Control  52.0 ± 29.3 49.7 ± 29.9 
 
Notes:  a determined by Welch’s t test;  
b determined by ANCOVA test 
 
 
Self-management behaviour was not associated with gender, age, duration of 
diabetes, or education, or with other outcomes of knowledge and HbA1c (Table 
6.15). Participants with the lowest and the highest income had higher self-






Table 6.15: Association analysis of self-management behaviour score at baseline and participants 
demographic characteristics, and other outcomes 
 Total self-management 
behaviour score at baseline 
Total self-management 
behaviour score at follow up 
Gender a F (1,64) = 0.147 
p-value = 0.702 
F (1,59) = 0.451 
p-value = 0.504 
Age b Pearson’s r = -0.034 
p-value = 0.785 
Pearson’s r = - 0.017 
p-value = 0.895 
Education level a F (3,62) = 0.295 
p-value = 0.829 
F (3,57) = 2.88 
p-value = 0.044 
Income a F (4,61) = 2.66 
p-value = 0.041 * 
F (4,56) = 0.402 
p-value = 0.807 
Duration of diabetes b Pearson’s r = -0.112 
p-value = 0.373 
Pearson’s r = 0.048 
p-value = 0.713 
HbA1c b Pearson’s r = 0.026 
p-value = 0.841 
Pearson’s r = - 0.075 
p-value = 0.570 
Knowledge score b Pearson’s r = -0.227 
p-value = 0.067 
Pearson’s r = - 0.233 
p-value = 0.071 
 
Notes:  a determined by ANOVA  
b determined by Pearson correlation  
* statistically significant (p value < 0.05) 
 
6.7.5 Discussion of self-management behaviour outcomes 
The study found that there were no significant differences in self-management 
behaviours between participants in the control and intervention groups. Analysis 
of specific self-management behaviours (dietary habits, exercise, and other self-
management behaviours) also showed that there were no differences between 
participants in the intervention and control groups. The behaviour scores were 
statistically unchanged, except in the number of days attending exercise 
programme, where participants in the intervention did participate more in 
structured exercise activities, relative to control.  
Studies of diabetes interventions have reported positive results on HbA1c and 
knowledge outcomes, but showed more conflicting results on behavioural 
outcomes. A systematic review of diabetes intervention studies in Iran showed 
that most studies have positive effects on knowledge and HbA1c outcomes, but the 
effects on attitude and behavioural outcomes varied [592]. Most diabetes 
interventions conducted in other developing countries also reported favourable 
outcomes of HbA1c, however, only a minority of them had small impacts on other 




and Sidani [457] reported that the diabetes self-management interventions 
produced the lowest effect size on behavioural outcomes compared to knowledge 
and HbA1c [457]. Hawthorne, et al. [467] also conducted a systematic review of 
diabetes interventions in socially disadvantaged ethnic minority communities 
living in developed countries, and found that the interventions improved clinical 
outcome of HbA1c and knowledge. The interventions, however, resulted in no 
significant improvement in the other patient-centred outcomes including attitude, 
quality of life, and self-efficacy [467]. A systematic review of diabetes 
interventions conducted in China also showed that most of the interventions 
improved participants’ knowledge and glycaemic control, while only limited 
interventions resulted in positive effect on behaviour [593].  
This accumulating evidence suggests two likely explanations of why some people 
with diabetes have their clinical outcome improved but with limited improvement 
in behavioural outcomes: firstly, it may relate to measurement issues; and 
secondly, it may relate to the intervention not being able to change participants’ 
behaviour.  
Measuring adherence to self-management behaviours of people with diabetes is 
complicated as it includes a wide ranges of activities: from dietary control to foot 
care [594]. Some methods are recommended, including clinical outcome 
indicators, behavioural observation, pill counts, and patients’ self-reports. Patient 
self-report is regarded as the most reliable approach compared to the others, as 
this method enables the researcher to detect specific behaviours they 
implemented that may contribute to their clinical outcome [594]. Self-reported 
data are, however, subject to bias which may come from over-reporting [595]. In 
our study, we asked participants at baseline and follow up to recall their 
behaviour within the last week. The statistical analysis showed no changes in 
behavioural scores over time. Bias from over-reporting behaviours at the baseline 
measurement may provide a likely explanation on this result. Furthermore, 
recalling data may also be influenced by memory error. Johnson [594], therefore, 
suggested it is possible to gather good quality self-report data on self-management 




that it more understandable. Further, in order to improve quality of recall data, 
short term recall (for example, one day) or multiple sources of recall including 
both patients and their caregiver are recommended [594].  
Issues of reliability of measurement tools also emerged. Previous studies have 
attempted to develop and measure reliability of self-management or self-care 
behaviours. As an example, Toobert, et al. [596] developed The Summary of 
Diabetes Self-Care Activities Measure, and reviewed its validity; and Schmitt, et al. 
[597] developed the 16 item Diabetes Self-Management Questionnaire and 
evaluated its relationship with glycaemic control. Applying previously developed 
and validated questionnaires in different community contexts is however 
problematic. Both of those questionnaires, for example, asked participants about 
their behaviour related to self-monitoring of blood glucose. In the Indonesian 
context, this is less applicable. Most people with diabetes in Indonesia do not have 
their own blood glucose measurement tools. Most previously validated 
questionnaires are also developed in a western community context, so that their 
questions about dietary control might not be appropriate in the Indonesian 
context. In our study we therefore did not use a previously validated 
questionnaire; instead we developed the questionnaire based on knowledge 
gathered at the qualitative study. This study did not, however, aim to measure the 
validity and reliability of this questionnaire. Future study needs to be conducted in 
this area, so that a valid and reliable questionnaire for measuring self-
management behaviour applicable in the Indonesian context is established.  
Secondly, it is widely recognised that behavioural change is the most challenging 
part of diabetes management. At the last intervention session, some participants 
expressed “iya, kita ini sudah pintar kalau ditanya disini bias jawab, tapi begitu 
sampai dirumah susah sekali kita laksanakan” (yes, we now knew a lot about 
diabetes and how to manage it, and we could respond well when we were asked 
questions related to that. However, when we get home, it is really difficult to apply 
what we know). 
The Social Cognitive Theory (SCT) explains that behaviour is a result of a complex 




The central determinant of SCT is self-efficacy, which is the perceived ability to 
perform such behaviour. The intervention sessions in this study focused not only 
on improving knowledge, but also increasing participants’ self-efficacy by 
providing encouragement, and facilitation for them to practise the recommended 
behaviours. The likely explanation for this failure in improving behaviour, 
however, is the short-term duration of the intervention which was only for three 
months. This allowed limited time for monitoring and giving feedback to the 
participants. Fan and Sidani [457] suggested that diabetes interventions 
conducted over a longer duration (>24 weeks) resulted in larger effects for 
clinical, knowledge, and behavioural outcomes.  
Furthermore, Baker, et al. [598] identified a number of strategies employed by 
some successful diabetes prevention programmes in changing lifestyle behaviours. 
Among the strategies implemented was that the methods of delivering counselling 
and education for behavioural change was face-to-face interaction, individually or 
in small groups after an initial individual counselling, with the duration of delivery 
of around a year. Those explanations imply that interventions to change behaviour 
need to be conducted more intensively, involving individual assessment of 
barriers and problems in applying recommended behaviour, and developing 
individual strategies to implement the recommended behaviours. Interventions 
for behavioural change also need a longer time to have an effect, as behaviour 
change needs to be a gradual process.  
The other important component of behaviour change is environmental support 
[280]. Changing individual behaviour is likely to be successful when 
environmental factors are also taken into account [599]. The qualitative study 
revealed that the implementation of dietary control and physical activity were 
challenged by unsupportive family members, and cultural practices. Family’s 
attitude has shown to have an important impact on diabetes self-management 
[600]. This implies that interventions for changing lifestyle should not only target 
individuals, but also the influence of family members and cultural practices on the 
behaviours. In the absence of these supports, the outcome of behavioural change 




acknowledged the importance of support. However, we only included peer 
support from other diabetes patients through peer-modelling. This may not be 
enough in encouraging participants to change behaviours.  
 
6.8 Acceptability of the intervention programme to participants and health 
professionals 
Four individual interviews and a focus group were conducted with participants 
involved in the intervention group after the intervention sessions were completed. 
Individual interviews with two Prolanis (programme for managing chronic 
illnesses) team leaders in the intervention groups were also conducted. The 
interviews and focus group aimed to gather participants’ and health professionals’ 
opinions about the implementation of the intervention.  
From the interviews with participants, most perceived benefit from the 
intervention: that the intervention improved their knowledge about diabetes and 
their conditions. Some participants also suggested that health professionals’ 
attitude toward the patients is important in encouraging the participants to adopt 
the recommended actions. Interactive and continuing communication improved 
health professionals-patient relationships, and the good relationship supported 
participants to attend the session regularly.  
The activities help us ... I mean our health is getting better ... controlled 
... because we exercised routinely, as we rarely do it at home 
[individually] (Individual interview). 
We really like to come here as the health professionals always smile to 
us, and provide the best health services to us. So, we really appreciated 
them (Group discussions). 
The activities really help us, and I wish that this is continued, and I also 
wish that my friends here come to the programme regularly, and not 
absent... for our [better] health (Group discussion). 
She, my friend [who also has diabetes] doesn’t want to come, what can I 
do, she will know the impact later... (why she doesn’t want to come?) 




The participants also wished that the members of the groups would routinely 
come and participate in the activities in the future. They said that level of 
individual awareness of the importance of the sessions, and time constraints 
hindered some of their friends with diabetes from attending the programme.  
From the Prolanis teams’ perspectives, the intervention improved participants’ 
attendance at the programme, compared to the usual Prolanis activities. The 
Prolanis teams also mentioned that the intervention sessions increased 
participants’ enthusiasm about being actively involved in the activities, 
particularly in educational sessions. The continued and structured education 
sessions, and the individual tasks and small rewards increased the participants’ 
motivation to attend the sessions and practise the recommended actions. The 
HbA1c measurement also increased participants’ enthusiasm to know more about 
their conditions. These new initiatives implemented in the intervention session 
were perceived positively by the Prolanis teams, and will be continued in their 
usual Prolanis activities. The Prolanis team in Puskesmas Oebobo - who have 
increased the frequency of their Prolanis activities from fortnightly to once a week 
- reported that more intensive activities increased not only the enthusiasm of the 
participants to come to the sessions, but also improved the personal relationship 
among the participants. In this intervention group, the members of the group 
initiated establishing a social self-managed group, which was not only concerned 
with improving health, but also other social activities.  
Participants’ attendance improved. And the participants were also 
enthusiastic in the education sessions, as usually we rarely provided 
education for them. With this intervention, the education was done 
regularly with more structured material. This encouraged them to come 
to the session. And the glucose measurement … (Prolanis team Oepoi). 
Usually we performed Prolanis activities once in two weeks, because of 
limited health professionals’ availability to manage the programme, but 
then we observed the participants’ enthusiasm with this intensified 
programme [once a week], so we will do our best to continue the 
activities once a week (Prolanis team Oebobo). 
Yes, probably because of more frequently they meet, the participants 
then feel that the programme belongs to them, so increase their 
belonging to the programme, so they then also have other ideas for 




6.9 Discussion of overall results of type 2 diabetes intervention study 
The findings of the current study showed that outcomes for the participants in 
each of the study arms did not differ statistically. A significant overall reduction of 
HbA1c level from 8.3 ± 2.23% to 7.9 ± 2.16% within three months of study 
duration was a welcome finding, however, and was observed in both groups. 
Participants’ knowledge outcomes also improved, although their medication 
adherence and self-management behaviours did not change statistically.  
These results, however, were in contrast to the majority of type 2 diabetes self-
management intervention studies. Systematic reviews of diabetes self-
management interventions conducted in both developed and developing 
countries’ contexts mostly reported favourable outcomes of knowledge, metabolic, 
and behavioural improvement [457, 458, 465, 468, 477, 559-562, 592, 593]. Most 
diabetes intervention studies implemented a Randomised Controlled Trial (RCT) 
design. A quasi-experimental non-equivalent control group, and pre-experimental 
pre-and-post single group were applied more often in developing countries’ 
contexts [559, 560, 592].  
An RCT is widely recognised as the most robust design for measuring a ‘true 
experiment’ effect, as randomisation prevents selection bias. In clinical practice, 
however, randomisation might not be possible. In the context of this study’s 
location, randomisation was neither practical nor feasible (detailed in Chapter 5). 
The quasi-experimental design is regarded as the most powerful alternative in 
cases where randomisation cannot be undertaken [601]. The addition of a control 
group in the quasi-experimental design, even if the control group is un-matched or 
non-equivalent, greatly reduces equivocality (ambiguous findings) resulting from 
single group pre-and post-test [602]. Further, Campbell [602] underlined that the 
control group in the quasi-experimental design is more effective when more 
similarities are found between the two groups confirmed by the score at pre-test 
[602]. In this study, statistical analysis showed no significant differences in 
demographic characteristics and outcomes measured at baseline between 




although it was not matched and non-equivalent, can effectively act as the 
comparison group.  
A few studies on type 2 diabetes interventions published in peer-reviewed 
journals reported unfavourable outcomes, or non-significant differences of 
outcomes between group arms. Sperl-Hillen, et al. [603], Sperl-Hillen, et al. [604] 
compared three study arms: individual education; group education; and usual care 
of poorly controlled type 2 diabetes patients in Minnesota. They found that 
participants in all group arms experienced an improvement in HbA1c, with the 
highest reduction in the individual education group. The HbA1c reduction of 
participants in the group education cohort was similar to that in usual care. They 
concluded that the individual education was more effective in their setting. Rygg, 
et al. [605] evaluated the effectiveness of an ongoing diabetes programme 
conducted in local hospitals and included poorly controlled type 2 diabetes 
patients in Norway. The results showed that the programme prevented the 
patients’ diabetes deteriorating: participants in the intervention group 
experienced a small reduction of HbA1c while those in the control group showed 
an increase in HbA1c value. Further, Partapsingh, et al. [606] implemented a 
diabetes intervention guided by the Stages of Change model in patient-physician 
consultations in Trinidad. With an RCT design, this study found that there was an 
overall increase in HbA1c level of participants in both groups, with those in the 
control group experiencing a higher increase of HbA1c. The authors attributed the 
worsening conditions of the study participants to the harsh economic condition in 
the study location at the time of the study.  
Frosch, et al. [607] evaluated the effectiveness of ongoing telephone support for 
poorly controlled type 2 diabetes patients compared to only providing an 
educational booklet. The study reported that there was a significant overall 
reduction of HbA1c from baseline to six months, but there were no differences 
observed between groups, with the higher improvement in the control group. 
There were also no significant differences between groups for other outcomes. 
Skelly, et al. [608] also reported that tailored home-visit diabetes intervention for 




study arms in HbA1c, and other physiological and behavioural outcomes. 
Participants in both study groups experienced an improvement in all outcomes 
measured. They assumed that multiple extraneous factors might have affected the 
internal validity of the study. Cooper, et al. [609], Gary, et al. [610] also found a 
small improvement of participants in the intervention group. Cooper, et al. [609] 
found that HbA1c level at 12 months correlated negatively with attendance rates 
with the higher attendance rates predicting the greater level of HbA1c reduction. 
Anderson, et al. [611] also reported that both control and intervention 
participants showed an improvement in outcomes during six weeks of 
intervention activities focused on problem-based empowerment education. They 
attributed the findings to volunteer bias, study effect, and intervention impact. 
The possible causes of improvement in both intervention and control groups in an 
experimental study is explained by Becker, et al. [612], including reactivity of 
measurement, contamination, maturation, and history. Further, Campbell [602] 
listed history, maturation, and testing effect among eight extraneous variables 
which may influence internal validity of experimental study design. We believe 
that measurement reactivity, contamination, and history contributed to the lack of 
differences observed between intervention and control in our study.  
6.9.1 Measurement reactivity 
Reactivity of measurement is defined as the change of participants’ outcomes 
simply as a result of being measured [612, 613]. Measurement reactivity has been 
shown to influence participants’ behaviour, emotion, and cognition [613]. 
Measurement reactivity is similar to the Hawthorne effect [614, 615], testing effect 
[602, 615], and mere measurement effect [616]. The Hawthorne effect is defined 
as the impact of merely participating in the study which results in increasing 
awareness and behaviour [614, 615]. The testing effect explains that the 
participants experienced an improvement in the second testing as they learned 
from the first one [602]. Similarly, mere measurement effect describes the change 
in actual behaviour as a result of being asked. The mere measurement effect has 





In this study, we believe that measurement reactivity provides a likely explanation 
of the significant improvement of some outcomes in both groups. We assume that 
the HbA1c measurement, providing the results of the HbA1c to both participants 
and health professionals, and interview-type questionnaire triggered more 
intensive diabetes management in the study location.  
This intervention study provided participants their first experience of HbA1c 
measurement. The HbA1c test has not been included in the standard diabetes care 
in the health facilities involved in the study. People with diabetes commonly 
received fasting or random blood glucose tests with a point of care device. The 
frequency of blood glucose measurement, however, also depended on the health 
facility’s capability and financial support to conduct the measurement. In 
measuring the HbA1c, this study also collaborated with a private clinical 
laboratory in the city, which was perceived by most people as a highly qualified 
clinical laboratory, that differed from what the participants usually received. This 
may have further increased their enthusiasm about the measurement itself. 
Further, providing information about the study, and that they would have their 
HbA1c measured at baseline and three months after, may also have made the 
participants aware of being evaluated over time, and encouraged participants to 
better manage the disease.  
Furthermore, the HbA1c test results were reported both to participants and health 
professionals soon after the baseline data collection was completed. Providing the 
results early provided feedback for both participants and health professionals 
about how well their diabetes was managed. It has been found that providing a 
report of a comprehensive diabetes evaluation to participants and health 
professionals,  can be a form of intervention that affects diabetes outcomes [611, 
618]. The measurement of HbA1c and providing the results to both participants 
and their health professionals might therefore trigger the participants to more 
intensively self-manage the disease, and trigger health professionals to more 
intensively manage the patients. This study did not prohibit participants in either 




usual healthcare providers. This study also did not prohibit the participants 
seeking or being involved in any other education programme.  
This study was not, however, able to record and evaluate changes in treatment 
provided by health professionals that the participants experienced during the 
study period. The only data source we had about changes in treatment was the 
questionnaire. One question asked about the number of medications for diabetes 
the participants received at baseline and at follow-up. In many cases, however, the 
participants could not differentiate between the medicines for diabetes or other 
comorbid conditions. These self-reported data were therefore less reliable. 
Attempts were made to collect data about participants’ treatment changes over 
time through medical records. In some cases, however, the medical records were 
poorly written, so that we could not retrieve that data. The impact of treatment 
changes given by the healthcare providers on the outcomes could not therefore be 
evaluated. 
Measurement reactivity might also come from the questions asked of the 
participants. Capellan, et al. [619], for example, found that the participants in the 
control group learned about how to better manage catheter-related problems 
through questions asked in repeated interviews, so that their self-monitoring 
behaviour improved [619]. This effect of asking questions has also been studied in 
relation to physical activity behaviour with a Solomon four-group design [595, 
620]. These two studies suggested that participants’ self-reported walking 
behaviour increased as a result of completing a questionnaire or wearing a 
pedometer. Completing the questionnaire did not, however, affect the actual (not 
self-reported) walking behaviour [595]. In our study, the participants’ reactivity 
may also come from the questions covering knowledge, medication adherence, 
and self-management behaviour administered face-to-face by the research 
assistants. It has been previously found that merely administering a questionnaire 
resulted in higher self-reported behaviour, and this effect was often higher when 
the questions were asked by an interviewer [595, 620]. In the interview process, 
two-way communication cannot be avoided. It was observed during the data 




correct answer for the questions afterwards. This process might also act as 
knowledge-enhancing intervention. The questions on medication adherence and 
self-management behaviours may also increase people’s awareness of the 
recommended behaviours for managing diabetes.  
We found, however, that the self-management behaviour scores at baseline and 
follow up did not change statistically. This means that in this study we did not 
obtain a higher score for self-management behaviour at follow up. This may 
preclude the possibility of the questionnaire as a source of measurement 
reactivity. Interestingly, participants’ HbA1c outcome improved. This may imply 
that the participants experienced a change in their diabetes management; 
however, we were unable to identify the change.  
6.9.2 History 
History effects, defined as contextual changes occurring between the first and 
follow up measurements, might also explain some of the improvement in both 
control and intervention groups [602, 612]. Two contextual changes in the 
healthcare environment in the study location were observed during the study 
period. Firstly, the healthcare facility from which the control participants were 
recruited (Puskesmas Sikumana) intensified their activities in the Prolanis 
programme (a programme for managing diabetes and hypertension patients) 
from once a month to once a week. This intensified Prolanis activity might also 
have provided more intensive care for participants involved in the control group. 
Secondly, during the study period the universal health coverage management 
(BPJS Kesehatan) in the study location provided more health services to people 
with diabetes and hypertension, including participants involved in both 
intervention and control groups. The insurance management (BPJS Kesehatan) 
provided a complete blood check including HbA1c and total cholesterol level in 
December 2016, and centralised Prolanis activities twice in the three month 
period of the study. These activities had not been conducted before the study 
period. These changes may have increased the diabetes participants’ involvement 





Contamination of the control group means that the participants in the control 
group actively or passively received the intervention programme from the other 
participants involved in the intervention group [612]. To avoid contamination, we 
designed the study so that the intervention and control participants were 
allocated based on the health centres they were registered in. The people in the 
study location commonly registered with the health facility closest to their home, 
so that the transportation problem is minimised. With this design, participants in 
both groups were geographically separated, so that the contamination of 
information about the intervention was minimised.  
This may not have been enough to ensure that participants from both groups did 
not interact, however. Most participants in the study were registered under the 
universal health coverage (UHC) scheme. We observed that during the 
intervention period, the management of the health insurance (BPJS Kesehatan) 
conducted integrated education and health check activities for all diabetes 
patients in the city. During this session, all diabetes patients under the UHC 
management, including those involved in the intervention and control groups, 
were invited to a designated place and time to have their blood drawn, and 
received standard diabetes education. This event provides an example of a chance 
for participants in the intervention and the control groups to interact. Although 
effort was made to minimise contamination bias, we could not therefore ensure 
that there were no interactions between the participants in both groups.  
 
Based on this explanation, we believe that we developed an effective intervention 
but employed a method that did not allow us to ascertain the relative effect of 
extraneous forces of measurement reactivity, history, and contamination. The 
most effective approach to minimise this threat to internal validity is to conduct a 
study for a longer period, during which neither patients nor physicians receive any 
study data. The longer time would allow us to ascertain whether the change was 
as a result of the intervention or merely as reactivity of the participants to the 




the results of blood glucose measurement, from either participants or physician. 
Although the participants involved in the study were registered at healthcare 
facilities, most healthcare facilities provided blood glucose monitoring services 
once a month, and most participants did not have a device for self-blood glucose 
monitoring. Most participants therefore wanted to know about the results of their 
blood glucose measurement, so that withholding the results seemed to 
disadvantage them.  
Regardless of issues about study design, the intervention programme in our study 
provided a positive impact through increasing the management of diabetes in the 
intervention group, and stimulating local healthcare providers to more intensively 
manage their diabetes patients. The intervention activities in our study were 
conducted based on availability of the health professionals in the study location; 






Section D – Discussion and conclusion 
7 Chapter 7: Discussion and conclusion  
7.1 Introduction 
This study was prompted by the fact that there are few studies in the Indonesian 
context that address the problem of child immunisation and diabetes, as explained 
in Chapter 1. The goal set for the thesis was to investigate whether it was possible 
to improve health indicators and outcomes. The literature study in Chapter 2 
shows that understanding people’s behaviours related to health problems is 
crucial in developing acceptable and effective interventions. Understanding lay 
people’s perspectives enables researchers to tailor interventions based on 
community needs and preferences. Literature on lay people’s perspectives and 
health behaviour related to child immunisation and diabetes in Indonesia, 
however, is very limited. The qualitative study with focus group discussions 
presented in Chapter 3 was therefore performed as an attempt to gather 
information on Indonesian people’s behaviour related to child immunisation and 
diabetes. The questions were developed based on Kroeger’s framework of factors 
determining choice of health providers, including characteristics of the individual, 
the disease, and the health providers [279]. Findings from the qualitative study 
directed the focus and design of the major study, which was an intervention pilot 
study for type 2 diabetes patients in Kupang, the capital city of East Nusa Tenggara 
Province. A literature review on diabetes interventions described in Chapter 4 
provided further guidelines in developing the intervention study. The 
methodology of the intervention study is detailed in Chapter 5. A quasi-
experimental design was applied to compare the effectiveness of intensive group-
based intervention to usual care for people with diabetes. The intervention 
activities were conducted in collaboration with the Prolanis programme in 
primary healthcare facilities. With this collaboration, the intervention was 
conducted based on available resources in the study location, which further 
enabled the intervention to be continued even after the project ended. The results 




Chapter 7 summarises the thesis findings, describes lessons learned, the strengths 
and limitations of the study, and suggests implication, recommendations, and 
future research directions. The chapter ends with the conclusions of the thesis.  
7.2 Summary of the thesis findings 
7.2.1 The qualitative study 
The qualitative study aimed to answer three research questions: 1) What are 
people’s perceptions, beliefs, and experiences related to child immunisation and 
diabetes?; 2) What are the individual and social factors that may influence 
people’s behaviour related to child immunisation and diabetes?; and 3) What are 
the health provider factors that may determine people’s behaviour in seeking 
care? 
The study revealed that characteristics of the individual, characteristics of the 
health problems and how they are perceived, and characteristics of the health 
providers determined health-related behaviours of people in Indonesia (Figure 
7.1). These findings underline the importance and applicability of the framework 
developed by Kroeger [279] in understanding people’s behaviour in the context of 
study location. Focusing on two different health problems, child immunisation and 
diabetes, enabled us to understand the extent to which each factor that 
determines people’s behaviours may vary. 
7.2.1.1 Child immunisation 
We found that most mothers utilised Posyandu for child immunisation. When the 
children were considered sick on the day of Posyandu service, they were referred 
to other immunisation services. This study also highlighted issues related to the 
implementation of Posyandu. Financial issues and lack of community participation 
often hindered Posyandu implementation. Potential missed opportunities were 
also often noted. In overcoming these, increasing the skills of community-based 
health workers is crucial.  
Moreover, the most notable factors influencing mothers’ behaviour were the 




Within the characteristics of the subject, the qualitative study underlined the 
importance of mothers’ interaction with the family, including their status in the 
household in making decisions related to child immunisation. As has been detailed 
previously, the most frequent reason mentioned by mothers for refusing 
immunisation was that the fathers did not agree. Although the mothers are 
responsible for taking care of the children, decisions related to health services 
utilisation therefore depended on the fathers as the leader and the decision maker 
in the family. Most mothers who participated in the study were housewives. This 
may imply that the housewife mothers have less power in their family in the 
decision-making process.  
 
Figure 7.1: Indonesian people's health behaviours in child immunisation and diabetes based on 
Kroeger's framework 
Characteristics of the immunisation services, namely relationships between 
mothers and community-based health workers influenced their behaviours. The 
relationships facilitated the mothers to perform recommended behaviours, not 
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only in child immunisation, but also in engaging with other health services 
including maternal and child care. This underlined the importance of health 
professionals’ attitudes and communication in improving the acceptability of 
health services.  
Characteristics of the disorder and its perception were also found to influence 
child immunisation behaviours. It seemed, however, that this factor was not 
strongly associated with behaviour. Most mothers participating in the child 
immunisation programme, for example, kept immunising their children despite 
limited understanding about immunisation and the diseases the vaccines 
protected against. Only a few participants mentioned that they did not immunise 
their children as they perceived no benefit from having immunisation. 
7.2.1.2 Diabetes 
Participants experienced late diagnosis, uncontrolled blood glucose levels, and 
diabetes related complications. Diabetes patients’ behaviours in managing the 
disease were determined mostly by individual lay perceptions, evaluation and 
experiences of their disease and its treatment. Based on the Kroeger’s framework 
[279], this factor is categorised as characteristics of the disorder and perceptions 
of it. Diabetes patients perceived the disease in their own explanations of 
aetiological model, and expected benefit of treatment. Because diabetes is a 
chronic disease, lay evaluation is a continuing process over time.  
The results of the lay evaluation of the disease and the effectiveness of its 
treatment further influenced the appeal and acceptability of specific health 
services. Diabetes patients, who perceived that medicines could not cure the 
disease, for example, chose traditional medicines for treating diabetes. In the lay 
evaluation process, the diabetes patients sought and received recommendations 
from significant others. Unlike those in the topic of child immunisation, in the case 
of diabetes, the significant others were other people with diabetes including family 
members or friends. As an example, the diabetes patients decided to take 




Other factors categorised as characteristics of subject, including cultural beliefs 
and practices also influenced people’s behaviour in managing the disease. 
Diabetes participants in the study saw the disease in a broader cultural context. 
Their perceived ability in managing the disease was therefore challenged by these 
cultural beliefs and practices.  
7.2.2 Findings of the intervention pilot study 
The intervention pilot study failed to show statistically significant differences in 
outcomes between participants in the intervention and control groups. 
Participants in both groups, however, experienced an improvement in clinical 
outcome and knowledge. Therefore, we believe that we developed an intervention 
that was effective in improving outcomes, but we were not able to detect the 
relative effect of extraneous forces including measurement reactivity, 
contamination, and history.  
Participants in the quasi-experimental study were 60% female, mean age 57, and 
had diabetes for an average of 4.5 years. Baseline HbA1c did not differ (control 
mean 8.35%, SD 2.60; intervention 8.26%, SD 1.89). Post-intervention, both 
groups showed improvement in HbA1c (control mean 7.95%, SD 2.53; 
intervention 7.84%, SD 1.82). Although more intervention than control 
participants achieved an HbA1c reduction of 0.5%, 43% compared to 31%, change 
between groups was not different (p = 0.9).  
In terms of knowledge, most participants had a moderate level of knowledge at 
baseline. The highest score was on knowledge about risk factors, and the lowest 
score was on knowledge about diet. The mean of total knowledge was 54.3 (SD 
12.1) for participants in the control group, and 56.6 (SD 9.03) for participants in 
the intervention group. At follow up, the knowledge score of participants in both 
groups had improved, 56.8 (SD 13.9) in the control group, and 58.9 (SD 11.8) in 
the intervention group. Statistical analysis of ANCOVA showed that there was no 
significant difference in the knowledge score change between participants in the 
control and intervention groups (p=0.54). Most participants were aware that 
diabetes can be prevented and that high blood pressure is one of risk factors for 




controlling diet and performing exercise in managing the disease. Participants 
involved in the study had suffered from diabetes for some period and had 
experience of attending specific programme for diabetes. Their level of knowledge 
may not therefore be similar to the general population or newly diagnosed 
diabetes patients. With this level of understanding, a small knowledge gain was 
observed within three months.  
In the outcome of medication adherence, the study did not find statistically 
significant differences over time between participants in the control and the 
intervention group. The mean score of medication adherence for participants in 
the control group was 10.4 ± 3.84 at baseline, and 10.9 ± 3.26 at follow up. 
Meanwhile, participants in the intervention group had a mean score of 9.97 ± 3.54 
at baseline, and 10.4 ± 4.24 at follow up. Although the intervention was not able to 
significantly improve adherence to medication of the participants, it has increased 
awareness about the importance of taking medicines. Nine participants reported 
discontinuing taking medicines at baseline, and seven of them reported taking 
medicines at follow up.  
Furthermore, the study found that participants’ self-management behaviours did 
not change during the three months of the study period, except for the number of 
days attending an exercise programme during the last week. Within the exercise 
behaviour, the number of days attending an exercise programme during the last 
week improved significantly for participants in the intervention group, compared 
to the control group. At baseline, the mean total behavioural score of participants 
in the control group was 52.0 (SD 29.3), and those in the intervention group was 
41.1 (SD 29.3). At follow up, the mean of total behavioural score of participants in 
the control group decreased to 49.7 (SD 29.9), while the mean score of 
participants in the intervention group increased to 51.9 (SD 29). Statistical 
analysis of ANCOVA, however, showed that the change of the scores of participants 
in both groups did not differ with p=0.9. Many participants reported that they had 
reduced the portion of rice, and added a greater portion of vegetables in their 
meals. They, however, reported eating less fruits and protein-containing food. 




exercise, some of them also mentioned that they exercised on some days during 
the last week. Foot care has not been commonly practised yet. A few male 
participants reported that they smoked during the last week.  
The association analysis revealed that the HbA1c outcome was not associated with 
any participant’ characteristics, diabetes experiences, and outcomes measured. 
Follow-up data, however, showed that higher HbA1c was associated with lower 
medication adherence, which suggests that poorer self-reported adherence is 
associated with poorer glycaemic control. The knowledge outcome was 
statistically associated with participants’ education level and income. 
Interestingly, knowledge gain was associated with gender with male participants 
having their knowledge level improved significantly, while the female participants 
did not experience an improvement in knowledge.  
7.3 Lessons learned  
Discussions on results of the qualitative and intervention studies have been 
presented above. This chapter presents the lessons learned from the study overall 
including the importance of understanding people’s behaviour in designing the 
intervention, the challenges in the implementation of diabetes interventions and 
evaluation of their effectiveness.  
7.3.1 Importance of understanding people’s behaviour before designing the 
intervention  
The thesis shows the importance of understanding people’s perspectives in 
designing an intervention. This understanding enabled the researcher to tailor the 
design of the intervention, develop the content of the intervention, and modify 
delivery methods for it. This contextual understanding may also facilitate people’s 
acceptance of the intervention.  
Findings from the qualitative study on diabetes highlights that the characteristics 
of the individual, particularly the individuals’ interactions with other diabetes 
patients, greatly influenced patients’ behaviour. Acknowledging this, the 




members acted as support for each other and also provided positive role models 
for others.  
Furthermore, in the study location, diabetes patients interacted with each other, 
and this interaction would likely increase for those who visit the same health 
providers, those who have familial relationships, or those who are living nearby. 
Because of this, we believed that individual randomisation would result in 
significant cross contamination from participants in the intervention group to 
those in the control group. A quasi-experimental study with non-randomised 
participants was therefore used.  
Findings from the qualitative study also highlighted that diabetes patients’ 
behaviour was influenced by the characteristics of the disorder and their 
perception. As described previously, the nature of diabetes as a chronic disease led 
the patients to perform lay evaluation of their disease and the results of the 
treatment. It is therefore important that the content of the intervention focused on 
assisting individuals in the process of lay evaluation, and in facilitating positive 
experiences from practising the recommended treatment. In addressing this, the 
principles of self-regulatory processes, facilitation, and intensive motivation were 
applied in the intervention.  
During the research process, intervention activities were also modified based on 
the characteristics of people in the study location. As an example, we initially 
planned that healthy potluck meals would be included in the activities of the 
intervention; however, we decided not to do this. This was because the 
participants ranged widely in term of socio-economic status – from low, middle, to 
high income. This income variation affected their ability to prepare food to share. 
Culturally, people would be ashamed if they cannot provide a good and proper 
meal for others. As this activity would burden the poor more, we excluded this 
activity from the intervention sessions. 
The studies reviewed in Chapter 4 show that culturally tailored interventions for 
diabetes patients are more acceptable and effective in influencing behaviour. The 




participants’ language and level of understanding. As an example, in the context of 
the study location, educating people on carbohydrate and calorie counting would 
be difficult. Most people in Kupang cook their meals from raw ingredients which 
are locally grown or available in the local market. Information on the number of 
calories for specific local food does not exist. The number of dietitians available in 
the study location is also limited. The plate method and recognising which food 
sources are recommended or should be restricted are therefore the most practical 
and feasible ways to educate people about diet. Furthermore, people in the study 
location felt appreciated when they were given time to share their experiences. In 
delivering the education, interactive methods were therefore used.  
Interventions focused on diabetes should also address the patients’ problems in 
practising recommended self-management behaviour. In terms of medication, for 
example, the most common problem of non-adherence to medication was the 
feeling of getting fed up with taking medicines. Effort should therefore be focused 
on overcoming the psychological problem of getting fed up, and facilitating 
participants to improve their adherence to diabetes medication.  
Indonesia has a culturally diverse population. This suggests that interventions for 
diabetes patients should be specifically tailored based on understanding about 
local culture. This study found that diabetes participants in West Sumatera 
mentioned the types of their traditional cuisine challenged them to practise 
healthy eating. Meanwhile, in East Nusa Tenggara, it is not the traditional cuisine, 
but the frequent ethnic feasts that challenged diabetes patients in adhering to the 
recommended diet. With these differences, different approaches should be 
established to facilitate diabetes patients practising recommended behaviour.  
7.3.2 Challenges in implementing the intervention study on diabetes 
7.3.2.1 Participation rates 
Based on experiences in delivering the intervention sessions, the most substantial 
challenge was to improve participants’ uptake and engagement with the activities, 
and to create active participation rather than passive participation. This challenge 




programme: that the participants’ attendance at the Prolanis programme 
fluctuated and tended to decrease over time. This may relate to Indonesian 
people’s beliefs about health and illness. Indonesian people consider themselves 
healthy if they can perform their everyday activities without disruption. Thus, 
people generally went to healthcare facilities when symptoms prevented this. This 
also applied to managing disease, and some participants shared that they had no 
symptoms of diabetes so they thought that their disease was controlled.  
Other studies on diabetes self-management education reported that the main 
challenge of delivering interventions was low participants’ retention to the 
programme [459]. Further, Lepard, et al. [621] reviewed studies focusing on 
diabetes interventions for people residing in rural areas of the United States, and 
reported that the retention rate for interventions which were delivered to the 
participant’s home were higher than those that required participants to travel to 
the intervention site.  
The intervention sessions in this study were conducted in the health facilities 
closest to the participants’ home. This aimed to facilitate the participants coming 
to the sessions. In the study location context, limited transportation systems and 
the cost of travel to the intervention site may hinder participants from coming. 
The motorbike was the main method of transport in the study location. Public 
transport is available in connecting people to and from the main roads, so that 
people residing far from the main road are unable to access it. The motorbike taxis 
are the main transportation system for people far from the main road; however, 
they are more expensive. Some participants relied on their other family members 
to take them to the intervention site. Participants who regularly attended the 
sessions, therefore, were those who had no problem with transport to the 
intervention site.  
Weather also challenged the intervention programme. The intervention study was 
conducted from September 2016 to January 2017. In the study location, heavy-
rain season starts in December and continues until January. The participation rate 
decreased during the rainy period. In one health facility, the sessions were 




rained heavily at the day of follow-up data collection session, so that many 
participants could not come to the session. An individual approach, however, was 
successful for collecting data from some missing participants.  
7.3.2.2 Health professional availability for managing diabetes patients 
The government has introduced Prolanis, a specific programme for managing 
chronic illnesses. Implementation of this programme, however, depends on the 
availability of health professionals in healthcare facilities to manage the 
programme. Some health facilities have Prolanis activities conducted once a week, 
while the others are only able to manage it once a month. Our intervention study 
showed that intensified group activities increase people’s participation and 
engagement with the programme. Further, intensified group activities also 
increase interaction and integration of health professionals with the people. By 
doing this, a trusted relationship is established. It has been widely acknowledged 
that relationships between patients and health providers based on trust improve 
patients’ adherence and continuation with health interventions [374-376]. Based 
on the fieldwork experience, increasing health professional-patient relationships 
improved patients’ engagement with intervention activities. In the Indonesian 
context, however, health professionals’ availability to manage the programme is 
often limited as they are commonly often over burdened by the high number of 
patients and other administrative tasks.  
Studies have also shown that interventions for diabetes patients are best 
conducted by a team involving multidisciplinary health professionals [461]. The 
role of a pharmacist in diabetes interventions has been studied and pharmacist 
involvement has been found to improve patients’ outcomes [591]. Findings from 
the current study imply that the involvement of pharmacist and dietitian in 
managing diabetes patients is needed. Many participants in the study discontinued 
taking medicines, or alternated and/or combined medicines with traditional 
therapeutics for various reasons. Limited understanding about medicines also 
hindered participants from adhering to their medication regimen. These findings 
and experiences imply that the role of pharmacist and pharmaceutical care are 




pharmacist employed in the Puskesmas and other primary healthcare facilities in 
Kupang. The medicines were commonly dispensed by pharmacy technicians, and 
the information about medications provided to the patients was limited to 
instruction about medicine taking, and how many times a day to take it. The 
involvement of dietitians in diabetes management was also limited, which further 
led to limited information about the proper diet for diabetes. The diabetes patients 
often evaluated the effect of certain local foods to their blood glucose level, 
subjectively or objectively. Collaborative work involving multidisciplinary health 
professionals is therefore needed. Availability of some specific health 
professionals in the study locations was limited, however.  
7.3.3 Evaluating effectiveness of the diabetes intervention 
This study provided substantial knowledge in designing a study aimed at 
assessing the effectiveness of diabetes intervention in the Indonesian context. In 
this study, we believe that external factors precluded us from finding statistically 
significant differences in outcomes between participants in the intervention group 
and those in the control group. The strongest external factors interfering with the 
study outcomes were likely to be measurement reactivity, and cross-
contamination. This implies that measuring the ‘true experiment’ effect is more 
challenging in the context of study location. 
Addressing the problem of measurement reactivity, Solomon [622] recommended 
designing an intervention with four groups, after randomising participants into 
control and intervention groups. This allows both the control and intervention 
group to have a group with pre-testing, and a group without pre-testing. This 
design enables researcher to detect the pre-testing effect. Furthermore, due to the 
social nature of the communities, cluster randomisation would be appropriate in a 
larger sample to minimise cross contamination bias. In the Indonesian context, the 
cluster should be defined in the larger geographical areas, for example, different 
cities or provinces.  
Acknowledging these sources of threat to internal validity, a simple design is also 
suggested. As explained in Chapter 6, we believed that the HbA1c measurement 




professionals has led to more intensive diabetes management. To minimise the 
effect of measurement reactivity, therefore, the study needs to be designed for a 
longer period, without providing the results to both participants and their health 
professionals. This seems unethical, however. A possible alternative is measuring 
the effect of the intervention as part of the ongoing diabetes programme at the 
healthcare facilities, without changing the type of clinical measurement that is 
normally provided.  
Furthermore, in evaluating secondary outcomes of knowledge, medication 
adherence and self-management behaviours, an interviewer-administered 
questionnaire was applied. The questionnaire asked participants to self-report 
their behaviour. The self-reported questions increased people’s chance to over-
estimate or over-report [595, 620]. To minimise this problem, self-reported 
measurement should be combined with more objective measurement, particularly 
in behavioural-related outcomes. In evaluating medication adherence, for 
example, the questionnaire may be supplemented by medicines counting or 
timeliness of participants in refilling the medication. In evaluating dietary and 
exercise behaviour outcomes, a daily food and exercise log may also be 
implemented. When technology is available, photos and/or videos may also be 
used for evaluating the behavioural outcomes.  
 
7.4 Strengths and limitations 
7.4.1 Strength of the study 
A number of strengths may be attributed to the current research. Firstly, this 
study implemented an intervention that was developed based on understanding of 
the community’s perspectives and local context. It has been widely recognised that 
understanding community behaviour is important before developing an 
intervention, and understanding health behaviour may have no direct impact 




Secondly, the intervention study provided comprehensive self-management 
education aimed at improving not only knowledge, but also skills and self-efficacy 
through facilitation, and peer modelling. The content of the education also covered 
most recommended self-management behaviours for diabetes including dietary 
control, medication adherence, exercise, and foot care behaviour. For assessing the 
effectiveness of the intervention, a combination of clinical outcome measures 
(HbA1c) and self-reported data from questionnaires was used. The clinical 
outcome of HbA1c provided objective results of the effect of the intervention.  
Thirdly, the intervention was conducted in collaboration with an existing 
programme of Prolanis. This collaboration enabled the intervention to be 
conducted with available resources, and continued after the project was ended. 
The intervention could also be further implemented in other locations, 
particularly in East Nusa Tenggara Province, with similar participants’ 
characteristics and environmental context.  
Lastly, this research was performed in areas outside Java Island, which addresses 
geographical disparities in health research in Indonesia. 
7.4.2 Limitations of the study 
7.4.2.1 Qualitative study 
The qualitative study included a small number of participants in East Nusa 
Tenggara, and West Sumatera provinces. Therefore, the results may be different in 
other culturally different contexts, or in areas of Indonesia with different 
characteristics. Furthermore, in investigating child immunisation, the qualitative 
study was also limited by the methods of recruiting participants, who were 
mothers involved in the Posyandu programme. It may therefore not be able to 
capture behaviours of mothers who are employed or who used other 
immunisation services. Gathering data from these mothers, however, revealed 
problems within the Posyandu programme, the long-established outreach 
programme for increasing mother and child health. For the study on diabetes, 




professionals, so that it may not represent people with undiagnosed diabetes or 
people who did not utilise formal health services. 
Furthermore, limitations of the qualitative study may come from the methods of 
gathering data through focus group discussions. Within the discussions, 
participants may have felt ashamed to express their individual opinion if it was 
different from the group opinion. In one discussion, the participants involved in 
the discussion were divided into two groups based on their individual opinion: 
those who only took medicines from the doctors; and those who also took 
traditional medicines. The role of facilitator was important in directing the 
discussions.  
Lastly, the qualitative study was also limited by the involvement of two or more 
languages. The discussion questions were first developed in English and 
translated into Bahasa Indonesia, whereas the transcripts were first written in 
Bahasa Indonesia, and translated into English. Although during this process I was 
assisted by persons who were fluent in both languages, there remains a risk that 
some meaning was lost in some cases. Furthermore, the qualitative study was also 
conducted in two different cultures, neither of which is the culture that I come 
from. The discussions were conducted mainly in Bahasa Indonesia, and most 
participants spoke Bahasa Indonesia. In some cases, particularly in more rural 
areas, most participants used a combination of local language and Bahasa 
Indonesia. Although I was assisted by research assistants who were native 
speakers of the participants’ local language, and efforts were made to reduce the 
risk of losing meaning, it is inevitable that the process of translation involving 
multiple languages may have resulted in some loss of integrity of the data.  
7.4.2.2 Quantitative intervention study 
The intervention study also has some limitations. Firstly, the intervention study 
was developed in response to the lack of literature on diabetes interventions in 
the Indonesian context. The design and content of the intervention were therefore 
developed solely based on the findings and experiences gathered from the 




studies conducted in other developed or developing country contexts. The 
intervention study also involved a relatively small number of participants for the 
experimental design. Increasing the sample size would potentially increase the 
chance that the effect would be detectable.  
Secondly, the intervention sessions were conducted in collaboration with health 
professionals at the healthcare facilities who agreed to be involved in the study. 
The sessions in each group were therefore delivered by different health 
professionals. Although the content and instruments for the education sessions 
were developed by the researcher, and discussions with the health professionals 
were also held, there were differences in style and ability to perform education 
activities between health professionals. These differences may further impact on 
the differences in information received by participants, which may also impact on 
their outcomes. This method, however, represented natural differences in the real 
clinical settings.  
The study may also be limited by the use of research assistants in interviewing 
participants to gather data on knowledge, adherence to medications, and self-
management behaviours. Although criteria were applied in recruiting the research 
assistants, and training was also conducted, differences in communication style 
and ability to convey the meaning of the questions between research assistants 
remained. This may impact on the quality of the data collected. In the context of 
people’s characteristics in the study location, however, self-administered 
questionnaires were not feasible.  
Another limitation of the study was the lack of medical record data for diabetes 
patients in the study locations. We were therefore not able to gather participants’ 
history of the disease and treatment changes provided by their health 
professionals during the intervention period. Information about disease 
experiences, for example duration of having diabetes and type of medicines they 
were taking, were retrieved from self-report data in the questionnaire. In some 
cases, we found a remarkable difference in their answers at baseline and at follow 
up. As an example, one participant mentioned that she had diabetes for about 




up. With this limitation, we solely relied on the information available from the 
questionnaire output, and in case there was a remarkable difference, we used the 
information at the baseline. These experiences, however, may also suggest that in 
Indonesian context, particularly in the study location, self-reported data should 
ideally be supplemented by objective data.  
 
7.5 Implications of and recommendations from the study 
7.5.1 Child immunisation programme 
The findings from the qualitative study about child immunisation provide three 
main implications and recommendations. Firstly, mothers’ behaviour in 
immunising their child is shaped and influenced by the fathers as the decision 
makers. This implies that family support is crucial in improving immunisation 
uptake. Interventions should therefore be established by involving not only 
mothers, but also their families. Although the study found that limited 
understanding about immunisation and the diseases the vaccines protected 
against did not always correlate with negative behaviour towards immunisation, 
interventions for improving understanding are important to avoid vague 
conceptualisation and unrealistic expectations. Improving family members’ and 
wider communities’ understanding and awareness of immunisation would 
therefore be beneficial in supporting mothers to immunise their children.  
Secondly, although Posyandu is a long-established community-based programme 
focused on maternal and child health including child immunisation, it still faces 
some practical challenges in its implementation. These practical problems 
decreased opportunities for the children to receive immunisation, and 
discouraged mothers from utilising the Posyandu service. The roles of community-
based health workers are crucial in addressing the practical problems and 
facilitating the success of Posyandu implementation. The implication of this 
finding would be for the health system to focus on improving the skills and 




supervision have been acknowledged as factors determining the effectiveness of 
programmes involving community-based health workers [623]. 
Lastly, participation of all community stakeholders is important for the 
sustainability of community-based programmes. Community support and 
participation in the Posyandu programme seemed to be lacking. Efforts should 
therefore be made to involve community stakeholders to improve participation 
and support for the programme. The role of the government is also important to 
minimise disparities in health services in the community-based programme 
because of differences in the community capability to support the programme.  
7.5.2 Diabetes 
The current research on the topic of diabetes implies that the problem of diabetes 
in Indonesia is alarming. This thesis therefore recommends the health system in 
Indonesia makes diabetes a priority disease to focus on. Efforts should be made to 
prevent the diabetes epidemic in the country.  
This study found that most diabetes patients were diagnosed late when they 
experienced a very high level of blood glucose, or had diabetes related 
complications. Some of them also detected diabetes accidentally when they went 
to health facilities for other health complaints. This showed limited awareness 
about diabetes in the community. This problem is complicated by people’s beliefs 
related to health and illness. Indonesian people commonly consider themselves to 
be healthy when they perceive no symptoms that disrupted their daily activities. 
This implies that efforts should be made to improve people’s awareness and 
understanding about the asymptomatic nature of diabetes, and encourage them to 
detect diabetes risk factors early. On the other hand, from the health providers’ 
perspective, early diabetes screening programmes need to be intensified. A study 
revealed that health professionals in Indonesia showed low adherence to the 
guideline, including detecting risk factors and early screening. The doctors tended 
not to advise their patients to be screened for diabetes unless several 




Secondly, the current research involved diabetes patients who had been diagnosed 
and were being managed by health professionals. The majority of them, however, 
experienced uncontrolled blood glucose levels. This evidence has implications 
from both patients’ and health providers’ perspectives. From the patients’ 
perspective, the uncontrolled blood glucose level may be a result of not 
implementing recommended actions in managing diabetes, including diet, 
exercise, and medication taking. On the other hand, this problem of uncontrolled 
blood glucose level may also be caused by insufficient or ineffective treatment 
provided by health professionals. Interventions should therefore be conducted on 
both sides: interventions focused on improving diabetes patients’ self-
management behaviours; and interventions focused on evaluating and improving 
diabetes management practices of the health professionals.  
Thirdly, this study highlights that diabetes in Indonesia not only affects people in 
urban areas, but also people in more rural areas. Diabetes burdened the people 
and the health system more in areas with lower socio-economic status. It has been 
acknowledged that the risk of developing diabetes is higher in people with a 
history of stunting in early childhood [15]. Diabetes in East Nusa Tenggara may 
provide evidence for this correlation. The prevalence of undernutrition and 
stunting in children under five in East Nusa Tenggara province were reported to 
be the highest in the country [22]. More research should be conducted in this area. 
This implies that interventions for preventing the diabetes epidemic in the context 
of East Nusa Tenggara Province need to also address the problems of 
undernutrition and stunting in children under five.  
Lastly, primary prevention of diabetes should also be initiated. The cost of treating 
diabetes, particularly those with complications, is high. This burdens not only the 
patients and their family, but also the community and the country, particularly in 
the universal health coverage era. Programmes focusing on non-communicable 
diseases including diabetes have been implemented. Evaluation of those 
programmes, however, is lacking, and the implementation of the health 
programmes also differs depending on the capacity and capability of health 




on non-communicable diseases need to be empowered and evaluated to achieve 
the target of improving people’s health and general wellbeing.  
 
7.6 Future research direction 
The current study directed the future research agenda in the topic of child 
immunisation and diabetes. In general, literature study found that there are 
disparities in health research across the regions in Indonesia. Most available 
studies were concentrated in Java Island, the most developed region in the 
country. This implies that more research on health should be conducted outside of 
Java.  
7.6.1 Child immunisation 
Although the qualitative study investigated health behaviours in child 
immunisation and diabetes, the study was only able to develop and implement an 
intervention focused on diabetes. Intervention studies aiming at improving 
immunisation uptake, based on the results of child immunisation programmes 
need be established. To gather richer information about child immunisation 
behaviour, studies on immunisation behaviour involving a broader cross-section 
of the community, including mothers who are not housewives and do not use 
Posyandu for immunisation services are also needed.  
7.6.2 Diabetes 
Studies aimed at understanding diabetes patients’ views and behaviour in 
managing the disease are needed in other communities with different 
characteristics and cultural backgrounds. These studies would inform a variety 
different interventions in these various context. This is important in informing the 
design, content, and delivery methods for diabetes interventions. To increase the 
richness of the information on people’s behaviours related to diabetes, studies 
involving the general population, people with undiagnosed diabetes, people with 
newly-diagnosed diabetes, and diabetes patients who do not utilise formal 




The results of the qualitative study also showed that diabetes patients experienced 
different problems and differing ability to cope with the disease. The group-based 
intervention conducted in this study was unable to address individual problems in 
managing diabetes. Instead, we addressed the common problems of diabetes 
patients in the study location based on information gathered from the qualitative 
study. Future interventions for diabetes patients should be designed to combine 
both individual and group-based approaches. Previous research has reported that 
the combination of a group-based and an individual approach resulted in the 
largest improvement in outcomes [458]. 
Although this current study detected no differences in outcomes between the 
intervention and usual care groups, the improvement in clinical outcomes 
experienced by most participants was a welcome finding. The external factors that 
potentially interfered with the results of the study should be acknowledged and 
minimised in the future study. Future research should be conducted also by 
escalating the study in terms of sample size and duration of intervention. This 
current study detected an improvement of HbA1c in a short period of time, so the 
sustainability of this outcome improvement needs to be evaluated. 
The results of the current study showed that the participants experienced an 
improvement in the clinical and knowledge outcomes. There was no improvement 
observed in the medication adherence and self-management behaviours 
outcomes, however. Participants in the current study mentioned that their self-
management behaviour in managing the disease was influenced by support from 
their family members, and their cultural practices. Intervention studies targeting 
not only the individual, but also social and environmental determinants of 
behaviours are therefore also needed to facilitate patients to implement the 
recommended behaviours.  
Lastly, future research needs to be conducted to evaluate the effectiveness of 
existing programmes in non-communicable diseases in achieving their goals. 
Efforts should also be made to maximise health resources currently available to 




7.7 Conclusions  
The thesis revealed a number of factors influencing mothers’ behaviours in 
immunising children, and factors influencing diabetes patients in managing the 
disease. The findings add substantial value to the existing literature, particularly in 
Indonesia, and in a developing country context. The findings also help to fill the 
gap created by the limited qualitative studies for understanding health problems 
from the communities’ perspectives in Indonesia, particularly in the case of child 
immunisation and diabetes.  
The thesis demonstrated that an intervention that was developed based on an 
understanding of community was able to improve diabetes patients’ clinical, 
knowledge, and medication adherence outcomes. Although the effect of the 
intervention was statistically insignificant compared to the usual care, we believe 
that external factors contributed to this. The findings of this intervention study 
also add to knowledge about diabetes interventions in Indonesia. The literature 
review has shown that although research about diabetes has been widely 
conducted, those focusing on improving patients’ outcomes were very limited.  
The findings of the current study recommend that the government and related 
stakeholders implement interventions to improve health outcomes by 
acknowledging factors influencing communities’ behaviours in these health-
related problems. In the topic of diabetes, specifically, the thesis recommends that 
the government and related stakeholders focus on primary prevention, early 
detection, and outcomes improvement. The diabetes epidemic is threatening the 
country, and with continuing socio-economic development and genetic 
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Appendix 1 – Articles included in the literature review about health-seeking behaviour of people in Indonesia 
Table A1.1 Studies included in the review gathered from peer-reviewed journals 






ny, et al. 
[281] 
Secondary 
data of 2010 
Basic Health 
Research 
Focus on data retrieved 
from 12,226 adults aged 
15 years and above who 




Quantitative analysis of data from a 
cross-sectional household survey. 
Data were collected by interviewing 
household heads and household 




out of 33 
provinces 
Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 








Mothers with postnatal 
complications (8), family 
members (6), and village 
midwives (5)  
Post-
natal care 
A qualitative study with in-depth 






Determinant of health provider choices: 
socio-cultural beliefs (the use of herbal 
remedies during pregnancy) 
3 
Kurniawa





Adults aged ≥18 year old 
visited community health 




Quantitative cross-sectional design 




Self-medication with antibiotics 
4 




12 newly diagnosed 
nasopharyngeal 
carcinoma (NPC) patients 
between March-June 2014 
at Dr. Sardjito Hospital. 
NPC 
Qualitative research. Patients were 
interviewed using semi-structured 




Concept of health and illness- will seek care 
if the symptoms hinder daily activities, 
believe that illness were form God, either 
God's gift, or punishment. Determinant of 
health provider choices: significant others, 
socio-cultural beliefs, experiences with 
medical services including negative 
experiences, and cost (indirect cost of 
medical treatment), complex insurance 













data, and a 
community 
based study 
Quantitative analysis: DHS 
2012 data gathered from 
poor women who had a 
live birth 5 years 
preceding the survey. 
Qualitative: poor women 
who had a live birth 
between 2010 and 2012 
(n = 20), midwives (n = 
12), and government 
representatives (n = 19). 
Birth 
delivery 
Mixed-methods design, utilising data 
from the 2012 Indonesian 
Demographic and Health Survey for 
quantitative analysis, supplemented 
by in-depth interview for qualitative 







Pattern of health care utilization, 
determinant of health provider choices: 
socio demographic determinants, socio-
cultural beliefs, perceptions about health 
care systems: negative experiences with 
medical care and quality of care, cost: 







38 Tuberculosis (TB) 
patients chosen randomly 
based on the PHC’s 
records.  
TB 
Quantitative, a cross-sectional study 
with Social Network Analysis (SNA) 
to get seeking treatment behaviour 
pattern of TB patients and supporting 





Determinant of health provider choices: 
significant others. Care pathway. Self- 







5 newly diagnosed 
pulmonary TB patients  
TB 
Explorative qualitative research, with 
semi-structured interview.  
East Java 
Province 









11 older persons with 
hypertension and 3 lay 









Determinant of health provider choices: 
socio-cultural beliefs (reasons for choosing 
alternative treatment).  
9 
Praptinin





identified as the most 
knowledgeable about the 
health conditions of 
household members from 





Quantitative, cross-sectional survey 
with face-to-face interviews using a 
structured questionnaire in East 





Determinant of health provider choices: 






110 participants were 
interviewed. 7 FGDs with 




Explorative qualitative approach, 
with semi-structured interviews, and 
focus group discussions in 8 villages 






Determinant of provider choices: significant 
others, traditional beliefs and cultural 
practices, accessibility, and cost (indirect 














16 family members of 17 
patients who 
accompanied the patients 
to the hospital  
Psychosis 
Qualitative. Data were collected via 
in-depth interviews at the outpatient 
clinic of the Aceh Psychiatric Hospital 
in Banda Aceh.  
Aceh 
Province 
Determinant of provider choices: significant 
others, causality beliefs, cost (indirect cost of 
medical treatment), accessibility, negative 
perception of medical services. Care 








100 patients with early 
psychosis and their 
caregivers at Sardjito 
Hospital, Grhasia Mental 
Hospital, Jogjakarta 
District Hospital and Puri 
Nirmala Mental Hospital. 
Psychosis 
A descriptive analytic study with 
cross-sectional design. Respondents 
were in-depth interviewed, and the 
data were analysed and coded to 
allow quantitative analysis. 
Yogyakarta 
Province 
Determinant of health provider choices: 
perception about disease and causality. Care 











Adult of 2520 households 
who was most 
knowledgeable about the 
health conditions of 
household members. N = 
554 physicians from in 
various types of health 





All community respondents, 
regardless of illness history, were 
asked questions about perceptions of 
health care services and intentions to 
seek treatment in hypothetical 
scenarios where they developed 
HPAI H5N1 signs/symptoms. A 






Determinant of health provider choices: 








825 households. The 
survey was conducted 
with the head of the 
household or another 
suitable adult  
Malaria 
A randomised cross-sectional 
household survey. The survey was 








Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 












Quantitative cross-sectional study 
with questionnaires. The 
questionnaires were read aloud to 






Concept of health and illness: older people 
went to health services when perceived 















Parents of 145 children 




Quantitative cross-sectional study 





Determinant of health provider choices: 
significant others, cultural beliefs, negative 









In total, 50 participants: 
17 TB patients, 16 ex-TB 
patients, 8 village TB 
volunteers, and 9 village 
leaders across six villages, 
and also were between 18 
– 30 TB leadership group 
members who 
participated in the FGD. 
TB 
Qualitative study with descriptive 
analysis. Data collection included 
interviews, group discussions, 
observations, field notes and audit of 
records. Intervention: Tuberculosis 
leadership groups were only 
established in the three villages that 









Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 
socio-cultural beliefs, lay term, and lay 
perception of disease and its causality. Self-







25 adults >18 years old 









Qualitative study as part of a mixed-
methods study examining self-
medication with antibiotics based on 
the TPB in Yogyakarta City, 
Indonesia. Face-to-face interviews 
were used to collect data. An 






Determinant of health provider choices: 
negative experiences with medical services. 
Care pathway: if the sick person is a child. 
Self-medication with antibiotics 
19 
Prabawa






209 waria (male to female 
transgender) 
HIV 
The study was part of a broader 
study that covered condom use and 
HIV-related health seeking 
behaviours. Cross-sectional data 
were gathered through face to-face 




Determinant of provider choices: perception 







30 women with type 2 
diabetes recruited from 
PERSADIA-Indonesia 
Diabetes Association  
Type 2 
diabetes 
Qualitative, with in-depth interview 
as method for collecting data. The 
study applied grounded theory, and a 
constant comparative analysis for 




Concept of health and illness- will seek care 
if the symptoms hinder daily activities, and 
concept of balance and harmony, believe that 
illness were form God, either God's gift, or 
punishment. Determinant of health provider 














203 household in round 1, 
221 household in round 2, 
220 households in round 
3 and 219 households in 
round 4.  
General 
health 
Mixed methods. This article presents 
a comparative analysis of socio-
economic disparities in relation to 
treatment seeking strategies and 
healthcare expenditures in poor 
neighbourhoods in four cities in 
India, Indonesia and Thailand. In 
Jogjakarta, the study was conducted 
in two poor neighbourhoods, with a 
total of 8105 households. 
Yogyakarta 
Province 
Care pathway: treatment effectiveness is a 








study: 24 respondents 
who had experienced 
malaria during the 
outbreaks or had 
contracted malaria in the 
previous three years, and 
three malaria health 
officers. 
Malaria 
A mix method study presents a case 
of malaria resurgence after five years 
of low endemicity. Cross-sectional 
survey to map each malaria cases 
during the malaria outbreak, and 
qualitative study to describe the 
community perceptions and health 
services delivery situation that 





Determinant of health provider choices: 
socio-cultural beliefs (the use of herbal 
remedies for malaria) 
23 
Iskandars




50 breast cancer patients 




Qualitative study with semi-
structured interviews to explore 
patients’ experiences during their 
diagnosis and treatment. Interviews 
were conducted in the clinic waiting 
room while participants waited for 




Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 
cultural beliefs: traditional healer provide 
comprehensive services, significant others, 




al. [302]  
Community 
based 
53 participants were 
interviewed, and 20 FGD 
were conducted. 
Leprosy 
A Qualitative study with in-depth 
interviews with people currently 
under treatment for leprosy or 
already cured and focus groups 
discussions with neighbours of those 
who had leprosy, community and 
religious leaders, mothers of children 






Concept of health and illness: believe that 
illness were form God, either God's gift, or 
punishment. Determinant of health provider 
choices: socio-cultural beliefs, causality 
beliefs (supernatural causes). Care pathway: 
















A total of 746 individuals 
age ≥15 years with cough 
for >2 weeks  
TB 
Quantitative: A cross-sectional 
survey to assess determinants of 
care-seeking behaviour among 
patients with suspected TB at the 
population level. Patients were 
interviewed using a structured 





Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 








212 infertile women 
recruited through 
invitations posted at three 
infertility clinics  
Inferti-
lity 
Quantitative research with 
interviewer-administered survey. 
Data was subject to descriptive 





Determinants of health provider choices: 
accessibility, perceived effectiveness of 







145 married women who 




Quantitative cross sectional study 
with self-administered questionnaire. 
Questionnaire was distributed to the 






Determinants of health provider choices: 















Qualitative study as part of a mix 
methods study investigating 
women’s adherence to iron 
supplementation in pregnancy in 





Socio-cultural beliefs (the use of herbal 
remedies during pregnancy) 
29 
Widayati, 
et al. [41] 
Population 
survey 
Adults over 18 years old 
living in Yogyakarta City. 
A total of 559 
questionnaires were 







Quantitative: This cross-sectional 
population-based survey used a 
pretested questionnaire which was 










194 TB suspects 
(coughing lasted for at 
least 2 weeks) that 
registered at the lung 
clinics. 
TB 
Quantitative: Cross-sectional data 
were gathered with a structured 
questionnaire in which psychosocial 
determinants were based on an 
extended version of the theory of 
planned behaviour (TPB).  
Yogyakarta 
Province 
Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 
socio-cultural beliefs, perception of medical 
services and healthcare systems. Care 
pathway: combining or alternating 
medicines from different providers. Self-

















The data gathered from 
10,857 (4202 urban and 
6673 rural) uninsured 
adults aged ≥15 years 
who report having had 
some kind of illness 
during the past one month  
General 
illnesses 
Quantitative with secondary data 
from Indonesian Family Life Survey 
2000 to investigates the importance 
of medical fee and distance to health 
care provider on individual’s decision 






determinant of health providers choices: 
cost, and health insurance: people in more 






253 newly diagnosed TB 
patients in 89 DOTS 
facilities.  
TB 
Quantitative cross-sectional survey 
amongst newly diagnosed TB 
patients. The history of care-seeking 
was reconstructed through 
retrospective interviews. Patients 









Determinant of health provider choices: 
socio demographic characteristics did not 






In total 295 participants: 
119 mothers of children 
aged 40 days to four 
months, 40 fathers, 26 
health professionals, 20 
village cadres, 37 
traditional birth 
attendants, 42 community 
and religious leaders, and 





A qualitative study FGDs and in-
depth interviews to explore 
community members’ perspectives 
on antenatal and postnatal care 
services, including reasons for using 
or not using these services, the 
services received during antenatal 
and postnatal care, and cultural 
practices during antenatal and 





West Java  
Determinants of health provider choices: 
cost, including indirect cost, limited 






Same as above (No 33) 
Birth 
delivery 
A qualitative study FGDs and in-
depth interviews to explore reasons 
for using a trained or a traditional 
birth attendant and reasons for 







Determinant of health provider choices: 
significant others, socio-cultural beliefs, 






11 persons with stroke 
(aged 32-69 years) and 18 
of their caregivers.  
Stroke 
Qualitative study informed by both 
hermeneutic phenomenology and 
ethnography. Data were gathered 
through interviews, photographs and 





Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
determinant of health provider choices: 













Involving lay people with 
high and low socio-






Qualitative study with a combination 
of 2 individuals interview and 8 FGDs 
(78 informants). Data were analysed 
with content analysis.  
Yogyakarta 
Province 
Lay concept of health and illness: maintain 
balance and harmony.  
37 
D'Ambru




A total of 104 cases of 
women who had died 
during pregnancy were 




A mixed methods. A routine health 
surveillance of verbal autopsy with 
75 closed questions was used to 
generate cause-specific mortality 
profiles. In the second part, 
respondents were asked about the 
circumstances and events 
surrounding the death in a semi-
structured format with free dialogue. 







Determinant of health provider choices: 
complex insurance systems, and insurance 
problem from health provider perspectives.  
38 
Rintiswat









In total, 67 newly 
diagnosed or diagnosed a 
maximum of 3 months 
before the data collection 
TB patients and 22 family 
members were 
interviewed and 6 FGDs 
were performed.  
TB 
Qualitative study with in-depth 
interviews with TB patients and 
members of their family and through 









Determinant of health provider choices: 
significant others, socio-cultural beliefs, 
causality beliefs (lay perception of causality), 
perception of medical services and 
healthcare systems. Care pathway. Self-








Cases: 421 smear positive 
TB patients.  
TB 
Quantitative analysis with Limited 
Access (LA) forms administer by 
health workers in health care 
facilities related to healthcare 
utilisation pattern of smear positive 




Determinants of health provider choices: 
urban-and rural setting: accessibility.  
40 
Utarini, et 
al. [315]  
Community 
based 
All 3746 clinical malaria 
cases aged 6 months to 92 
years treating by Village 
Malaria Worker during 
the study period.  
Malaria 
Mixed study. A year longitudinal 
study of all clinical malaria cases 
treated by Village Malaria Workers 
(VMWs). Data on health seeking 
behaviour during 7 days illness 
period were collected using diary, 24 
interaction were audiotaped. Data 






Determinant of health provider choices: 











et al. [39]  
Household 
survey 
1,000 households: the 
head of household, or any 
resident more than 15 
years of age. 
Malaria 
Quantitative with a pre-tested survey 
instrument consisting of 93 questions 
The survey was taken by in-person 





Determinant of health provider choices: 
socio-cultural beliefs (the use of herbal 
remedies for malaria). Care pathway. Self-







54 consecutive patients 
who had attended the 
Bangli Mental Hospital in 
Bali and had no prior 




Quantitative analysis to provide 
statistical evidence of Balinese beliefs 
related to mental disorders. Data 
collected through interview with 




Determinant of health provider choices: 
significant others, causality beliefs. Care 








In total, 39 individuals 
with schizophrenia were 
detected in 36 households.  
Schizophr
enia 
Quantitative study with a 
questionnaire developed by the 
authors that listed 15 possible causes 
of schizophrenia was used to 
examine the respondents’ beliefs.  
Bali 
Province 






data of DHS 
1997 
The 1997 DHS is national 
survey conducted 






Quantitative analysis of the data for 
understanding patterns and 
predictors of health services 






Determinant of health provider choices: 
socio demographic characteristics, 
perception of medical services and 






37 clinic staff involved in 
delivery of TB treatment 
services  
TB 
An exploratory qualitative design 
with semi-structured interviews to 
explore factors perceived to influence 
TB treatment delivery based on 
health professionals’ perspective.  
Bali 
Province 
Lay concepts of health and illness: 
perception of early symptoms of 
tuberculosis as not serious.  Determinants of 








people who had been 
diagnosed with TB (5 
respondents) or who 
suspected of having TB (6 
respondents)  
TB 
An exploratory qualitative design 
with in-depth interview to study the 
issues associated with treatment-
seeking behaviour for TB in Bali from 
patients’ perspective.  
Bali 
Province 
Concept of health and illness- will seek care 
if the symptoms hinder daily activities. 
Determinant of health provider choices: 
significant others, socio-cultural beliefs, 
causality beliefs, perception of health care 
systems. Care pathway: combining or 
alternating medicines from different 
providers. Care pathway: for illnesses 
attributed to supernatural causes. Self-










tak, et al. 
[321] 
Census 
The total population 
enumerated by the study 
was 160,261 individuals, 
living in 34,503 
households  
Diarrhoea 
Quantitative with A de jure census: 
all members living in a household for 
more than six months and planning 
to stay in the household were 
included in the census. Data were 
collected through a structured 
interview with a household member, 











The main subgroups were: 
pregnant women (10), 
caretakers of the under-
fives (10), traditional 
health providers (6), 
formal and informal 
leaders (10), cases or 
caretakers of cases (13). 
FGD: 7 involving 54 
participants.  
Malaria 
Qualitative method with Rapid 
Assessment Procedures or RAP 
during a 3-month intensive data 
collection period. Data were 
retrieved from 38 free-listings, 28 in-
depth interviews, seven focus group 







Determinant of health provider choices: 
socio-cultural beliefs (the use of herbal 
remedies for malaria), lay term, and lay 
perception of disease and its causality. Care 
pathway, treatment effectiveness is a matter 







Quantitative: 124 patients, 
consisted of 38 patients 
with early stage and 86 
patients with advanced 
stage. Qualitative: 6 
patients, 1 midwife, and 
husband of 1 patient. 
Cervical 
cancer 
This research employs cross 




Determinants of delay in seeking treatment: 







150 households for 
household study, 75 
people for cohort study, 
42 people suffered from 
chronic illness selected 







Mixed qualitative and quantitative 
research methods. Semi-structured 
interviews with the cohort sample 
have yielded general and unspecified 
statements on experience and 





Concept of health and illness- will seek care 







In total, 28 focus groups 
with community 
members, 42 open-ended 
interviews with 
community leaders, and 
28 in-depth interviews 
with TB patients' family 
members were conducted. 
TB 
Qualitative methods including 
participant observation, case studies, 




Determinant of health provider choices: 
significant others, socio-cultural beliefs, cost: 
payment for traditional health can be made 
with food for example, causality beliefs. Care 


















The survey was conducted 
in 1993 involving 2429 
randomly selected 
households. The data 
were collected by 




Quantitative and descriptive analysis 
of the data aiming at developing 
methodology and evaluating 














A survey of 690 mothers 




Quantitative analyses Jakarta 
Determinant of health provider choices: 







Cases: 141 deaths in 
children less than 5 years 




Method: Cohort study with repeat 
visits to every household every 3 
months. Subsequently, whenever a 
death was reported, a "verbal 
autopsy", and also a questionnaire 




Determinant of health provider choices: 
duration of illness, and mothers’ 
participations in Posyandu. Socio-
demographic characteristics were not 
associated with choices of health providers.  
55 
Darmawa




Adults over 15 years old 
including 2499 women 
and 2184 men from two 
villages and total of 590 
women and 481 men from 
two city neighbourhoods 




Quantitative survey with house to 




Determinant of health provider choices: 








The household survey 
yielded data on 2697 




Quantitative: Household members 
were asked a wide range of questions 
about utilisation of curative, 
preventive and community-based 
health care. The illness care data 
were responses to two-week recall of 






Concept of health and illness- will seek care 
if the symptoms hinder daily activities. Care 
pathway: combining or alternating 










Table A1.2 Studies included in the review gathered from Indonesian journals 






Adults over 18 years old, 
640 respondents with 
90% response rate.  
General 
illness 
A cross-sectional survey using a pre-
tested questionnaire.  
Yogyakarta 
Determinant of health provider choices: 
socio demographic characteristics did not 
associated with seeking behaviour. Care 
pathway: combining or alternating 






88 People who sought 






This research was conducted 




Determinant of health provider choices: 
socio-cultural beliefs for alternative 







Head of the 185 
household or adults over 
18 years old living in that 
households 
Malaria 
Cross sectional survey, data was 
collected through direct observation 
and interview with respondents. The 












750 People suffered from 
cough more than two 
weeks, aged 15 or older.  
TB 
Cross sectional survey in Bantul 
district, Sleman district, and 
Yogyakarta city.  
Yogyakarta 
Province 
Determinant of health provider choices: 
socio demographic characteristics did not 







34 People sough care to 




Quantitative, descriptive study with 
questionnaire developed based on 
Health Belief Model. 
Sumedang, 
West Java  
Determinant of health provider choices: 
socio-cultural beliefs for alternative 






54 adults working as 
peasant and fisherman 




Qualitative, ethnography study using 
observation and in-depth interview  
Yogyakarta 
and Central 
Java   
Determinant of health provider choices: 
socio-cultural beliefs for alternative 









Participants: people who 
were ill during the past 
month and took 






s use  
The data derived from Susenas 200) 
consist of 280.000 households in 33 




Determinant of health provider choices: 










al. [338]  
Community 
based 
Community leaders, and 
people positive malaria 
based on blood test (the 
number of participants 
were not explained) 
Malaria 
A qualitative study include 
observation, in depth interview with 




Determinant of health provider choices: 
socio-cultural beliefs (the use of herbal 






6 Hypertension patients 
who did cupping therapy 
in An-Nahl, and Natura 







qualitative design. Data were 






Determinant of health provider choices: 
socio-cultural beliefs for alternative 






12 Patients, 6 sinshe(s) 
(Chinese traditional 
healers), 1 staff of health 
office, 1 doctor, and 1 






A qualitative study using grounded 
theory approach with observation 




Determinant of health provider choices: 
socio-cultural beliefs, reasons for choosing 










6 FGD of 8 – 10 
respondents each 
involving women in their 
reproductive age and men 
in their working age.  
General 
health 
A qualitative study with FGD 




Care pathways: self-medication first, and if 
symptoms persist visited health workers. 
But if the sick person is their child/children, 






People who took 
medicine, traditional 
medicine and or 
traditional methods on 
self-medication during the 




Quantitative analysis of The National 
Socio-Economic Survey data 2001 to 
obtain information on the pattern of 
the use of medicine, traditional 




Determinant of health provider choices: 







100 People resided in the 
area 
malaria 
Quantitative cross sectional 
descriptive study. Data were 





Determinant of health provider choices: 
socio-cultural beliefs (the use of herbal 







101 Mothers who have 
child/ren under 5 with 
pneumonia related 








A quantitative cross sectional study 
with questioner which was 




















72 Rheumatism patients 
who sought care to 
traditional healers, 15 





This paper is part of study on 
traditional medication for diabetes, 
hypertension and rheumatism 
conducted by Health Ecology and 
Development Centre in 1998/1999. 
The research used mixed methods. 
Quantitative: structured interview 
with rheumatism patients who 
sought care to traditional healer. 
Qualitative: in depth interview with 





Determinant of health provider choices: 
socio-cultural beliefs, reasons for choosing 
alternative treatments; safe, natural 
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The research used mixed methods. 
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with diabetes patients. Qualitative: in 
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Appendix 3 – Participant information sheets and consent forms for the 
qualitative study 
Appendix 3.1: Participant information sheet for the qualitative study about child 
immunisation in English 
Participant Information Sheet 
 
Study title: Immunisation Behaviour of Indonesian Communities 
Principal investigator: Name: Prof. Pauline Norris  
Department: Pharmacy 
Contact phone number: 
+64 274 80 95 95 
 
Introduction 
Thank you for showing an interest in this project. Please read this information sheet carefully. Take time 
to consider and, if you wish, talk with relatives or friends, before deciding whether or not to participate.  
If you decide to participate we thank you. If you decide not to take part there will be no disadvantage to 
you and we thank you for considering our request.  
 
What is the aim of this research project? 
This project aims to understand people’ perspective, beliefs, experiences and opinions about 
immunisation how the people decide whether or not to immunise their children. This understanding is 
very important in helping the government to create specific programmes on immunisation that may be 
well-accepted and afforded by the people. It also helps the government to improve the quality of 
immunisation-related health services. 
 
Who is funding this project? 
This project is funded by New Zealand Ministry of Foreign Affairs and Trade through New Zealand 
ASEAN Scholarship and the University of Otago, New Zealand. 
 
Who are we seeking to participate in the project? 
Mothers aged at least 17 years who have child or children aged 12 – 24 months will be chosen from 
primary health centres data and community-based child care organisations. The selection criteria are: has 
no formal health education background, does not work for a formal health provider, and has agreed to 
participate and shared their experience in immunisation. This project involves about 60 participants from 
different locations with 4 – 10 participants in each discussion. 
 
If you participate, what will you be asked to do? 
Should you agree to take part in this project, you will be asked to answer questions in group discussion. 
There is no right or wrong in your answer and we will not evaluate your answer as right or wrong. We 
just asked you to answer based on your personal opinion. Every of your answer is meaningful and very 
important. We will respect to any information that you have given. The discussion will take about 1 – 2 
hours. You may decide not to involve or to stop or leave the discussion at any time you wish without any 
disadvantage to yourself at any kind.  
 
Is there any risk of discomfort or harm from participation? 
Any of your information that you have given will only be used for academic purposes. There will be no 
physical or psychological risk or harm as every effort will be made to keep your personal identification 
safely and preserve your anonymity. However, as the nature of discussion, your shared information may 
be known by other person involved in the discussion. Should you disagree with such question, or your 
answer of such question is very confidential, you may refuse to answer it or answer it in a written format.  
 
What data or information will be collected, and how will they be used?  
The questions that we will ask to you are about your experiences, beliefs, opinions, perception about 
immunisation and how you make decisions whether or not to immunise your children. We will also 




If you agree, I will record our discussion in order to avoid missing any information that you have given. 
The recording will be transcribed and this transcript will be a raw data. This raw data will be retained for 
at least 5 years in secure storage. Any personal information may be destroyed at the completion of the 
research even though the raw data derived from the research will, in most cases, be kept for much longer 
or possibly indefinitely.  
Then, we will analyse the raw data and include it in the final result of the project. Your information may 
be appear in the form of quotes in the report and publication, but you will not be identified by name 
anywhere in the reports or published information. Every effort will be made to make secure any personal 
information. 
 
The results of the project may be published and will be available in the University of Otago Library 
(Dunedin, New Zealand) but every attempt will be made to preserve your anonymity. If you wish, you 
can request to the final report. 
 
What about anonymity and confidentiality? 
I will give you a copy of the transcript for you to check whether or not it represents your opinion 
accurately. After your checking process, the transcript will be translated into English with the help of 
research assistants. 
The audio recording and the transcript will be securely stored in such a way that only I, my supervisors 
and research assistants will be able to access it. The research assistants will only can have access to the 
data until the translation process is finished. 
You will not be identified by name anywhere in the research reports or published information. Every 
effort will be made to make secure any personal information. 
 
 
If you agree to participate, can you withdraw later? 





If you have any questions now or in the future, please feel free to contact: 
 
Name: Anna Wahyuni Widayanti 
Position: Mahasiswa peneliti 





This study has been approved by the University of Otago Human Ethics Committee (Health). If you have 
any concerns about the ethical conduct of the research you may contact the Committee through the 
Human Ethics Committee Administrator (phone +64 3 479 8256 or email gary.witte@otago.ac.nz). Any 






Appendix 3.2: Participant information sheet for the qualitative study about child 
immunisation in Indonesian 
 
Lembar Informasi untuk partisipan 
Judul penelitian:  Perilaku terhadap imunisasi pada masyarakat di Indonesia. 
Ketua peneliti: Nama: Prof. Pauline Norris   
Departemen: Farmasi 
Kontak: 
+64 274 80 95 95 
 
Pendahuluan  
Terima kasih atas ketertarikan anda untuk terlibat dalam penelitian ini. Mohon bacalah lembar informasi 
ini dengan seksama. Luangkan waktu untuk berpikir, dan jika anda inginkan, bicaralah dengan teman 
atau saudara, sebelum memutuskan bersedia atau tidak untuk berpartisipasi dalam penelitian ini. 
Jika anda memutuskan untuk berpartisipasi, kami sangat berterima kasih. Jika anda memutuskan untuk 
tidak berpartisipasi, tidak akan ada konsekuensi apapun, dan kami juga berterima kasih telah 
mempertimbangkan permohonan kami.  
 
Apakah tujuan dari penelitian ini? 
Penelitian ini bertujuan untuk memahami persepsi, kepercayaan, pengalaman dan pendapat masyarakat 
mengenai imunisasi. Pemahaman ini sangat penting dalam membantu pemerintah untuk memperbaiki 
program imunisasi, sehingga dapat diterima dengan baik, dan terjangkau oleh masyarakat. Hal tersebut 
juga membantu pemerintah untuk meningkatkan kualitas pelayanan imunisasi.  
 
Siapakah yang membiayai penelitian ini? 
Penelitian ini dibiayai oleh Kementerian Perdagangan dan Urusan Luar Negeri New Zealand melalui 
beasiswa New Zealand ASEAN dan Universitas Otago, New Zealand. 
 
Siapa sajakah yang kami cari untuk berpartisipasi dalam penelitian ini? 
Ibu, berusia paling rendah 18 tahun, yang mempunyai anak berusia 12 – 24 bulan. Calon partisipan 
dipilih dari data di rumah sakit, puskesmas atau posyandu. Kriteria seleksi untuk calon partisipan adalah: 
tidak memiliki latar belakang pendidikan bidang kesehatan, tidak bekerja di tempat pelayanan kesehatan, 
dan bersedia untuk berpartisipasi dan membagi pengalamannya terkait dengan imunisasi untuk anak. 
Penelitian ini akan melibatkan kurang lebih 60 partisipan dari lokasi penelitian yang berbeda-beda 
dengan 4 – 10 partisipan dalam setiap kali diskusi. 
 
Jika anda berpartisipasi, apa yang anda akan lakukan? 
Jika anda setuju untuk berpartisipasi, anda akan diminta untuk menjawab pertanyaan dalam diskusi 
kelompok. Tidak ada kategori jawaban benar atau salah, dan kami tidak akan mengevaluasi jawaban 
anda dengan benar atau salah. Kami akan meminta anda untuk menjawab berdasarkan pendapat pribadi 
anda. Semua jawaban anda adalah sangat berharga bagi kami. Kami akan sangat menghormati semua 
informasi yang anda sampaikan. Diskusi akan berlangsung selama 1 – 2 jam. Anda dapat juga 
memutuskan untuk meninggalkan diskusi di setiap saat jika anda inginkan tanpa adanya resiko apapun 
terhadap diri anda. 
 
Apakah ada resiko ketidaknyamanan atau bahaya dari keterlibatan dalam penelitian? 
Semua informasi yang anda sampaikan hanya akan kami gunakan untuk kepentingan akademik. Tidak 
ada ada resiko atau bahaya fisik atau psikologis sebagai hasil dari keterlibatan anda dalam penelitian. 
Kami mengupayakan segala usaha yang akan menjaga identitas diri anda dengan aman. Kami juga 
meminta semua partisipan dalam diskusi untuk menghormati kerahasiaan informasi yang disampaikan 
oleh orang lain, tetapi dalam sebuah diskusi kami tidak bisa sepenuhnya menjamin bahwa partisipan lain 
pasti akan menjaga kerahasiaan informasi yang akan anda sampaikan. Jika anda tidak ingin menjawab 
sebuah atau beberapa pertanyaan, atau anda merasa jawaban anda adalah rahasia untuk partisipan lain 





Data atau informasi apa yang diinginkan dan bagaimana data atau informasi tersebut akan 
digunakan? 
Kami akan bertanya kepada anda mengenai pengalaman, kepercayaan, pendapat dan persepsi anda 
mengenai imunisasi untuk anak anda. Kami juga akan bertanya mengenai bagaimana anda memutuskan 
untuk melakukan imunisasi untuk anak anda atau tidak. Kami juga akan mengumpulkan data nama, jenis 
kelamin, usia, pekerjaan dan alamat anda. 
Jika anda setuju, kami akan merekam percakapan dalam diskusi untuk menghindari adanya kehilangan 
informasi berharga yang anda sampaikan. Rekaman ini selanjutnya akan kami salin dalam bentuk tertulis 
sebagai transkrip asli. Transkrip ini akan kami simpan selama paling tidak 5 tahun di tempat 
penyimpanan yang aman. Namun, nama anda tidak akan kami simpan. Semua informasi identitas diri 
anda akan kami hapus setelah penelitian ini selesai meskipun data lain hasil penelitian akan kami simpan 
untuk jangka waktu yang lebih lama.  
Selanjutnya, kami akan menganalisis transkrip ini dan memasukkannya dalam laporan akhir hasil 
penelitian.  Informasi yang anda sampaikan mungkin muncul dalam hasil laporan penelitian tersebut, 
tetapi identitas diri anda tidak akan pernah disebutkan dimanapun dalam laporan hasil penelitian. Segala 
usaha akan kami lakukan untuk menjaga kerahasiaan identitas anda. 
Hasil penelitian ini juga akan kami publikasikan secara luas, namun segala upaya akan kami lakukan 
untuk menjaga kerahasiaan identitas anda. Jika anda berkeinginan, anda dapat juga meminta fotokopi 
dari laporan akhir penelitian.  
 
Bagaimana dengan kerahasiaan nama dan informasi? 
Transkrip salinan rekaman akan diterjemahkan ke dalam Bahasa Inggris dengan bantuan asisten peneliti. 
Hasil rekaman dan salinan transkrip ini akan kami simpan di tempat yang aman sehingga hanya peneliti, 
pembimbing peneliti dan asisten peneliti yang dapat mengaksesnya. Asisten peneliti hanya dapat 
mengakses data hanya sampai proses penerjemahan selesai. 
Identitas diri anda tidak akan teridentifikasi dimanapun dalam laporan atau publikasi hasil penelitian. 
Segala upaya akan kami lakukan untuk menjaga keamanan informasi dan data identitas pribadi anda. 
 
Jika anda setuju untuk berpartisipasi, dapatkah anda berhenti untuk berpartisipasi di setiap saat? 
Anda dapat memutuskan untuk mengundurkan diri dari berpartisipasi kapanpun, dan tanpa konsekuensi 
atau resiko apapun terhadap diri anda. 
 
Ada pertanyaan? 
Jika anda mempunyai pertanyaan saat ini atau di kemudian hari, anda dapat mengontak peneliti: 
Nama : Anna Wahyuni Widayanti 
Jabatan dalam penelitian : Mahasiswa peneliti 





Penelitian ini telah disetujui oleh komite etik Universitas Otago. Jika anda mempunyai pertanyaan atau 
keluhan yang berkaitan dengan etik penelitian, anda dapat menghubungi komite melalui bagian 
administrasi komite etik, Universitas Otago, dengan nomor telepon +64 34798256 atau melalui email ke 
alamat: gary.witte@otago.ac.nz. Semua permasalahan yang anda kemukakan akan diperlakukan dan 






Appendix 3.3: Participant information sheet for the qualitative study about diabetes 
in English 
Participant Information Sheet 
 
Study title: Health Seeking Behaviour of Indonesian Communities for diabetes 
and common cold 
Principal investigator: Name: Prof. Pauline Norris  
Department: Pharmacy 
Contact phone number: 
+64 274 80 95 95 
 
Introduction 
Thank you for showing an interest in this project. Please read this information sheet carefully. Take time 
to consider and, if you wish, talk with relatives or friends, before deciding whether or not to participate.  
If you decide to participate we thank you. If you decide not to take part there will be no disadvantage to 
you and we thank you for considering our request.   
What is the aim of this research project? 
This project aims to understand people’ perspective, beliefs, experiences and opinions about diabetes and 
the common cold and how the people decide to choose any mode of treatment. This understanding is 
very important in helping the government to create specific programmes on diabetes and the common 
cold that may be well-accepted and afforded by the people. It also helps the government to improve the 
quality of health services. 
 
Who is funding this project? 
This project is funded by New Zealand Ministry of Foreign Affairs and Trade through New Zealand 
ASEAN Scholarship and the University of Otago, New Zealand. 
 
Who are we seeking to participate in the project? 
Adult aged at least 30 years, both males and females. Participants are chosen from hospitals or primary 
health centres data. The selection criteria are: has been diagnosed with diabetes for at least one year, has 
no formal health education background, does not work in any health services, and has agreed to 
participate and share their experience in managing diabetes and the common cold. This project will 
involve about 60 participants from different locations with 4 – 10 participants in each discussion. 
 
If you participate, what will you be asked to do? 
Should you agree to take part in this project, you will be asked to answer questions in group discussion. 
There is no right or wrong in your answer and we will not evaluate your answer as right or wrong. We 
just asked you to answer based on your personal opinion. Every of your answer is meaningful and very 
important. We will respect to any information that you have given. The discussion will take about 1 – 2 
hours. You may decide not to involve or to stop or leave the discussion at any time you wish without any 
disadvantage to yourself at any kind.  
 
Is there any risk of discomfort or harm from participation? 
Any of your information that you have given will only be used for academic purposes. There will be no 
physical or psychological risk or harm as every effort will be made to keep your personal identification 
safely and preserve your anonymity. However, as the nature of discussion, your shared information may 
be known by other person involved in the discussion. Should you disagree with such question, or your 
answer of such question is very confidential, you may refuse to answer it or answer it in a written format.  
 
What data or information will be collected, and how will they be used?  
The questions that we will ask to you are about your experiences, beliefs, opinions, perception about 
diabetes and the common cold and how you make decisions in choosing any treatment available. We also 
will collect your personal information such as name, gender, age, job and address.  
If you agree, I will record our discussion in order to avoid missing any information that you have given. 
The recording will be transcribed and this transcript will be a raw data. This raw data will be retained for 




research even though the raw data derived from the research will, in most cases, be kept for much longer 
or possibly indefinitely.  
Then, we will analyse the raw data and include it in the final result of the project. Your information may 
be appear in the form of quotes in the report and publication, but you will not be identified by name 
anywhere in the reports or published information. Every effort will be made to make secure any personal 
information. 
The results of the project may be published and will be available in the University of Otago Library 
(Dunedin, New Zealand) but every attempt will be made to preserve your anonymity. If you wish, you 
can request to the final report. 
What about anonymity and confidentiality? 
I will give you a copy of the transcript for you to check whether or not it represents your opinion 
accurately. After your checking process, the transcript will be translated into English with the help of 
research assistants.  
The audio recording and the transcript will be securely stored in such a way that only I, my supervisors 
and research assistants will be able to access it. The research assistants will only can have access to the 
data until the translation process is finished 
You will not be identified by name anywhere in the research reports or published information. Every 
effort will be made to make secure any personal information. 
 
If you agree to participate, can you withdraw later? 




If you have any questions now or in the future, please feel free to contact: 
 
Name: Anna Wahyuni Widayanti 
Position: Mahasiswa peneliti 





This study has been approved by the University of Otago Human Ethics Committee (Health). If you have 
any concerns about the ethical conduct of the research you may contact the Committee through the 
Human Ethics Committee Administrator (phone +64 3 479 8256 or email gary.witte@otago.ac.nz). Any 





Appendix 3.4: Participant information sheet for the qualitative study about diabetes 
in Indonesian  
 
 
Lembar Informasi untuk partisipan 
Judul penelitian:  Perilaku pencarian pengobatan pada masyarakat Indonesia terkait 
dengan diabetes dan flu  
Ketua peneliti: Nama: Prof. Pauline Norris   
Departemen: Farmasi 
Kontak: 
+64 274 80 95 95 
 
Pendahuluan  
Terima kasih atas ketertarikan anda untuk terlibat dalam penelitian ini. Mohon bacalah lembar informasi 
ini dengan seksama. Luangkan waktu untuk berpikir, dan jika anda inginkan, bicaralah dengan teman 
atau saudara, sebelum memutuskan bersedia atau tidak untuk berpartisipasi dalam penelitian ini. 
Jika anda memutuskan untuk berpartisipasi, kami sangat berterima kasih. Jika anda memutuskan untuk 
tidak berpartisipasi, tidak akan ada konsekuensi apapun, dan kami juga berterima kasih anda telah 
mempertimbangkan permohonan kami.  
 
Apakah tujuan dari penelitian ini? 
Penelitian ini bertujuan untuk memahami persepsi, kepercayaan, pengalaman dan pendapat masyarakat 
mengenai diabetes dan flu. Pemahaman ini sangat penting dalam membantu pemerintah untuk membuat 
program diabetes dan flu yang dapat diterima dengan baik, dan terjangkau oleh masyarakat. Hal tersebut 
juga membantu pemerintah untuk meningkatkan kualitas pelayanan kesehatan.  
 
Siapakah yang membiayai penelitian ini? 
Penelitian ini dibiayai oleh Kementerian Perdagangan dan Urusan Luar Negeri New Zealand melalui 
beasiswa New Zealand ASEAN dan Universitas Otago, New Zealand. 
 
Siapa sajakah yang kami cari untuk berpartisipasi dalam penelitian ini? 
Masyarakat dewasa, berusia paling rendah 30 tahun, baik laki-laki maupun perempuan. Calon partisipan 
dipilih dari data pasien di rumah sakit atau puskesmas. Kriteria seleksi untuk calon partisipan adalah: 
telah didiagnosa diabetes selama minimal 1 tahun, tidak memiliki latar belakang pendidikan bidang 
kesehatan, tidak bekerja di tempat pelayanan kesehatan, dan bersedia untuk berpartisipasi dan membagi 
pengalamannya dalam mengatasi diabetes dan flu. Penelitian ini akan melibatkan kurang lebih 60 
partisipan dari lokasi penelitian yang berbeda-beda dengan 4 – 10 partisipan dalam setiap kali diskusi. 
 
Jika anda berpartisipasi, apa yang anda akan lakukan? 
Jika anda setuju untuk berpartisipasi, anda akan diminta untuk menjawab pertanyaan dalam diskusi 
kelompok. Tidak ada kategori jawaban benar atau salah, dan kami tidak akan mengevaluasi jawaban 
anda dengan benar atau salah. Kami akan meminta anda untuk menjawab berdasarkan pendapat pribadi 
anda. Semua jawaban anda adalah sangat berharga bagi kami. Kami akan sangat menghormati semua 
informasi yang anda sampaikan. Diskusi akan berlangsung selama 1 – 2 jam. Anda dapat juga 
memutuskan untuk meninggalkan diskusi di setiap saat jika anda inginkan tanpa adanya resiko apapun 
terhadap diri anda. 
 
Apakah ada resiko ketidaknyamanan atau bahaya dari keterlibatan dalam penelitian? 
Semua informasi yang anda sampaikan hanya akan kami gunakan untuk kepentingan akademik. Tidak 
akan ada resiko, bahaya fisik atau psikologis sebagai hasil dari keterlibatan anda dalam penelitian ini. 
Kami mangupayakan segala usaha yang akan menjaga identitas diri anda dengan aman. Kami juga 




oleh orang lain, tetapi dalam sebuah diskusi kami tidak bisa sepenuhnya menjamin bahwa partisipan lain 
pasti akan menjaga kerahasiaan informasi yang akan anda sampaikan. Jika anda tidak ingin menjawab 
sebuah atau beberapa pertanyaan, atau anda merasa jawaban anda adalah rahasia untuk partisipan lain 
dalam diskusi, anda dapat menolak untuk menjawabnya atau dapat juga menjawabnya secara tertulis.  
 
Data atau informasi apa yang diinginkan dan bagaimana data atau informasi tersebut akan 
digunakan? 
Kami akan bertanya kepada anda mengenai pengalaman, pendapat dan persepsi anda mengenai diabetes 
dan flu. Kami juga akan bertanya mengenai bagaimana anda memutuskan untuk mencari pengobatan 
untuk mengatasi diabetes dan flu. Kami juga akan mengumpulkan data nama, jenis kelamin, usia, 
pekerjaan dan alamat anda. 
Jika anda setuju, kami akan merekam percakapan dalam diskusi untuk menghindari adanya kehilangan 
informasi berharga yang anda sampaikan. Rekaman ini selanjutnya akan kami salin dalam bentuk tertulis 
sebagai transkrip. Transkrip ini akan kami simpan selama paling tidak 5 tahun di tempat penyimpanan 
yang aman. Namun, nama anda tidak akan kami simpan. Semua informasi identitas diri akan kami hapus 
setelah penelitian ini selesai meskipun data lain hasil penelitian akan kami simpan untuk jangka waktu 
yang lebih lama.  
Selanjutnya, kami akan menganalisis transkrip ini dan memasukkannya dalam laporan akhir hasil 
penelitian.  Informasi yang anda sampaikan mungkin muncul dalam hasil laporan penelitian tersebut, 
tetapi nama anda tidak akan pernah disebutkan dimanapun di dalam laporan hasil penelitian. Segala 
usaha akan kami lakukan untuk menjaga kerahasiaan identitas anda. 
Hasil penelitian ini akan kami publikasikan secara luas, namun segala upaya akan kami lakukan untuk 
menjaga kerahasiaan identitas diri anda. Jika anda berkeinginan, anda dapat juga meminta fotokopi dari 
laporan akhir penelitian.  
 
Bagaimana dengan kerahasiaan nama dan informasi? 
Transkrip salinan rekaman akan diterjemahkan ke dalam Bahasa Inggris dengan bantuan asisten peneliti. 
Hasil rekaman dan salinan transkrip ini akan kami simpan di tempat yang aman sehingga hanya peneliti, 
pembimbing peneliti dan asisten peneliti yang dapat mengaksesnya. Asisten peneliti hanya dapat 
mengakses data sampai proses penerjemahan selesai. 
Identitas diri anda tidak akan teridentifikasi dimanapun dalam laporan atau publikasi hasil penelitian. 
Segala upaya akan kami lakukan untuk menjaga keamanan informasi dan data identitas pribadi anda. 
 
Jika anda setuju untuk berpartisipasi, dapatkah anda berhenti untuk berpartisipasi di setiap saat? 
Anda dapat memutuskan untuk mengundurkan diri dari berpartisipasi kapanpun, dan tanpa konsekuensi 
atau resiko apapun terhadap diri anda. 
 
Ada pertanyaan? 
Jika anda mempunyai pertanyaan saat ini atau di kemudian hari, anda dapat mengontak peneliti: 
 
Nama : Anna Wahyuni Widayanti 
Jabatan dalam penelitian : Mahasiswa peneliti 





Penelitian ini telah disetujui oleh komite etik Universitas Otago. Jika anda mempunyai pertanyaan atau 
keluhan yang berkaitan dengan etik penelitian, anda dapat menghubungi komite melalui bagian 
administrasi komite etik, Universitas Otago, dengan nomor telepon +64 34798256 atau melalui email ke 
alamat: gary.witte@otago.ac.nz. Semua permasalahan yang anda kemukakan akan diperlakukan dan 






Appendix 3.5: Consent form for participants involved in the qualitative study about 
child immunisation in English 
 
Immunisation Behaviour of Indonesian Communities 
 
Principal Investigator: Prof. Pauline Norris (pauline.norris@otago.ac.nz, +64274809595) 
 
CONSENT FORM FOR PARTICIPANTS 
 
Following signature and return to the research team this form will be stored in a secure place for ten 
years. 
Name of participant:………………………………………….. 
1. I have read the Information Sheet concerning this study and understand the aims of this research 
project. 
2. I have had sufficient time to talk with other people of my choice about participating in the study.   
3. I confirm that I meet the criteria for participation which are explained in the Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, and I understand that I 
am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am free to withdraw from 
the project at any time without disadvantage. 
6. I know that as a participant I will involve in a group discussion.  
7. I know that the discussion will explore the perspective, beliefs, experiences and opinions about 
immunisation and how the people decide whether or not to immunising the children and that if the 
line of questioning develops in such a way that I feel hesitant or uncomfortable I may decline to 
answer any particular question(s), and /or may withdraw from the project without disadvantage of 
any kind. 
8. I understand the nature and size of the risks of discomfort or harm which are explained in the 
Information Sheet. 
9. I know that when the project is completed all personal identifying information will be removed 
from the paper records and electronic files which represent the data from the project, and that these 
will be placed in secure storage and kept for at least ten years.  
10. I understand that the results of the project may be published and be available in the University of 
Otago Library, but that I agree that any personal identifying information will remain confidential 
between myself and the researchers during the study, and will not appear in any spoken or written 
report of the study. 
11. I know that there is no remuneration offered for this study, and that no commercial use will be made 
of the data.  
1)  










Appendix 3.6: Consent forms for participants involved the qualitative study about 
child immunisation in Indonesian 
 
Perilaku terhadap imunisasi pada masyarakat di Indonesia 
 
Ketua peneliti: Professor Pauline Norris (pauline.norris@otago.ac.nz, +64274809595) 
 
Lembar persetujuan untuk partisipan 
 
Mohon untuk ditandatangani dan dikembalikan kepada tim peneliti. Lembar ini akan disimpan 
dengan aman, dalam kurun waktu sepuluh tahun. 
Nama partisipan: …………………………………………….. 
1. Saya telah membaca Lembar Informasi yang berkaitan dengan penelitian ini dan memahami tujuan 
dari penelitian ini. 
2. Saya telah diberi cukup waktu untuk mempertimbangkan dan berbicara dengan orang lain terkait 
keputusan saya untuk terlibat dalam penelitian ini. 
3. Saya menyatakan bahwa saya memenuhi kriteria sebagai partisipan yang telah dijelaskan dalam 
Lembar Informasi. 
4. Semua pertanyaan saya terkait penelitian telah dijawab dengan memuaskan, dan saya memahami 
bahwa saya berhak untuk meminta informasi lebih lanjut kapanpun.  
5. Saya mengerti bahwa partisipasi saya dalam penelitian sepenuhnya adalah sukarela, dan saya bebas 
untuk mengundurkan diri dari berpartisipasi dalam penelitian ini kapanpun tanpa adanya resiko 
apapun. 
6. Saya memahami bahwa sebagai partisipan, saya akan terlibat dalam sebuah diskusi kelompok.  
7. Saya mengetahui bahwa dalam diskusi kelompok tersebut, saya akan diberi pertanyaan mengenai 
persepsi, kepercayaan, pengalaman dan pendapat saya terkait imunisasi untuk anak saya, dan 
bagaimana saya memutuskan mengimunisasi anak saya atau tidak. Saya juga memahami bahwa jika 
pertanyaan dapat berkembang ke arah yang membuat saya enggan atau tidak nyaman untuk 
menjawab, saya dapat menolak untuk menjawab pertanyaan tertentu tersebut, dan/atau dapat juga 
mengundurkan diri dari berpartisipasi dalam penelitian tanpa adanya resiko apapun.  
8. Saya memahami tentang kemungkinan resiko atau ketidaknyamanan yang telah dijelaskan dalam 
Lembar Informasi. 
9. Saya mengetahui bahwa ketika penelitian telah selesai, semua data identitas diri saya akan dihapus 
dari transkrip atau salinan rekaman dan juga dari data elektronik. Saya juga mengetahui bahwa data 
lain akan disimpan di tempat yang aman selama paling tidak sepuluh tahun. 
10. Saya memahami bahwa hasil penelitian ini dapat dipublikasikan dan juga tersedia di perpustakaan 
Universitas Otago, tapi saya menyetujui bahwa semua informasi terkait data identitas diri saya akan 
tetap dirahasiakan dan tidak akan muncul dalam laporan penelitian baik secara lisan ataupun 
tertulis.  
11. Saya mengetahui bahwa tidak akan ada imbalan dalam bentuk uang yang diberikan kepada saya 
atas keterlibatan saya dalam penelitian, dan saya juga mengetahui bahwa data penelitian juga tidak 
akan digunakan untuk kepentingan komersial. 
2)  
3)  









Appendix 3.7: Consent form for participants involved the qualitative study about 
diabetes in English 
 
 
Health-seeking behaviour of Indonesian communities for diabetes and common cold 
 
Principal Investigator: Professor Pauline Norris (pauline.norris@otago.ac.nz, +64 274 80 95 95) 
 
CONSENT FORM FOR PARTICIPANTS 
 
Following signature and return to the research team this form will be stored in a secure place for ten 
years. 
Name of participant:………………………………………….. 
1. I have read the Information Sheet concerning this study and understand the aims of this research 
project. 
2. I have had sufficient time to talk with other people of my choice about participating in the study.   
3. I confirm that I meet the criteria for participation which are explained in the Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, and I understand that I 
am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am free to withdraw from 
the project at any time without disadvantage. 
6. I know that as a participant I will involve in a group discussion.  
7. I know that the discussion will explore the perspective, beliefs, experiences and opinions about 
diabetes and the common cold and how the people decide to choose any mode of treatment and that 
if the line of questioning develops in such a way that I feel hesitant or uncomfortable I may decline 
to answer any particular question(s), and /or may withdraw from the project without disadvantage 
of any kind. 
8. I understand the nature and size of the risks of discomfort or harm which are explained in the 
Information Sheet. 
9. I know that when the project is completed all personal identifying information will be removed 
from the paper records and electronic files which represent the data from the project, and that these 
will be placed in secure storage and kept for at least ten years.  
10. I understand that the results of the project may be published and be available in the University of 
Otago Library, but that I agree that any personal identifying information will remain confidential 
between myself and the researchers during the study, and will not appear in any spoken or written 
report of the study. 
11. I know that there is no remuneration offered for this study, and that no commercial use will be made 
of the data.  
4)  











Appendix 3.8: Consent form for participants involved in the qualitative study about 
diabetes in Indonesian 
 
Perilaku pencarian pengobatan pada masyarakat Indonesia terkait 
dengan diabetes dan flu 
 
Ketua peneliti: Professor Pauline Norris (pauline.norris@otago.ac.nz, +64 274 80 95 95) 
 
Lembar persetujuan untuk partisipan 
 
Mohon untuk ditandatangani dan dikembalikan kepada tim peneliti. Lembar ini akan disimpan 
dengan aman, dalam kurun waktu sepuluh tahun. 
 
Nama partisipan: …………………………………………….. 
1. Saya telah membaca Lembar Informasi yang berkaitan dengan penelitian ini dan memahami tujuan 
dari penelitian ini. 
2. Saya telah diberi cukup waktu untuk mempertimbangkan dan berbicara dengan orang lain terkait 
keputusan saya untuk terlibat dalam penelitian ini. 
3. Saya menyatakan bahwa saya memenuhi kriteria sebagai partisipan yang telah dijelaskan dalam 
Lembar Informasi. 
4. Semua pertanyaan saya terkait penelitian telah dijawab dengan memuaskan, dan saya memahami 
bahwa saya berhak untuk meminta informasi lebih lanjut kapanpun.  
5. Saya mengerti bahwa partisipasi saya dalam penelitian sepenuhnya adalah sukarela, dan saya bebas 
untuk mengundurkan diri dari berpartisipasi dalam penelitian ini kapanpun tanpa adanya resiko 
apapun. 
6. Saya memahami bahwa sebagai partisipan, saya akan terlibat dalam sebuah diskusi kelompok.  
7. Saya mengetahui bahwa dalam diskusi kelompok tersebut, saya akan diberi pertanyaan mengenai 
persepsi, kepercayaan, pengalaman dan pendapat saya terkait dengan diabetes dan flu, dan 
bagaimana saya memutuskan untuk mencari pengobatan untuk diabetes dan flu. Saya juga 
memahami bahwa jika pertanyaan dapat berkembang ke arah yang membuat saya enggan atau tidak 
nyaman untuk menjawab, saya dapat menolak untuk menjawab pertanyaan tersebut, dan/atau dapat 
juga mengundurkan diri dari berpartisipasi dalam penelitian tanpa adanya resiko apapun.  
8. Saya memahami tentang kemungkinan resiko atau ketidaknyamanan yang telah dijelaskan dalam 
Lembar Informasi. 
9. Saya mengetahui bahwa ketika penelitian telah selesai, semua data identitas diri saya akan dihapus 
dari transkrip atau salinan rekaman dan juga dari data elektronik. Saya juga mengetahui bahwa data 
lain akan disimpan di tempat yang aman selama paling tidak sepuluh tahun. 
10. Saya memahami bahwa hasil penelitian ini dapat dipublikasikan dan juga tersedia di perpustakaan 
Universitas Otago, tapi saya menyetujui bahwa semua informasi terkait data identitas diri saya akan 
tetap dirahasiakan dan tidak akan muncul dalam laporan penelitian baik secara lisan ataupun 
tertulis.  
11. Saya mengetahui bahwa tidak akan ada imbalan dalam bentuk uang yang diberikan kepada saya 
atas keterlibatan saya dalam penelitian, dan saya juga mengetahui bahwa data penelitian juga tidak 
akan digunakan untuk kepentingan komersial. 
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Appendix 5 – Participant information sheet and consent form for the 
intervention study 
Appendix 5.1: Participant information sheet for the intervention study in English 
Participant Information Sheet 
Study title: Community-based intervention for type 2 diabetes patients in 
East Nusa Tenggara, Indonesia 
Principal investigator: Name : Pauline Norris 
Department : Pharmacy 
Position : Professor 
Contact phone number: 
+64 274 80 95 95 
 
Introduction 
Thank you for showing an interest in this project.  Please read this information sheet carefully. Take time 
to consider and, if you wish, talk with relatives or friends, before deciding whether or not to participate.  
If you decide to participate we thank you.  If you decide not to take part there will be no disadvantage to 
you and we thank you for considering our request.   
What is the aim of this research project? 
This study aims to compare the effectiveness of two diabetes intervention: an intensive community-based 
care and standard care.  This is crucial in order to establish the best strategy for managing diabetes, and 
improve patients’ outcome in diabetes management.  
 
Who is funding this project? 
This study is funded by New Zealand Ministry of Foreign Affairs and Trade through New Zealand ASEAN 
Scholarship and the University of Otago, New Zealand. 
 
Who are we seeking to participate in the project? 
Adults aged 20 – 65 years old, both males and females. The selection criteria are: 1) diagnosed with type 
2 diabetes mellitus, 2) on diabetes medication, 3) able to understand and comprehend information, 4) 
without major organ complication of diabetes, 5) not pregnant, and 6) willing to participate in the study. 
This research will involve about 66 participants in total selected from 2 sub-districts in Kupang 
municipality.  
 
If you participate, what will you be asked to do? 
Should you agree to participate, you will be in one of the two groups of participants: 1) participants who 
will be involved in an intensive community-based diabetes intervention, and 2) participants who will 
receive standard care. You may not choose to be in either first or second groups as it has been designed 
based on your home location.  
Duration of your participation is 4 months. Before and after the study is started, you will be asked to 
complete a questionnaire with the help of a researcher. Your sugar level control, blood pressure, weight, 
and waist circumference will also be measured. A whole blood sample, and fingertip blood samples will 
be taken for measuring your sugar levels control. These measurements will show how your diabetes is 
progressing.  
Then, if you are in the first group, you will be asked to arrange a small group consisting of 8 – 10 
participants with a group leader. You will be asked to attend regular group session once a week for 4 
months. The group session will be held in a place that is arranged by group members. Activities in each 
group session will include outcomes measurement (fasting blood glucose, blood pressure and weight), 
giving encouragement and motivation, sharing experiences, giving education, goal setting, physical 
activity and healthy diet.  
If you are in the second group, you will be asked to visit your health providers regularly for monitoring 
your condition. After completing the study, you will be given NZD 10, as reimbursement of expenses for 




Is there any risk of discomfort or harm from participation? 
There will be no significant risk as a result of participating in this study. In completing questionnaire, 
you may complete by yourself or ask research staff to read the questions for you. The questionnaire is not 
a test for your level of knowledge as individual, but will be evaluated to understand the common 
knowledge about diabetes in your community. It will be evaluate as group, not individually. If you feel 
hesitant or uncomfortable, you may decline to answer any particular question(s), and /or may withdraw 
from the project without disadvantage of any kind.  
The risks associated with blood sample taking will be minimal, as we will ensure that safety procedure in 
taking and handling blood sample will be strictly followed. If you feel uncomfortable, you may refuse to 
have your blood sample taken, and may withdraw from participation at any time without any 
disadvantages.  
If you decided to withdraw you will still have a standard medical care from your usual health providers.  
What specimens, data or information will be collected, and how will they be used?  
We will collect your personal information such as name, gender, age, job and address, and also 
information related to diabetes from your medical records. We will also ask you questions about your 
understanding of diabetes, medication, and what you usually do to treat your diabetes. Apart from that, 
we will also collect your sugar levels control, blood pressure, weight, and waist circumference. For 
measuring your sugar levels control, we will take your blood sample from your fingertips and from your 
arms.  
All data generated from the study will only be used for academic purposes. Health information generated 
from this study will be retained for at least 5 years in secure storage. Your name will not be stored. Any 
personal information may be destroyed at the completion of the research even though the raw data 
derived from the research will, in most cases, be kept for much longer or possibly indefinitely. 
The results of the project may be published but every attempt will be made to preserve your anonymity. 
If you wish, you can request to the results. 
What about anonymity and confidentiality? 
The data collected in this study will be securely stored in such a way that only I, my supervisors and 
research team will be able to access it.   
You will not be identified by name anywhere in the research reports or published information. Every effort 
will be made to make secure any personal information. 
 
If you agree to participate, can you withdraw later? 
You may withdraw from participation in the project at any time and without any disadvantage to yourself.  
 
Any questions? 
If you have any questions now or in the future, please feel free to contact: 
Name : Anna Wahyuni Widayanti 
Position : Student investigator 
Department : Pharmacy 




This study has been approved by the University of Otago Human Ethics Committee (Health). If you have 
any concerns about the ethical conduct of the research you may contact the Committee through the 
Human Ethics Committee Administrator (phone +64 3 479 8256 or email gary.witte@otago.ac.nz). Any 




Appendix 5.2: Participant information sheet for the intervention study in Indonesian 
Lembar informasi untuk partisipan 
Judul penelitian Intervensi berbasis komunitas untuk pasien diabetes mellitus 
tipe 2 di Nusa Tenggara Timur, Indonesia 
Peneliti utama Nama : Pauline Norris 
Departemen : Farmasi 
Jabatan : Profesor 
Nomor telepon:  
+64 274 80 95 95 
 
Pendahuluan 
Terima kasih atas ketertarikan anda terhadap penelitian ini. Mohon bacalah lembar informasi ini dengan 
seksama. Luangkan waktu untuk berpikir, dan jika anda inginkan, bicaralah dengan teman atau saudara, 
sebelum memutuskan bersedia atau tidak untuk berpartisipasi dalam penelitian ini. 
Jika anda memutuskan untuk berpartisipasi, kami sangat berterima kasih. Jika anda memutuskan untuk 
tidak berpartisipasi, tidak akan ada konsekuensi apapun, dan kami juga berterima kasih anda telah 
mempertimbangkan permohonan kami.  
 
Apakah tujuan dari penelitian ini?  
This study aims to compare the effectiveness of two diabetes intervention: an intensive community-based 
care and standard care. This is crucial in order to establish the best strategy for managing diabetes, and 
improve patients’ outcome in diabetes management.  
Penelitian ini bertujuan untuk membandingkan efektifitas 2 macam pengelolaan untuk pasien diabetes: 
pengelolaan intensive berbasis komunitas dan pengelolaan standar untuk diabetes. Hal ini sangat penting 
untuk mencari strategi terbaik dalam pengelolaan pasien diabetes, dan meningkatkan keberhasilan terapi.  
Siapakah yang membiayai penelitian ini?  
Penelitian ini dibiayai oleh Kementerian Perdagangan dan Urusan Luar Negeri New Zealand melalui 
beasiswa New Zealand ASEAN dan Universitas Otago, New Zealand. 
 
Siapakah yang kami cari untuk berpartisipasi dalam penelitian ini?  
Masyarakat dewasa berusia antara 20 – 65 tahun, baik laki-laki maupun perempuan, dengan kriteria: 1) 
mempunyai penyakit gula atau diabetes melitus tipe 2, 2) menerima pengobatan untuk diabetes dari 
dokter, 3) mampu mengerti dan memahami informasi, 4) tidak mempunyai komplikasi berat dari 
diabetes, 5) tidak sedang mengandung, dan 6) bersedia untuk berpartisipasi. Penelitian ini akan 
melibatkan sekitar 66 partisipan yang berasal dati 2 kecamatan di wilayah kota Kupang, yaotu kecamatan 
Kelapa Lima dan Alak.  
 
Jika anda berpartisipasi, hal apa saja yang akan anda lakukan? 
Jika anda setuju untuk berpartisipasi, anda akan kami masukkan ke dalam satu dari 2 kelompok 
partisipan: 1) partisipan yang akan menerima pengelolaan diabetes berbasis komunitas, dan 2) partisipan 
yang akan menerima pengelolaan diabetes standar dari tempat pelayanan kesehatan. Anda mungkin tidak 
bias memilih untuk dimasukkan dalam kelompok yang mana karena hal tersebut sudah kami pilih 
berdasarkan lokasi tempat tinggal anda.  
Jangka waktu partisipasi anda dalam penelitian ini adalah 4 bulan. Sebelum dan setelah penelitian ini 
dimulai, anda kami mohon untuk melengkapi kuesinoner. Anda akan mendapatkan penjelasan dari tim 
peneliti mengenai kuesioner tersebut dan anda juga dapat meminta bantuan dari tim peneliti untuk 
membacakan pertanyaan pertanyaan dalam kuesioner terseut untuk anda. Kadar gula darah, tekanan 
darah, berat badan, dan lingkar pinggang anda juga akan kami ukur. Sample darah dari tangan dan juga 
ujung jari anda akan kami ambil untuk pengukuran kadar gula darah. Pengukuran ini penting untuk 
menunjukkan bagaimana kemajuan anda setelah mendapatkan satu diantara 2 macam pengelolaan 
diabetes.  
Lalu, jika anda dalam kelompok partisipan pertama, anda akan kami minta untuk membentuk grup kecil 
beranggotakan sekitar 8 – 10 partisipan per grup dengan satu orang ketua grup. Kemudian setiap grup 
kami minta untuk berkumpul secara rutin sekali seminggu selama 4 bulan. Mengenai tempat untuk 
berkumpul akan didiskusikan bersama anggota grup. Aktivitas dalam grup tersebut meliputi pengukuran 




kelompok, pemberian penjelasan mengenai diabetes, senam bersama, dan program makanan sehat untuk 
diabetes.  
Jika anda termasuk dalam kelompok partisipan yang kedua, anda akan kami mohon untuk datang secara 
rutin ke Puskesmas atau rumah sakit tempat anda memeriksakan kesehatan secara untuk memonitor 
perkembangan diabetes anda.  
Setelah menyelesaikan seluruh rangkaian keterlibatan dalam penelitian, anda akan menerima uang 
sejumlah Rp 100.000,00 sebagai ganti biaya transportasi.  
 
Apakah ada resiko atau bahaya dari keterlibatan anda dalam penelitian? 
Tidak aka nada resiko berat yang akan muncul sebagai akibat dari berpartisipasi dalam penelitian ini. 
Dalam mengisi kuesioner, anda dapat mengisi sendiri atau meminta bantuan kepada anggota peneliti 
untuk membacakan pertanyaan untuk anda. Pertanyaan pertanyaan dalam kuesioner bukan merupakan 
test untuk meilai tingkat pengetahuan anda secara individu, tetapi akan dievaluasi untuk memahami 
pengetahuan yang umumnya dipahami oleh masyarakat di sekitar anda. Sehingga evaluasi akan 
dilakukan secara kelompok, bukan individu. Jika anda merasa enggan atau merasa tidak nyaman, anda 
dapat menolak untuk menjawab pertanyaan tertentu, dan/atau anda dapat memutuskan untuk berhenti 
dari berpartisipasi dalam penelitian ini tanpa ada konsekuensi apapun. Resiko yang berkaitan dengan 
pengambilan sampe darah akan minimal, karena kami akan memastikan prosedur keamanan dalam 
pengambilan dan penanganan sampel darah akan dipatuhi secara ketat. Jika anda merasa tidak nyaman, 
anda dapat meolak untuk diambil sampel darahnya, dan/atau dapat memutuskan untuk berhenti dari 
berpartisipasi kapanpun tanpa ada konsekuensi apapun. Jika anda memutuskan untuk berhenti dari 
berpartisipasi, anda akan tetap mendapatkan pelayanan kesehatan untuk diabetes dari tempat pelayanan 
kesehatan yang biasanya anda kunjungi.  
 
Spesimen, data, atau informasi apa sajakah yang akan kami kumpulkan, dan bagaimana hal 
tersebut akan kami gunakan?  
Kami akan mengumpulkan data pribadi anda seperti nama, jenis kelamin, usia, pekerjaan, dan alamat 
rumah. Kami juga akan mengumpulkan informasi mengenai pengobatan diabetes yang pernah anda jalani 
dari rekam medis anda di Puskesmas atau Rumah Sakit. Kami juga akan bertanya kepada anda mengenai 
pemahaman anda tentang diabetes, pengobatan yang anda jalani, dana pa yang biasanya anda lakukan 
terkait diabetes anda. Selain itu, kami juga akan mengumpulkan data kadar gula darah, tekanan darah, 
berat badan dan lingkar pinggang anda. Untuk pengukuran gula darah, kami akan mengambil sampel 
darah dari tangan dan juga ujung jari anda.  
Semua data yang kami kumpulkan dalam penelitian ini hanya akan kami gunakan untuk kepentingan 
akademik. Data dan informasi ini akan kami simpan selamat paling tidak 5 tahun di tempat penyimpanan 
yang aman. Namun, data pribadi seperti nama anda tidak akan kami simpan. Semua informasi identitas 
diri akan kami hapus setelah penelitian ini selesai meskipun data lain hasil penelitian akan kami simpan 
untuk jangka waktu yang lebih lama.  
Hasil penelitian ini akan kami publikasikan secara luas, namun segala upaya akan kami lakukan untuk 
menjaga kerahasiaan identitas diri anda. Jika anda berkeinginan, anda dapat juga meminta fotokopi dari 
laporan akhir penelitian. 
Bagaimana dengan kerahasaiaan nama dan informasi?  
Semua data yang kami kumpulkan dalam penelitian ini akan kami simpan di tempat penyimpanan yang 
aman sehingga hanya saya, pembimbing, dan tim peneliti yang dapat mengaksesnya.  
Anda tidak akan teridentifikasi dimanapun dalam laporan atau publikasi hasil penelitian. Segala upaya 
akan kami lakukan untuk menjaga keamanan informasi dan data identitas pribadi anda. 
Jika anda setuju untuk berpartisipasi, dapatkah anda berhenti untuk berpartisipasi setiap saat?  
Anda dapat memutuskan untuk mengundurkan diri dari berpartisipasi kapanpun, dan tanpa konsekuensi 
atau resiko apapun terhadap diri anda. 
Ada pertanyaan?  
Jika anda mempunyai pertanyaan saat ini atau di kemudian hari, anda dapat mengontak peneliti: 
 
Nama : Anna Wahyuni Widayanti 
Jabatan dalam penelitian : Mahasiswa peneliti 
Departemen : Farmasi, Universitas Otago, New Zealand 
Nomor telepon: 
0 81328685900 
Penelitian ini telah disetujui oleh komite etik Universitas Otago. Jika anda mempunyai pertanyaan atau 
keluhan yang berkaitan dengan etik penelitian, anda dapat menghubungi komite melalui bagian 
administrasi komite etik, Universitas Otago, dengan nomor telepon +64 34798256 atau melalui email ke 
alamat: gary.witte@otago.ac.nz. Semua permasalahan yang anda kemukakan akan diperlakukan dan 




Appendix 5.3: Consent form for participants involved in the intervention study in 
English 
 
Community-based intervention for type 2 diabetes patients in East Nusa Tenggara, Indonesia 
Principal Investigator: Professor Pauline Norris 
(pauline.norris@otago.ac.nz phone +64 274 80 95 95) 
 
CONSENT FORM FOR PARTICIPANTS 
 
Following signature and return to the research team this form will be stored in a secure place for ten 
years. 
Name of participant:………………………………………….. 
 
1. I have read the Information Sheet concerning this study and understand the aims of this research 
project. 
2. I have had sufficient time to talk with other people of my choice about participating in the study.   
3. I confirm that I meet the criteria for participation which are explained in the Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, and I understand that I 
am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am free to withdraw from 
the project at any time without disadvantage. 
6. I know that as a participant I will receive either an intensive community-based diabetes care or 
standard care. I will also complete a questionnaire, and my sugar levels control, blood pressure, 
weight, and waist circumference will be measured. My blood sample will be taken for measuring 
sugar control levels.  
7. I know that the questionnaire will ask my understanding about diabetes, my medication and what I 
usually do for treating my diabetes. If the line of questioning develops in such a way that I feel 
hesitant or uncomfortable I may decline to answer any particular question(s), and /or may withdraw 
from the project without disadvantage of any kind. 
8. I understand the nature and size of the risks of discomfort or harm which are explained in the 
Information Sheet. 
9. I know that when the project is completed all personal identifying information will be removed 
from the paper records and electronic files which represent the data from the project, and that these 
will be placed in secure storage and kept for at least ten years.  
10. I understand that the results of the project may be published, and I agree that any personal 
identifying information will remain confidential between myself and the researchers during the 
study, and will not appear in any spoken or written report of the study  
11. I know that, after completing the study, I will receive NZD 10 as a reimbursement of expenses for 
participation such as travel cost. I also understand that no commercial use will be made of the data.  
5)  










Appendix 5.4: Consent form for participants involved in the intervention study in 
Indonesian 
 
Intervensi berbasis komunitas untuk pasien diabetes mellitus tipe 2 di Nusa Tenggara Timur, 
Indonesia 
Peneliti utama: Professor Pauline Norris 
(pauline.norris@otago.ac.nz, +64 274 80 95 95) 
 
Lembar persetujuan untuk partisipan 
Mohon untuk ditandatangani dan dikembalikan kepada tim peneliti. Lembar ini akan disimpan 
dengan aman, dalam kurun waktu sepuluh tahun. 
 
Nama partisipan: …………………………………………… 
1. Saya telah membaca Lembar Informasi yang berkaitan dengan penelitian ini dan memahami tujuan 
dari penelitian ini. 
2. Saya mempunyai cukup waktu untuk berbicara dengan orang lain terkait keputusan saya untuk 
terlibat dalam penelitian ini. 
3. Saya menyatakan bahwa saya memenuhi kriteria sebagai partisipan yang telah dijelaskan dalam 
Lembar Informasi. 
4. Semua pertanyaan saya terkait penelitian telah dijawab dengan memuaskan, dan saya memahami 
bahwa saya berhak untuk meminta informasi lebih lanjut kapanpun.  
5. Saya mengerti bahwa partisipasi saya dalam penelitian sepenuhnya adalah sukarela, dan saya bebas 
untuk mengundurkan diri dari berpartisipasi dalam penelitian ini kapanpun tanpa adanya resiko 
apapun. 
6. Saya memahami bahwa sebagai partisipan saya akan menerima satu diantara dua pengelolaan 
diabetes: pengelolaan diabetes berbasis komunitas atau pengelolaan diabetes standar dari tempat 
pelayanan kesehatan. Saya juga akan diminta untuk mengisi kuesioner. Kadar gula darah, tekanan 
darah, berat badan dan lingkar pinggang saya juga akan diukur. Untuk pengukuran kadar gula 
darah, sampel darah saya akan diambil.  
7. Saya memahami bahwa pertanyaaan pertanyaan dalam kuesioner adalah mengenai pemahaman saya 
terhadap diabetes, pengobatan yang saya lakukan, dana apa yang biasa saya lakukan terkait diabetes 
saya. Jika pertanyaan berkembang ke arah yang membuat saya enggan atau tidak nyaman untuk 
menjawab, saya dapat menolak untuk menjawab pertanyaan tersebut, dan/atau dapat juga 
mengundurkan diri dari berpartisipasi dalam penelitian tanpa adanya resiko apapun. 
8. Saya memahami tentang kemungkinan resiko atau ketidaknyamanan yang telah dijelaskan dalam 
Lembar Informasi. 
9. Saya mengetahui bahwa ketika penelitian telah selesai, semua data identitas diri saya akan dihapus 
dari transkrip atau salinan rekaman dan juga dari data elektronik. Saya juga mengetahui bahwa data 
lain akan disimpan di tempat yang aman selama paling tidak sepuluh tahun 
10. Saya memahami bahwa hasil penelitian ini dapat dipublikasikan, tapi saya menyetujui bahwa semua 
informasi terkait data identitas diri saya akan tetap dirahasiakan dan tidak akan muncul dalam 
laporan penelitian baik secara lisan ataupun tertulis. 
11. Saya mengetahui bahwa setelah menyelesaikan seluruh rangkaian keterlibatan dalam penelitian, 
saya akan menerima Rp 100.000,00 sebagai ganti biaya transportasi. saya juga mengetahui bahwa 
data penelitian juga tidak akan digunakan untuk kepentingan komersial. 
 








Appendix 6 – Education materials used in the intervention study 






Appendix 6.2: Apa arti hasil kadar gula darah anda? (What is the meaning of your 






Appendix 6.3: Tahukah anda obat diabetes atau hipertensi yang anda minum? (Do 



























Appendix 6.7: Komplikasi, apa dan bagaimana mencegahnya? (Diabetes 






































Appendix 7 – The questionnaire used in the intervention study 
 
Appendix 7.1: The questionnaire used in the intervention study in English 
QUESTIONNAIRES 
 
This questionnaire is strictly confidential. Please assist us by answering all questions. 
 
Your name    : ………………………………………………… 
Gender    : □ Male   □ Female 
What is your age?    …………………. Years 
What is your gender?   □ Male   □ Female 
 
How long have you had diabetes?……..years or ...…. Months or …….days 
Do you take medicines from doctors for your diabetes? □ Yes   □ No 
If yes, what type of your medicines from doctors?□ Tablets    and/or □ injection  
If you use injection, how many injections per day? 
□ 1 □ 2 □ 3 □ 4 □ other, please specify …………….. 
If you use tablets, how many different tablets? 
□ 1 □ 2 □ 3 □ other, please specify …………….. 
Do you also take herbals for your diabetes? □ Yes    □ No 
Have you ever attended specific diabetes programme? □ Yes   □ No 
Have you ever seen a dietitian?    □ Yes    □ No 
 
Income per month: 
□ < 500,000 
□ 500,000 – 1,499,999 
□ 1,500,000 – 2,499,999 
□ 2,500,000 – 4,999,999  
□ > 5,000,000 
 
Marital status 
□ Married   □ Not married   □ Widowed 
 
Highest education level 
□ Elementary school 
□ Junior high school 









The following questions ask about what you know about diabetes. I will read these 
statements, and please choose either true or false based on your opinion or 
understanding.  
Number Statement True False 
1. Diabetes is a condition that can be cured by adopting a healthy lifestyle   
2. Diabetes is a condition that can be cured with medicines   
3. Diabetes is a condition that currently not curable   
4. Diabetes is a disease that cannot be prevented   
5.  Diabetes is only suffered by people who have family history with it.   
6. Diabetes is only suffered by obese people   
7. Diabetes is a disease only suffered by older people   
8. If your blood sugar levels are normal or if you feel better, you can stop 
taking medicines from your doctor. 
  
9. Long-time use of medicines from the doctors may cause kidney 
damage 
  
10. Regular medical check-ups are necessary to assess whether to adjust 
diabetes medicines. 
  
11. People taking diabetes medicines from doctors do not need to worry 
about healthy eating 
  
12. If your diabetes is getting worse, you might get cancer   
13. If your diabetes is getting worse, you might get rheumatoid arthritis   
14. If your diabetes is getting worse, you might get lung problems   
15. If your diabetes is getting worse, you might get heart disease   
16. Feeling weakness is early symptom of diabetes   
17. Headache is early symptom of diabetes   
18. Feeling pain at the back of your neck is early symptom of diabetes   
19. Always feeling sleepy is early symptom of diabetes   
20. Avoid carbohydrates food is part of managing diabetes.   
21. Taking food supplement is part of managing diabetes.   
22. Stop smoking is part of managing diabetes.   
23. Having high blood pressure makes you more likely to get diabetes.   
24. Having contact with unhealed wound of diabetic patients makes you 
more likely to get diabetes. 
  
25. Sharing your food, eating equipment or clothing with diabetes patients 
makes you more likely to get diabetes. 
  
26. Unhealthy environment makes you more likely to get diabetes.   
27. People with diabetes must not eat anything sweet   
28. Potato is a vegetable, so it is carbohydrate free   
29. Taro, sweet potato, and corn cannot substitute white rice   
30. Diet recommendations for people with diabetes are the same as healthy 
diet recommended for general people. 
  
31. Skipping dinner is as part of healthy diet for people with diabetes   
32. Eat specific food product designed for diabetes is as part of healthy diet 
for people with diabetes 
  
33. Reduce the rice portion in every meal is as part of healthy diet for 
people with diabetes 
  
34. No meat diet is as part of healthy diet for people with diabetes   
35. Exercise for diabetes patients has to be done in a specific exercise class 
with an instructor 
  
36 Walking regularly is a form of exercise for diabetes patients   
37. Exercise for diabetes patients should be avoided in people with high 
blood sugar and hypertension 
  





The following questions ask about how you usually take your medicines from your 
doctor for diabetes. Please respond Yes or No to each statement. 
 
No. Statements Yes No 
1.  It has happened at least once that I forgot to take (one of) my 
medicines 
  
2. It happens occasionally that I take (one of) my medicines later than 
usual. 
  
3. I have never (temporarily) stopped taking (one of my) medicines.   
4. It has happened at least once that I did not take (one of) my medicines 
for a day 
  
5. I am positive that I have taken all the medication that I should have 
taken in the previous year. 
  
6. I take my medicines exactly at the same time every day.   
7. I have never change my medicine use myself.   
8. In the past month, I forgot to take my medicine at least once   
9. I faithfully follow my doctor’s prescription concerning the time I take 
my medicines 
  
10. I sometimes take (one of) my medicines at a different time than 
prescribed (e.g., with breakfast or in the evening) 
  
11. In the past, I once stopped taking (one of) my medicines completely.   
12. When I am away from home, I occasionally do not take (one of) my 
medicines. 
  
13. I sometimes take less medicines than prescribed by my doctor.   
14. It has happened (at least once) that I changed the dose of (one of) my 
medicines without discussing this with my doctor. 
  
15. It has happened (at least) once that I was too late with filling a 
prescription at the pharmacy. 
  
16. I take my medicines every day   
17. It has happened (at least once) that I did not start taking a medicine 
that was prescribed by my doctor. 
  
18. I sometimes take more medicines than prescribed by my doctor.   
 
The following questions ask about what you usually do for managing your diabetes 
1. How many days in the last week did you eat a meal where rice filled at least a 
quarter of your plate?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat a 
meal where rice filled at least a quarter of your plate? …………………. 
2. How many days in the last week did you eat a meal where vegetables and fruits 
filled at least half of your plate?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat a 
meal where green vegetables and fruits filled at least half of your plate? 
……………………. 
3. How many days in the last week did you eat a meal where protein-containing 
food filled at least as much as a quarter of your plate? 
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat a 
meal where protein-containing food filled at least as much as a quarter 




4. How many days in the last week did you have food in your plate like this 
picture? 
 
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you have 
food in your plate like the picture above? ……………………………… 
5. How many days in the last week did you substitute white rice with another type 
of carbohydrate? 
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you substitute 
white rice with another type of carbohydrate? ………………………….. 
6. How many days in the last week did you eat fried snacks?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat fried 
snacks? ……………….. 
7. How many days in the last week did you drink coffee or tea with sugar?  
0  1 2  3 4 5 6 7    
When you did that, on average, how many cups a day did you drink 
coffee or tea with sugar? …………… 
8. How many days in the last week did you eat cookies and sweet snacks?  
0 1 2  3 4 5 6 7 
When you did that, on average, how many times a day did you eat 
cookies and sweet snacks? …………….. 
9. How many days in the last week did you exercise on your own (including 
walking)? 
0 1 2  3 4 5 6 7 
When you did that, on average, how long did you exercise on your own 
per day? …….. 
10. How many days in the last week did you attend specific exercise programme 
such as “senam” or other group exercise?  
0 1 2  3 4 5 6 7 
11. How many days in the last week did you exercise (including walking) for about 
30 minutes a day?  





12. How many days in the last week did you take care of your feet, including 
washing, soaking and drying your feet? 
0 1 2  3 4 5 6 7 
 
13. How many times in the last month did you visit your health professional for 
checking your diabetes? ………… 
 
14. How many days in the last week did you smoke a cigarette – even one puff? 
0 1 2  3 4 5 6 7 
How many cigarettes did you smoke on an average day? 






Appendix 7.2: The questionnaire used in the intervention study in Indonesian 
KUESIONER 
Kuesioner ini bersifat sangat rahasia. Mohon bantuannya untuk menjawab semua 
pertanyaan, sepengetahuan bapak/ibu dan sesuai dengan kondisi bapak/ibu.  
 
Nama bapak/ibu  : …………………………………  
Jenis kelamin :      L / P 
Berapakah usia bapak/ibu? : ………………… tahun 
Berapa lama bapak/ibu mempunyai diabetes?...... tahun, ……..bulan, atau …….hari 
 
Apakah bapak/ibu menggunakan obat (dari dokter) untuk diabetes?  □ Ya   □ Tidak 
Jika iya, apakah jenis obat (dari dokter) yang bapak/ibu gunakan?  
□ Tablet/pil                     dan/atau                                       □ Suntik    
(bila menggunakan kedua jenis obat, mohon dicentang keduanya) 
Jika bapak/ibu menggunakan obat yang disuntik, berapa kali sehari bapak/ibu 
menggunakannya?  
□ 1  □ 2  □ 3  □ 4  □ lebih dari 4, mohon sebutkan………. 
Jika bapak/ibu menggunakan obat jenis tablet atau pil, berapa jenis tablet yang 
bapak/ibu gunakan  
□ 1 □ 2 □ 3 □ lebih dari 3, mohon sebutkan …………….. 
Apakah bapak/ibu menggunakan obat diabetes selain dari dokter, seperti misalnya obat 
tradisional atau ramuan herbal?  
□ Ya    □ Tidak 
Apakah bapak/ibu pernah menghadiri program khusus untuk diabetes?  
□ Ya    □ Tidak 
Pernahkah bapak/ibu berkonsultasi kepada ahli gizi? 
□ Ya    □ Tidak 
 
Pendapatan per bulan: 
□ < 500.000     □ 1.500.000 – 2.499.999 □ > 5.000.000 
□ 500.000 – 1.499.999   □ 2.500.000 – 4.999.999  
 
Status pernikahan: 
□ Menikah   □ Tidak/belum menikah   □ Janda/duda 
 
Tingkat pendidikan terakhir 
□ Tidak sekolah 
□ Sekolah Dasar 
□ Sekolah Menengah Pertama atau yang sederajat 
□ Sekolah Menengah Atas atau yang sederajat 





Bapak/ibu yang terhormat, 
Pernyatan pernyataan berikut adalah tentang apa yang bapak/ibu ketahui tentang 
diabetes. Mohon pilihlah benar atau salah dari setiap pernyataan yang saya bacakan 
berikut, menurut sepengetahuan bapak/ibu.  
No. Pernyataan Benar Salah 
1. Diabetes adalah suatu kondisi yang dapat disembuhkan dengan melakukan 
pola hidup sehat 
  
2. Diabetes adalah suatu kondisi yang dapat disembuhkan dengan obat   
3. Diabetes adalah suatu kondisi yang saat ini tidak dapat disembuhkan   
4. Diabetes adalah suatu kondisi yang tidak dapat dicegah   
5. Diabetes hanya dapat dialami oleh orang-orang yang mempunyai riwayat 
keluarga dengan diabetes 
  
6. Diabetes hanya dapat dialami oleh orang-orang yang gemuk   
7. Diabetes hanya dapat dialami oleh orang-orang yang sudah tua   
8. Jika kadar gula darah bapak/ibu sudah normal atau jika bapak/ibu sudah 
merasa membaik, bapak/ibu dapat berhenti menggunakan obat yang 
diberikan oleh dokter 
  
9. Penggunaan obat diabetes yang diberikan oleh dokter dalam jangka waktu 
lama dapat menyebabkan kerusakan ginjal 
  
10. Melakukan kontrol atau pengecekan rutin sangat penting untuk menilai 
perlu tidaknya perubahan obat diabetes yang digunakan 
  
11. Orang yang menggunakan obat diabetes tidak perlu melakukan pola makan 
sehat 
  
12. Jika diabetes bapak/ibu memburuk, bapak/ibu beresiko untuk mengalami 
komplikasi berupa penyakit kanker 
  
13. Jika diabetes bapak/ibu memburuk, bapak/ibu beresiko untuk mengalami 
komplikasi berupa penyakit rematik 
  
14. Jika diabetes bapak/ibu memburuk, bapak/ibu beresiko untuk mengalami 
komplikasi berupa penyakit paru paru 
  
15. Jika diabetes bapak/ibu memburuk, bapak/ibu beresiko untuk mengalami 
komplikasi berupa penyakit jantung 
  
16. Merasa lemah merupakan gejala awal dari diabetes   
17. Sakit kepala merupakan gejala awal dari diabetes   
18. Pegal pegal di tengkuk merupakan gejala awal dari diabetes   
19. Selalu merasa mengantuk merupakan gejala awal dari diabetes   
20. Menghindari makan nasi atau makanan yang mengandung karbohidrat 
merupakan bagian dari pengelolaan diabetes 
  
21. Mengkonsumsi suplemen makanan merupakan bagian dari pengelolaan 
diabetes 
  
22. Berhenti merokok merupakan bagian dari pengelolaan diabetes   
23. Mempunyai tekanan darah tinggi akan membuat seseorang lebih beresiko 
terkena diabetes 
  
24. Bersentuhan dengan luka yang belum sembuh dari penderita diabetes akan 
membuat seseorang lebih beresiko terkena diabetes 
  
25. Berbagi makanan, peralatan makan, atau pakaian dengan penderita diabetes 
akan membuat seseorang lebih beresiko terkena diabetes 
  
26. Lingkungan yang tidak sehat akan membuat seseorang lebih beresiko 
terkena diabetes 
  
27. Orang dengan diabetes tidak boleh memakan makanan manis   
28. Kentang termasuk sayur mayur, sehingga tidak mengandung karbohidrat   
29. Umbi umbian dan jagung tidak bisa menggantikan nasi putih   
30. Pola makan yang dianjurkan untuk orang dengan diabetes sama dengan 
pola makan sehat yang dianjurkan untuk orang-orang lain pada umumnya 
  






32. Makan produk khusus untuk penderita diabetes merupakan bagian dari pola 
makan sehat untuk orang dengan diabetes 
  
33. Mengurangi porsi nasi setiap kali makan merupakan bagian dari pola 
makan sehat untuk orang dengan diabetes 
  
34. Tidak makan daging merupakan bagian dari pola makan sehat untuk orang 
dengan diabetes 
  
35. Olahraga untuk pasien diabetes harus dilakukan secara khusus dengan 
seorang pelatih 
  
36. Jalan kaki secara teratur juga merupakan olahraga yang baik untuk pasien 
diabetes 
  
37. Olahraga tidak boleh dilakukan oleh orang dengan kadar gula dan tekanan 
darah tinggi 
  
38. Setelah berolahraga, orang dengan diabetes diperbolehkan makan lebih 
banyak untuk mengganti tenaga yang digunakan 
  
 
Pertanyaan berikut tentang bagaimana bapak/ibu biasanya meminum atau 
menyuntikkan obat diabetes dari dokter. Jawablah sesuai dengan kondisi bapak/ibu, ya 
atau tidak. 
 
No. Pernyataan Ya  Tidak 
1. Pernah terjadi setidaknya sekali, bapak/ibu lupa untuk meminum atau 
menyuntikkan (satu dari) obat. 
  
2. Kadang kadang bapak/ibu meminum atau menyuntikkan (satu dari) 
obat bapak/ibu lebih lambat dari jadwal biasanya. 
  
3. Bapak/ibu tidak pernah (untuk sementara) berhenti meminum atau 
menyuntikkan (satu dari) obat bapak/ibu. 
  
4. Pernah terjadi setidaknya sekali, bapak/ibu tidak meminum atau 
menyuntikkan (satu dari) obat bapak/ibu sehari penuh. 
  
5. Bapak/ibu yakin bahwa tahun lalu, bapak/ibu telah meminum atau 
menyuntikkan semua obat yang harus bapak/ibu gunakan. 
  
6.  Bapak/ibu selalu meminum atau menyuntikkan obat dalam waktu yang 
sama persis setiap harinya. 
  
7. Bapak/ibu tidak pernah mengubah aturan penggunaan obat atas 
keinginan sendiri. 
  
8. Dalam sebulan terakhir, bapak/ibu pernah lupa meminum atau 
menyuntikkan obat saya setidaknya satu kali. 
  
9. Bapak/ibu mengikuti aturan waktu meminum atau menyuntikkan obat 
dengan tepat sesuai anjuran dari dokter. 
  
10. Bapak/ibu kadang-kadang meminum atau menyuntikkan (satu dari) 
obat dalam waktu yang berbeda dengan yang diresepkan (misal: 
bersamaan dengan waktu sarapan atau pada sore hari). 
  
11. Di waktu lalu, bapak/ibu pernah berhenti sama sekali meminum atau 
menyuntikkan (satu dari) obat bapak/ibu. 
  
12. Ketika bapak/ibu tidak berada di rumah, bapak/ibu kadang-kadang 
tidak meminum atau menyuntikkan (satu dari) obat bapak/ibu. 
  
13. Bapak/ibu kadang-kadang mengurangi jumlah obat yang bapak/ibu 
minum atau bapak/ibu suntikkan dari yang diresepkan oleh dokter. 
  
14. Pernah terjadi (setidaknya sekali), bapak/ibu mengubah dosis (satu 
dari) obat bapak/ibu tanpa mendiskusikannya dengan dokter. 
  
15. Pernah terjadi (setidaknya) sekali, bapak/ibu sangat terlambat 
mengambil/menebus obat di apotek. 
  
16. Bapak/ibu meminum/menyuntikkan obat setiap hari   
17. Pernah terjadi (setidaknya sekali), bapak/ibu tidak memulai meminum 
atau menyuntikkan obat yang sudah diresepkan oleh dokter. 
  
18. Bapak/ibu kadang kadang meminum atau menyuntikkan obat dengan 






Pertanyaan berikut menanyakan tentang hal yang biasa bapak/ibu lakukan untuk 
pengelolaan diabetes bapak/ibu: 
 
1. Dalam seminggu terakhir, berapa hari bapak/ibu makan dengan porsi nasi sekitar 
seperempat dari isi piring?      
0   1  2   3  4 5 6 7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata berapa kali sehari 
bapak/ibu makan dengan porsi nasi seperempat dari isi piring? ………………. 
 
2. Dalam seminggu terakhir, berapa hari bapak/ibu makan dengan porsi sayuran dan 
buah sekitar setengah dari isi piring?        
0 1   2    3   4   5   6    7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa kali sehari 
bapak/ibu makan dengan porsi sayuran dan buah setengah dari isi piring? ............. 
 
3. Dalam seminggu terakhir, berapa hari bapak/ibu makan dengan porsi lauk sekitar 
seperempat dari isi piring?     
0    1    2     3    4    5    6     7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa kali sehari 
bapak/ibu makan dengan porsi lauk sekitar seperempat dari isi piring? ............. 
 
4. Dalam seminggu terakhir, berapa hari bapak/ibu makan dengan isi piring seperti 
terlihat dalam gambar ini?       
 
0 1 2 3 4 5 6 7 
 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa kali sehari 
bapak/ibu makan dengan isi piring seperti terlihat dalam gambar seperti diatas? ....... 
 
5. Dalam seminggu terakhir, berapa hari bapak/ibu mengganti nasi dengan sumber 
karbohidrat lain seperti jagung atau umbi-umbian?  
0 1 2  3 4 5 6 7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa kali sehari 
bapak/ibu makan sumber karbohidrat lain seperti jagung, atau umbi umbian sebagai 







6. Dalam seminggu terakhir, ada berapa hari bapak/ibu makan gorengan?  
0 1 2  3 4 5 6 7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa kali sehari 
bapak/ibu makan gorengan? …………. 
 
7. Dalam seminggu terakhir, ada berapa hari bapak/ibu minum kopi manis atau teh 
manis?  
0 1 2  3 4 5 6 7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa gelas bapak/ibu 
minum kopi manis atau teh manis dalam sehari? ……….. 
 
8. Dalam seminggu terakhir, ada berapa hari bapak/ibu makan kue-kue atau makanan 
kecil yang manis?   
0 1 2  3 4 5 6 7 
Pada hari bapak/ibu melakukan hal tersebut diatas, rata-rata, berapa kali sehari 
bapak/ibu makan kue kue atau makanan kecil yang manis? ……… 
 
9. Dalam seminggu terakhir, ada berapa hari bapak/ibu berolahraga mandiri (termasuk 
berjalan kaki)? 
0 1 2  3 4 5 6 7 
Ketika bapak/ibu melakukannya, rata-rata, berapa lama bapak/ibu berolahraga 
sendiri tiap harinya? ……… 
 
10. Dalam seminggu terakhir, ada berapa hari bapak/ibu datang ke acara olahraga 
seperti senam bersama, atau olahraga dalam kelompok lainnya?  
0 1 2  3 4 5 6 7 
11. Dalam seminggu terakhir, ada berapa hari bapak/ibu berolahraga (termasuk 
berjalan) selama sekitar 30 menit per hari atau lebih? 
0 1 2  3 4 5 6 7 
 
12. Dalam seminggu terakhir, ada berapa hari bapak/ibu merawat kaki bapak/ibu, 
termasuk mencuci, merendam, dan mengeringkan kaki bapak/ibu?  
0 1 2  3 4 5 6 7 
13. Dalam sebulan terakhir, berapa kali bapak/ibu datang ke dokter untuk mengecek 
kondisi diabetes bapak/ibu? ........... 
 
14. Apakah bapak/ibu merokok? Ya   Tidak 
Jika iya, dalam seminggu terakhir, ada berapa hari bapak/ibu merokok – 
meskipun hanya sekali hisap? 
0 1 2  3 4 5 6 7 









Appendix 8 – Rasch analysis output  
Rasch analysis was performed using the eRM package19 in R. For survey-type scales, Mean Square values between 0.6 and 1.4 are 
considered reasonable. Infit mean squares for our translated Indonesian ProMAS ranged from 0.729 to 1.285, while outfit mean squares 
ranged from 0.508 to 2.185. Lower values suggest some degree of redundancy, so overall, the model fit well, with some evidence for 
redundant items. Item fit, Indonesian language version and English translation of the items are presented in Table A.1 and Table A2. 
Table A8.1. ProMAS item fit information and Indonesian translation (baseline data) 













Pernah terjadi setidaknya sekali, saya 
lupa untuk meminum (satu dari) obat 
saya (R).  
It has happened at least once 
that I forgot to take (one of) 
my medicines (R). 
1.845838 2.03 44.11 53 0.803 0.817 0.942 -0.46 -0.25 
Kadang kadang saya meminum (satu 
dari) obat saya lebih lambat dari 
jadwal biasanya (R). 
It happens occasionally that I 
take (one of) my medicines at 
a later moment than usual (R) 
1.201612 1.93 59.038 53 0.264 1.093 1.015 0.47 0.16 
Saya tidak pernah (untuk sementara) 
berhenti meminum (satu dari) obat 
saya.  
I have never (temporarily) 
stopped taking (one of my) 
medicines 
0.48649 1.56 67.596 53 0.086 1.252 1.208 1.51 1.78 
Pernah terjadi setidaknya sekali, saya 
tidak meminum (satu dari) obat saya 
sehari penuh (R). 
It has happened at least once 
that I did not take (one of) my 
medicines for a day. (R) 
1.201612 1.23 46.496 53 0.724 0.861 0.909 -0.56 -0.66 
Saya yakin bahwa tahun lalu, saya 
telah meminum semua obat yang 
harus saya minum.  
I am positive that I have taken 
all the medication that I 
should have taken in the 
previous year. 








Saya selalu meminum obat dalam 
waktu yang sama persis setiap 
harinya.  
I take my medicines exactly at 
the same time every day 
0.400917 0.86 57.49 53 0.313 1.065 1.02 0.45 0.21 
Saya tidak pernah mengubah aturan 
penggunaan obat atas keinginan 
sendiri. 
I have never change my 
medicine use myself 
-0.11815 0.86 74.604 53 0.027 1.382 1.285 2.05 2.18 
Dalam sebulan terakhir, saya pernah 
lupa meminum obat saya setidaknya 
satu kali (R).  
 
In the past month, I forgot to 
take my medicine at least 
once. (R) 
0.923251 0.39 40.263 53 0.901 0.746 0.831 -1.38 -1.43 
Saya mengikuti aturan waktu 
meminum obat dengan tepat sesuai 
anjuran dari dokter.  
I faithfully follow my doctor’s 
prescription concerning the 
time I take my medicines 
-2.2403 0.29 41.242 53 0.88 0.764 0.846 -0.24 -0.39 
Saya kadang kadang meminum (satu 
dari) obat dalam waktu yang berbeda 
dengan yang diresepkan (misalnya 
bersamaan dengan waktu sarapan 
atau pada sore hari) (R).  
 
I sometimes take (one of) my 
medicines at a different time 
than prescribed (e.g., with 
breakfast or in the evening). 
(R) 
1.106758 -0.05 47.627 53 0.683 0.882 0.983 -0.5 -0.09 
Di waktu lalu, saya pernah berhenti 
sama sekali meminum (satu dari) obat 
saya (R).  
In the past, I once stopped 
taking (one of) my medicines 
completely. (R) 
-0.11815 -0.35 56.06 53 0.361 1.038 1.048 0.28 0.43 
Ketika saya tidak berada di rumah, 
saya kadang kadang tidak meminum 
(satu dari) obat saya (R).  
When I am away from home, I 
occasionally do not take (one 
of) my medicines. (R) 
 
0.658729 -0.37 37.221 53 0.951 0.689 0.768 -2 -2.17 
Saya kadang kadang mengurangi 
jumlah obat yang saya minum dari 
yang diresepkan oleh dokter (R).  
I sometimes take less 
medicines than prescribed by 
my doctor. (R) 
-0.89379 -0.98 43.452 53 0.822 0.805 0.888 -0.69 -0.65 
Pernah terjadi (setidaknya sekali) 
saya mengubah dosis (satu dari) obat 
saya tanpa mendiskusikannya dengan 
dokter (R).  
It has happened (at least 
once) that I changed the dose 
of (one of) my medicines 
without discussing this with 
my doctor. (R) 








Pernah terjadi (setidaknya) sekali, 
saya sangat terlambat mengambil atau 
menebus obat di apotek (R).  
It has happened (at least) 
once that I was too late with 
filling a prescription at the 
pharmacy. (R) 
0.48649 -1.31 45.791 53 0.748 0.848 0.913 -0.95 -0.76 
Saya menimum obat setiap hari. I take my medicines every day -1.83793 -1.44 27.441 53 0.999 0.508 0.781 -1.13 -0.81 
Pernah terjadi (setidaknya sekali), 
saya tidak memulai meminum obat 
yang sudah diresepkan oleh dokter 
(R).  
It has happened (at least 
once) that I did not start 
taking a medicine that was 
prescribed by my doctor. (R) 
0.315426 -1.94 48.049 53 0.667 0.89 0.908 -0.68 -0.81 
Saya kadang kadang meminum obat 
dengan jumlah lebih banyak dari yang 
diresepkan dokter (R).  
I sometimes take more 
medicines than prescribed by 
my doctor. (R) 
-2.81414 -2.47 62.82 53 0.167 1.163 1.036 0.46 0.23 
 








Table A8.2. ProMAS item fit information and Indonesian translation (follow up data) 













Pernah terjadi setidaknya sekali, 
saya lupa untuk meminum (satu 
dari) obat saya (R).  
 
It has happened at least once that 
I forgot to take (one of) my 
medicines (R). 
1.933766 2.03 40.807 56 0.937 0.716 0.905 -0.74 -0.51 
Kadang kadang saya meminum (satu 
dari) obat saya lebih lambat dari 
jadwal biasanya (R). 
 
It happens occasionally that I take 
(one of) my medicines at a later 
moment than usual (R) 
1.82257 1.93 56.577 56 0.453 0.993 1.122 0.09 0.77 
Saya tidak pernah (untuk 
sementara) berhenti meminum (satu 
dari) obat saya.  
I have never (temporarily) 
stopped taking (one of my) 
medicines 
0.521866 1.56 58.717 56 0.376 1.03 1.07 0.22 0.6 
Pernah terjadi setidaknya sekali, 
saya tidak meminum (satu dari) obat 
saya sehari penuh (R). 
 
It has happened at least once that 
I did not take (one of) my 
medicines for a day. (R) 
0.521866 1.23 37.425 56 0.973 0.657 0.745 -1.94 -2.23 
Saya yakin bahwa tahun lalu, saya 
telah meminum semua obat yang 
harus saya minum.  
I am positive that I have taken all 
the medication that I should have 
taken in the previous year. 
-0.37533 1.09 78.283 56 0.026 1.373 1.103 1.4 0.74 
Saya selalu meminum obat dalam 
waktu yang sama persis setiap 
harinya.  
I take my medicines exactly at the 
same time every day 
1.227274 0.86 47.218 56 0.792 0.828 0.937 -0.65 -0.43 
Saya tidak pernah mengubah aturan 
penggunaan obat atas keinginan 
sendiri. 
I have never change my medicine 
use myself 
0.521866 0.86 71.569 56 0.079 1.256 1.161 1.27 1.28 
Dalam sebulan terakhir, saya pernah 
lupa meminum obat saya setidaknya 
satu kali (R).  
 
In the past month, I forgot to take 
my medicine at least once. (R) 
 








Saya mengikuti aturan waktu 
meminum obat dengan tepat sesuai 
anjuran dari dokter.  
I faithfully follow my doctor’s 
prescription concerning the time 
I take my medicines 
-1.25896 0.29 57.197 56 0.43 1.003 1.188 0.15 0.95 
Saya kadang kadang meminum (satu 
dari) obat dalam waktu yang 
berbeda dengan yang diresepkan 
(misalnya bersamaan dengan waktu 
sarapan atau pada sore hari) (R).  
I sometimes take (one of) my 
medicines at a different time than 
prescribed (e.g., with breakfast or 
in the evening). (R) 
1.32033 -0.05 57.326 56 0.426 1.006 1.058 0.11 0.46 
Di waktu lalu, saya pernah berhenti 
sama sekali meminum (satu dari) 
obat saya (R).  
In the past, I once stopped taking 
(one of) my medicines 
completely. (R) 
0.174054 -0.35 35.952 56 0.983 0.631 0.729 -2.05 -2.3 
Ketika saya tidak berada di rumah, 
saya kadang kadang tidak meminum 
(satu dari) obat saya (R).  
When I am away from home, I 
occasionally do not take (one of) 
my medicines. (R) 
0.261704 -0.37 56.466 56 0.457 0.991 1.047 0.02 0.41 
Saya kadang kadang mengurangi 
jumlah obat yang saya minum dari 
yang diresepkan oleh dokter (R).  
I sometimes take less medicines 
than prescribed by my doctor. (R) 
-1.13109 -0.98 50.085 56 0.697 0.879 0.882 -0.2 -0.58 
Pernah terjadi (setidaknya sekali) 
saya mengubah dosis (satu dari) 
obat saya tanpa mendiskusikannya 
dengan dokter (R).  
It has happened (at least once) 
that I changed the dose of (one 
of) my medicines without 
discussing this with my doctor(R) 
-2.06589 -1.09 38.425 56 0.965 0.674 0.763 -0.35 -0.77 
Pernah terjadi (setidaknya) sekali, 
saya sangat terlambat mengambil 
atau menebus obat di apotek (R).  
It has happened (at least) once 
that I was too late with filling a 
prescription at the pharmacy. (R) 
-0.00375 -1.31 57.875 56 0.406 1.015 1.057 0.14 0.47 
Saya menimum obat setiap hari. I take my medicines every day -1.00987 -1.44 53.396 56 0.574 0.937 1.03 -0.06 0.23 
Pernah terjadi (setidaknya sekali), 
saya tidak memulai meminum obat 
yang sudah diresepkan oleh dokter 
(R).  
It has happened (at least once) 
that I did not start taking a 
medicine that was prescribed by 
my doctor. (R) 
-0.27983 -1.94 46.074 56 0.825 0.808 0.912 -0.77 -0.6 
Saya kadang kadang meminum obat 
dengan jumlah lebih banyak dari 
yang diresepkan dokter (R).  
I sometimes take more medicines 
than prescribed by my doctor. (R) 

























Appendix 9 – Results of HbA1c measurement of participants in the 
intervention study at baseline and follow-up 
Table A9.1 Results of HbA1c measurement of participants in control and 


















1 9 8.4 32 6.4 5.6 
2 6.2 6.3 33 5.7 5.3 
3 6.4 6.7 34 8.4 7.8 
4 11.9 11.5 35 8.2 6.6 
5 6.8 6.8 36 5.8 5.5 
6 14.3 9.0 37** 8.3  
7 7 7.0 38** 13.0  
8 11.9 10.5 39 8.2 6.2 
9*   40 11.4 9.1 
10 6.1 5.9 41 6.9 6.3 
11 6.3 6.4 42 7.9 10.1 
12** 13.8  43 8.7 8.5 
13 6.1 5.9 44 6.2 6.2 
14 5.3 4.9 45 8.8 7.5 
15 9.4 8 46 10.7 12.0 
16 9.2 9.1 47 8.2 9.2 
17 7.3 6.6 48 9.2 8.8 
18 10.3 8.5 49 7.4 7.1 
19 7 7.1 50 10.4 9.5 
20 8.2 8.8 51 7.5 6.5 
21 6.9 6.6 52 7.1 9.0 
22 6.0 6.4 53 11.1 9.5 
23 9.0 8.9 54 7.2 7.1 
24 7.2 7.0 55 7.1 6.6 
25 10.6 9.1 56 8.1 8.4 
26 6.6 5.7 57 7.8 7.5 
27 6.8 7.2 58 8.9 7.9 
28 13.1 16.1 59 11.2 8.5 
29 5.4 5.1 60 6.0 6.1 
30 10.4 10.0 61** 12.2  
31 6 5.3 62 6.4 6.6 
 63 6.5 6.3 
64 8.3 7.9 
65 7.6 7 
66*, **   
67 6.2 6 
 
Notes: 
* Have a haemoglobin variant interfere with HbA1c measurement 
** Lost at follow up 
 
 
